{
 "documentInfo": {
  "documentType": "https://xbrl.org/2021/xbrl-json",
  "features": {
   "xbrl:canonicalValues": true
  },
  "namespaces": {
   "ifrs-full": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
   "iso4217": "http://www.xbrl.org/2003/iso4217",
   "sartoriusstedimbio": "http://sartorius.com/xbrl/2025",
   "scheme": "http://standards.iso.org/iso/17442",
   "xbrl": "https://xbrl.org/2021",
   "xbrli": "http://www.xbrl.org/2003/instance"
  },
  "taxonomy": [
   "http://sartorius.com/xbrl/2025/sartoriusstedimbio-2025-12-31.xsd"
  ]
 },
 "facts": {
  "fact-133": {
   "value": "2967500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:RevenueFromContractsWithCustomers",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-134": {
   "value": "2780000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:RevenueFromContractsWithCustomers",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-135": {
   "value": "1622200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CostOfSales",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-136": {
   "value": "1573300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CostOfSales",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-137": {
   "value": "1345300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:GrossProfit",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-138": {
   "value": "1206700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:GrossProfit",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-139": {
   "value": "479000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DistributionCosts",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-140": {
   "value": "479800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DistributionCosts",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-141": {
   "value": "133100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ResearchAndDevelopmentExpense",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-142": {
   "value": "144100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ResearchAndDevelopmentExpense",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-143": {
   "value": "182300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdministrativeExpense",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-144": {
   "value": "168700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdministrativeExpense",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-145": {
   "value": "56600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-146": {
   "value": "37000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-147": {
   "value": "81800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherExpenseByFunction",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-148": {
   "value": "80600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherExpenseByFunction",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-149": {
   "value": "525700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossFromOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-150": {
   "value": "370600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossFromOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-151": {
   "value": "40200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-152": {
   "value": "45400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-153": {
   "value": "192700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceCosts",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-154": {
   "value": "196700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceCosts",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-155": {
   "value": "-152500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncomeCost",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-156": {
   "value": "-151300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncomeCost",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-157": {
   "value": "373200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-158": {
   "value": "219200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-159": {
   "value": "107300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-160": {
   "value": "40700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-161": {
   "value": "266000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-162": {
   "value": "178500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-163": {
   "value": "265600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-164": {
   "value": "175100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-165": {
   "value": "300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-166": {
   "value": "3400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-167": {
   "value": "2.73",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:BasicEarningsLossPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-168": {
   "value": "1.81",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:BasicEarningsLossPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-169": {
   "value": "2.73",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:DilutedEarningsLossPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-170": {
   "value": "1.81",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:DilutedEarningsLossPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-171": {
   "value": "266000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-172": {
   "value": "178500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-173": {
   "value": "32400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-174": {
   "value": "-17200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-175": {
   "value": "44200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-176": {
   "value": "-13800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-177": {
   "value": "11800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-178": {
   "value": "3400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-179": {
   "value": "9700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-180": {
   "value": "-5200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-181": {
   "value": "-127600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-182": {
   "value": "63300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-183": {
   "value": "-105000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-184": {
   "value": "51300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-185": {
   "value": "1500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-186": {
   "value": "-2900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-187": {
   "value": "700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-188": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-189": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-190": {
   "value": "-2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-191": {
   "value": "-104100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-192": {
   "value": "48900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-193": {
   "value": "161800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-194": {
   "value": "227400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-195": {
   "value": "162500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-196": {
   "value": "224800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-197": {
   "value": "-700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-198": {
   "value": "2700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-199": {
   "value": "2883800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Goodwill",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-200": {
   "value": "2907900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Goodwill",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-201": {
   "value": "1536700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-202": {
   "value": "1631700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-203": {
   "value": "2024600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-204": {
   "value": "1885200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-205": {
   "value": "19000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:FinancialAssetsNonCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-206": {
   "value": "24000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:FinancialAssetsNonCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-207": {
   "value": "3600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherNoncurrentNonfinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-208": {
   "value": "3300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherNoncurrentNonfinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-209": {
   "value": "75200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-210": {
   "value": "63200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-211": {
   "value": "6542800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-212": {
   "value": "6515400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-213": {
   "value": "690900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Inventories",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-214": {
   "value": "684900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Inventories",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-215": {
   "value": "192800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:TradeReceivablesAndContractAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-216": {
   "value": "265900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:TradeReceivablesAndContractAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-217": {
   "value": "23600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentFinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-218": {
   "value": "11700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentFinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-219": {
   "value": "31500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentTaxAssetsCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-220": {
   "value": "33800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentTaxAssetsCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-221": {
   "value": "76300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentNonfinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-222": {
   "value": "65800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentNonfinancialAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-223": {
   "value": "426100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-224": {
   "value": "678900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-225": {
   "value": "1441200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-226": {
   "value": "1741000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentAssets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-227": {
   "value": "7984000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Assets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-228": {
   "value": "8256400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Assets",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-229": {
   "value": "4090500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EquityAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-230": {
   "value": "3986600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EquityAttributableToOwnersOfParent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-231": {
   "value": "19500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssuedCapital",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-232": {
   "value": "19500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssuedCapital",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-233": {
   "value": "1424100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CapitalReserve",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-234": {
   "value": "1424100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CapitalReserve",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-235": {
   "value": "2647000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:OtherReservesAndRetainedEarnings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-236": {
   "value": "2543100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:OtherReservesAndRetainedEarnings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-237": {
   "value": "35600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-238": {
   "value": "37200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncontrollingInterests",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-239": {
   "value": "4126200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-240": {
   "value": "4023800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-241": {
   "value": "32600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-242": {
   "value": "33600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-243": {
   "value": "16800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherLongtermProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-244": {
   "value": "15100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherLongtermProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-245": {
   "value": "1867300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:LongtermBorrowings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-246": {
   "value": "2684400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:LongtermBorrowings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-247": {
   "value": "151200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-248": {
   "value": "120600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-249": {
   "value": "2200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherNoncurrentFinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-250": {
   "value": "81900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherNoncurrentFinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-251": {
   "value": "375600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-252": {
   "value": "358200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-253": {
   "value": "2445800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-254": {
   "value": "3293800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-255": {
   "value": "16300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherShorttermProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-256": {
   "value": "17400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherShorttermProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-257": {
   "value": "277800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-258": {
   "value": "310000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-259": {
   "value": "167600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentContractLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-260": {
   "value": "216100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentContractLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-261": {
   "value": "557300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-262": {
   "value": "39500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-263": {
   "value": "23400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-264": {
   "value": "25000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-265": {
   "value": "141700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentFinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-266": {
   "value": "71900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentFinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-267": {
   "value": "99100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-268": {
   "value": "88200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-269": {
   "value": "82000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentTaxLiabilitiesCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-270": {
   "value": "123200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentTaxLiabilitiesCurrent",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-271": {
   "value": "47000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentNonfinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-272": {
   "value": "47600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentNonfinancialLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-273": {
   "value": "1412100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-274": {
   "value": "938800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CurrentLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-275": {
   "value": "7984000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EquityAndLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-276": {
   "value": "8256400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EquityAndLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-277": {
   "value": "373200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-278": {
   "value": "219200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-279": {
   "value": "-152500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForFinanceIncomeCost",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-280": {
   "value": "-151300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForFinanceIncomeCost",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-281": {
   "value": "318100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-282": {
   "value": "301700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-283": {
   "value": "-500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-284": {
   "value": "2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForProvisions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-285": {
   "value": "42900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-286": {
   "value": "38300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-287": {
   "value": "-46400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-288": {
   "value": "207600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-289": {
   "value": "-21400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-290": {
   "value": "2800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-291": {
   "value": "17500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:InterestReceivedClassifiedAsOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-292": {
   "value": "22900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:InterestReceivedClassifiedAsOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-293": {
   "value": "149100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-294": {
   "value": "133500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-295": {
   "value": "5500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherAdjustmentsForNoncashItems",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-296": {
   "value": "2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherAdjustmentsForNoncashItems",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-297": {
   "value": "692200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-298": {
   "value": "815100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-299": {
   "value": "393200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:CapitalExpenditures",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-300": {
   "value": "339800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:CapitalExpenditures",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-301": {
   "value": "4400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-302": {
   "value": "100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-303": {
   "value": "-397700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-304": {
   "value": "-340000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-305": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromIssuingShares",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-306": {
   "value": "1193600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromIssuingShares",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-307": {
   "value": "153600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-308": {
   "value": "176900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-309": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-310": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-311": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-312": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-313": {
   "value": "334800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:RepaymentOfBorrowingsAndLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-314": {
   "value": "879200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:RepaymentOfBorrowingsAndLeaseLiabilities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-315": {
   "value": "13300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-316": {
   "value": "17300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-317": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchaseSaleOfOwnShares",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-318": {
   "value": "-1900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchaseSaleOfOwnShares",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-319": {
   "value": "-542800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-320": {
   "value": "84900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-321": {
   "value": "-248300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-322": {
   "value": "560000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-323": {
   "value": "678900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-324": {
   "value": "116600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-325": {
   "value": "-4500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-326": {
   "value": "2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-327": {
   "value": "426100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-328": {
   "value": "678900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-329": {
   "value": "18400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-330": {
   "value": "231500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-331": {
   "value": "10400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-332": {
   "value": "-6800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-333": {
   "value": "2391100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-334": {
   "value": "-6200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-335": {
   "value": "2638500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-336": {
   "value": "35300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-337": {
   "value": "2673800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-338": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-339": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-340": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-341": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-342": {
   "value": "175100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-343": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-344": {
   "value": "175100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-345": {
   "value": "3400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-346": {
   "value": "178500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-347": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-348": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-349": {
   "value": "-17200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-350": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-351": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-352": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-353": {
   "value": "-17200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-354": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-355": {
   "value": "-17200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-356": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-357": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-358": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-359": {
   "value": "-2900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-360": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-361": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-362": {
   "value": "-2900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-363": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-364": {
   "value": "-2900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-365": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-366": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-367": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-368": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-369": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-370": {
   "value": "64000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-371": {
   "value": "64000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-372": {
   "value": "-700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-373": {
   "value": "63300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-374": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-375": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-376": {
   "value": "-5200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-377": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-378": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-379": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-380": {
   "value": "-5700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-381": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-382": {
   "value": "-5700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-383": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-384": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-385": {
   "value": "-12000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-386": {
   "value": "-2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-387": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-388": {
   "value": "64000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-389": {
   "value": "49700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-390": {
   "value": "-700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-391": {
   "value": "48900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-392": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-393": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-394": {
   "value": "-12000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-395": {
   "value": "-2300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-396": {
   "value": "175100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-397": {
   "value": "64000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-398": {
   "value": "224800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-399": {
   "value": "2700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-400": {
   "value": "227400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-401": {
   "value": "1000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-402": {
   "value": "1192500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-403": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-404": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-405": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-406": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-407": {
   "value": "1193600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-408": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-409": {
   "value": "1193600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-410": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-411": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-412": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-413": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-414": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-415": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-416": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-417": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-418": {
   "value": "68000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-419": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-420": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-421": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-422": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-423": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-424": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-425": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-426": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-427": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-428": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-429": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-430": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-431": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-432": {
   "value": "-1900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-433": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-434": {
   "value": "-1900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-435": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-436": {
   "value": "-1900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-437": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-438": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-439": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-440": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-441": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-442": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-443": {
   "value": "-600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-444": {
   "value": "100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-445": {
   "value": "-500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2024-01-01T00:00:00/2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-446": {
   "value": "19500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-447": {
   "value": "1424100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-448": {
   "value": "-1600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-449": {
   "value": "-9100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-450": {
   "value": "2496000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-451": {
   "value": "57800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-452": {
   "value": "3986600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-453": {
   "value": "37200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-454": {
   "value": "4023800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-455": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-456": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-457": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-458": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-459": {
   "value": "265600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-460": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-461": {
   "value": "265600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-462": {
   "value": "300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-463": {
   "value": "266000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-464": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-465": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-466": {
   "value": "32400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-467": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-468": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-469": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-470": {
   "value": "32400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-471": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-472": {
   "value": "32400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-473": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-474": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-475": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-476": {
   "value": "1500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-477": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-478": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-479": {
   "value": "1500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-480": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-481": {
   "value": "1500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-482": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-483": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-484": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-485": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-486": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-487": {
   "value": "-126600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-488": {
   "value": "-126600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-489": {
   "value": "-1000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-490": {
   "value": "-127600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-491": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-492": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-493": {
   "value": "9700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-494": {
   "value": "700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-495": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-496": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-497": {
   "value": "10400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-498": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-499": {
   "value": "10400000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-500": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-501": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-502": {
   "value": "22600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-503": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-504": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-505": {
   "value": "-126600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-506": {
   "value": "-103100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-507": {
   "value": "-1000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-508": {
   "value": "-104100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-509": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-510": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-511": {
   "value": "22600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-512": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-513": {
   "value": "265600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-514": {
   "value": "-126600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-515": {
   "value": "162500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-516": {
   "value": "-700000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-517": {
   "value": "161800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-518": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-519": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-520": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-521": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-522": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-523": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-524": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-525": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-526": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-527": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-528": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-529": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-530": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-531": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-532": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-533": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-534": {
   "value": "900000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-535": {
   "value": "68000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsPaid",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-536": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-537": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-538": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-539": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-540": {
   "value": "8200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-541": {
   "value": null,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-542": {
   "value": "8200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-543": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-544": {
   "value": "8200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "sartoriusstedimbio:PurchasePriceLiabilityCellgenix",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-545": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-546": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-547": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-548": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-549": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-550": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-551": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-552": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-553": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-554": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-555": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-556": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-557": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-558": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-559": {
   "value": null,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-560": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-561": {
   "value": "0.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-562": {
   "value": "200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-563": {
   "value": "19500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-564": {
   "value": "1424100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:CapitalReserveMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-565": {
   "value": "21100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfCashFlowHedgesMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-566": {
   "value": "-8300000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-567": {
   "value": "2703000000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-568": {
   "value": "-68800000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-569": {
   "value": "4090500000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:EquityAttributableToOwnersOfParentMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-570": {
   "value": "35600000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:NoncontrollingInterestsMember",
    "unit": "iso4217:EUR"
   }
  },
  "fact-571": {
   "value": "4126200000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-1": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-8-level-0\" dir=\"ltr\"><sub>1. </sub></span><div class=\"list-paragraph-container_1\"><sub>Informations g\u00e9n\u00e9rales</sub></div></div><div class=\"defaultParagraph_1 Standard\">Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est un partenaire international de premier plan de l\u2019industrie biopharmaceutique. </span>En tant que fournisseur de solutions innovantes, le Groupe aide ses clients \u00e0 fabriquer des m\u00e9dicaments biotechnologiques, tels que les th\u00e9rapies cellulaires et g\u00e9niques, de mani\u00e8re plus s\u00fbre, plus rapide et plus durable. <span dir=\"ltr\" style=\"background-color:#FFFFFF\">Pr\u00e9sent dans le monde entier, le Groupe poss\u00e8de des sites de fabrication, de R&amp;D et de vente en Europe, en Am\u00e9rique du Nord et en Asie. </span></div><div class=\"defaultParagraph_1 Standard\">Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">(LEI\u00a0: </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">52990006IVXY7GCSSR39</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">) </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">est cot\u00e9e sur Euronext Paris (code ISIN\u00a0: FR0013154002) et a son si\u00e8ge social </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">est</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Z.I. Les Paluds - Avenue de Jouques - CS</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Aubagne, </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">France</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La soci\u00e9t\u00e9 m\u00e8re de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">, dont le si\u00e8ge est bas\u00e9 \u00e0 G\u00f6ttingen, en Allemagne. </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG est cot\u00e9e sur plusieurs places boursi\u00e8res allemandes (codes ISIN\u00a0: DE0007165607 pour les actions ordinaires et DE0007165631 pour les actions pr\u00e9f\u00e9rentielles).</span></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Conform\u00e9ment au r\u00e8glement europ\u00e9en 1606/2002 du 19\u00a0juillet\u00a02002 qui impose aux soci\u00e9t\u00e9s cot\u00e9es d\u2019appliquer les normes comptables internationales, les \u00e9tats financiers consolid\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> pour l'exercice clos le 31\u00a0d\u00e9cembre\u00a0</span><span class=\"hyperlink-no-style_1\"></span>2025<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> ont \u00e9t\u00e9 \u00e9tablis en conformit\u00e9 avec les normes comptables IFRS et les normes et interpr\u00e9tations IFRIC de l\u2019IASB telles qu'elles ont \u00e9t\u00e9 adopt\u00e9es par l'Union europ\u00e9enne. Ces normes sont consultables sur le site\u00a0:</span></div><div class=\"defaultParagraph_1 Standard\">https://finance.ec.europa.eu//capital-markets-union-and-financial-markets/company-reporting-and-auditing/company-reporting_fr</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s sont libell\u00e9s en euros. Sauf mention contraire, tous les montants sont exprim\u00e9s en millions d'euros (abr\u00e9viation\u00a0: \u00ab\u00a0en millions\u00a0\u20ac \u00bb). Dans certains cas, les totaux et pourcentages indiqu\u00e9s peuvent pr\u00e9senter des \u00e9carts minimes en raison des arrondis.</div><div class=\"defaultParagraph_1 Standard\">Ces \u00e9tats financiers consolid\u00e9s ont \u00e9t\u00e9 approuv\u00e9s par le Conseil d'administration, le 4\u00a0f\u00e9vrier\u00a02026, et seront soumis \u00e0 l'approbation de l'Assembl\u00e9e g\u00e9n\u00e9rale des actionnaires, le 24\u00a0mars\u00a02026.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-2": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est un partenaire international de premier plan de l\u2019industrie biopharmaceutique. </span>En tant que fournisseur de solutions innovantes, le Groupe aide ses clients \u00e0 fabriquer des m\u00e9dicaments biotechnologiques, tels que les th\u00e9rapies cellulaires et g\u00e9niques, de mani\u00e8re plus s\u00fbre, plus rapide et plus durable. <span dir=\"ltr\" style=\"background-color:#FFFFFF\">Pr\u00e9sent dans le monde entier, le Groupe poss\u00e8de des sites de fabrication, de R&amp;D et de vente en Europe, en Am\u00e9rique du Nord et en Asie. </span></div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-3": {
   "value": "Sartorius Stedim Biotech\u00a0S.A.",
   "dimensions": {
    "concept": "ifrs-full:NameOfReportingEntityOrOtherMeansOfIdentification",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-7": {
   "value": "Z.I. Les Paluds - Avenue de Jouques - CS Aubagne, France.",
   "dimensions": {
    "concept": "ifrs-full:AddressOfRegisteredOfficeOfEntity",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-6": {
   "value": "Z.I. Les Paluds - Avenue de Jouques - CS Aubagne, France",
   "dimensions": {
    "concept": "ifrs-full:PrincipalPlaceOfBusiness",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-5": {
   "value": "France",
   "dimensions": {
    "concept": "ifrs-full:CountryOfIncorporation",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-4": {
   "value": "France",
   "dimensions": {
    "concept": "ifrs-full:DomicileOfEntity",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-8": {
   "value": "S.A.",
   "dimensions": {
    "concept": "ifrs-full:LegalFormOfEntity",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-9": {
   "value": "Sartorius\u00a0AG",
   "dimensions": {
    "concept": "ifrs-full:NameOfParentEntity",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-10": {
   "value": "<div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Conform\u00e9ment au r\u00e8glement europ\u00e9en 1606/2002 du 19\u00a0juillet\u00a02002 qui impose aux soci\u00e9t\u00e9s cot\u00e9es d\u2019appliquer les normes comptables internationales, les \u00e9tats financiers consolid\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> pour l'exercice clos le 31\u00a0d\u00e9cembre\u00a0</span><span class=\"hyperlink-no-style_1\"></span>2025<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> ont \u00e9t\u00e9 \u00e9tablis en conformit\u00e9 avec les normes comptables IFRS et les normes et interpr\u00e9tations IFRIC de l\u2019IASB telles qu'elles ont \u00e9t\u00e9 adopt\u00e9es par l'Union europ\u00e9enne. Ces normes sont consultables sur le site\u00a0:</span></div><div class=\"defaultParagraph_1 Standard\">https://finance.ec.europa.eu//capital-markets-union-and-financial-markets/company-reporting-and-auditing/company-reporting_fr</div>",
   "dimensions": {
    "concept": "ifrs-full:StatementOfIFRSCompliance",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-11": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Ces \u00e9tats financiers consolid\u00e9s ont \u00e9t\u00e9 approuv\u00e9s par le Conseil d'administration, le 4\u00a0f\u00e9vrier\u00a02026, et seront soumis \u00e0 l'approbation de l'Assembl\u00e9e g\u00e9n\u00e9rale des actionnaires, le 24\u00a0mars\u00a02026.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-12": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\">2. </span><div class=\"list-paragraph-container_1\">Impact des nouvelles normes</div></div><div class=\"defaultParagraph_1 Standard\">Les nouvelles r\u00e8gles comptables suivantes ont \u00e9t\u00e9 appliqu\u00e9es pour la premi\u00e8re fois aux pr\u00e9sents \u00e9tats financiers consolid\u00e9s du Groupe, sans avoir d\u2019impact significatif sur ces \u00e9tats\u00a0:</div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Modification de la norme IAS 21 \u2013 Absence de convertibilit\u00e9\u00a0:</div></div><div class=\"defaultParagraph_1 Standard\">Les modifications pr\u00e9cisent les conditions selon lesquelles une monnaie est consid\u00e9r\u00e9e comme convertible en une autre monnaie, ainsi que les cas o\u00f9 elle ne l\u2019est pas. Elles d\u00e9finissent \u00e9galement la m\u00e9thode de d\u00e9termination du taux de change applicable lorsqu\u2019une monnaie est identifi\u00e9e comme non convertible. Ces modifications introduisent enfin, des obligations d\u2019information sp\u00e9cifiques dans les cas o\u00f9 une monnaie est jug\u00e9e non convertible.</div><div class=\"defaultParagraph_1 Standard\">L\u2019application de ces nouvelles r\u00e8gles n\u2019a pas eu d\u2019impact significatif sur les \u00e9tats financiers consolid\u00e9s.</div><div class=\"defaultParagraph_1 berschrift4\">Nouvelles normes et modifications non encore appliqu\u00e9es</div><div class=\"defaultParagraph_1 Standard\">Les normes, interpr\u00e9tations et modifications suivantes ne sont pas encore appliqu\u00e9es aux \u00e9tats financiers consolid\u00e9s de l'exercice, soit parce qu\u2019elles n'ont encore \u00e9t\u00e9 adopt\u00e9es par l'Union europ\u00e9enne, soit parce que leur application n'\u00e9tait pas obligatoire pour l\u2019exercice <span class=\"hyperlink-no-style_1\"></span>2025\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d38052d\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>Normes<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Interpr\u00e9tations</div></td><td class=\"c25063\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Titre</div></td><td class=\"d62aceb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-right:0px\">Applicable <br/>aux exercices <br/>ouverts au<sup>1</sup></div></td><td class=\"d62aceb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">Adoption par <br/>la Commission <br/>europ\u00e9enne</div></td></tr><tr><td class=\"ca1d7f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 9 et IFRS 7</div></td><td class=\"d52429\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Contrats faisant r\u00e9f\u00e9rence \u00e0 l\u2019\u00e9lectricit\u00e9 d\u00e9pendante de la nature</div></td><td class=\"c9474b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"c9474b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 1, IFRS 7, IFRS 9, IFRS 10 et IAS 7</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Am\u00e9liorations annuelles des normes IFRS de comptabilit\u00e9 - Volume 11 (publi\u00e9 le 18 juillet 2024)</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 9 et IFRS 7</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Modifications touchant le classement et l\u2019\u00e9valuation des instruments financiers</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">IFRS 18</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">\u00c9tats financiers : Pr\u00e9sentation et informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">IFRS 19</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Filiales n\u2019ayant pas d\u2019obligation d\u2019information du public : Informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Amendements \u00e0 IFRS 19</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"text-align:left\">Filiales n\u2019ayant pas d\u2019obligation d\u2019information du public : Informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Amendements \u00e0 IAS 21</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"text-align:left\">Conversion dans une monnaie de pr\u00e9sentation qui est celle d'une \u00e9conomie hyperinflationniste</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Non</div></td></tr><tr><td class=\"d707ca2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d74a845\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d40df2d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d40df2d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 TNote_1\">1<sup> </sup>Les normes doivent \u00eatre appliqu\u00e9es une fois qu'elles ont \u00e9t\u00e9 approuv\u00e9es par la Commission europ\u00e9enne. Les dates mentionn\u00e9es ci-dessus sont les dates requises par la norme elle-m\u00eame (dates d'entr\u00e9e en vigueur de l'IASB).</div><div class=\"defaultParagraph_1 Standard\">\u00c0 l\u2019exception de la norme IFRS 18, le Groupe n\u2019anticipe pas que ces changements auront un impact significatif sur ses \u00e9tats financiers consolid\u00e9s.</div><div class=\"defaultParagraph_1 berschrift4\">IFRS 18, Pr\u00e9sentation et informations \u00e0 fournir dans les \u00e9tats financiers</div><div class=\"defaultParagraph_1 Standard\">La norme IFRS 18 (Pr\u00e9sentation et informations \u00e0 fournir dans les \u00e9tats financiers) a \u00e9t\u00e9 publi\u00e9e en avril 2024. La norme contient des exigences modifi\u00e9es relatives \u00e0 la pr\u00e9sentation et \u00e0 la divulgation d'informations dans les \u00e9tats financiers \u00e9tablis selon les IFRS et vise \u00e0 am\u00e9liorer la comparabilit\u00e9 et la transparence. En particulier, la structure du compte de r\u00e9sultat est impact\u00e9e, n\u00e9cessitant d\u00e9sormais de ranger les produits et les charges en trois cat\u00e9gories\u00a0: exploitation, investissement et financement. La classification des produits et des charges d\u00e9pend de l\u2019activit\u00e9 principale de l\u2019entreprise. De plus, la norme IFRS 18 impose la divulgation obligatoire des sous-totaux \u00ab r\u00e9sultat op\u00e9rationnel \u00bb et \u00ab r\u00e9sultat avant financement et imp\u00f4ts \u00bb. La norme IFRS 18 exige d\u00e9sormais la publication obligatoire de certaines mesures de performance d\u00e9finies par la direction (<span dir=\"ltr\" style=\"font-style:italic\">Management-defined Performance Management</span>, MPM) et fournit des orientations am\u00e9lior\u00e9es sur l\u2019agr\u00e9gation et la d\u00e9sagr\u00e9gation des informations dans les \u00e9tats financiers. Dans le tableau des flux de tr\u00e9sorerie, les choix de classification pour les int\u00e9r\u00eats et les dividendes ne s\u2019appliqueront plus et le \u00ab r\u00e9sultat op\u00e9rationnel \u00bb deviendra le point de d\u00e9part obligatoire pour la d\u00e9termination des flux de tr\u00e9sorerie op\u00e9rationnelle. L\u2019application de la norme IFRS 18 sera obligatoire pour les exercices ouverts \u00e0 compter du 1<sup>er</sup> janvier 2027. Lors de la premi\u00e8re application, la p\u00e9riode comparative devra \u00e9galement \u00eatre pr\u00e9sent\u00e9e conform\u00e9ment aux nouvelles r\u00e8gles. La norme IFRS 18 s\u2019applique \u00e0 toutes les entit\u00e9s qui \u00e9tablissent leurs \u00e9tats financiers selon les normes IFRS.</div><div class=\"defaultParagraph_1 Standard\">En 2024, le Groupe a entam\u00e9 l\u2019analyse des exigences futures et de leur impact sur les \u00e9tats financiers consolid\u00e9s. Il est convenu que les r\u00e8gles relatives \u00e0 la structure du compte de r\u00e9sultat pour les entreprises dont l\u2019activit\u00e9 principale n\u2019est pas sp\u00e9cifi\u00e9e s\u2019appliqueront au Groupe (en tant que \u00ab soci\u00e9t\u00e9 manufacturi\u00e8re \u00bb). \u00c0 l\u2019avenir, la pr\u00e9sentation du compte de r\u00e9sultat changera, n\u00e9cessitant une reclassification des produits et des charges. Cela concernera notamment les \u00e9l\u00e9ments actuellement inclus dans le \u00ab r\u00e9sultat financier \u00bb, qui devront probablement \u00eatre reclass\u00e9s dans deux cat\u00e9gories : Exploitation (par exemple, produits et charges li\u00e9s aux d\u00e9riv\u00e9s de couverture des risques de change portant sur l\u2019activit\u00e9 du Groupe) et Investissement (par exemple, revenus d\u2019int\u00e9r\u00eats, r\u00e9sultats des investissements en actions).</div><div class=\"defaultParagraph_1 Standard\">En raison de nouvelles directives sur l\u2019agr\u00e9gation et la d\u00e9sagr\u00e9gation, d\u2019autres d\u00e9clarations, notamment les notes annexes pourraient \u00e9galement \u00eatre affect\u00e9es. De plus, le point de d\u00e9part du tableau des flux de tr\u00e9sorerie et l'affectation des int\u00e9r\u00eats per\u00e7us changeront, les int\u00e9r\u00eats per\u00e7us devant d\u00e9sormais \u00eatre pr\u00e9sent\u00e9s dans la section \u00ab activit\u00e9s d\u2019investissement \u00bb du tableau des flux de tr\u00e9sorerie. L\u2019indicateur de performance actuel du Groupe, appel\u00e9 \u00ab EBITDA courant \u00bb (une mesure non d\u00e9finie par les normes IFRS) pourrait \u00eatre affect\u00e9 par les nouvelles exigences en mati\u00e8re d\u2019information sur les indicateurs de performance sp\u00e9cifique \u00e0 l\u2019entreprise. Enfin, la norme IFRS 18 ne devrait pas avoir d\u2019incidence directe sur la comptabilisation et l\u2019\u00e9valuation des \u00e9l\u00e9ments financiers.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-13": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\">2. </span><div class=\"list-paragraph-container_1\">Impact des nouvelles normes</div></div><div class=\"defaultParagraph_1 Standard\">Les nouvelles r\u00e8gles comptables suivantes ont \u00e9t\u00e9 appliqu\u00e9es pour la premi\u00e8re fois aux pr\u00e9sents \u00e9tats financiers consolid\u00e9s du Groupe, sans avoir d\u2019impact significatif sur ces \u00e9tats\u00a0:</div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Modification de la norme IAS 21 \u2013 Absence de convertibilit\u00e9\u00a0:</div></div><div class=\"defaultParagraph_1 Standard\">Les modifications pr\u00e9cisent les conditions selon lesquelles une monnaie est consid\u00e9r\u00e9e comme convertible en une autre monnaie, ainsi que les cas o\u00f9 elle ne l\u2019est pas. Elles d\u00e9finissent \u00e9galement la m\u00e9thode de d\u00e9termination du taux de change applicable lorsqu\u2019une monnaie est identifi\u00e9e comme non convertible. Ces modifications introduisent enfin, des obligations d\u2019information sp\u00e9cifiques dans les cas o\u00f9 une monnaie est jug\u00e9e non convertible.</div><div class=\"defaultParagraph_1 Standard\">L\u2019application de ces nouvelles r\u00e8gles n\u2019a pas eu d\u2019impact significatif sur les \u00e9tats financiers consolid\u00e9s.</div><div class=\"defaultParagraph_1 berschrift4\">Nouvelles normes et modifications non encore appliqu\u00e9es</div><div class=\"defaultParagraph_1 Standard\">Les normes, interpr\u00e9tations et modifications suivantes ne sont pas encore appliqu\u00e9es aux \u00e9tats financiers consolid\u00e9s de l'exercice, soit parce qu\u2019elles n'ont encore \u00e9t\u00e9 adopt\u00e9es par l'Union europ\u00e9enne, soit parce que leur application n'\u00e9tait pas obligatoire pour l\u2019exercice <span class=\"hyperlink-no-style_1\"></span>2025\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d38052d\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>Normes<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Interpr\u00e9tations</div></td><td class=\"c25063\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Titre</div></td><td class=\"d62aceb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-right:0px\">Applicable <br/>aux exercices <br/>ouverts au<sup>1</sup></div></td><td class=\"d62aceb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">Adoption par <br/>la Commission <br/>europ\u00e9enne</div></td></tr><tr><td class=\"ca1d7f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 9 et IFRS 7</div></td><td class=\"d52429\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Contrats faisant r\u00e9f\u00e9rence \u00e0 l\u2019\u00e9lectricit\u00e9 d\u00e9pendante de la nature</div></td><td class=\"c9474b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"c9474b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 1, IFRS 7, IFRS 9, IFRS 10 et IAS 7</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Am\u00e9liorations annuelles des normes IFRS de comptabilit\u00e9 - Volume 11 (publi\u00e9 le 18 juillet 2024)</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Amendements \u00e0 IFRS 9 et IFRS 7</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Modifications touchant le classement et l\u2019\u00e9valuation des instruments financiers</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2026</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Oui</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">IFRS 18</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">\u00c9tats financiers : Pr\u00e9sentation et informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">IFRS 19</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; text-align:left\">Filiales n\u2019ayant pas d\u2019obligation d\u2019information du public : Informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Amendements \u00e0 IFRS 19</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"text-align:left\">Filiales n\u2019ayant pas d\u2019obligation d\u2019information du public : Informations \u00e0 fournir</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Non</div></td></tr><tr><td class=\"d29d933\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Amendements \u00e0 IAS 21</div></td><td class=\"ae201f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"text-align:left\">Conversion dans une monnaie de pr\u00e9sentation qui est celle d'une \u00e9conomie hyperinflationniste</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1<sup>er</sup> janvier 2027</div></td><td class=\"f4d7a6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Non</div></td></tr><tr><td class=\"d707ca2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d74a845\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d40df2d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d40df2d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 TNote_1\">1<sup> </sup>Les normes doivent \u00eatre appliqu\u00e9es une fois qu'elles ont \u00e9t\u00e9 approuv\u00e9es par la Commission europ\u00e9enne. Les dates mentionn\u00e9es ci-dessus sont les dates requises par la norme elle-m\u00eame (dates d'entr\u00e9e en vigueur de l'IASB).</div><div class=\"defaultParagraph_1 Standard\">\u00c0 l\u2019exception de la norme IFRS 18, le Groupe n\u2019anticipe pas que ces changements auront un impact significatif sur ses \u00e9tats financiers consolid\u00e9s.</div><div class=\"defaultParagraph_1 berschrift4\">IFRS 18, Pr\u00e9sentation et informations \u00e0 fournir dans les \u00e9tats financiers</div><div class=\"defaultParagraph_1 Standard\">La norme IFRS 18 (Pr\u00e9sentation et informations \u00e0 fournir dans les \u00e9tats financiers) a \u00e9t\u00e9 publi\u00e9e en avril 2024. La norme contient des exigences modifi\u00e9es relatives \u00e0 la pr\u00e9sentation et \u00e0 la divulgation d'informations dans les \u00e9tats financiers \u00e9tablis selon les IFRS et vise \u00e0 am\u00e9liorer la comparabilit\u00e9 et la transparence. En particulier, la structure du compte de r\u00e9sultat est impact\u00e9e, n\u00e9cessitant d\u00e9sormais de ranger les produits et les charges en trois cat\u00e9gories\u00a0: exploitation, investissement et financement. La classification des produits et des charges d\u00e9pend de l\u2019activit\u00e9 principale de l\u2019entreprise. De plus, la norme IFRS 18 impose la divulgation obligatoire des sous-totaux \u00ab r\u00e9sultat op\u00e9rationnel \u00bb et \u00ab r\u00e9sultat avant financement et imp\u00f4ts \u00bb. La norme IFRS 18 exige d\u00e9sormais la publication obligatoire de certaines mesures de performance d\u00e9finies par la direction (<span dir=\"ltr\" style=\"font-style:italic\">Management-defined Performance Management</span>, MPM) et fournit des orientations am\u00e9lior\u00e9es sur l\u2019agr\u00e9gation et la d\u00e9sagr\u00e9gation des informations dans les \u00e9tats financiers. Dans le tableau des flux de tr\u00e9sorerie, les choix de classification pour les int\u00e9r\u00eats et les dividendes ne s\u2019appliqueront plus et le \u00ab r\u00e9sultat op\u00e9rationnel \u00bb deviendra le point de d\u00e9part obligatoire pour la d\u00e9termination des flux de tr\u00e9sorerie op\u00e9rationnelle. L\u2019application de la norme IFRS 18 sera obligatoire pour les exercices ouverts \u00e0 compter du 1<sup>er</sup> janvier 2027. Lors de la premi\u00e8re application, la p\u00e9riode comparative devra \u00e9galement \u00eatre pr\u00e9sent\u00e9e conform\u00e9ment aux nouvelles r\u00e8gles. La norme IFRS 18 s\u2019applique \u00e0 toutes les entit\u00e9s qui \u00e9tablissent leurs \u00e9tats financiers selon les normes IFRS.</div><div class=\"defaultParagraph_1 Standard\">En 2024, le Groupe a entam\u00e9 l\u2019analyse des exigences futures et de leur impact sur les \u00e9tats financiers consolid\u00e9s. Il est convenu que les r\u00e8gles relatives \u00e0 la structure du compte de r\u00e9sultat pour les entreprises dont l\u2019activit\u00e9 principale n\u2019est pas sp\u00e9cifi\u00e9e s\u2019appliqueront au Groupe (en tant que \u00ab soci\u00e9t\u00e9 manufacturi\u00e8re \u00bb). \u00c0 l\u2019avenir, la pr\u00e9sentation du compte de r\u00e9sultat changera, n\u00e9cessitant une reclassification des produits et des charges. Cela concernera notamment les \u00e9l\u00e9ments actuellement inclus dans le \u00ab r\u00e9sultat financier \u00bb, qui devront probablement \u00eatre reclass\u00e9s dans deux cat\u00e9gories : Exploitation (par exemple, produits et charges li\u00e9s aux d\u00e9riv\u00e9s de couverture des risques de change portant sur l\u2019activit\u00e9 du Groupe) et Investissement (par exemple, revenus d\u2019int\u00e9r\u00eats, r\u00e9sultats des investissements en actions).</div><div class=\"defaultParagraph_1 Standard\">En raison de nouvelles directives sur l\u2019agr\u00e9gation et la d\u00e9sagr\u00e9gation, d\u2019autres d\u00e9clarations, notamment les notes annexes pourraient \u00e9galement \u00eatre affect\u00e9es. De plus, le point de d\u00e9part du tableau des flux de tr\u00e9sorerie et l'affectation des int\u00e9r\u00eats per\u00e7us changeront, les int\u00e9r\u00eats per\u00e7us devant d\u00e9sormais \u00eatre pr\u00e9sent\u00e9s dans la section \u00ab activit\u00e9s d\u2019investissement \u00bb du tableau des flux de tr\u00e9sorerie. L\u2019indicateur de performance actuel du Groupe, appel\u00e9 \u00ab EBITDA courant \u00bb (une mesure non d\u00e9finie par les normes IFRS) pourrait \u00eatre affect\u00e9 par les nouvelles exigences en mati\u00e8re d\u2019information sur les indicateurs de performance sp\u00e9cifique \u00e0 l\u2019entreprise. Enfin, la norme IFRS 18 ne devrait pas avoir d\u2019incidence directe sur la comptabilisation et l\u2019\u00e9valuation des \u00e9l\u00e9ments financiers.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-14": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>3. </sub></span><div class=\"list-paragraph-container_1\"><sub>Principales r\u00e8gles et m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Les principales r\u00e8gles et m\u00e9thodes comptables sont d\u00e9taill\u00e9es dans les notes annexes aux \u00e9tats financiers, o\u00f9 les postes sp\u00e9cifiques des \u00e9tats financiers consolid\u00e9s sont expliqu\u00e9s plus en profondeur. Les conventions comptables g\u00e9n\u00e9rales significatives sont pr\u00e9sent\u00e9es ci-dessous.</div><div class=\"defaultParagraph_1 berschrift4\">Base de pr\u00e9paration</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe sont \u00e9tablis selon le principe du co\u00fbt historique (co\u00fbt d'acquisition, de construction ou de production), \u00e0 l'exception des \u00e9l\u00e9ments comptabilis\u00e9s \u00e0 la juste valeur, tels que les instruments financiers d\u00e9riv\u00e9s.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Op\u00e9rations en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\" style=\"margin-bottom:0px\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La monnaie de pr\u00e9sentation des \u00e9tats financiers consolid\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est l'euro (les montants sont pr\u00e9sent\u00e9s en millions d'euros). </span>Dans les \u00e9tats financiers de chaque entit\u00e9 du Groupe, les op\u00e9rations libell\u00e9es en devises \u00e9trang\u00e8res sont converties en monnaie fonctionnelle de la filiale au taux de change en vigueur \u00e0 la date de la transaction. Les actifs mon\u00e9taires et les dettes libell\u00e9es en devises \u00e9trang\u00e8res sont convertis au taux de change \u00e0 la date de cl\u00f4ture de l\u2019exercice. Les gains et pertes de change sont comptabilis\u00e9s dans le compte de r\u00e9sultat pour la p\u00e9riode.</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Conversion des \u00e9tats financiers \u00e9tablis en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers des filiales \u00e9tablis en devises \u00e9trang\u00e8res sont convertis conform\u00e9ment \u00e0 la norme IAS 21 (Effets des variations des cours des monnaies \u00e9trang\u00e8res), selon le concept de monnaie fonctionnelle. Les filiales \u00e9trang\u00e8res sont consid\u00e9r\u00e9es comme des entit\u00e9s ind\u00e9pendantes du Groupe Sartorius Stedim Biotech. Les actifs (y compris le goodwill) et les passifs des entit\u00e9s dont la monnaie fonctionnelle diff\u00e8re de la monnaie de pr\u00e9sentation sont convertis au taux de change en vigueur \u00e0 la date de cl\u00f4ture. Les produits, les charges et les flux de tr\u00e9sorerie sont convertis au taux de change moyen annuel, \u00e0 condition que ce taux refl\u00e8te de mani\u00e8re approximative les taux de change appliqu\u00e9s aux dates des transactions, en l\u2019absence de fluctuations significatives. Les \u00e9carts de conversion r\u00e9sultant de cette conversion sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. Le Groupe applique la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) \u00e0 l'entit\u00e9 situ\u00e9e en Turquie, acquise en juin 2023 (note 12).</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les taux de change des principales devises \u00e9trang\u00e8res par rapport \u00e0 l\u2019euro sont pr\u00e9sent\u00e9s dans le tableau ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change \u00e0 la<br/>date de cl\u00f4ture</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change<br/> moyens</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">Pour 1 \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">USD</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,17390</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,04140</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,12997</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,08233</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">GBP</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,87370</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,82977</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,85689</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,84658</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CHF</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93130</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,94175</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93708</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,95236</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">JPY</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">183,89000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,32000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">169,10988</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,79945</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">SGD</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,51020</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,41830</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,47572</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,44577</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">KRW</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0698,23000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0534,45000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0606,00262</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0475,13229</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CNY</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,20400</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,60150</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,11911</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,78790</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div><div class=\"defaultParagraph_1 berschrift4\">Evaluation de la juste valeur</div><div class=\"defaultParagraph_1 Standard\">Un certain nombre de r\u00e9glementations comptables et d'informations \u00e0 fournir par le Groupe exige l\u2019\u00e9valuation de la juste valeur, tant pour les actifs et passifs financiers que non financiers, y compris les justes valeurs de niveau 3 (donn\u00e9es non observables).</div><div class=\"defaultParagraph_1 Standard\">Lorsque des informations provenant de tiers, telles que des cotations de courtiers ou des services de valorisation, sont retenus pour d\u00e9terminer la juste valeur, il appartient \u00e0 la direction d\u2019\u00e9valuer les \u00e9l\u00e9ments probants fournis par les tiers afin de s\u2019assurer que ces conclusions satisfont aux exigences des normes IFRS, y compris le niveau de la hi\u00e9rarchie des justes valeurs dans laquelle ces \u00e9valuations doivent \u00eatre class\u00e9es.</div><div class=\"defaultParagraph_1 Standard\">Lors de l\u2019\u00e9valuation de la juste valeur d\u2019un actif ou d\u2019un passif, le Groupe recourt autant que possible \u00e0 des donn\u00e9es de march\u00e9 observables. Si les donn\u00e9es utilis\u00e9es pour \u00e9valuer la juste valeur d\u2019un actif ou d\u2019un passif rel\u00e8vent de diff\u00e9rents niveaux de la hi\u00e9rarchie de la juste valeur, l\u2019\u00e9valuation de la juste valeur est class\u00e9e dans son int\u00e9gralit\u00e9 au niveau de la hi\u00e9rarchie correspondant \u00e0 la donn\u00e9e d\u2019entr\u00e9e de niveau le plus bas ayant une importance significative pour l\u2019ensemble de la mesure. L'\u00e9valuation de la juste valeur est particuli\u00e8rement pertinente pour la comptabilisation des regroupements d'entreprises (note\u00a08), des instruments financiers (note\u00a036) et des paiements fond\u00e9s sur des actions (note\u00a044).</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>5. </sub></span><div class=\"list-paragraph-container_1\"><sub>Information sectorielle</sub></div></div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IFRS 8 (Secteurs op\u00e9rationnels), l\u2019identification des segments op\u00e9rationnels refl\u00e8te la structure interne de gestion de l\u2019activit\u00e9, selon une approche \u00ab manag\u00e9riale \u00bb. Cela signifie que les segments sont d\u00e9finis de mani\u00e8re analogue au reporting financier interne de l'entit\u00e9. Ainsi un domaine d\u2019activit\u00e9 est consid\u00e9r\u00e9 comme un segment op\u00e9rationnel d\u00e8s lors que ses activit\u00e9s op\u00e9rationnelles sont susceptibles de g\u00e9n\u00e9rer des produits et des charges, que ses r\u00e9sultats op\u00e9rationnels sont r\u00e9guli\u00e8rement examin\u00e9s par le principal d\u00e9cideur op\u00e9rationnel de l\u2019entit\u00e9 (\u00e0 savoir les membres ex\u00e9cutifs du Conseil d\u2019administration) et que des informations financi\u00e8res distinctes sont disponibles dans le reporting interne. Le contr\u00f4le interne et le reporting au sein de Sartorius Stedim Biotech reposent sur le positionnement du Groupe en tant que \u00ab fournisseur de solutions globales \u00bb (<span dir=\"ltr\" style=\"font-style:italic\">total solutions provider</span>) pour ses clients. En cons\u00e9quence, il n'existe qu'un seul secteur op\u00e9rationnel identifi\u00e9 pour Sartorius Stedim Biotech guid\u00e9 par une perspective produit et client\u00a0:<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> le secteur \u00ab\u00a0Biopharm\u00a0\u00bb. </span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'indicateur cl\u00e9 de performance du segment op\u00e9rationnel du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est \u00ab\u00a0l\u2019EBITDA courant\u00a0\u00bb dans la mesure o\u00f9 le Conseil d'administration surveille cet indicateur de performance au niveau consolid\u00e9 et consid\u00e8re qu\u2019il est utile et pertinent pour appr\u00e9hender la performance financi\u00e8re du Groupe.</span></div><div class=\"defaultParagraph_1 Standard\">L'EBITDA correspond au r\u00e9sultat avant int\u00e9r\u00eats, imp\u00f4ts, d\u00e9pr\u00e9ciations et amortissements ; le terme \u00ab\u00a0EBITDA courant\u00a0\u00bb d\u00e9signe \u00e0 l'EBITDA corrig\u00e9 des \u00e9l\u00e9ments non r\u00e9currents (ou exceptionnels). Les \u00e9l\u00e9ments non r\u00e9currents comprennent les produits et charges li\u00e9s aux mesures d\u2019am\u00e9lioration de l\u2019efficacit\u00e9, aux acquisitions, ainsi qu\u2019\u00e0 d\u2019autres gains ou pertes susceptibles de fausser la rentabilit\u00e9 durable du segment, tels que les gains ou pertes r\u00e9sultant de la cession d\u2019immobilisations corporelles ou d\u2019investissement. Les mesures visant \u00e0 am\u00e9liorer l\u2019efficacit\u00e9 comprennent principalement les produits et les charges li\u00e9s aux activit\u00e9s de restructuration, tels que les indemnit\u00e9s de d\u00e9part, ou les projets majeurs du Groupe, notamment les projets informatiques d\u2019envergure.</div><div class=\"defaultParagraph_1 Standard\">L'EBITDA et l\u2019EBITDA courant ne constituent d\u2019aucune mani\u00e8re, des indicateurs de performance d\u00e9finis dans les normes IFRS. La d\u00e9finition \u00e9tablie par le Groupe peut diff\u00e9rer des indicateurs de performance et des informations similaires fournies par d'autres soci\u00e9t\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les actifs et passifs par segment ne sont pas communiqu\u00e9s de mani\u00e8re r\u00e9guli\u00e8re au principal d\u00e9cideur op\u00e9rationnel et ne sont, par cons\u00e9quent, pas inclus dans l\u2019information sectorielle.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Informations compl\u00e9mentaires par r\u00e9gion</div><div class=\"defaultParagraph_1 Standard\">Afin de fournir des informations suppl\u00e9mentaires exig\u00e9es par la norme IFRS 8, le tableau ci-dessous pr\u00e9sente des informations compl\u00e9mentaires par zone g\u00e9ographique. Les principaux chiffres relatifs aux actifs non courants des zones g\u00e9ographiques concernent le lieu d\u2019implantation des soci\u00e9t\u00e9s, tandis ce que le chiffre d'affaires est rapport\u00e9 selon la localisation des clients. </div><div class=\"defaultParagraph_1 Standard\">Les actifs non courants comprennent les immobilisations corporelles ainsi que les immobilisations incorporelles (y compris le goodwill).</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>6. </sub></span><div class=\"list-paragraph-container_1\"><sub>Tableau des flux de tr\u00e9sorerie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau des flux de tr\u00e9sorerie pr\u00e9sente l'impact des entr\u00e9es et sorties de tr\u00e9sorerie sur les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie du Groupe. Les flux de tr\u00e9sorerie sont class\u00e9s en trois cat\u00e9gories\u00a0: activit\u00e9s op\u00e9rationnelles, activit\u00e9s d\u2019investissement et activit\u00e9s de financement, conform\u00e9ment \u00e0 la norme IAS 7 (Tableau des flux de tr\u00e9sorerie).</div><div class=\"defaultParagraph_1 Standard\">Dans ce contexte, les \u00e9quivalents de tr\u00e9sorerie sont des actifs qui peuvent \u00eatre convertis en liquidit\u00e9 dans un d\u00e9lai court, g\u00e9n\u00e9ralement inf\u00e9rieur \u00e0 trois mois. Le montant retenu dans le tableau des flux de tr\u00e9sorerie correspond au montant des disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie figurant dans le bilan consolid\u00e9 (note 29). </div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>7. </sub></span><div class=\"list-paragraph-container_1\"><sub>P\u00e9rim\u00e8tre de consolidation</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech incluent les \u00e9tats financiers annuels de toutes les soci\u00e9t\u00e9s qui sont contr\u00f4l\u00e9es directement ou indirectement par Sartorius Stedim Biotech\u00a0S.A. Selon la norme IFRS 10 (\u00c9tats financiers consolid\u00e9s), le Groupe Sartorius Stedim Biotech contr\u00f4le une entit\u00e9 lorsqu'il est expos\u00e9 \u00e0 des rendements variables r\u00e9sultant de son implication dans cette entit\u00e9 et qu'il dispose de la capacit\u00e9 \u00e0 influencer ces rendements par le biais de son pouvoir sur cette entit\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Ces entit\u00e9s sont incluses dans les \u00e9tats financiers consolid\u00e9s d\u00e8s lors que Sartorius Stedim Biotech\u00a0S.A. ou une de ses filiales acquiert ce contr\u00f4le jusqu'\u00e0 la date \u00e0 laquelle le contr\u00f4le cesse. Les filiales sont incluses sur la base de leurs \u00e9tats financiers annuels pour la m\u00eame p\u00e9riode de reporting que la soci\u00e9t\u00e9 m\u00e8re, en utilisant des m\u00e9thodes de reconnaissance et d\u2019\u00e9valuation uniformes au sein du Groupe. Tous les actifs et passifs intragroupes, les capitaux propres, les produits, les charges et les flux de tr\u00e9sorerie li\u00e9s aux transactions entre membres du Groupe sont \u00e9limin\u00e9s lors de la consolidation.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>8. </sub></span><div class=\"list-paragraph-container_1\"><sub>Regroupements d'entreprises</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les regroupements d'entreprises sont comptabilis\u00e9s selon la m\u00e9thode de l'acquisition. La comptabilisation des regroupements d'entreprises exige que la contrepartie transf\u00e9r\u00e9e ainsi que les actifs acquis et les passifs repris soient \u00e9valu\u00e9s \u00e0 leurs justes valeurs respectives \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 Standard\">L'application de la m\u00e9thode de l'acquisition n\u00e9cessite le recours \u00e0 des estimations et des hypoth\u00e8ses, notamment en ce qui concerne les justes valeurs de la contrepartie transf\u00e9r\u00e9e, les immobilisations incorporelles acquises, les immobilisations corporelles, et les passifs repris \u00e0 la date d'acquisition, ainsi que les dur\u00e9es d'utilit\u00e9 des actifs. Ces \u00e9valuations reposent dans une large mesure sur des flux de tr\u00e9sorerie pr\u00e9visionnels. Si les flux de tr\u00e9sorerie r\u00e9els diff\u00e8rent de ceux utilis\u00e9s pour d\u00e9terminer les justes valeurs, cela pourrait affecter de mani\u00e8re significative les r\u00e9sultats futurs du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Pour les acquisitions significatives, l'allocation du prix d'acquisition est r\u00e9alis\u00e9e avec l\u2019assistance de sp\u00e9cialistes en valorisation externes et ind\u00e9pendants. Les valorisations sont bas\u00e9es sur les informations disponibles \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>9. </sub></span><div class=\"list-paragraph-container_1\"><sub>Chiffre d'affaires</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le chiffre d'affaires est comptabilis\u00e9 conform\u00e9ment \u00e0 la norme IFRS 15 (Produits des activit\u00e9s ordinaires tir\u00e9s de contrats conclus avec des clients). Le chiffre d\u2019affaires issu de l\u2019activit\u00e9 commerciale contractuelle avec les clients est ventil\u00e9 par zones g\u00e9ographiques (note 5 \u2013 Information sectorielle) et selon la nature des revenus (r\u00e9currents et non r\u00e9currents). Le Groupe d\u00e9finit les revenus r\u00e9currents comme les revenus provenant des consommables et des services, tandis que les revenus non r\u00e9currents sont principalement d\u00e9finis comme les revenus des instruments.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe fabrique et commercialise des instruments et des consommables destin\u00e9s \u00e0 des clients du secteur biopharmaceutique. Le Groupe satisfait \u00e0 ses obligations de performance en fonction des biens \u00e0 transf\u00e9rer et des services promis. La majorit\u00e9 des revenus provenant de la vente de produits est comptabilis\u00e9e au moment o\u00f9 le client dispose du contr\u00f4le des biens. C'est g\u00e9n\u00e9ralement le cas lorsque les risques et les avantages significatifs li\u00e9s \u00e0 la propri\u00e9t\u00e9 des biens sont transf\u00e9r\u00e9s au client. En cons\u00e9quence, le moment de la comptabilisation peut varier en fonction des accords conclus avec chaque client.</div><div class=\"defaultParagraph_1 Standard\">Lorsque des instruments sont vendus conjointement avec un service initial, tel que la mise en service initiale, et que ces deux \u00e9l\u00e9ments constituent deux obligations de prestation distinctes, le prix de transaction est attribu\u00e9 sur la base des prix de vente s\u00e9par\u00e9s et relatifs. Pour les produits complexes n\u00e9cessitant une installation sur le site du client, le chiffre d\u2019affaires est constat\u00e9 et comptabilis\u00e9 apr\u00e8s l\u2019acceptation formelle du client. Dans une moindre mesure, le chiffre d\u2019affaires est comptabilis\u00e9 au fil du temps dans le cadre d\u2019activit\u00e9s de projet sp\u00e9cifiques au client. Dans ces cas, le chiffre d\u2019affaires est reconnu en fonction de l'avancement du projet, mesur\u00e9 sur la base du pourcentage des co\u00fbts engag\u00e9s \u00e0 ce jour par rapport au total estim\u00e9 des co\u00fbts du contrat (m\u00e9thode des intrants). Le montant des co\u00fbts r\u00e9els engag\u00e9s \u00e0 ce jour refl\u00e8te de mani\u00e8re appropri\u00e9e l'avancement et le transfert du contr\u00f4le au client, dans la mesure o\u00f9 le Groupe dispose d\u2019un droit de remboursement des co\u00fbts engag\u00e9s \u00e0 ce jour, major\u00e9s d'une marge appropri\u00e9e si le projet est annul\u00e9 par le client sans motif valable.</div><div class=\"defaultParagraph_1 Standard\">Les revenus provenant des services sont g\u00e9n\u00e9ralement constat\u00e9s lorsque les services sont ex\u00e9cut\u00e9s ou ont \u00e9t\u00e9 ex\u00e9cut\u00e9s. Lorsque les services sont rendus de mani\u00e8re continue sur une p\u00e9riode donn\u00e9e, le Groupe comptabilise le produit correspondant au fil du temps. Dans ce cas, les revenus sont g\u00e9n\u00e9ralement constat\u00e9s au prorata temporis par rapport \u00e0 la dur\u00e9e totale du contrat. Les ventes de produits sont g\u00e9n\u00e9ralement assorties d\u2019une garantie l\u00e9gale obligatoire, et couverte par des provisions pour garanties (note\u00a025). L\u2019ensemble des garanties \u00e9tendues jug\u00e9es comme significatives est comptabilis\u00e9 comme une obligation de prestation distincte, pour laquelle le chiffre d\u2019affaires est comptabilis\u00e9 sur la dur\u00e9e de la garantie.</div><div class=\"defaultParagraph_1 Standard\">Selon les conditions g\u00e9n\u00e9rales de paiement, les r\u00e8glements des clients sont exigibles \u00e0 court terme, g\u00e9n\u00e9ralement dans un d\u00e9lai de 30 \u00e0 60 jours. Dans une certaine mesure, le Groupe per\u00e7oit des paiements anticip\u00e9s, afin de limiter par exemple les risques de cr\u00e9dit. Par cons\u00e9quent, le Groupe comptabilise r\u00e9guli\u00e8rement des passifs sur contrats de service lorsque les clients paient \u00e0 l'avance.</div><div class=\"defaultParagraph_1 Standard\">Les contrats comportant des composantes de financement significatives n\u2019ont pas d\u2019effet mat\u00e9riel. Le Groupe applique la mesure de simplification pr\u00e9vue par la norme comptable concernant l\u2019existence d\u2019une composante de financement significative. Cela signifie qu\u2019une composante de financement est prise en compte uniquement lorsque la dur\u00e9e entre le transfert des biens ou des services et l\u2019encaissement de la contrepartie est susceptible de d\u00e9passer un an et que l'effet est significatif. </div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>10. </sub></span><div class=\"list-paragraph-container_1\"><sub>Les co\u00fbts op\u00e9rationnels</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le compte de r\u00e9sultat est pr\u00e9sent\u00e9 selon le format du \u00ab co\u00fbt des ventes \u00bb, c'est-\u00e0-dire que les charges ont \u00e9t\u00e9 directement affect\u00e9es aux diff\u00e9rentes fonctions pertinentes de production, de vente et de marketing, de recherche et d\u00e9veloppement et de frais g\u00e9n\u00e9raux. Les d\u00e9penses relatives \u00e0 des initiatives ou projets transversaux sont imput\u00e9es aux co\u00fbts fonctionnels correspondants selon un principe d\u2019allocation appropri\u00e9.</div><div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab co\u00fbt des ventes \u00bb comprend les co\u00fbts des produits vendus et les co\u00fbts d\u2019acquisition des marchandises vendues. Outre les d\u00e9penses directement imputables, telles que les mati\u00e8res premi\u00e8res et les fournitures, les d\u00e9penses li\u00e9es aux avantages du personnel et les d\u00e9penses d'\u00e9nergie, le co\u00fbt des ventes inclut \u00e9galement les frais g\u00e9n\u00e9raux imputables \u00e0 la zone de production, ainsi que les dotations aux amortissements et d\u00e9pr\u00e9ciations correspondantes.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de vente et de distribution concernent notamment les co\u00fbts des fonctions commerciales et marketing, de la distribution et des \u00e9tudes de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les frais de recherche et d\u00e9veloppement comprennent les co\u00fbts de recherche, ainsi que les frais li\u00e9s au d\u00e9veloppement de produits et de proc\u00e9d\u00e9s, sauf si ces derniers sont comptabilis\u00e9s \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab frais g\u00e9n\u00e9raux \u00bb inclut principalement les charges du personnel et le co\u00fbt des fournitures et du mat\u00e9riel de la fonction administration g\u00e9n\u00e9rale.</div><div class=\"defaultParagraph_1 Standard\">Tous les \u00e9l\u00e9ments du compte de r\u00e9sultat qui ne peuvent pas \u00eatre rattach\u00e9s \u00e0 l\u2019un des domaines fonctionnels susmentionn\u00e9s sont comptabilis\u00e9s en autres produits et charges. Cela comprend essentiellement les effets li\u00e9s \u00e0 la conversion des transactions en devises \u00e9trang\u00e8res, la cession d\u2019immobilisation ainsi que les d\u00e9pr\u00e9ciations des cr\u00e9ances clients.</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9l\u00e9ments non r\u00e9currents, tels que les co\u00fbts de restructuration ou autres produits ou charges non r\u00e9currents, sont g\u00e9n\u00e9ralement pr\u00e9sent\u00e9s dans les charges op\u00e9rationnelles. Si ces derniers ne peuvent \u00eatre imput\u00e9s aux charges op\u00e9rationnelles, les \u00e9l\u00e9ments non r\u00e9currents sont alors comptabilis\u00e9s dans les \u00ab autres produits et charges \u00bb.</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es aux produits sont enregistr\u00e9es en \u00ab autres produits \u00bb lorsqu'il existe une certitude raisonnable que les conditions attach\u00e9es aux subventions soient respect\u00e9es et que les subventions seront per\u00e7ues. Elles sont syst\u00e9matiquement comptabilis\u00e9es en tant que produits sur la p\u00e9riode au cours de laquelle les co\u00fbts correspondants sont enregistr\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les charges op\u00e9rationnelles sont d\u00e9taill\u00e9s dans la ventilation par nature du r\u00e9sultat op\u00e9rationnel (note\u00a014).</div>Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier.<div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts courants sur le r\u00e9sultat sont d\u00e9termin\u00e9s sur la base du r\u00e9sultat fiscal local de la p\u00e9riode et des r\u00e8gles fiscales locales. En outre, les imp\u00f4ts courants incluent des ajustements relatifs aux paiements d\u2019imp\u00f4ts incertains ou aux remboursements d\u2019imp\u00f4ts pour les p\u00e9riodes non \u00e9valu\u00e9es, ainsi que les r\u00e9ajustements pour les ann\u00e9es ant\u00e9rieures. Les variations des actifs et passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont inclus dans la ligne des imp\u00f4ts diff\u00e9r\u00e9s, \u00e0 l'exception des changements comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global ou dans les capitaux propres (note\u00a019).</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS\u00a033 (R\u00e9sultat par action), le b\u00e9n\u00e9fice par action de base (BPA de base) est calcul\u00e9 sur la base du nombre moyen pond\u00e9r\u00e9 d'actions ordinaires pendant la p\u00e9riode.</div>Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">L\u2019amortissement des immobilisations incorporelles se r\u00e9f\u00e8re aux dur\u00e9es de vie utiles suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>Logiciel</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2 \u00e0 10 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Technologies</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3 \u00e0 20 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">4 \u00e0 6 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Relations client</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1 \u00e0 20 ans</div></td></tr><tr><td class=\"daba0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Marque</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">De 2 ans \u00e0 l'infini</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">A compter du 31 d\u00e9cembre 2025, le poste \u00ab Brevets, licences et droits similaires \u00bb inclut les technologies issues de l\u2019acquisition de Polyplus, pour un montant d\u2019environ 659,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 705,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent), avec des dur\u00e9es de vie utiles allant jusqu\u2019\u00e0 16 ans.</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Les amortissements des immobilisations incorporelles sont affect\u00e9s aux fonctions correspondantes dans le compte de r\u00e9sultat. Pour les frais de d\u00e9veloppement capitalis\u00e9s, les amortissements sont comptabilis\u00e9s en \u00ab\u00a0co\u00fbts des ventes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab\u00a0Immobilisations corporelles\u00a0\u00bb du bilan consolid\u00e9 inclut les actifs li\u00e9s aux droits d'utilisation comptabilis\u00e9s conform\u00e9ment \u00e0 la norme IFRS 16 (note\u00a018). Les immobilisations corporelles sont comptabilis\u00e9es au co\u00fbt d\u2019acquisition, diminu\u00e9 des amortissements cumul\u00e9s et calcul\u00e9s selon la m\u00e9thode lin\u00e9aire sur leur dur\u00e9e de vie utile. Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur. </div><div class=\"defaultParagraph_1 Standard\">Les immobilisations en cours en <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 concernent principalement des projets d\u2019extension des capacit\u00e9s de production en Allemagne, en France, en Cor\u00e9e et \u00e0 Porto Rico. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Les amortissements sont \u00e9chelonn\u00e9s sur les dur\u00e9es de vie suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>Constructions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">15 \u00e0 50 ans</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">5 \u00e0 15 ans</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier et mat\u00e9riel de bureau</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3 \u00e0 13 ans</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les dotations aux amortissements et la charge de d\u00e9pr\u00e9ciation sont incluses dans le compte de r\u00e9sultat selon l'utilisation des actifs, r\u00e9parties entre les co\u00fbts des ventes, les frais commerciaux et de distribution, les frais de recherche et d\u00e9veloppement, les frais g\u00e9n\u00e9raux et les autres charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts d'emprunt sont comptabilis\u00e9s en charges, sauf s\u2019ils sont directement attribuables \u00e0 l'acquisition, \u00e0 la construction ou \u00e0 la production d'un actif qualifi\u00e9, auquel ils sont incorpor\u00e9s au co\u00fbt de cet actif conform\u00e9ment \u00e0 la norme IAS\u00a023. En <span class=\"hyperlink-no-style_1\"></span>2025, des co\u00fbts d\u2019emprunt de 17,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 capitalis\u00e9s, principalement en lien avec de nouveaux sites et d\u2019extensions (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 19,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le taux d\u2019emprunt utilis\u00e9 pour la capitalisation s\u2019\u00e9levait \u00e0 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es \u00e0 des actifs sont d\u00e9duites du co\u00fbt d\u2019acquisition de ces actifs.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>18. </sub></span><div class=\"list-paragraph-container_1\"><sub>Contrats de location</sub></div></div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des contrats de location est conforme \u00e0 la norme IFRS 16 (Contrats de location). Pour le Groupe, ces contrats de location ne rev\u00eatent pas une importance majeure dans la structure de financement. Les principales consid\u00e9rations concernent des aspects pratiques, tels que la gestion du mat\u00e9riel informatique ou la gestion du parc automobile. Ainsi, les contrats de locations de mat\u00e9riel informatique et de v\u00e9hicules repr\u00e9sentent la majorit\u00e9 des contrats de location du Groupe. La dur\u00e9e des contrats de location est g\u00e9n\u00e9ralement fixe et s'\u00e9tend habituellement sur une p\u00e9riode de trois \u00e0 cinq ans. En revanche, les contrats de location conclus avec des parties li\u00e9es, lorsque le bailleur est une entit\u00e9 contr\u00f4l\u00e9e par la soci\u00e9t\u00e9 m\u00e8re ultime Sartorius\u00a0AG, sont en g\u00e9n\u00e9ral de courte dur\u00e9e, afin d\u2019offrir une flexibilit\u00e9 op\u00e9rationnelle aux deux parties contractantes. Par ailleurs, sur certains sites, le Groupe dispose de contrats de location \u00e0 long terme portant sur des immeubles. Les contrats de location peuvent comporter des options de prolongation incluses dans la dur\u00e9e du contrat de location, conform\u00e9ment \u00e0 la norme IFRS 16, lorsque le Groupe s\u2019est raisonnablement assur\u00e9 de l\u2019exercice de ces options. Le Groupe n'agit pas, de mani\u00e8re significative, en qualit\u00e9 de bailleur.</div><div class=\"defaultParagraph_1 Standard\">Selon la norme IFRS 16, les contrats de location sont comptabilis\u00e9s, en principe, au bilan du preneur. Celui-ci reconna\u00eet un droit d'usage (repr\u00e9sentant son droit d'utiliser le bien lou\u00e9), ainsi qu'une dette de location (r\u00e9sultant de son obligation \u00e0 payer les loyers). Le Groupe applique les exemptions pr\u00e9vues pour les contrats de location de courte dur\u00e9e et les contrats portant sur des actifs de faible valeur, et comptabilise les paiements correspondants en charges, g\u00e9n\u00e9ralement selon la m\u00e9thode lin\u00e9aire sur la dur\u00e9e du contrat concern\u00e9. Par cons\u00e9quent, aucun actif au titre du droit d\u2019utilisation et aucun passif locatif ne sont comptabilis\u00e9s pour ces contrats de location. Par ailleurs, le Groupe n\u2019applique pas la Norme aux contrats de location d\u2019actifs incorporels.</div><div class=\"defaultParagraph_1 Standard\">Dans le bilan consolid\u00e9, le Groupe pr\u00e9sente l'actif du droit d'usage en fonction de la nature de l'actif du contrat de location sous-jacent dans la rubrique \u00ab Immobilisations corporelles \u00bb. Ils sont comptabilis\u00e9s au co\u00fbt, diminu\u00e9s des amortissements cumul\u00e9s et, le cas \u00e9ch\u00e9ant, d\u2019\u00e9ventuelles pertes de valeur. Le co\u00fbt des actifs li\u00e9s au droit d'utilisation comprend la valeur actuelle des paiements des loyers futurs, l\u2019ensemble des paiements vers\u00e9s \u00e0 la date de d\u00e9but du contrat ou avant le commencement du bail, les co\u00fbts directs initiaux ainsi que les co\u00fbts de d\u00e9mant\u00e8lement ou de remise en \u00e9tat de l'actif lou\u00e9. Les actifs li\u00e9s au droit d'utilisation sont g\u00e9n\u00e9ralement amortis sur la dur\u00e9e du contrat de location. Lorsque le transfert de propri\u00e9t\u00e9 l\u00e9gale du bien lou\u00e9 est act\u00e9 \u00e0 la fin de la dur\u00e9e du contrat, l\u2019actif est amorti sur la dur\u00e9e de vie \u00e9conomique de l\u2019actif sous-jacent. Dans le compte de r\u00e9sultat, l\u2019amortissement est comptabilis\u00e9 dans les charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les dettes de location sont pr\u00e9sent\u00e9es s\u00e9par\u00e9ment au bilan. Elles sont initialement comptabilis\u00e9es \u00e0 la valeur actualis\u00e9e des paiements de location futurs. Les paiements de loyers n\u2019incluent g\u00e9n\u00e9ralement pas les paiements relatifs aux composantes non locatives. Le taux d\u2019emprunt marginal du Groupe, sp\u00e9cifique au pays, \u00e0 la devise et \u00e0 la dur\u00e9e du contrat, est g\u00e9n\u00e9ralement utilis\u00e9 pour l\u2019actualisation. Par la suite, la valeur comptable des passifs locatifs est augment\u00e9e des charges d\u2019int\u00e9r\u00eats et diminu\u00e9e des paiements de loyers effectu\u00e9s. Les charges d\u2019int\u00e9r\u00eats sont comptabilis\u00e9es dans le r\u00e9sultat financier et, lorsqu\u2019elles sont pay\u00e9es, dans la section financement du tableau des flux de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\">Les actifs ou passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont d\u00e9termin\u00e9s en fonction des diff\u00e9rences temporaires entre les valeurs comptables et la valeur fiscale des actifs et passifs concern\u00e9s, en conformit\u00e9 avec la norme IAS 12, y compris les reports d\u00e9ficitaires et les cr\u00e9dits d\u2019imp\u00f4t, \u00e0 l\u2019exception des cas express\u00e9ment exclus par cette norme. L'\u00e9valuation repose sur les taux d'imposition qui devraient s\u2019appliquer au cours de la p\u00e9riode durant laquelle l\u2019actif sera r\u00e9alis\u00e9 ou le passif r\u00e9gl\u00e9, ou lorsque les pertes fiscales seront utilis\u00e9es. \u00c0 cette fin, le Groupe utilise les taux d\u2019imposition et les r\u00e8gles fiscales adopt\u00e9s ou quasi adopt\u00e9s \u00e0 la date de cl\u00f4ture. L\u2019impact de la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer la place \u00e9conomique de l\u2019Allemagne \u00bb est d\u00e9taill\u00e9 en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d\u00e9coulant de l\u2019imp\u00f4t diff\u00e9r\u00e9 est refl\u00e9t\u00e9e dans l\u2019\u00e9l\u00e9ment \u00ab\u00a0Charge d\u2019imp\u00f4t\u00a0\u00bb dans le compte de r\u00e9sultat, sauf pour ces \u00e9l\u00e9ments qui sont reconnus dans d\u2019autres revenus globaux et pour des effets d\u00e9riv\u00e9s de regroupements d\u2019entreprises.</div><div class=\"defaultParagraph_1 Standard\">Des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont comptabilis\u00e9s pour toutes les diff\u00e9rences temporelles d\u00e9ductibles et les pertes fiscales non utilis\u00e9es dans la mesure o\u00f9 il est probable qu\u2019un b\u00e9n\u00e9fice imposable futur sera disponible pour permettre leur imputation. Les estimations relatives aux b\u00e9n\u00e9fices imposables futurs ainsi qu\u2019\u00e0 la p\u00e9riode de r\u00e9cup\u00e9ration des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s reposent sur des hypoth\u00e8ses, compte tenu de l\u2019incertitude inh\u00e9rente aux \u00e9volutions futures, dont certaines \u00e9chappent au contr\u00f4le de la direction. Ces estimations sont r\u00e9vis\u00e9es lorsque des \u00e9l\u00e9ments probants suffisants sont disponibles. Lorsqu\u2019aucune indication ne permet de conclure \u00e0 la r\u00e9alisation probable de tout ou partie d\u2019une diff\u00e9rence temporelle d\u00e9ductible ou d\u2019une perte fiscale, le montant correspondant n\u2019est pas comptabilis\u00e9 \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe exerce ses activit\u00e9s dans de nombreuses juridictions fiscales. En cons\u00e9quence, les positions fiscales pr\u00e9sent\u00e9es dans les \u00e9tats financiers consolid\u00e9s sont d\u00e9termin\u00e9es en tenant compte des l\u00e9gislations fiscales locales applicables ainsi que des interpr\u00e9tations pertinentes des administrations fiscales concern\u00e9es. En raison de leur complexit\u00e9, ces positions peuvent faire l\u2019objet d\u2019interpr\u00e9tations divergentes entre les contribuables et les autorit\u00e9s fiscales. Le montant des positions fiscales incertaines est d\u00e9termin\u00e9 sur la base de la meilleure estimation du paiement d\u2019imp\u00f4t attendu.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique l\u2019exon\u00e9ration obligatoire concernant la comptabilisation des imp\u00f4ts diff\u00e9r\u00e9s susceptibles de r\u00e9sulter de l\u2019application des r\u00e8gles d\u2019imposition minimale mondiale (Pilier Deux). Les effets de ces r\u00e8gles sur le Groupe sont pr\u00e9sent\u00e9s en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">Les mati\u00e8res premi\u00e8res et les fournitures, y compris les marchandises, sont d\u00e9clar\u00e9es sous la rubrique \u00ab\u00a0Stocks\u00a0\u00bb selon la m\u00e9thode du co\u00fbt moyen pond\u00e9r\u00e9. Les produits finis et l\u2019en-cours de production sont \u00e9valu\u00e9s au co\u00fbt de revient. Ce co\u00fbt int\u00e8gre les co\u00fbts directs, pouvant \u00eatre affect\u00e9s \u00e0 ces stocks ainsi qu\u2019une quote-part des frais g\u00e9n\u00e9raux de production et de manutention des mat\u00e9riaux, des frais administratifs g\u00e9n\u00e9raux ainsi que les amortissements et d\u00e9pr\u00e9ciations fond\u00e9s sur la capacit\u00e9 normale de production, sous r\u00e9serve que ces charges soient li\u00e9es \u00e0 la production.</div><div class=\"defaultParagraph_1 Standard\">Les stocks doivent \u00eatre \u00e9valu\u00e9s au plus faible du co\u00fbt et de la valeur nette de r\u00e9alisation. La valeur nette de r\u00e9alisation correspond au prix de vente estim\u00e9 dans le cours normal de l\u2019activit\u00e9, diminu\u00e9 des co\u00fbts estim\u00e9s d\u2019ach\u00e8vement ainsi que des co\u00fbts estim\u00e9s n\u00e9cessaires \u00e0 la commercialisation, \u00e0 la vente et \u00e0 la distribution. Lorsque des risques li\u00e9s aux stocks existent, tels que le risque de r\u00e9duction de la dur\u00e9e de conservation en raison des p\u00e9riodes de stockage ou d\u2019une utilisabilit\u00e9 limit\u00e9e, des d\u00e9pr\u00e9ciations sont comptabilis\u00e9es en cons\u00e9quence.</div><div class=\"defaultParagraph_1 berschrift4\">R\u00e9gimes \u00e0 prestations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\">Les provisions pour retraites et obligations similaires sont comptabilis\u00e9es dans les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech, conform\u00e9ment aux principes actuariels. La norme IAS\u00a019 (Avantages du personnel) prescrit l\u2019utilisation de la m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es (\u00ab\u00a0projected unit credit method\u00a0\u00bb) comme m\u00e9thode d'\u00e9valuation. Outre les rentes tir\u00e9es des pensions acquises et de l\u2019esp\u00e9rance de vie, cette m\u00e9thode tient compte des augmentations futures de salaires et de pensions.</div><div class=\"defaultParagraph_1 Standard\">Les taux d'actualisation appliqu\u00e9s refl\u00e8tent les taux d'int\u00e9r\u00eat observ\u00e9s \u00e0 la date d'arr\u00eat\u00e9 pour des obligations d\u2019entreprise de premier ordre, libell\u00e9es dans les devises concern\u00e9es (principalement en euro) et pr\u00e9sentant des maturit\u00e9s \u00e9quivalentes. En l\u2019absence d\u2019obligations d\u2019entreprises disponibles avec des \u00e9ch\u00e9ances \u00e0 long terme \u00e9quivalentes, les taux d\u2019int\u00e9r\u00eat sont d\u00e9termin\u00e9s par extrapolation.</div><div class=\"defaultParagraph_1 Standard\">En raison de l'\u00e9volution des conditions du march\u00e9 et de l'\u00e9conomie, les hypoth\u00e8ses cl\u00e9s retenues peuvent diff\u00e9rer des d\u00e9veloppements r\u00e9els et provoquer des variations importantes des obligations de retraite et autres avantages post-emploi. Une analyse de sensibilit\u00e9 est pr\u00e9sent\u00e9e ci-apr\u00e8s.</div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des obligations (et actifs) au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies sont pr\u00e9sent\u00e9es dans les autres \u00e9l\u00e9ments du r\u00e9sultat global, conform\u00e9ment \u00e0 la norme IAS\u00a019.</div><div class=\"defaultParagraph_1 Standard\">L'analyse de sensibilit\u00e9 pr\u00e9sent\u00e9e ci-dessus peut ne pas \u00eatre repr\u00e9sentative de la variation r\u00e9elle de l'obligation, car il est peu probable que les changements d\u2019hypoth\u00e8ses se produisent de mani\u00e8re isol\u00e9e. En outre, la valeur actuelle de ces obligations a \u00e9t\u00e9 calcul\u00e9e en utilisant la m\u00eame m\u00e9thode que celle appliqu\u00e9e pour \u00e9valuer les obligations comptabilis\u00e9es dans le bilan consolid\u00e9 (m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es).</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>28. </sub></span><div class=\"list-paragraph-container_1\"><sub>Instruments financiers : principales m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\">Un instrument financier est un contrat qui donne lieu \u00e0 un actif financier pour une entit\u00e9 et \u00e0 un passif financier ou un instrument de capitaux propres pour une autre entit\u00e9. Les notes ci-apr\u00e8s pr\u00e9sentent une vue d\u2019ensemble de l\u2019incidence des instruments financiers sur les \u00e9tats financiers du Groupe Sartorius Stedim Biotech et transmettent des informations compl\u00e9mentaires sur les postes du bilan contenant des instruments financiers.</div><div class=\"defaultParagraph_1 Standard\">Les actifs financiers du Groupe comprennent principalement les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie, les cr\u00e9ances clients et pr\u00eats et les instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive.</div><div class=\"defaultParagraph_1 Standard\">Les passifs financiers du Groupe comprennent principalement des emprunts contract\u00e9s aupr\u00e8s de Sartorius\u00a0AG et Sartorius Finance B.V., des dettes fournisseurs, des dettes de location et des instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur n\u00e9gative. Les passifs financiers autres que les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des instruments financiers respecte la norme IFRS\u00a09 (Instruments financiers). Selon la norme IFRS 9, l\u2019approche de classification et d\u2019\u00e9valuation des actifs financiers repose \u00e0 la fois sur le mod\u00e8le \u00e9conomique de l\u2019entit\u00e9 (d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement, d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement et \u00e0 la vente, ou autres) dans lequel les actifs sont d\u00e9tenus, ainsi que sur les caract\u00e9ristiques contractuelles des flux de tr\u00e9sorerie (crit\u00e8re \u00ab\u00a0SPPI\u00a0\u00bb\u00a0: paiements constitu\u00e9s uniquement du principal et des int\u00e9r\u00eats). Aucune reclassification d\u2019instruments financiers n\u2019a eu lieu au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div><div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div>Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles.<div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-15": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>3. </sub></span><div class=\"list-paragraph-container_1\"><sub>Principales r\u00e8gles et m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Les principales r\u00e8gles et m\u00e9thodes comptables sont d\u00e9taill\u00e9es dans les notes annexes aux \u00e9tats financiers, o\u00f9 les postes sp\u00e9cifiques des \u00e9tats financiers consolid\u00e9s sont expliqu\u00e9s plus en profondeur. Les conventions comptables g\u00e9n\u00e9rales significatives sont pr\u00e9sent\u00e9es ci-dessous.</div><div class=\"defaultParagraph_1 berschrift4\">Base de pr\u00e9paration</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe sont \u00e9tablis selon le principe du co\u00fbt historique (co\u00fbt d'acquisition, de construction ou de production), \u00e0 l'exception des \u00e9l\u00e9ments comptabilis\u00e9s \u00e0 la juste valeur, tels que les instruments financiers d\u00e9riv\u00e9s.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-16": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Op\u00e9rations en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\" style=\"margin-bottom:0px\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La monnaie de pr\u00e9sentation des \u00e9tats financiers consolid\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est l'euro (les montants sont pr\u00e9sent\u00e9s en millions d'euros). </span>Dans les \u00e9tats financiers de chaque entit\u00e9 du Groupe, les op\u00e9rations libell\u00e9es en devises \u00e9trang\u00e8res sont converties en monnaie fonctionnelle de la filiale au taux de change en vigueur \u00e0 la date de la transaction. Les actifs mon\u00e9taires et les dettes libell\u00e9es en devises \u00e9trang\u00e8res sont convertis au taux de change \u00e0 la date de cl\u00f4ture de l\u2019exercice. Les gains et pertes de change sont comptabilis\u00e9s dans le compte de r\u00e9sultat pour la p\u00e9riode.</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Conversion des \u00e9tats financiers \u00e9tablis en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers des filiales \u00e9tablis en devises \u00e9trang\u00e8res sont convertis conform\u00e9ment \u00e0 la norme IAS 21 (Effets des variations des cours des monnaies \u00e9trang\u00e8res), selon le concept de monnaie fonctionnelle. Les filiales \u00e9trang\u00e8res sont consid\u00e9r\u00e9es comme des entit\u00e9s ind\u00e9pendantes du Groupe Sartorius Stedim Biotech. Les actifs (y compris le goodwill) et les passifs des entit\u00e9s dont la monnaie fonctionnelle diff\u00e8re de la monnaie de pr\u00e9sentation sont convertis au taux de change en vigueur \u00e0 la date de cl\u00f4ture. Les produits, les charges et les flux de tr\u00e9sorerie sont convertis au taux de change moyen annuel, \u00e0 condition que ce taux refl\u00e8te de mani\u00e8re approximative les taux de change appliqu\u00e9s aux dates des transactions, en l\u2019absence de fluctuations significatives. Les \u00e9carts de conversion r\u00e9sultant de cette conversion sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. Le Groupe applique la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) \u00e0 l'entit\u00e9 situ\u00e9e en Turquie, acquise en juin 2023 (note 12).</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les taux de change des principales devises \u00e9trang\u00e8res par rapport \u00e0 l\u2019euro sont pr\u00e9sent\u00e9s dans le tableau ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change \u00e0 la<br/>date de cl\u00f4ture</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change<br/> moyens</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">Pour 1 \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">USD</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,17390</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,04140</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,12997</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,08233</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">GBP</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,87370</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,82977</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,85689</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,84658</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CHF</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93130</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,94175</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93708</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,95236</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">JPY</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">183,89000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,32000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">169,10988</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,79945</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">SGD</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,51020</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,41830</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,47572</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,44577</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">KRW</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0698,23000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0534,45000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0606,00262</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0475,13229</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CNY</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,20400</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,60150</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,11911</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,78790</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div>Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier.",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-17": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Op\u00e9rations en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\" style=\"margin-bottom:0px\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La monnaie de pr\u00e9sentation des \u00e9tats financiers consolid\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est l'euro (les montants sont pr\u00e9sent\u00e9s en millions d'euros). </span>Dans les \u00e9tats financiers de chaque entit\u00e9 du Groupe, les op\u00e9rations libell\u00e9es en devises \u00e9trang\u00e8res sont converties en monnaie fonctionnelle de la filiale au taux de change en vigueur \u00e0 la date de la transaction. Les actifs mon\u00e9taires et les dettes libell\u00e9es en devises \u00e9trang\u00e8res sont convertis au taux de change \u00e0 la date de cl\u00f4ture de l\u2019exercice. Les gains et pertes de change sont comptabilis\u00e9s dans le compte de r\u00e9sultat pour la p\u00e9riode.</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Conversion des \u00e9tats financiers \u00e9tablis en devises \u00e9trang\u00e8res</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers des filiales \u00e9tablis en devises \u00e9trang\u00e8res sont convertis conform\u00e9ment \u00e0 la norme IAS 21 (Effets des variations des cours des monnaies \u00e9trang\u00e8res), selon le concept de monnaie fonctionnelle. Les filiales \u00e9trang\u00e8res sont consid\u00e9r\u00e9es comme des entit\u00e9s ind\u00e9pendantes du Groupe Sartorius Stedim Biotech. Les actifs (y compris le goodwill) et les passifs des entit\u00e9s dont la monnaie fonctionnelle diff\u00e8re de la monnaie de pr\u00e9sentation sont convertis au taux de change en vigueur \u00e0 la date de cl\u00f4ture. Les produits, les charges et les flux de tr\u00e9sorerie sont convertis au taux de change moyen annuel, \u00e0 condition que ce taux refl\u00e8te de mani\u00e8re approximative les taux de change appliqu\u00e9s aux dates des transactions, en l\u2019absence de fluctuations significatives. Les \u00e9carts de conversion r\u00e9sultant de cette conversion sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. Le Groupe applique la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) \u00e0 l'entit\u00e9 situ\u00e9e en Turquie, acquise en juin 2023 (note 12).</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les taux de change des principales devises \u00e9trang\u00e8res par rapport \u00e0 l\u2019euro sont pr\u00e9sent\u00e9s dans le tableau ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change \u00e0 la<br/>date de cl\u00f4ture</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Taux de change<br/> moyens</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">Pour 1 \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">USD</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,17390</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,04140</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,12997</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,08233</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">GBP</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,87370</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,82977</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,85689</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,84658</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CHF</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93130</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,94175</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,93708</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,95236</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">JPY</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">183,89000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,32000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">169,10988</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">163,79945</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">SGD</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,51020</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,41830</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,47572</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,44577</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">KRW</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0698,23000</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0534,45000</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0606,00262</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1\u00a0475,13229</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">CNY</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,20400</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,60150</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,11911</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,78790</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>11. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres produits et charges op\u00e9rationnels</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Gains de change</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">31,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">21,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s \u00e0 la diminution des charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits tir\u00e9s de la reprise de provisions et de passifs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s aux subventions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">16,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">37,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201334,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201316,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201311,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201332,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres charges</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201331,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres charges op\u00e9rationnelles</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201381,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201380,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Total autres produits et charges op\u00e9rationnels</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201325,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201343,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les postes \u00ab gains (pertes) de change \u00bb comprennent les gains (pertes) de change li\u00e9s aux d\u00e9p\u00f4ts bancaires et aux pr\u00eats et dettes de financement libell\u00e9s en devises \u00e9trang\u00e8res.</div><div class=\"defaultParagraph_1 Standard\">Les charges d'int\u00e9r\u00eats vers\u00e9es aux entreprises affili\u00e9es sont li\u00e9es aux pr\u00eats accord\u00e9s par la soci\u00e9t\u00e9 m\u00e8re ultime du Groupe, Sartorius\u00a0AG et par Sartorius Finance B.V., entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par Sartorius\u00a0AG (notes 32 et 45).</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9pr\u00e9ciation de la participation dans l\u2019entreprise associ\u00e9e ViroCell Biologics Ltd. (note 7) \u00e9tait incluse dans les autres charges financi\u00e8res en 2025.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe poss\u00e8de une soci\u00e9t\u00e9 de commerciale bas\u00e9e en Turquie. La Turquie \u00e9tait de nouveau consid\u00e9r\u00e9e et pr\u00e9sent\u00e9e comme une \u00e9conomie hyperinflationniste durant l\u2019exercice. Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier. L'indice g\u00e9n\u00e9ral des prix \u00e0 la consommation de l'Institut turc de statistique a \u00e9t\u00e9 retenu (indice appliqu\u00e9 \u00e0 la fin <span class=\"hyperlink-no-style_1\"></span>2025\u00a0: 3\u00a0483,0\u00a0; fin\u00a02024\u00a0: 2\u00a0657,2\u00a0; augmentation de 131<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-18": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>4. </sub></span><div class=\"list-paragraph-container_1\"><sub>Hypoth\u00e8ses, estimations et retraitements retenus</sub></div></div><div class=\"defaultParagraph_1 Standard\">Lors de la pr\u00e9paration des \u00e9tats financiers consolid\u00e9s, la direction utilise des estimations et hypoth\u00e8ses en ad\u00e9quation avec sa meilleure connaissance de la situation actuelle et future. Cependant, les r\u00e9sultats r\u00e9els peuvent diff\u00e9rer de ces estimations. Ces estimations et hypoth\u00e8ses sont r\u00e9vis\u00e9es r\u00e9guli\u00e8rement, et l'impact des changements est comptabilis\u00e9 de mani\u00e8re prospective.</div><div class=\"defaultParagraph_1 Standard\">L\u2019incertitude g\u00e9n\u00e9rale inh\u00e9rente aux estimations et hypoth\u00e8ses comptables reste relativement \u00e9lev\u00e9e, en partie en raison des changements li\u00e9s \u00e0 la situation g\u00e9opolitique et \u00e9conomique mondiale. Cela inclut la politique tarifaire du gouvernement am\u00e9ricain, les tendances au d\u00e9couplage de divers \u00c9tats, ainsi que des conflits en cours entre la Russie et l\u2019Ukraine sans oublier la situation au Moyen-Orient. En 2025, Sartorius Stedim Biotech a enregistr\u00e9 une croissance \u00e9lev\u00e9e de son chiffre d\u2019affaires (n\u00e9anmoins inf\u00e9rieure \u00e0 deux chiffres), et une am\u00e9lioration de la marge d\u2019EBITDA courant d\u2019environ 3 points de pourcentage, pour atteindre environ 31<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Cette progression a \u00e9t\u00e9 stimul\u00e9e par l\u2019activit\u00e9 des consommables pour la fabrication de produits biopharmaceutiques, favoris\u00e9e par de hautes marges commerciales. A contrario, l\u2019activit\u00e9 li\u00e9e aux \u00e9quipements et syst\u00e8mes de bioproc\u00e9d\u00e9s s\u2019est mod\u00e9r\u00e9e puis stabilis\u00e9e en raison de la r\u00e9ticence des clients \u00e0 investir. Le Groupe continue d\u2019anticiper une croissance rentable dans les ann\u00e9es \u00e0 venir. </div><div class=\"defaultParagraph_1 Standard\">Par ailleurs, la direction du Groupe exerce son jugement pour d\u00e9finir le traitement comptable de certaines transactions lorsque les normes et interpr\u00e9tations en vigueur ne traitent pas de mani\u00e8re pr\u00e9cise les probl\u00e9matiques comptables concern\u00e9es. Les jugements et les estimations significatifs sont d\u00e9crits dans les notes, qui fournissent des explications sur les positions des \u00e9tats financiers consolid\u00e9s si elles se rapportent \u00e0 des \u00e9l\u00e9ments sp\u00e9cifiques. Les hypoth\u00e8ses g\u00e9n\u00e9rales et les estimations portent principalement sur les sujets suivants\u00a0:</div><div class=\"defaultParagraph_1 berschrift4\">Impact de la politique tarifaire du gouvernement des \u00c9tats-Unis</div><div class=\"defaultParagraph_1 Standard\">En 2025, le gouvernement am\u00e9ricain a annonc\u00e9 et introduit des droits de douane suppl\u00e9mentaires et variables sur les importations en provenance de divers pays. Pour Sartorius Stedim Biotech, les droits de douane sur les importations en provenance de l'UE, qui se sont \u00e9lev\u00e9s \u00e0 15 %, sont particuli\u00e8rement importants. Dans l\u2019ensemble, l\u2019impact des droits de douane sur la situation financi\u00e8re et les r\u00e9sultats de Sartorius Stedim Biotech reste contenu et sera att\u00e9nu\u00e9 par diverses mesures compensatoires. Par exemple, la majorit\u00e9 des frais suppl\u00e9mentaires de livraison li\u00e9s \u00e0 cette augmentation des droits de douane se r\u00e9percute directement sur le prix de vente client. En outre, Sartorius Stedim Biotech fabrique localement une part importante des produits qu\u2019elle vend aux Etats-Unis et a continu\u00e9 d\u2019accro\u00eetre sa part sur la valeur ajout\u00e9e locale. Les droits de douane am\u00e9ricains sur les importations en provenance de Chine ont peu affect\u00e9 Sartorius Stedim Biotech, car les importations en provenance de ce pays sont marginales.</div><div class=\"defaultParagraph_1 Standard\">L\u2019incertitude demeure r\u00e9solument \u00e9lev\u00e9e en raison de la volatilit\u00e9 persistante, du caract\u00e8re impr\u00e9visible et d\u00e9routant des d\u00e9cisions \u00e0 venir du gouvernement am\u00e9ricain, ainsi que des r\u00e9actions potentiellement d\u00e9favorables de ses partenaires commerciaux. Le Groupe surveille en permanence les d\u00e9veloppements actuels et examine de pr\u00e8s ses cha\u00eenes d\u2019approvisionnement, ses sites de production et ses cha\u00eenes de valeur afin de pallier l\u2019augmentation continue des droits de douane. En tant que Groupe dont le si\u00e8ge social est situ\u00e9 en France, Sartorius ne se consid\u00e8re pas comme d\u00e9savantag\u00e9 dans un environnement concurrentiel en raison du march\u00e9 g\u00e9n\u00e9ralement r\u00e9glement\u00e9 dans le secteur biopharmaceutique et des cha\u00eenes d\u2019approvisionnement mondiales courantes dans l\u2019industrie.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Conflit entre la Russie et l\u2019Ukraine </div><div class=\"defaultParagraph_1 Standard\">En 2024, le Groupe avait d\u00e9j\u00e0 mis fin aux derni\u00e8res activit\u00e9s commerciales r\u00e9siduelles en Russie. En 2025, aucun changement significatif n\u2019est intervenu pour le Groupe. Celui-ci demeure donc principalement expos\u00e9 \u00e0 d\u2019\u00e9ventuels effets indirects du conflit, tels qu\u2019une hausse de l\u2019inflation, des perturbations des cha\u00eenes d\u2019approvisionnement ou d\u2019\u00e9ventuelles p\u00e9nuries de gaz et d\u2019\u00e9nergie. Le Groupe suit attentivement ces effets indirects et continue actuellement de supposer qu\u2019il existe suffisamment de contre-mesures potentielles pour \u00e9viter un effet significatif sur la rentabilit\u00e9 du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Les liquidit\u00e9s d\u00e9tenues en Russie d\u2019un montant de 6,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 6,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) restent soumises \u00e0 des restrictions quant \u00e0 leur utilisation en dehors de la Russie. Soulignons que toute redistribution significative de liquidit\u00e9s est actuellement impossible.</div><div class=\"defaultParagraph_1 berschrift4\">Impact du conflit au Moyen-Orient </div><div class=\"defaultParagraph_1 Standard\">Le Groupe exploite un site de production de milieux de culture cellulaire \u00e0 Beit HaEmek, dans le nord d\u2019Isra\u00ebl. La production sur site ainsi que le transport et la logistique ont \u00e9t\u00e9 maintenus jusqu\u2019\u00e0 pr\u00e9sent. Une nouvelle escalade du conflit en Isra\u00ebl ou dans l\u2019ensemble de la r\u00e9gion pourrait toutefois entra\u00eener un arr\u00eat temporaire de la production. Afin de renforcer sa r\u00e9silience et d\u2019assurer le respect des d\u00e9lais de livraison, le Groupe a d\u00e9velopp\u00e9 des capacit\u00e9s de secours pour des produits qui n\u2019\u00e9taient jusqu\u2019\u00e0 pr\u00e9sent fabriqu\u00e9s que sur ce site. Dans l\u2019ensemble, le volume d\u2019affaires des produits fabriqu\u00e9s en Isra\u00ebl n\u2019est pas critique pour le Groupe. \u00c0 ce jour, aucun impact significatif n\u2019est relev\u00e9 sur les \u00e9tats financiers consolid\u00e9s.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Evaluation de la juste valeur</div><div class=\"defaultParagraph_1 Standard\">Un certain nombre de r\u00e9glementations comptables et d'informations \u00e0 fournir par le Groupe exige l\u2019\u00e9valuation de la juste valeur, tant pour les actifs et passifs financiers que non financiers, y compris les justes valeurs de niveau 3 (donn\u00e9es non observables).</div><div class=\"defaultParagraph_1 Standard\">Lorsque des informations provenant de tiers, telles que des cotations de courtiers ou des services de valorisation, sont retenus pour d\u00e9terminer la juste valeur, il appartient \u00e0 la direction d\u2019\u00e9valuer les \u00e9l\u00e9ments probants fournis par les tiers afin de s\u2019assurer que ces conclusions satisfont aux exigences des normes IFRS, y compris le niveau de la hi\u00e9rarchie des justes valeurs dans laquelle ces \u00e9valuations doivent \u00eatre class\u00e9es.</div><div class=\"defaultParagraph_1 Standard\">Lors de l\u2019\u00e9valuation de la juste valeur d\u2019un actif ou d\u2019un passif, le Groupe recourt autant que possible \u00e0 des donn\u00e9es de march\u00e9 observables. Si les donn\u00e9es utilis\u00e9es pour \u00e9valuer la juste valeur d\u2019un actif ou d\u2019un passif rel\u00e8vent de diff\u00e9rents niveaux de la hi\u00e9rarchie de la juste valeur, l\u2019\u00e9valuation de la juste valeur est class\u00e9e dans son int\u00e9gralit\u00e9 au niveau de la hi\u00e9rarchie correspondant \u00e0 la donn\u00e9e d\u2019entr\u00e9e de niveau le plus bas ayant une importance significative pour l\u2019ensemble de la mesure. L'\u00e9valuation de la juste valeur est particuli\u00e8rement pertinente pour la comptabilisation des regroupements d'entreprises (note\u00a08), des instruments financiers (note\u00a036) et des paiements fond\u00e9s sur des actions (note\u00a044).</div><div class=\"defaultParagraph_1 berschrift4\">Enjeux li\u00e9s au climat</div><div class=\"defaultParagraph_1 Standard\">Le d\u00e9veloppement durable est l\u2019une des valeurs fondamentales du Groupe. En tant que sous-groupe, Sartorius Stedim Biotech n\u2019a pas adopt\u00e9 d\u2019objectifs distincts en vue d\u00b4att\u00e9nuer son impact climatique, mais s\u2019inscrit dans ceux fix\u00e9s par la soci\u00e9t\u00e9 m\u00e8re, le Groupe Sartorius. Sartorius vise \u00e0 r\u00e9duire ses \u00e9missions brutes de gaz \u00e0 effet de serre (GES) des Scopes 1 et 2 (li\u00e9es au march\u00e9) de 42<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% d\u2019ici 2030 par rapport \u00e0 l\u2019ann\u00e9e de r\u00e9f\u00e9rence 2022. Les \u00e9missions de GES de Scope 3 doivent quant \u00e0 elles \u00eatre r\u00e9duites de 51,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% d\u2019ici 2030 par rapport \u00e0 2022, en rapport avec la valeur ajout\u00e9e. Sartorius r\u00e9visera prochainement ses ambitions en mati\u00e8re d\u00b4objectifs climatiques, ce qui permettra au Groupe d\u2019atteindre la neutralit\u00e9 carbone d\u2019ici 2045.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts futurs attendus li\u00e9s aux mesures relatives au climat sont pris en compte par la direction lors de l\u2019\u00e9laboration des calculs de planification, dans la mesure o\u00f9 ils peuvent \u00eatre estim\u00e9s, et sont donc \u00e9galement int\u00e9gr\u00e9s dans les \u00e9valuations financi\u00e8res associ\u00e9es \u00e0 des fins d'information financi\u00e8re. \u00c0 ce jour, les enjeux li\u00e9s au climat n\u2019ont pas d\u2019impact significatif sur les actifs et passifs du Groupe. En outre, selon l\u2019\u00e9tat actuel des connaissances, aucun effet direct n\u00e9gatif significatif des risques climatiques sur les activit\u00e9s du Groupe n\u2019est attendu.</div><div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Pour cette p\u00e9riode de planification sp\u00e9cifique, des taux de croissance \u00e9lev\u00e9s du chiffre d\u2019affaires (\u00e0 un ou deux chiffres) ainsi que des augmentations mod\u00e9r\u00e9es de la marge d\u2019EBITDA ont \u00e9t\u00e9 adopt\u00e9s. En outre, le Groupe retient, pour les ann\u00e9es post\u00e9rieures \u00e0 2029, un taux de croissance perp\u00e9tuel de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Ce taux d\u00e9rive des anticipations d\u2019inflation \u00e0 long terme et des attentes du march\u00e9, pr\u00e9voyant \u00e0 ce titre une activit\u00e9 croissante pour le march\u00e9 biopharmaceutique cibl\u00e9. Les principaux vecteurs de croissance pour le Groupe Sartorius Stedim Biotech seront le vieillissement et l\u2019augmentation de la population, un acc\u00e8s facilit\u00e9 aux m\u00e9dicaments dans les pays \u00e9mergents, ainsi que la transition continue des produits r\u00e9utilisables vers des produits \u00e0 usage unique utilis\u00e9s dans la bioproduction par l\u2019industrie biopharmaceutique. Par ailleurs, un nombre croissant de nouvelles modalit\u00e9s th\u00e9rapeutiques, notamment dans le domaine des th\u00e9rapies cellulaires et g\u00e9niques, devrait stimuler la croissance des activit\u00e9s du Groupe.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les taux d'actualisation appliqu\u00e9s correspondent au co\u00fbt moyen pond\u00e9r\u00e9 du capital ; ils ont \u00e9t\u00e9 reconnus comme suit\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2025</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2024</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Avant imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Apr\u00e8s imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Avant imp\u00f4t</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Apr\u00e8s imp\u00f4t</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Segment Biopharm</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1%</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,0%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,0%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, le test de d\u00e9pr\u00e9ciation n'a pas conduit \u00e0 la comptabilisation de pertes de valeur. A cet \u00e9gard, diff\u00e9rentes analyses de sensibilit\u00e9, s\u2019appuyant sur des variations raisonnables et r\u00e9alistes des hypoth\u00e8ses d\u00e9crites ci-dessus, n'ont pas non plus mis en \u00e9vidence de d\u00e9pr\u00e9ciation. Les variations suivantes repr\u00e9senteraient th\u00e9oriquement le \u00ab\u00a0seuil de rentabilit\u00e9\u00a0\u00bb, o\u00f9 la valeur recouvrable serait \u00e9gale \u00e0 la valeur comptable nette :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,5%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux de croissance perp\u00e9tuel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,6%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,4%</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Flux de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201347,1%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,0%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9valuation des obligations concernant les avantages post\u00e9rieurs \u00e0 l\u2019emploi repose sur les principales hypoth\u00e8ses actuarielles suivantes\u00a0:</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Pour l'Allemagne\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en %</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,80</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,17</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des salaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,00</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,00</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des pensions de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,10</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,10</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Pour la France\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en %</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,80</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,30</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des salaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,60</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,25</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les hypoth\u00e8ses de mortalit\u00e9 et d'invalidit\u00e9 s\u2019appuient sur les tables \u00ab\u00a0Richttafeln (RT) 2018 G\u00a0\u00bb de Klaus Heubeck pour l\u2019Allemagne et le tableau \u00ab\u00a0INSEE F 2016-2018\u00a0\u00bb pour la France.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-19": {
   "value": "4. Hypoth\u00e8ses, estimations et retraitements retenusLors de la pr\u00e9paration des \u00e9tats financiers consolid\u00e9s, la direction utilise des estimations et hypoth\u00e8ses en ad\u00e9quation avec sa meilleure connaissance de la situation actuelle et future. Cependant, les r\u00e9sultats r\u00e9els peuvent diff\u00e9rer de ces estimations. Ces estimations et hypoth\u00e8ses sont r\u00e9vis\u00e9es r\u00e9guli\u00e8rement, et l'impact des changements est comptabilis\u00e9 de mani\u00e8re prospective.L\u2019incertitude g\u00e9n\u00e9rale inh\u00e9rente aux estimations et hypoth\u00e8ses comptables reste relativement \u00e9lev\u00e9e, en partie en raison des changements li\u00e9s \u00e0 la situation g\u00e9opolitique et \u00e9conomique mondiale. Cela inclut la politique tarifaire du gouvernement am\u00e9ricain, les tendances au d\u00e9couplage de divers \u00c9tats, ainsi que des conflits en cours entre la Russie et l\u2019Ukraine sans oublier la situation au Moyen-Orient. En 2025, Sartorius Stedim Biotech a enregistr\u00e9 une croissance \u00e9lev\u00e9e de son chiffre d\u2019affaires (n\u00e9anmoins inf\u00e9rieure \u00e0 deux chiffres), et une am\u00e9lioration de la marge d\u2019EBITDA courant d\u2019environ 3 points de pourcentage, pour atteindre environ 31\u00a0%. Cette progression a \u00e9t\u00e9 stimul\u00e9e par l\u2019activit\u00e9 des consommables pour la fabrication de produits biopharmaceutiques, favoris\u00e9e par de hautes marges commerciales. A contrario, l\u2019activit\u00e9 li\u00e9e aux \u00e9quipements et syst\u00e8mes de bioproc\u00e9d\u00e9s s\u2019est mod\u00e9r\u00e9e puis stabilis\u00e9e en raison de la r\u00e9ticence des clients \u00e0 investir. Le Groupe continue d\u2019anticiper une croissance rentable dans les ann\u00e9es \u00e0 venir. Par ailleurs, la direction du Groupe exerce son jugement pour d\u00e9finir le traitement comptable de certaines transactions lorsque les normes et interpr\u00e9tations en vigueur ne traitent pas de mani\u00e8re pr\u00e9cise les probl\u00e9matiques comptables concern\u00e9es. Les jugements et les estimations significatifs sont d\u00e9crits dans les notes, qui fournissent des explications sur les positions des \u00e9tats financiers consolid\u00e9s si elles se rapportent \u00e0 des \u00e9l\u00e9ments sp\u00e9cifiques. Les hypoth\u00e8ses g\u00e9n\u00e9rales et les estimations portent principalement sur les sujets suivants\u00a0:Impact de la politique tarifaire du gouvernement des \u00c9tats-UnisEn 2025, le gouvernement am\u00e9ricain a annonc\u00e9 et introduit des droits de douane suppl\u00e9mentaires et variables sur les importations en provenance de divers pays. Pour Sartorius Stedim Biotech, les droits de douane sur les importations en provenance de l'UE, qui se sont \u00e9lev\u00e9s \u00e0 15 %, sont particuli\u00e8rement importants. Dans l\u2019ensemble, l\u2019impact des droits de douane sur la situation financi\u00e8re et les r\u00e9sultats de Sartorius Stedim Biotech reste contenu et sera att\u00e9nu\u00e9 par diverses mesures compensatoires. Par exemple, la majorit\u00e9 des frais suppl\u00e9mentaires de livraison li\u00e9s \u00e0 cette augmentation des droits de douane se r\u00e9percute directement sur le prix de vente client. En outre, Sartorius Stedim Biotech fabrique localement une part importante des produits qu\u2019elle vend aux Etats-Unis et a continu\u00e9 d\u2019accro\u00eetre sa part sur la valeur ajout\u00e9e locale. Les droits de douane am\u00e9ricains sur les importations en provenance de Chine ont peu affect\u00e9 Sartorius Stedim Biotech, car les importations en provenance de ce pays sont marginales.L\u2019incertitude demeure r\u00e9solument \u00e9lev\u00e9e en raison de la volatilit\u00e9 persistante, du caract\u00e8re impr\u00e9visible et d\u00e9routant des d\u00e9cisions \u00e0 venir du gouvernement am\u00e9ricain, ainsi que des r\u00e9actions potentiellement d\u00e9favorables de ses partenaires commerciaux. Le Groupe surveille en permanence les d\u00e9veloppements actuels et examine de pr\u00e8s ses cha\u00eenes d\u2019approvisionnement, ses sites de production et ses cha\u00eenes de valeur afin de pallier l\u2019augmentation continue des droits de douane. En tant que Groupe dont le si\u00e8ge social est situ\u00e9 en France, Sartorius ne se consid\u00e8re pas comme d\u00e9savantag\u00e9 dans un environnement concurrentiel en raison du march\u00e9 g\u00e9n\u00e9ralement r\u00e9glement\u00e9 dans le secteur biopharmaceutique et des cha\u00eenes d\u2019approvisionnement mondiales courantes dans l\u2019industrie.Conflit entre la Russie et l\u2019Ukraine En 2024, le Groupe avait d\u00e9j\u00e0 mis fin aux derni\u00e8res activit\u00e9s commerciales r\u00e9siduelles en Russie. En 2025, aucun changement significatif n\u2019est intervenu pour le Groupe. Celui-ci demeure donc principalement expos\u00e9 \u00e0 d\u2019\u00e9ventuels effets indirects du conflit, tels qu\u2019une hausse de l\u2019inflation, des perturbations des cha\u00eenes d\u2019approvisionnement ou d\u2019\u00e9ventuelles p\u00e9nuries de gaz et d\u2019\u00e9nergie. Le Groupe suit attentivement ces effets indirects et continue actuellement de supposer qu\u2019il existe suffisamment de contre-mesures potentielles pour \u00e9viter un effet significatif sur la rentabilit\u00e9 du Groupe.Les liquidit\u00e9s d\u00e9tenues en Russie d\u2019un montant de 6,5\u00a0millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 6,5\u00a0millions d\u2019euros) restent soumises \u00e0 des restrictions quant \u00e0 leur utilisation en dehors de la Russie. Soulignons que toute redistribution significative de liquidit\u00e9s est actuellement impossible.Impact du conflit au Moyen-Orient Le Groupe exploite un site de production de milieux de culture cellulaire \u00e0 Beit HaEmek, dans le nord d\u2019Isra\u00ebl. La production sur site ainsi que le transport et la logistique ont \u00e9t\u00e9 maintenus jusqu\u2019\u00e0 pr\u00e9sent. Une nouvelle escalade du conflit en Isra\u00ebl ou dans l\u2019ensemble de la r\u00e9gion pourrait toutefois entra\u00eener un arr\u00eat temporaire de la production. Afin de renforcer sa r\u00e9silience et d\u2019assurer le respect des d\u00e9lais de livraison, le Groupe a d\u00e9velopp\u00e9 des capacit\u00e9s de secours pour des produits qui n\u2019\u00e9taient jusqu\u2019\u00e0 pr\u00e9sent fabriqu\u00e9s que sur ce site. Dans l\u2019ensemble, le volume d\u2019affaires des produits fabriqu\u00e9s en Isra\u00ebl n\u2019est pas critique pour le Groupe. \u00c0 ce jour, aucun impact significatif n\u2019est relev\u00e9 sur les \u00e9tats financiers consolid\u00e9s.D\u00e9pr\u00e9ciation d'actifsLes valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.Evaluation de la juste valeurUn certain nombre de r\u00e9glementations comptables et d'informations \u00e0 fournir par le Groupe exige l\u2019\u00e9valuation de la juste valeur, tant pour les actifs et passifs financiers que non financiers, y compris les justes valeurs de niveau 3 (donn\u00e9es non observables).Lorsque des informations provenant de tiers, telles que des cotations de courtiers ou des services de valorisation, sont retenus pour d\u00e9terminer la juste valeur, il appartient \u00e0 la direction d\u2019\u00e9valuer les \u00e9l\u00e9ments probants fournis par les tiers afin de s\u2019assurer que ces conclusions satisfont aux exigences des normes IFRS, y compris le niveau de la hi\u00e9rarchie des justes valeurs dans laquelle ces \u00e9valuations doivent \u00eatre class\u00e9es.Lors de l\u2019\u00e9valuation de la juste valeur d\u2019un actif ou d\u2019un passif, le Groupe recourt autant que possible \u00e0 des donn\u00e9es de march\u00e9 observables. Si les donn\u00e9es utilis\u00e9es pour \u00e9valuer la juste valeur d\u2019un actif ou d\u2019un passif rel\u00e8vent de diff\u00e9rents niveaux de la hi\u00e9rarchie de la juste valeur, l\u2019\u00e9valuation de la juste valeur est class\u00e9e dans son int\u00e9gralit\u00e9 au niveau de la hi\u00e9rarchie correspondant \u00e0 la donn\u00e9e d\u2019entr\u00e9e de niveau le plus bas ayant une importance significative pour l\u2019ensemble de la mesure. L'\u00e9valuation de la juste valeur est particuli\u00e8rement pertinente pour la comptabilisation des regroupements d'entreprises (note\u00a08), des instruments financiers (note\u00a036) et des paiements fond\u00e9s sur des actions (note\u00a044).Enjeux li\u00e9s au climatLe d\u00e9veloppement durable est l\u2019une des valeurs fondamentales du Groupe. En tant que sous-groupe, Sartorius Stedim Biotech n\u2019a pas adopt\u00e9 d\u2019objectifs distincts en vue d\u00b4att\u00e9nuer son impact climatique, mais s\u2019inscrit dans ceux fix\u00e9s par la soci\u00e9t\u00e9 m\u00e8re, le Groupe Sartorius. Sartorius vise \u00e0 r\u00e9duire ses \u00e9missions brutes de gaz \u00e0 effet de serre (GES) des Scopes 1 et 2 (li\u00e9es au march\u00e9) de 42\u00a0% d\u2019ici 2030 par rapport \u00e0 l\u2019ann\u00e9e de r\u00e9f\u00e9rence 2022. Les \u00e9missions de GES de Scope 3 doivent quant \u00e0 elles \u00eatre r\u00e9duites de 51,6\u00a0% d\u2019ici 2030 par rapport \u00e0 2022, en rapport avec la valeur ajout\u00e9e. Sartorius r\u00e9visera prochainement ses ambitions en mati\u00e8re d\u00b4objectifs climatiques, ce qui permettra au Groupe d\u2019atteindre la neutralit\u00e9 carbone d\u2019ici 2045.Les co\u00fbts futurs attendus li\u00e9s aux mesures relatives au climat sont pris en compte par la direction lors de l\u2019\u00e9laboration des calculs de planification, dans la mesure o\u00f9 ils peuvent \u00eatre estim\u00e9s, et sont donc \u00e9galement int\u00e9gr\u00e9s dans les \u00e9valuations financi\u00e8res associ\u00e9es \u00e0 des fins d'information financi\u00e8re. \u00c0 ce jour, les enjeux li\u00e9s au climat n\u2019ont pas d\u2019impact significatif sur les actifs et passifs du Groupe. En outre, selon l\u2019\u00e9tat actuel des connaissances, aucun effet direct n\u00e9gatif significatif des risques climatiques sur les activit\u00e9s du Groupe n\u2019est attendu.Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.Comme en 2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour 2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.Pour cette p\u00e9riode de planification sp\u00e9cifique, des taux de croissance \u00e9lev\u00e9s du chiffre d\u2019affaires (\u00e0 un ou deux chiffres) ainsi que des augmentations mod\u00e9r\u00e9es de la marge d\u2019EBITDA ont \u00e9t\u00e9 adopt\u00e9s. En outre, le Groupe retient, pour les ann\u00e9es post\u00e9rieures \u00e0 2029, un taux de croissance perp\u00e9tuel de 2,5\u00a0%. Ce taux d\u00e9rive des anticipations d\u2019inflation \u00e0 long terme et des attentes du march\u00e9, pr\u00e9voyant \u00e0 ce titre une activit\u00e9 croissante pour le march\u00e9 biopharmaceutique cibl\u00e9. Les principaux vecteurs de croissance pour le Groupe Sartorius Stedim Biotech seront le vieillissement et l\u2019augmentation de la population, un acc\u00e8s facilit\u00e9 aux m\u00e9dicaments dans les pays \u00e9mergents, ainsi que la transition continue des produits r\u00e9utilisables vers des produits \u00e0 usage unique utilis\u00e9s dans la bioproduction par l\u2019industrie biopharmaceutique. Par ailleurs, un nombre croissant de nouvelles modalit\u00e9s th\u00e9rapeutiques, notamment dans le domaine des th\u00e9rapies cellulaires et g\u00e9niques, devrait stimuler la croissance des activit\u00e9s du Groupe.Les taux d'actualisation appliqu\u00e9s correspondent au co\u00fbt moyen pond\u00e9r\u00e9 du capital ; ils ont \u00e9t\u00e9 reconnus comme suit\u00a0:\u00a020252024\u00a0Avant imp\u00f4tApr\u00e8s imp\u00f4tAvant imp\u00f4tApr\u00e8s imp\u00f4tSegment Biopharm11,1%8,7%10,0%8,0%",
   "dimensions": {
    "concept": "ifrs-full:ExplanationOfAssumptionAboutFutureWithSignificantRiskOfResultingInMaterialAdjustments",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-20": {
   "value": "Les liquidit\u00e9s d\u00e9tenues en Russie d\u2019un montant de 6,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 6,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) restent soumises \u00e0 des restrictions quant \u00e0 leur utilisation en dehors de la Russie. Soulignons que toute redistribution significative de liquidit\u00e9s est actuellement impossible.<div class=\"defaultParagraph_1 Standard\">Les fonds en liquidit\u00e9s pr\u00e9sents localement dans certains pays (par exemple, la Chine et l\u2019Inde) ne sont disponibles pour le Groupe que pour des transactions transfrontali\u00e8res soumises \u00e0 des contr\u00f4les des changes. Pour les restrictions concernant les fonds d\u00e9tenus par les entit\u00e9s russes du Groupe, veuillez consulter la note\u00a04.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-21": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div>Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">L\u2019amortissement des immobilisations incorporelles se r\u00e9f\u00e8re aux dur\u00e9es de vie utiles suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>Logiciel</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2 \u00e0 10 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Technologies</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3 \u00e0 20 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">4 \u00e0 6 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Relations client</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1 \u00e0 20 ans</div></td></tr><tr><td class=\"daba0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Marque</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">De 2 ans \u00e0 l'infini</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">A compter du 31 d\u00e9cembre 2025, le poste \u00ab Brevets, licences et droits similaires \u00bb inclut les technologies issues de l\u2019acquisition de Polyplus, pour un montant d\u2019environ 659,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 705,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent), avec des dur\u00e9es de vie utiles allant jusqu\u2019\u00e0 16 ans.</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Les amortissements des immobilisations incorporelles sont affect\u00e9s aux fonctions correspondantes dans le compte de r\u00e9sultat. Pour les frais de d\u00e9veloppement capitalis\u00e9s, les amortissements sont comptabilis\u00e9s en \u00ab\u00a0co\u00fbts des ventes\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-22": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div>Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div>Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur.",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-23": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>16. </sub></span><div class=\"list-paragraph-container_1\"><sub>Goodwill et autres immobilisations incorporelles</sub></div></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Goodwill</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Goodwill</div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0885,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left; margin-top:1px; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Goodwill</span></div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u201324,1</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Regroupement d'entreprises</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2025</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles. A l\u2019instar de l\u2019exercice pr\u00e9c\u00e9dent, aucun regroupement d\u2019entreprises n\u2019a \u00e9t\u00e9 finalis\u00e9 en 2025.</div><div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Pour cette p\u00e9riode de planification sp\u00e9cifique, des taux de croissance \u00e9lev\u00e9s du chiffre d\u2019affaires (\u00e0 un ou deux chiffres) ainsi que des augmentations mod\u00e9r\u00e9es de la marge d\u2019EBITDA ont \u00e9t\u00e9 adopt\u00e9s. En outre, le Groupe retient, pour les ann\u00e9es post\u00e9rieures \u00e0 2029, un taux de croissance perp\u00e9tuel de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Ce taux d\u00e9rive des anticipations d\u2019inflation \u00e0 long terme et des attentes du march\u00e9, pr\u00e9voyant \u00e0 ce titre une activit\u00e9 croissante pour le march\u00e9 biopharmaceutique cibl\u00e9. Les principaux vecteurs de croissance pour le Groupe Sartorius Stedim Biotech seront le vieillissement et l\u2019augmentation de la population, un acc\u00e8s facilit\u00e9 aux m\u00e9dicaments dans les pays \u00e9mergents, ainsi que la transition continue des produits r\u00e9utilisables vers des produits \u00e0 usage unique utilis\u00e9s dans la bioproduction par l\u2019industrie biopharmaceutique. Par ailleurs, un nombre croissant de nouvelles modalit\u00e9s th\u00e9rapeutiques, notamment dans le domaine des th\u00e9rapies cellulaires et g\u00e9niques, devrait stimuler la croissance des activit\u00e9s du Groupe.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les taux d'actualisation appliqu\u00e9s correspondent au co\u00fbt moyen pond\u00e9r\u00e9 du capital ; ils ont \u00e9t\u00e9 reconnus comme suit\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2025</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2024</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Avant imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Apr\u00e8s imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Avant imp\u00f4t</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Apr\u00e8s imp\u00f4t</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Segment Biopharm</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1%</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,0%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,0%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, le test de d\u00e9pr\u00e9ciation n'a pas conduit \u00e0 la comptabilisation de pertes de valeur. A cet \u00e9gard, diff\u00e9rentes analyses de sensibilit\u00e9, s\u2019appuyant sur des variations raisonnables et r\u00e9alistes des hypoth\u00e8ses d\u00e9crites ci-dessus, n'ont pas non plus mis en \u00e9vidence de d\u00e9pr\u00e9ciation. Les variations suivantes repr\u00e9senteraient th\u00e9oriquement le \u00ab\u00a0seuil de rentabilit\u00e9\u00a0\u00bb, o\u00f9 la valeur recouvrable serait \u00e9gale \u00e0 la valeur comptable nette :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,5%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux de croissance perp\u00e9tuel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,6%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,4%</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Flux de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201347,1%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,0%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-24": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>16. </sub></span><div class=\"list-paragraph-container_1\"><sub>Goodwill et autres immobilisations incorporelles</sub></div></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Goodwill</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Goodwill</div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0885,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left; margin-top:1px; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Goodwill</span></div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u201324,1</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Regroupement d'entreprises</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2025</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles. A l\u2019instar de l\u2019exercice pr\u00e9c\u00e9dent, aucun regroupement d\u2019entreprises n\u2019a \u00e9t\u00e9 finalis\u00e9 en 2025.</div><div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Pour cette p\u00e9riode de planification sp\u00e9cifique, des taux de croissance \u00e9lev\u00e9s du chiffre d\u2019affaires (\u00e0 un ou deux chiffres) ainsi que des augmentations mod\u00e9r\u00e9es de la marge d\u2019EBITDA ont \u00e9t\u00e9 adopt\u00e9s. En outre, le Groupe retient, pour les ann\u00e9es post\u00e9rieures \u00e0 2029, un taux de croissance perp\u00e9tuel de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Ce taux d\u00e9rive des anticipations d\u2019inflation \u00e0 long terme et des attentes du march\u00e9, pr\u00e9voyant \u00e0 ce titre une activit\u00e9 croissante pour le march\u00e9 biopharmaceutique cibl\u00e9. Les principaux vecteurs de croissance pour le Groupe Sartorius Stedim Biotech seront le vieillissement et l\u2019augmentation de la population, un acc\u00e8s facilit\u00e9 aux m\u00e9dicaments dans les pays \u00e9mergents, ainsi que la transition continue des produits r\u00e9utilisables vers des produits \u00e0 usage unique utilis\u00e9s dans la bioproduction par l\u2019industrie biopharmaceutique. Par ailleurs, un nombre croissant de nouvelles modalit\u00e9s th\u00e9rapeutiques, notamment dans le domaine des th\u00e9rapies cellulaires et g\u00e9niques, devrait stimuler la croissance des activit\u00e9s du Groupe.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les taux d'actualisation appliqu\u00e9s correspondent au co\u00fbt moyen pond\u00e9r\u00e9 du capital ; ils ont \u00e9t\u00e9 reconnus comme suit\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2025</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2024</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Avant imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Apr\u00e8s imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Avant imp\u00f4t</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Apr\u00e8s imp\u00f4t</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Segment Biopharm</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1%</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,0%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,0%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, le test de d\u00e9pr\u00e9ciation n'a pas conduit \u00e0 la comptabilisation de pertes de valeur. A cet \u00e9gard, diff\u00e9rentes analyses de sensibilit\u00e9, s\u2019appuyant sur des variations raisonnables et r\u00e9alistes des hypoth\u00e8ses d\u00e9crites ci-dessus, n'ont pas non plus mis en \u00e9vidence de d\u00e9pr\u00e9ciation. Les variations suivantes repr\u00e9senteraient th\u00e9oriquement le \u00ab\u00a0seuil de rentabilit\u00e9\u00a0\u00bb, o\u00f9 la valeur recouvrable serait \u00e9gale \u00e0 la valeur comptable nette :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,5%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux de croissance perp\u00e9tuel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,6%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,4%</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Flux de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201347,1%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,0%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Immobilisations incorporelles</div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d57eb77\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"d04ce71\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Marque</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Relations clients</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"c27fe3\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"d2b86e4\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0468,9</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">33,7</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,2</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,8</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0198,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">82,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0484,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">34,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">352,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">429,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0302,3</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s<br/>au 1<sup>er</sup> janv. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013217,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013163,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013119,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013504,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,4</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013100,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201319,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201342,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013164,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20136,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013182,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013160,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013670,6</div></td></tr><tr><td class=\"fb5602\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"d63f045\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0163,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">27,4</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">170,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">269,1</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0631,7</div></td></tr><tr><td class=\"d57e8cf\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e2fd43\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a465a7\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d791d98\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Marque</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Relations clients</div></td><td class=\"cb49ac\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Acomptes vers\u00e9s</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d29461\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6b9bd7\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0484,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">34,0</div></td><td class=\"d59c7d6\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">352,9</div></td><td class=\"d792f0f\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">429,3</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d44d455\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0302,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201315,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20138,7</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,6</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Regroupement d'entreprises</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Acquisitions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">90,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">93,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0470,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">33,8</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">338,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">508,5</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0352,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s <br/>au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,6</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013182,9</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013160,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013670,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,8</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201395,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,5</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201318,1</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201352,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013168,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises sur cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">14,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013410,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20139,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013191,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013204,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013815,3</div></td></tr><tr><td class=\"d56ee30\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d3085b5\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0059,5</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,8</div></td><td class=\"fa1b9c\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">147,0</div></td><td class=\"d9857f8\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">303,9</div></td><td class=\"d99a874\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d531c79\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0536,7</div></td></tr><tr><td class=\"ed9345\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2586f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2ea1fa\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">L\u2019amortissement des immobilisations incorporelles se r\u00e9f\u00e8re aux dur\u00e9es de vie utiles suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>Logiciel</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2 \u00e0 10 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Technologies</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3 \u00e0 20 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">4 \u00e0 6 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Relations client</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1 \u00e0 20 ans</div></td></tr><tr><td class=\"daba0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Marque</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">De 2 ans \u00e0 l'infini</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">A compter du 31 d\u00e9cembre 2025, le poste \u00ab Brevets, licences et droits similaires \u00bb inclut les technologies issues de l\u2019acquisition de Polyplus, pour un montant d\u2019environ 659,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 705,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent), avec des dur\u00e9es de vie utiles allant jusqu\u2019\u00e0 16 ans.</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Les amortissements des immobilisations incorporelles sont affect\u00e9s aux fonctions correspondantes dans le compte de r\u00e9sultat. Pour les frais de d\u00e9veloppement capitalis\u00e9s, les amortissements sont comptabilis\u00e9s en \u00ab\u00a0co\u00fbts des ventes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 Standard\">Des d\u00e9pr\u00e9ciations d'un montant de <span class=\"hyperlink-no-style_1\"></span>0,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros ont \u00e9t\u00e9 constat\u00e9es en <span class=\"hyperlink-no-style_1\"></span>2025 sur les frais de d\u00e9veloppement capitalis\u00e9s (7,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Ces pertes de valeur sont renseign\u00e9es dans le compte de r\u00e9sultat au poste de \u00ab\u00a0frais de recherche et d\u00e9veloppement\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-25": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div>La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.<div class=\"defaultParagraph_1 Standard\">La d\u00e9pr\u00e9ciation de la participation dans l\u2019entreprise associ\u00e9e ViroCell Biologics Ltd. (note 7) \u00e9tait incluse dans les autres charges financi\u00e8res en 2025.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>16. </sub></span><div class=\"list-paragraph-container_1\"><sub>Goodwill et autres immobilisations incorporelles</sub></div></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Goodwill</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Goodwill</div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0885,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0907,9</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left; margin-top:1px; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Goodwill</span></div></td></tr><tr><td class=\"a0df03\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0907,9</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u201324,1</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Regroupement d'entreprises</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 1<sup>er</sup> janv. 2025</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Pertes li\u00e9es aux tests de d\u00e9pr\u00e9ciation au 31 d\u00e9c. 2025</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d0be3cd\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden; margin-top:1px; margin-bottom:2px\">2\u00a0883,8</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles. A l\u2019instar de l\u2019exercice pr\u00e9c\u00e9dent, aucun regroupement d\u2019entreprises n\u2019a \u00e9t\u00e9 finalis\u00e9 en 2025.</div><div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Pour cette p\u00e9riode de planification sp\u00e9cifique, des taux de croissance \u00e9lev\u00e9s du chiffre d\u2019affaires (\u00e0 un ou deux chiffres) ainsi que des augmentations mod\u00e9r\u00e9es de la marge d\u2019EBITDA ont \u00e9t\u00e9 adopt\u00e9s. En outre, le Groupe retient, pour les ann\u00e9es post\u00e9rieures \u00e0 2029, un taux de croissance perp\u00e9tuel de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Ce taux d\u00e9rive des anticipations d\u2019inflation \u00e0 long terme et des attentes du march\u00e9, pr\u00e9voyant \u00e0 ce titre une activit\u00e9 croissante pour le march\u00e9 biopharmaceutique cibl\u00e9. Les principaux vecteurs de croissance pour le Groupe Sartorius Stedim Biotech seront le vieillissement et l\u2019augmentation de la population, un acc\u00e8s facilit\u00e9 aux m\u00e9dicaments dans les pays \u00e9mergents, ainsi que la transition continue des produits r\u00e9utilisables vers des produits \u00e0 usage unique utilis\u00e9s dans la bioproduction par l\u2019industrie biopharmaceutique. Par ailleurs, un nombre croissant de nouvelles modalit\u00e9s th\u00e9rapeutiques, notamment dans le domaine des th\u00e9rapies cellulaires et g\u00e9niques, devrait stimuler la croissance des activit\u00e9s du Groupe.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les taux d'actualisation appliqu\u00e9s correspondent au co\u00fbt moyen pond\u00e9r\u00e9 du capital ; ils ont \u00e9t\u00e9 reconnus comme suit\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2025</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">2024</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Avant imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Apr\u00e8s imp\u00f4t</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Avant imp\u00f4t</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Apr\u00e8s imp\u00f4t</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Segment Biopharm</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1%</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,0%</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,0%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, le test de d\u00e9pr\u00e9ciation n'a pas conduit \u00e0 la comptabilisation de pertes de valeur. A cet \u00e9gard, diff\u00e9rentes analyses de sensibilit\u00e9, s\u2019appuyant sur des variations raisonnables et r\u00e9alistes des hypoth\u00e8ses d\u00e9crites ci-dessus, n'ont pas non plus mis en \u00e9vidence de d\u00e9pr\u00e9ciation. Les variations suivantes repr\u00e9senteraient th\u00e9oriquement le \u00ab\u00a0seuil de rentabilit\u00e9\u00a0\u00bb, o\u00f9 la valeur recouvrable serait \u00e9gale \u00e0 la valeur comptable nette :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,5%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux de croissance perp\u00e9tuel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,6%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,4%</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Flux de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201347,1%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,0%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Immobilisations incorporelles</div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d57eb77\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"d04ce71\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Marque</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Relations clients</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"c27fe3\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"d2b86e4\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0468,9</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">33,7</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,2</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,8</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0198,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">82,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0484,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">34,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">352,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">429,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0302,3</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s<br/>au 1<sup>er</sup> janv. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013217,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013163,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013119,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013504,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,4</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013100,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201319,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201342,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013164,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20136,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013182,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013160,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013670,6</div></td></tr><tr><td class=\"fb5602\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"d63f045\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0163,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">27,4</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">170,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">269,1</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0631,7</div></td></tr><tr><td class=\"d57e8cf\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e2fd43\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a465a7\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d791d98\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Marque</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Relations clients</div></td><td class=\"cb49ac\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Acomptes vers\u00e9s</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d29461\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6b9bd7\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0484,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">34,0</div></td><td class=\"d59c7d6\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">352,9</div></td><td class=\"d792f0f\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">429,3</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d44d455\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0302,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201315,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20138,7</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,6</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Regroupement d'entreprises</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Acquisitions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">90,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">93,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0470,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">33,8</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">338,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">508,5</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0352,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s <br/>au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,6</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013182,9</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013160,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013670,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,8</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201395,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,5</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201318,1</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201352,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013168,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises sur cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">14,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013410,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20139,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013191,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013204,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013815,3</div></td></tr><tr><td class=\"d56ee30\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d3085b5\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0059,5</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,8</div></td><td class=\"fa1b9c\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">147,0</div></td><td class=\"d9857f8\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">303,9</div></td><td class=\"d99a874\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d531c79\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0536,7</div></td></tr><tr><td class=\"ed9345\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2586f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2ea1fa\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Des d\u00e9pr\u00e9ciations d'un montant de <span class=\"hyperlink-no-style_1\"></span>0,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros ont \u00e9t\u00e9 constat\u00e9es en <span class=\"hyperlink-no-style_1\"></span>2025 sur les frais de d\u00e9veloppement capitalis\u00e9s (7,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Ces pertes de valeur sont renseign\u00e9es dans le compte de r\u00e9sultat au poste de \u00ab\u00a0frais de recherche et d\u00e9veloppement\u00a0\u00bb.</div><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, comme pour l'exercice <span class=\"hyperlink-no-style_1\"></span>2024, aucune d\u00e9pr\u00e9ciation significative n\u2019a \u00e9t\u00e9 comptabilis\u00e9e sur les immobilisations corporelles.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-26": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div>Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div>Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur.<div class=\"defaultParagraph_1 Standard\">Les stocks doivent \u00eatre \u00e9valu\u00e9s au plus faible du co\u00fbt et de la valeur nette de r\u00e9alisation. La valeur nette de r\u00e9alisation correspond au prix de vente estim\u00e9 dans le cours normal de l\u2019activit\u00e9, diminu\u00e9 des co\u00fbts estim\u00e9s d\u2019ach\u00e8vement ainsi que des co\u00fbts estim\u00e9s n\u00e9cessaires \u00e0 la commercialisation, \u00e0 la vente et \u00e0 la distribution. Lorsque des risques li\u00e9s aux stocks existent, tels que le risque de r\u00e9duction de la dur\u00e9e de conservation en raison des p\u00e9riodes de stockage ou d\u2019une utilisabilit\u00e9 limit\u00e9e, des d\u00e9pr\u00e9ciations sont comptabilis\u00e9es en cons\u00e9quence.</div><div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-27": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation d'actifs</div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des immobilisations corporelles (notes\u00a017 et 18) et incorporelles, y compris le goodwill (note\u00a016), sont soumises \u00e0 un test de d\u00e9pr\u00e9ciation lorsqu\u2019il existe un indice de perte de valeur et, au moins un fois par an, pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e ou non encore disponibles \u00e0 l'utilisation, conform\u00e9ment \u00e0 la norme IAS\u00a036 (D\u00e9pr\u00e9ciation d\u2019actifs). Lorsqu'un actif est soumis \u00e0 un test de d\u00e9pr\u00e9ciation, la valeur recouvrable de l'actif est estim\u00e9e. La valeur recouvrable d'un actif ou d'une unit\u00e9 g\u00e9n\u00e9ratrice de tr\u00e9sorerie (UGT) correspond \u00e0 la valeur la plus \u00e9lev\u00e9e entre sa juste valeur diminu\u00e9e des co\u00fbts de sortie et sa valeur d'utilit\u00e9. Lorsque la valeur recouvrable d\u2019un actif individuel ne peut \u00eatre estim\u00e9e, la valeur recouvrable de l\u2019UGT \u00e0 laquelle il appartient d\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Lorsque la valeur recouvrable estim\u00e9e d'un actif (ou d'une UGT) devient inf\u00e9rieure \u00e0 sa valeur comptable, cette derni\u00e8re est ramen\u00e9e \u00e0 la valeur recouvrable (la perte de valeur \u00e9tant alors affect\u00e9e en priorit\u00e9 au goodwill). Si les causes de la d\u00e9pr\u00e9ciation des actifs ne s\u2019appliquent plus, la valeur comptable de l'actif (ou de l'UGT) est augment\u00e9e jusqu\u2019\u00e0 la valeur recouvrable nouvellement estim\u00e9e (\u00e0 l\u2019exception du goodwill). Toutefois, l'augmentation de la valeur comptable est limit\u00e9e \u00e0 la valeur que l'actif (ou l\u2019UGT) aurait eue si aucune perte de valeur n'avait \u00e9t\u00e9 comptabilis\u00e9e au cours des exercices ant\u00e9rieurs.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le calcul de la valeur d\u2019utilit\u00e9 repose g\u00e9n\u00e9ralement sur les m\u00e9thodes d\u2019actualisation des flux de tr\u00e9sorerie, fond\u00e9es sur des projections de flux couvrant une p\u00e9riode maximale de cinq ans. Ces projections tiennent lieu de l\u2019exp\u00e9rience pass\u00e9e et traduisent les choix de la direction quant \u00e0 la meilleure estimation de l'\u00e9volution du chiffre d'affaires et des co\u00fbts. Les flux de tr\u00e9sorerie au-del\u00e0 de la p\u00e9riode de planification sont extrapol\u00e9s \u00e0 l\u2019aide de taux de croissance sp\u00e9cifiques. Les hypoth\u00e8ses principales retenues par la direction pour la d\u00e9termination de la valeur d'utilit\u00e9 comprennent notamment l\u2019estimation des taux de croissance de l\u2019activit\u00e9, les marges de rentabilit\u00e9, le co\u00fbt moyen pond\u00e9r\u00e9 du capital et les taux d'imposition. Ces estimations peuvent avoir une incidence importante sur le calcul des valeurs d\u00e9termin\u00e9es et se r\u00e9percutent, en fin de compte, sur le montant d\u2019\u00e9ventuelles pertes de valeur.</div>Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-28": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">Evaluation de la juste valeur</div><div class=\"defaultParagraph_1 Standard\">Un certain nombre de r\u00e9glementations comptables et d'informations \u00e0 fournir par le Groupe exige l\u2019\u00e9valuation de la juste valeur, tant pour les actifs et passifs financiers que non financiers, y compris les justes valeurs de niveau 3 (donn\u00e9es non observables).</div><div class=\"defaultParagraph_1 Standard\">Lorsque des informations provenant de tiers, telles que des cotations de courtiers ou des services de valorisation, sont retenus pour d\u00e9terminer la juste valeur, il appartient \u00e0 la direction d\u2019\u00e9valuer les \u00e9l\u00e9ments probants fournis par les tiers afin de s\u2019assurer que ces conclusions satisfont aux exigences des normes IFRS, y compris le niveau de la hi\u00e9rarchie des justes valeurs dans laquelle ces \u00e9valuations doivent \u00eatre class\u00e9es.</div><div class=\"defaultParagraph_1 Standard\">Lors de l\u2019\u00e9valuation de la juste valeur d\u2019un actif ou d\u2019un passif, le Groupe recourt autant que possible \u00e0 des donn\u00e9es de march\u00e9 observables. Si les donn\u00e9es utilis\u00e9es pour \u00e9valuer la juste valeur d\u2019un actif ou d\u2019un passif rel\u00e8vent de diff\u00e9rents niveaux de la hi\u00e9rarchie de la juste valeur, l\u2019\u00e9valuation de la juste valeur est class\u00e9e dans son int\u00e9gralit\u00e9 au niveau de la hi\u00e9rarchie correspondant \u00e0 la donn\u00e9e d\u2019entr\u00e9e de niveau le plus bas ayant une importance significative pour l\u2019ensemble de la mesure. L'\u00e9valuation de la juste valeur est particuli\u00e8rement pertinente pour la comptabilisation des regroupements d'entreprises (note\u00a08), des instruments financiers (note\u00a036) et des paiements fond\u00e9s sur des actions (note\u00a044).</div>Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e.<div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div>Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles.<div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-29": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">Evaluation de la juste valeur</div><div class=\"defaultParagraph_1 Standard\">Un certain nombre de r\u00e9glementations comptables et d'informations \u00e0 fournir par le Groupe exige l\u2019\u00e9valuation de la juste valeur, tant pour les actifs et passifs financiers que non financiers, y compris les justes valeurs de niveau 3 (donn\u00e9es non observables).</div><div class=\"defaultParagraph_1 Standard\">Lorsque des informations provenant de tiers, telles que des cotations de courtiers ou des services de valorisation, sont retenus pour d\u00e9terminer la juste valeur, il appartient \u00e0 la direction d\u2019\u00e9valuer les \u00e9l\u00e9ments probants fournis par les tiers afin de s\u2019assurer que ces conclusions satisfont aux exigences des normes IFRS, y compris le niveau de la hi\u00e9rarchie des justes valeurs dans laquelle ces \u00e9valuations doivent \u00eatre class\u00e9es.</div><div class=\"defaultParagraph_1 Standard\">Lors de l\u2019\u00e9valuation de la juste valeur d\u2019un actif ou d\u2019un passif, le Groupe recourt autant que possible \u00e0 des donn\u00e9es de march\u00e9 observables. Si les donn\u00e9es utilis\u00e9es pour \u00e9valuer la juste valeur d\u2019un actif ou d\u2019un passif rel\u00e8vent de diff\u00e9rents niveaux de la hi\u00e9rarchie de la juste valeur, l\u2019\u00e9valuation de la juste valeur est class\u00e9e dans son int\u00e9gralit\u00e9 au niveau de la hi\u00e9rarchie correspondant \u00e0 la donn\u00e9e d\u2019entr\u00e9e de niveau le plus bas ayant une importance significative pour l\u2019ensemble de la mesure. L'\u00e9valuation de la juste valeur est particuli\u00e8rement pertinente pour la comptabilisation des regroupements d'entreprises (note\u00a08), des instruments financiers (note\u00a036) et des paiements fond\u00e9s sur des actions (note\u00a044).</div>Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e.<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"line-height:23px; text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>36. </sub></span><div class=\"list-paragraph-container_1\"><sub>Valeurs comptables et justes valeurs d'instruments financiers par cat\u00e9gorie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau suivant pr\u00e9sente les valeurs comptables et justes valeurs des actifs et passifs financiers ventil\u00e9s par cat\u00e9gorie d'instrument financier selon la norme IFRS 9 au 31 d\u00e9cembre 2025 et au 31 d\u00e9cembre 2024 :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:630px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"e4c45a\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d30621b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Cat\u00e9gorie selon la norme<br/>IFRS 9</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Juste valeur</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Juste valeur<br/>31 d\u00e9c. 2024</div></td></tr><tr><td class=\"db3afa\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Investissements dans des filiales, coentreprises et entreprises associ\u00e9es non consolid\u00e9es</div></td><td class=\"d55976\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de capitaux propres \u00e0 la juste valeur par le bias du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances et autres actifs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0424,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0541,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0724,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0882,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Dettes fournisseurs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers \u00e0 la juste valeur : impact en compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">143,2</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">142,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">137,3</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">134,2</div></td></tr><tr><td class=\"d3e535e\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres passifs financiers</div></td><td class=\"d2aa465\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,9</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,1</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">153,8</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">150,7</div></td></tr><tr><td class=\"d242a59\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d8186b4\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Les montants comprennent la partie non d\u00e9sign\u00e9e des contrats.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les contreparties conditionnelles li\u00e9es aux acquisitions de BIA Separations et de Xell, pr\u00e9c\u00e9demment \u00e9valu\u00e9es \u00e0 la juste valeur, sont arriv\u00e9es \u00e0 \u00e9ch\u00e9ance. Dans les deux cas, aucun paiement suppl\u00e9mentaire du prix d\u2019acquisition bas\u00e9 sur le chiffre d\u2019affaires g\u00e9n\u00e9r\u00e9 ne sera effectu\u00e9. Les passifs li\u00e9s \u00e0 ces contreparties conditionnelles ont donc \u00e9t\u00e9 d\u00e9comptabilis\u00e9s au 31 d\u00e9cembre 2025. La valeur de la contrepartie conditionnelle li\u00e9e \u00e0 l\u2019acquisition de BIA Separations \u00e0 la derni\u00e8re date de cl\u00f4ture, le 31 d\u00e9cembre 2024 (valeur\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros), a \u00e9t\u00e9 comptabilis\u00e9e en compte de r\u00e9sultat en 2025.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles. </div><div class=\"defaultParagraph_1 Standard\">La dette incluse dans les autres passifs financiers au titre de l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires dans la filiale Sartorius CellGenix GmbH est \u00e9valu\u00e9e selon la m\u00e9thode du taux d\u2019int\u00e9r\u00eat effectif. Le Groupe applique l\u2019option consistant \u00e0 comptabiliser directement en capitaux propres toute variation de valeur. Ce passif correspond \u00e0 une option de vente (\u00ab\u00a0put option\u00a0\u00bb) d\u00e9tenue par les actionnaires minoritaires et arrive \u00e0 \u00e9ch\u00e9ance en 2026. Le montant du prix d\u2019achat des actions \u00e0 acqu\u00e9rir d\u00e9pend du chiffre d\u2019affaires des ann\u00e9es 2023 \u00e0 2025. Sur cette base, la dette relative des 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants d\u2019actions en circulation s\u2019\u00e9l\u00e8ve \u00e0 71,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 79,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-30": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>5. </sub></span><div class=\"list-paragraph-container_1\"><sub>Information sectorielle</sub></div></div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IFRS 8 (Secteurs op\u00e9rationnels), l\u2019identification des segments op\u00e9rationnels refl\u00e8te la structure interne de gestion de l\u2019activit\u00e9, selon une approche \u00ab manag\u00e9riale \u00bb. Cela signifie que les segments sont d\u00e9finis de mani\u00e8re analogue au reporting financier interne de l'entit\u00e9. Ainsi un domaine d\u2019activit\u00e9 est consid\u00e9r\u00e9 comme un segment op\u00e9rationnel d\u00e8s lors que ses activit\u00e9s op\u00e9rationnelles sont susceptibles de g\u00e9n\u00e9rer des produits et des charges, que ses r\u00e9sultats op\u00e9rationnels sont r\u00e9guli\u00e8rement examin\u00e9s par le principal d\u00e9cideur op\u00e9rationnel de l\u2019entit\u00e9 (\u00e0 savoir les membres ex\u00e9cutifs du Conseil d\u2019administration) et que des informations financi\u00e8res distinctes sont disponibles dans le reporting interne. Le contr\u00f4le interne et le reporting au sein de Sartorius Stedim Biotech reposent sur le positionnement du Groupe en tant que \u00ab fournisseur de solutions globales \u00bb (<span dir=\"ltr\" style=\"font-style:italic\">total solutions provider</span>) pour ses clients. En cons\u00e9quence, il n'existe qu'un seul secteur op\u00e9rationnel identifi\u00e9 pour Sartorius Stedim Biotech guid\u00e9 par une perspective produit et client\u00a0:<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> le secteur \u00ab\u00a0Biopharm\u00a0\u00bb. </span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'indicateur cl\u00e9 de performance du segment op\u00e9rationnel du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est \u00ab\u00a0l\u2019EBITDA courant\u00a0\u00bb dans la mesure o\u00f9 le Conseil d'administration surveille cet indicateur de performance au niveau consolid\u00e9 et consid\u00e8re qu\u2019il est utile et pertinent pour appr\u00e9hender la performance financi\u00e8re du Groupe.</span></div><div class=\"defaultParagraph_1 Standard\">L'EBITDA correspond au r\u00e9sultat avant int\u00e9r\u00eats, imp\u00f4ts, d\u00e9pr\u00e9ciations et amortissements ; le terme \u00ab\u00a0EBITDA courant\u00a0\u00bb d\u00e9signe \u00e0 l'EBITDA corrig\u00e9 des \u00e9l\u00e9ments non r\u00e9currents (ou exceptionnels). Les \u00e9l\u00e9ments non r\u00e9currents comprennent les produits et charges li\u00e9s aux mesures d\u2019am\u00e9lioration de l\u2019efficacit\u00e9, aux acquisitions, ainsi qu\u2019\u00e0 d\u2019autres gains ou pertes susceptibles de fausser la rentabilit\u00e9 durable du segment, tels que les gains ou pertes r\u00e9sultant de la cession d\u2019immobilisations corporelles ou d\u2019investissement. Les mesures visant \u00e0 am\u00e9liorer l\u2019efficacit\u00e9 comprennent principalement les produits et les charges li\u00e9s aux activit\u00e9s de restructuration, tels que les indemnit\u00e9s de d\u00e9part, ou les projets majeurs du Groupe, notamment les projets informatiques d\u2019envergure.</div><div class=\"defaultParagraph_1 Standard\">L'EBITDA et l\u2019EBITDA courant ne constituent d\u2019aucune mani\u00e8re, des indicateurs de performance d\u00e9finis dans les normes IFRS. La d\u00e9finition \u00e9tablie par le Groupe peut diff\u00e9rer des indicateurs de performance et des informations similaires fournies par d'autres soci\u00e9t\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les actifs et passifs par segment ne sont pas communiqu\u00e9s de mani\u00e8re r\u00e9guli\u00e8re au principal d\u00e9cideur op\u00e9rationnel et ne sont, par cons\u00e9quent, pas inclus dans l\u2019information sectorielle.</div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 THeadfirstText_1\">\u00a0</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Biopharm</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Groupe</div></td></tr><tr><td class=\"d20a881\"><div class=\"defaultParagraph_1 THeadlastText_1\">en millions \u20ac</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td></tr><tr><td class=\"d574c0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"margin-left:15px\">En % du chiffre d'affaires</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">R\u00e9conciliation du compte de r\u00e9sultat du segment op\u00e9rationnel</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant du segment op\u00e9rationnel</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations et amortissements</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9l\u00e9ments non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201370,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013106,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat avant imp\u00f4t</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">373,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">219,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>\u00c9l\u00e9ments non r\u00e9currents</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Mesures d\u2019efficience</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201361,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201396,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Projets de fusions et acquisitions<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Co\u00fbts d'int\u00e9gration</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20137,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Groupe</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u201370,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013106,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9l\u00e9ments non r\u00e9currents inclus dans les mesures d\u2019am\u00e9lioration de l\u2019efficacit\u00e9 pour l\u2019exercice 2025 concernent principalement des projets d\u2019envergure au niveau du Groupe, tels que le projet S/4HANA, ainsi que des d\u00e9penses de restructuration, notamment des indemnit\u00e9s de d\u00e9part. Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, les d\u00e9penses li\u00e9es aux projets du Groupe sont principalement comptabilis\u00e9es dans les charges administratives g\u00e9n\u00e9rales et les autres charges op\u00e9rationnelles, tandis que les co\u00fbts de restructuration sont majoritairement pr\u00e9sent\u00e9s dans le co\u00fbt des ventes.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Informations compl\u00e9mentaires par r\u00e9gion</div><div class=\"defaultParagraph_1 Standard\">Afin de fournir des informations suppl\u00e9mentaires exig\u00e9es par la norme IFRS 8, le tableau ci-dessous pr\u00e9sente des informations compl\u00e9mentaires par zone g\u00e9ographique. Les principaux chiffres relatifs aux actifs non courants des zones g\u00e9ographiques concernent le lieu d\u2019implantation des soci\u00e9t\u00e9s, tandis ce que le chiffre d'affaires est rapport\u00e9 selon la localisation des clients. </div><div class=\"defaultParagraph_1 Standard\">Les actifs non courants comprennent les immobilisations corporelles ainsi que les immobilisations incorporelles (y compris le goodwill).</div><div class=\"defaultParagraph_1 Standard\">Comme pour la p\u00e9riode de reporting pr\u00e9c\u00e9dente, le montant du chiffre d'affaires r\u00e9alis\u00e9 avec un seul client ne d\u00e9passe pas 10<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% du chiffre d'affaires consolid\u00e9 pour la p\u00e9riode de reporting <span class=\"hyperlink-no-style_1\"></span>2025.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\" style=\"line-height:14px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Actifs non courants</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\" style=\"line-height:14px; overflow:hidden\">en millions \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">EMEA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0241,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0159,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0737,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0709,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Allemagne</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">255,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">236,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0263,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0191,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont France</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">120,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">130,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0101,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0088,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Am\u00e9riques</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0053,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">982,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont \u00c9tats-Unis</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">995,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">930,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Asie<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Pacifique</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">672,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">639,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">299,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">232,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Chine</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">173,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">175,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">19,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,6</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Cor\u00e9e du Sud</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">157,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">148,9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">258,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Groupe</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0967,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0780,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0445,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0424,8</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-31": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>5. </sub></span><div class=\"list-paragraph-container_1\"><sub>Information sectorielle</sub></div></div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IFRS 8 (Secteurs op\u00e9rationnels), l\u2019identification des segments op\u00e9rationnels refl\u00e8te la structure interne de gestion de l\u2019activit\u00e9, selon une approche \u00ab manag\u00e9riale \u00bb. Cela signifie que les segments sont d\u00e9finis de mani\u00e8re analogue au reporting financier interne de l'entit\u00e9. Ainsi un domaine d\u2019activit\u00e9 est consid\u00e9r\u00e9 comme un segment op\u00e9rationnel d\u00e8s lors que ses activit\u00e9s op\u00e9rationnelles sont susceptibles de g\u00e9n\u00e9rer des produits et des charges, que ses r\u00e9sultats op\u00e9rationnels sont r\u00e9guli\u00e8rement examin\u00e9s par le principal d\u00e9cideur op\u00e9rationnel de l\u2019entit\u00e9 (\u00e0 savoir les membres ex\u00e9cutifs du Conseil d\u2019administration) et que des informations financi\u00e8res distinctes sont disponibles dans le reporting interne. Le contr\u00f4le interne et le reporting au sein de Sartorius Stedim Biotech reposent sur le positionnement du Groupe en tant que \u00ab fournisseur de solutions globales \u00bb (<span dir=\"ltr\" style=\"font-style:italic\">total solutions provider</span>) pour ses clients. En cons\u00e9quence, il n'existe qu'un seul secteur op\u00e9rationnel identifi\u00e9 pour Sartorius Stedim Biotech guid\u00e9 par une perspective produit et client\u00a0:<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> le secteur \u00ab\u00a0Biopharm\u00a0\u00bb. </span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'indicateur cl\u00e9 de performance du segment op\u00e9rationnel du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est \u00ab\u00a0l\u2019EBITDA courant\u00a0\u00bb dans la mesure o\u00f9 le Conseil d'administration surveille cet indicateur de performance au niveau consolid\u00e9 et consid\u00e8re qu\u2019il est utile et pertinent pour appr\u00e9hender la performance financi\u00e8re du Groupe.</span></div><div class=\"defaultParagraph_1 Standard\">L'EBITDA correspond au r\u00e9sultat avant int\u00e9r\u00eats, imp\u00f4ts, d\u00e9pr\u00e9ciations et amortissements ; le terme \u00ab\u00a0EBITDA courant\u00a0\u00bb d\u00e9signe \u00e0 l'EBITDA corrig\u00e9 des \u00e9l\u00e9ments non r\u00e9currents (ou exceptionnels). Les \u00e9l\u00e9ments non r\u00e9currents comprennent les produits et charges li\u00e9s aux mesures d\u2019am\u00e9lioration de l\u2019efficacit\u00e9, aux acquisitions, ainsi qu\u2019\u00e0 d\u2019autres gains ou pertes susceptibles de fausser la rentabilit\u00e9 durable du segment, tels que les gains ou pertes r\u00e9sultant de la cession d\u2019immobilisations corporelles ou d\u2019investissement. Les mesures visant \u00e0 am\u00e9liorer l\u2019efficacit\u00e9 comprennent principalement les produits et les charges li\u00e9s aux activit\u00e9s de restructuration, tels que les indemnit\u00e9s de d\u00e9part, ou les projets majeurs du Groupe, notamment les projets informatiques d\u2019envergure.</div><div class=\"defaultParagraph_1 Standard\">L'EBITDA et l\u2019EBITDA courant ne constituent d\u2019aucune mani\u00e8re, des indicateurs de performance d\u00e9finis dans les normes IFRS. La d\u00e9finition \u00e9tablie par le Groupe peut diff\u00e9rer des indicateurs de performance et des informations similaires fournies par d'autres soci\u00e9t\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les actifs et passifs par segment ne sont pas communiqu\u00e9s de mani\u00e8re r\u00e9guli\u00e8re au principal d\u00e9cideur op\u00e9rationnel et ne sont, par cons\u00e9quent, pas inclus dans l\u2019information sectorielle.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Informations compl\u00e9mentaires par r\u00e9gion</div><div class=\"defaultParagraph_1 Standard\">Afin de fournir des informations suppl\u00e9mentaires exig\u00e9es par la norme IFRS 8, le tableau ci-dessous pr\u00e9sente des informations compl\u00e9mentaires par zone g\u00e9ographique. Les principaux chiffres relatifs aux actifs non courants des zones g\u00e9ographiques concernent le lieu d\u2019implantation des soci\u00e9t\u00e9s, tandis ce que le chiffre d'affaires est rapport\u00e9 selon la localisation des clients. </div><div class=\"defaultParagraph_1 Standard\">Les actifs non courants comprennent les immobilisations corporelles ainsi que les immobilisations incorporelles (y compris le goodwill).</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-32": {
   "value": "<table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 THeadfirstText_1\">\u00a0</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Biopharm</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Groupe</div></td></tr><tr><td class=\"d20a881\"><div class=\"defaultParagraph_1 THeadlastText_1\">en millions \u20ac</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td></tr><tr><td class=\"d574c0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"margin-left:15px\">En % du chiffre d'affaires</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Informations compl\u00e9mentaires par r\u00e9gion</div><div class=\"defaultParagraph_1 Standard\">Afin de fournir des informations suppl\u00e9mentaires exig\u00e9es par la norme IFRS 8, le tableau ci-dessous pr\u00e9sente des informations compl\u00e9mentaires par zone g\u00e9ographique. Les principaux chiffres relatifs aux actifs non courants des zones g\u00e9ographiques concernent le lieu d\u2019implantation des soci\u00e9t\u00e9s, tandis ce que le chiffre d'affaires est rapport\u00e9 selon la localisation des clients. </div><div class=\"defaultParagraph_1 Standard\">Les actifs non courants comprennent les immobilisations corporelles ainsi que les immobilisations incorporelles (y compris le goodwill).</div><div class=\"defaultParagraph_1 Standard\">Comme pour la p\u00e9riode de reporting pr\u00e9c\u00e9dente, le montant du chiffre d'affaires r\u00e9alis\u00e9 avec un seul client ne d\u00e9passe pas 10<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% du chiffre d'affaires consolid\u00e9 pour la p\u00e9riode de reporting <span class=\"hyperlink-no-style_1\"></span>2025.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\" style=\"line-height:14px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Actifs non courants</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\" style=\"line-height:14px; overflow:hidden\">en millions \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">EMEA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0241,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0159,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0737,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0709,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Allemagne</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">255,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">236,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0263,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0191,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont France</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">120,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">130,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0101,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0088,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Am\u00e9riques</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0053,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">982,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont \u00c9tats-Unis</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">995,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">930,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Asie<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Pacifique</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">672,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">639,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">299,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">232,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Chine</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">173,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">175,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">19,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,6</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Cor\u00e9e du Sud</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">157,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">148,9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">258,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Groupe</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0967,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0780,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0445,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0424,8</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>9. </sub></span><div class=\"list-paragraph-container_1\"><sub>Chiffre d'affaires</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le chiffre d'affaires est comptabilis\u00e9 conform\u00e9ment \u00e0 la norme IFRS 15 (Produits des activit\u00e9s ordinaires tir\u00e9s de contrats conclus avec des clients). Le chiffre d\u2019affaires issu de l\u2019activit\u00e9 commerciale contractuelle avec les clients est ventil\u00e9 par zones g\u00e9ographiques (note 5 \u2013 Information sectorielle) et selon la nature des revenus (r\u00e9currents et non r\u00e9currents). Le Groupe d\u00e9finit les revenus r\u00e9currents comme les revenus provenant des consommables et des services, tandis que les revenus non r\u00e9currents sont principalement d\u00e9finis comme les revenus des instruments.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">en % du total</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">en % du total</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0967,5</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0780,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">revenu r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0508,9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">85%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0222,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">80%</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">revenu non r\u00e9currents</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">458,6</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">557,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe fabrique et commercialise des instruments et des consommables destin\u00e9s \u00e0 des clients du secteur biopharmaceutique. Le Groupe satisfait \u00e0 ses obligations de performance en fonction des biens \u00e0 transf\u00e9rer et des services promis. La majorit\u00e9 des revenus provenant de la vente de produits est comptabilis\u00e9e au moment o\u00f9 le client dispose du contr\u00f4le des biens. C'est g\u00e9n\u00e9ralement le cas lorsque les risques et les avantages significatifs li\u00e9s \u00e0 la propri\u00e9t\u00e9 des biens sont transf\u00e9r\u00e9s au client. En cons\u00e9quence, le moment de la comptabilisation peut varier en fonction des accords conclus avec chaque client.</div><div class=\"defaultParagraph_1 Standard\">Lorsque des instruments sont vendus conjointement avec un service initial, tel que la mise en service initiale, et que ces deux \u00e9l\u00e9ments constituent deux obligations de prestation distinctes, le prix de transaction est attribu\u00e9 sur la base des prix de vente s\u00e9par\u00e9s et relatifs. Pour les produits complexes n\u00e9cessitant une installation sur le site du client, le chiffre d\u2019affaires est constat\u00e9 et comptabilis\u00e9 apr\u00e8s l\u2019acceptation formelle du client. Dans une moindre mesure, le chiffre d\u2019affaires est comptabilis\u00e9 au fil du temps dans le cadre d\u2019activit\u00e9s de projet sp\u00e9cifiques au client. Dans ces cas, le chiffre d\u2019affaires est reconnu en fonction de l'avancement du projet, mesur\u00e9 sur la base du pourcentage des co\u00fbts engag\u00e9s \u00e0 ce jour par rapport au total estim\u00e9 des co\u00fbts du contrat (m\u00e9thode des intrants). Le montant des co\u00fbts r\u00e9els engag\u00e9s \u00e0 ce jour refl\u00e8te de mani\u00e8re appropri\u00e9e l'avancement et le transfert du contr\u00f4le au client, dans la mesure o\u00f9 le Groupe dispose d\u2019un droit de remboursement des co\u00fbts engag\u00e9s \u00e0 ce jour, major\u00e9s d'une marge appropri\u00e9e si le projet est annul\u00e9 par le client sans motif valable.</div><div class=\"defaultParagraph_1 Standard\">Les revenus provenant des services sont g\u00e9n\u00e9ralement constat\u00e9s lorsque les services sont ex\u00e9cut\u00e9s ou ont \u00e9t\u00e9 ex\u00e9cut\u00e9s. Lorsque les services sont rendus de mani\u00e8re continue sur une p\u00e9riode donn\u00e9e, le Groupe comptabilise le produit correspondant au fil du temps. Dans ce cas, les revenus sont g\u00e9n\u00e9ralement constat\u00e9s au prorata temporis par rapport \u00e0 la dur\u00e9e totale du contrat. Les ventes de produits sont g\u00e9n\u00e9ralement assorties d\u2019une garantie l\u00e9gale obligatoire, et couverte par des provisions pour garanties (note\u00a025). L\u2019ensemble des garanties \u00e9tendues jug\u00e9es comme significatives est comptabilis\u00e9 comme une obligation de prestation distincte, pour laquelle le chiffre d\u2019affaires est comptabilis\u00e9 sur la dur\u00e9e de la garantie.</div><div class=\"defaultParagraph_1 Standard\">Selon les conditions g\u00e9n\u00e9rales de paiement, les r\u00e8glements des clients sont exigibles \u00e0 court terme, g\u00e9n\u00e9ralement dans un d\u00e9lai de 30 \u00e0 60 jours. Dans une certaine mesure, le Groupe per\u00e7oit des paiements anticip\u00e9s, afin de limiter par exemple les risques de cr\u00e9dit. Par cons\u00e9quent, le Groupe comptabilise r\u00e9guli\u00e8rement des passifs sur contrats de service lorsque les clients paient \u00e0 l'avance.</div><div class=\"defaultParagraph_1 Standard\">Les contrats comportant des composantes de financement significatives n\u2019ont pas d\u2019effet mat\u00e9riel. Le Groupe applique la mesure de simplification pr\u00e9vue par la norme comptable concernant l\u2019existence d\u2019une composante de financement significative. Cela signifie qu\u2019une composante de financement est prise en compte uniquement lorsque la dur\u00e9e entre le transfert des biens ou des services et l\u2019encaissement de la contrepartie est susceptible de d\u00e9passer un an et que l'effet est significatif. </div><div class=\"defaultParagraph_1 Standard\">Au 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, le Groupe comptabilisait un passif de remboursement de <span class=\"hyperlink-no-style_1\"></span>43,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros r\u00e9sultant d'accords d'int\u00e9ressement avec des clients (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>21,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Le montant total du prix de transaction affect\u00e9 aux obligations de performance non satisfaites (ou partiellement satisfaites) \u00e0 la fin de la p\u00e9riode consid\u00e9r\u00e9e (commandes en cours) s'\u00e9l\u00e8vait \u00e0 <span class=\"hyperlink-no-style_1\"></span>1\u00a0308<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>1\u00a0482<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Le Groupe s'attend \u00e0 ce que la plupart des obligations de performance non satisfaites soient remplies en <span class=\"hyperlink-no-style_1\"></span>2026. </div><div class=\"defaultParagraph_1 Standard\">Aucune variation exceptionnelle n\u2019a \u00e9t\u00e9 constat\u00e9e dans les valeurs comptables des passifs et actifs contractuels au cours de l'exercice consid\u00e9r\u00e9. Un chiffre d'affaires de <span class=\"hyperlink-no-style_1\"></span>174,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros a \u00e9t\u00e9 comptabilis\u00e9 durant cette p\u00e9riode et inclus dans les passifs contractuels au d\u00e9but de la p\u00e9riode consid\u00e9r\u00e9e (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>176,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). </div><div class=\"defaultParagraph_1 Standard\">Les soldes des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9s \u00e0 la note 30. Pour plus de d\u00e9tails sur les d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels comptabilis\u00e9s au cours de l\u2019exercice consid\u00e9r\u00e9, veuillez consulter la note 42. </div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>30. </sub></span><div class=\"list-paragraph-container_1\"><sub>Cr\u00e9ances clients courantes</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Autres cr\u00e9ances</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients tiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">156,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">227,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe Sartorius\u00a0AG</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">23,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">192,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des cr\u00e9ances clients et autres cr\u00e9ances sont repr\u00e9sentatives de leur juste valeur compte tenu de la date d'\u00e9ch\u00e9ance et des risques de cr\u00e9dit. Les actifs contractuels sont comptabilis\u00e9s en lien avec des contrats de construction sp\u00e9cifiques aux clients qui remplissent les conditions de comptabilisation du chiffre d\u2019affaires \u00e0 l\u2019avancement, conform\u00e9ment \u00e0 la norme IFRS 15 (note\u00a09).</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les droits relatifs aux cr\u00e9ances clients d\u2019un montant d\u2019environ <span class=\"hyperlink-no-style_1\"></span>307,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>269,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) ont \u00e9t\u00e9 c\u00e9d\u00e9s dans le cadre d\u2019un programme d\u2019affacturage. Les \u00e9ch\u00e9ances des cr\u00e9ances c\u00e9d\u00e9es sont inf\u00e9rieures \u00e0 douze mois. Si les risques de d\u00e9faut ainsi que les risques de change correspondants ont \u00e9t\u00e9 int\u00e9gralement transf\u00e9r\u00e9s \u00e0 l\u2019acqu\u00e9reur des cr\u00e9ances, le Groupe conserve toutefois une partie du risque de retard de paiement. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, le montant maximal de ce risque conserv\u00e9 et figurant dans les cr\u00e9ances clients avoisinait <span class=\"hyperlink-no-style_1\"></span>2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Ce risque maximal est calcul\u00e9 en fonction du volume des cr\u00e9ances c\u00e9d\u00e9es et des co\u00fbts de financement potentiels support\u00e9s par le Groupe entre la date d\u2019\u00e9ch\u00e9ance contractuelle et le paiement tardif. Les passifs associ\u00e9s pr\u00e9sent\u00e9s dans les autres passifs financiers courants s\u2019\u00e9l\u00e8vent \u00e0 <span class=\"hyperlink-no-style_1\"></span>3,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros), dont la juste valeur atteignait <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros). La cession de cr\u00e9ances a entra\u00een\u00e9 une diminution nette des cr\u00e9ances de <span class=\"hyperlink-no-style_1\"></span>304,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>266,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le programme d\u2019affacturage est organis\u00e9 par le d\u00e9partement de tr\u00e9sorerie du Groupe Sartorius\u00a0AG. Dans le cadre de ce programme, toutes les soci\u00e9t\u00e9s participantes du Groupe Sartorius\u00a0AG peuvent c\u00e9der des cr\u00e9ances pour un volume combin\u00e9 de 200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et de 220<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions de dollars am\u00e9ricains.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le poste </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00ab\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0\u00bb</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> concerne naturellement les autres filiales du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">45</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">). Les pertes de valeur sur les cr\u00e9ances clients et autres cr\u00e9ances sont comptabilis\u00e9es au moyen de comptes de provisions distincts. Pour plus de d\u00e9tails sur la d\u00e9termination des provisions pour d\u00e9pr\u00e9ciation</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">,</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> veuillez-vous r\u00e9f\u00e9rer \u00e0 la note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">42</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-33": {
   "value": "<table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 THeadfirstText_1\">\u00a0</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Biopharm</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Groupe</div></td></tr><tr><td class=\"d20a881\"><div class=\"defaultParagraph_1 THeadlastText_1\">en millions \u20ac</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td></tr><tr><td class=\"d574c0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"margin-left:15px\">En % du chiffre d'affaires</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift4\">R\u00e9conciliation du compte de r\u00e9sultat du segment op\u00e9rationnel</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant du segment op\u00e9rationnel</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations et amortissements</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9l\u00e9ments non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201370,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013106,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat avant imp\u00f4t</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">373,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">219,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>14. </sub></span><div class=\"list-paragraph-container_1\"><sub>Ventilation par nature du r\u00e9sultat op\u00e9rationnel</sub></div></div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Chiffre d\u2019affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0967,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0780,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Achats consomm\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013563,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013599,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres co\u00fbts et services li\u00e9s aux achats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013162,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013168,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de personnel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013855,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013852,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements et d\u00e9pr\u00e9ciations</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges op\u00e9rationnelles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013541,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013487,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Sous-total</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0441,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0409,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT (R\u00e9sultat op\u00e9rationnel)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4t sur le r\u00e9sultat</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013107,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Participations ne donnant pas le contr\u00f4le</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat net apr\u00e8s participations ne donnant pas le contr\u00f4le</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">175,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les autres charges op\u00e9rationnelles comprennent notamment des \u00e9l\u00e9ments tels que les gains et pertes de change, les frais de transport, les frais de d\u00e9placement, ainsi que les refacturations pour les services obtenus d'autres entit\u00e9s du Groupe Sartorius\u00a0AG (note\u00a045) et d\u2019autres produits et charges divers de nature op\u00e9rationnelle.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-34": {
   "value": "<table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 THeadfirstText_1\">\u00a0</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Biopharm</div></td><td class=\"cf9a3c\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\">Groupe</div></td></tr><tr><td class=\"d20a881\"><div class=\"defaultParagraph_1 THeadlastText_1\">en millions \u20ac</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">2024</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 THeadlastNumber_1\">Variation</div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0967,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0780,0</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7%</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17%</div></td></tr><tr><td class=\"d574c0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"margin-left:15px\">En % du chiffre d'affaires</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,8%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,0%</div></td><td class=\"d8b1a15\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Informations compl\u00e9mentaires par r\u00e9gion</div><div class=\"defaultParagraph_1 Standard\">Afin de fournir des informations suppl\u00e9mentaires exig\u00e9es par la norme IFRS 8, le tableau ci-dessous pr\u00e9sente des informations compl\u00e9mentaires par zone g\u00e9ographique. Les principaux chiffres relatifs aux actifs non courants des zones g\u00e9ographiques concernent le lieu d\u2019implantation des soci\u00e9t\u00e9s, tandis ce que le chiffre d'affaires est rapport\u00e9 selon la localisation des clients. </div><div class=\"defaultParagraph_1 Standard\">Les actifs non courants comprennent les immobilisations corporelles ainsi que les immobilisations incorporelles (y compris le goodwill).</div><div class=\"defaultParagraph_1 Standard\">Comme pour la p\u00e9riode de reporting pr\u00e9c\u00e9dente, le montant du chiffre d'affaires r\u00e9alis\u00e9 avec un seul client ne d\u00e9passe pas 10<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% du chiffre d'affaires consolid\u00e9 pour la p\u00e9riode de reporting <span class=\"hyperlink-no-style_1\"></span>2025.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 THeadfirstText_1\" style=\"line-height:14px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"d0ced95\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Actifs non courants</div></td></tr><tr><td class=\"f4a83a\"><div class=\"defaultParagraph_1 THeadlastText_1\" style=\"line-height:14px; overflow:hidden\">en millions \u20ac</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 THeadlastNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">EMEA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0241,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0159,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0737,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5\u00a0709,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Allemagne</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">255,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">236,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0263,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0191,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont France</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">120,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">130,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0101,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0088,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Am\u00e9riques</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0053,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">982,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont \u00c9tats-Unis</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">995,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">930,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">483,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Asie<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Pacifique</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">672,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">639,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">299,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">232,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Chine</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">173,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">175,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">19,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,6</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">dont Cor\u00e9e du Sud</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">157,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">148,9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">258,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Groupe</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0967,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0780,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0445,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">6\u00a0424,8</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>9. </sub></span><div class=\"list-paragraph-container_1\"><sub>Chiffre d'affaires</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le chiffre d'affaires est comptabilis\u00e9 conform\u00e9ment \u00e0 la norme IFRS 15 (Produits des activit\u00e9s ordinaires tir\u00e9s de contrats conclus avec des clients). Le chiffre d\u2019affaires issu de l\u2019activit\u00e9 commerciale contractuelle avec les clients est ventil\u00e9 par zones g\u00e9ographiques (note 5 \u2013 Information sectorielle) et selon la nature des revenus (r\u00e9currents et non r\u00e9currents). Le Groupe d\u00e9finit les revenus r\u00e9currents comme les revenus provenant des consommables et des services, tandis que les revenus non r\u00e9currents sont principalement d\u00e9finis comme les revenus des instruments.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">en % du total</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">en % du total</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0967,5</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0780,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">revenu r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0508,9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">85%</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0222,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">80%</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">revenu non r\u00e9currents</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">458,6</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">557,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20%</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe fabrique et commercialise des instruments et des consommables destin\u00e9s \u00e0 des clients du secteur biopharmaceutique. Le Groupe satisfait \u00e0 ses obligations de performance en fonction des biens \u00e0 transf\u00e9rer et des services promis. La majorit\u00e9 des revenus provenant de la vente de produits est comptabilis\u00e9e au moment o\u00f9 le client dispose du contr\u00f4le des biens. C'est g\u00e9n\u00e9ralement le cas lorsque les risques et les avantages significatifs li\u00e9s \u00e0 la propri\u00e9t\u00e9 des biens sont transf\u00e9r\u00e9s au client. En cons\u00e9quence, le moment de la comptabilisation peut varier en fonction des accords conclus avec chaque client.</div><div class=\"defaultParagraph_1 Standard\">Lorsque des instruments sont vendus conjointement avec un service initial, tel que la mise en service initiale, et que ces deux \u00e9l\u00e9ments constituent deux obligations de prestation distinctes, le prix de transaction est attribu\u00e9 sur la base des prix de vente s\u00e9par\u00e9s et relatifs. Pour les produits complexes n\u00e9cessitant une installation sur le site du client, le chiffre d\u2019affaires est constat\u00e9 et comptabilis\u00e9 apr\u00e8s l\u2019acceptation formelle du client. Dans une moindre mesure, le chiffre d\u2019affaires est comptabilis\u00e9 au fil du temps dans le cadre d\u2019activit\u00e9s de projet sp\u00e9cifiques au client. Dans ces cas, le chiffre d\u2019affaires est reconnu en fonction de l'avancement du projet, mesur\u00e9 sur la base du pourcentage des co\u00fbts engag\u00e9s \u00e0 ce jour par rapport au total estim\u00e9 des co\u00fbts du contrat (m\u00e9thode des intrants). Le montant des co\u00fbts r\u00e9els engag\u00e9s \u00e0 ce jour refl\u00e8te de mani\u00e8re appropri\u00e9e l'avancement et le transfert du contr\u00f4le au client, dans la mesure o\u00f9 le Groupe dispose d\u2019un droit de remboursement des co\u00fbts engag\u00e9s \u00e0 ce jour, major\u00e9s d'une marge appropri\u00e9e si le projet est annul\u00e9 par le client sans motif valable.</div><div class=\"defaultParagraph_1 Standard\">Les revenus provenant des services sont g\u00e9n\u00e9ralement constat\u00e9s lorsque les services sont ex\u00e9cut\u00e9s ou ont \u00e9t\u00e9 ex\u00e9cut\u00e9s. Lorsque les services sont rendus de mani\u00e8re continue sur une p\u00e9riode donn\u00e9e, le Groupe comptabilise le produit correspondant au fil du temps. Dans ce cas, les revenus sont g\u00e9n\u00e9ralement constat\u00e9s au prorata temporis par rapport \u00e0 la dur\u00e9e totale du contrat. Les ventes de produits sont g\u00e9n\u00e9ralement assorties d\u2019une garantie l\u00e9gale obligatoire, et couverte par des provisions pour garanties (note\u00a025). L\u2019ensemble des garanties \u00e9tendues jug\u00e9es comme significatives est comptabilis\u00e9 comme une obligation de prestation distincte, pour laquelle le chiffre d\u2019affaires est comptabilis\u00e9 sur la dur\u00e9e de la garantie.</div><div class=\"defaultParagraph_1 Standard\">Selon les conditions g\u00e9n\u00e9rales de paiement, les r\u00e8glements des clients sont exigibles \u00e0 court terme, g\u00e9n\u00e9ralement dans un d\u00e9lai de 30 \u00e0 60 jours. Dans une certaine mesure, le Groupe per\u00e7oit des paiements anticip\u00e9s, afin de limiter par exemple les risques de cr\u00e9dit. Par cons\u00e9quent, le Groupe comptabilise r\u00e9guli\u00e8rement des passifs sur contrats de service lorsque les clients paient \u00e0 l'avance.</div><div class=\"defaultParagraph_1 Standard\">Les contrats comportant des composantes de financement significatives n\u2019ont pas d\u2019effet mat\u00e9riel. Le Groupe applique la mesure de simplification pr\u00e9vue par la norme comptable concernant l\u2019existence d\u2019une composante de financement significative. Cela signifie qu\u2019une composante de financement est prise en compte uniquement lorsque la dur\u00e9e entre le transfert des biens ou des services et l\u2019encaissement de la contrepartie est susceptible de d\u00e9passer un an et que l'effet est significatif. </div><div class=\"defaultParagraph_1 Standard\">Au 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, le Groupe comptabilisait un passif de remboursement de <span class=\"hyperlink-no-style_1\"></span>43,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros r\u00e9sultant d'accords d'int\u00e9ressement avec des clients (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>21,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Le montant total du prix de transaction affect\u00e9 aux obligations de performance non satisfaites (ou partiellement satisfaites) \u00e0 la fin de la p\u00e9riode consid\u00e9r\u00e9e (commandes en cours) s'\u00e9l\u00e8vait \u00e0 <span class=\"hyperlink-no-style_1\"></span>1\u00a0308<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>1\u00a0482<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Le Groupe s'attend \u00e0 ce que la plupart des obligations de performance non satisfaites soient remplies en <span class=\"hyperlink-no-style_1\"></span>2026. </div><div class=\"defaultParagraph_1 Standard\">Aucune variation exceptionnelle n\u2019a \u00e9t\u00e9 constat\u00e9e dans les valeurs comptables des passifs et actifs contractuels au cours de l'exercice consid\u00e9r\u00e9. Un chiffre d'affaires de <span class=\"hyperlink-no-style_1\"></span>174,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros a \u00e9t\u00e9 comptabilis\u00e9 durant cette p\u00e9riode et inclus dans les passifs contractuels au d\u00e9but de la p\u00e9riode consid\u00e9r\u00e9e (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>176,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). </div><div class=\"defaultParagraph_1 Standard\">Les soldes des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9s \u00e0 la note 30. Pour plus de d\u00e9tails sur les d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels comptabilis\u00e9s au cours de l\u2019exercice consid\u00e9r\u00e9, veuillez consulter la note 42. </div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRevenueExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-35": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">R\u00e9conciliation du compte de r\u00e9sultat du segment op\u00e9rationnel</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant du segment op\u00e9rationnel</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations et amortissements</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9l\u00e9ments non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201370,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013106,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat avant imp\u00f4t</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">373,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">219,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>14. </sub></span><div class=\"list-paragraph-container_1\"><sub>Ventilation par nature du r\u00e9sultat op\u00e9rationnel</sub></div></div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Chiffre d\u2019affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0967,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0780,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Achats consomm\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013563,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013599,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres co\u00fbts et services li\u00e9s aux achats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013162,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013168,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de personnel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013855,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013852,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements et d\u00e9pr\u00e9ciations</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges op\u00e9rationnelles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013541,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013487,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Sous-total</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0441,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0409,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT (R\u00e9sultat op\u00e9rationnel)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4t sur le r\u00e9sultat</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013107,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Participations ne donnant pas le contr\u00f4le</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat net apr\u00e8s participations ne donnant pas le contr\u00f4le</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">175,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d57eb77\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"d04ce71\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Marque</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Relations clients</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"c27fe3\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"d2b86e4\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0468,9</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">33,7</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,2</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,8</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0198,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">82,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0484,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">34,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">352,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">429,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0302,3</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s<br/>au 1<sup>er</sup> janv. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013217,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013163,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013119,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013504,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,4</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013100,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201319,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201342,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013164,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20136,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013182,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013160,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013670,6</div></td></tr><tr><td class=\"fb5602\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"d63f045\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0163,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">27,4</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">170,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">269,1</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0631,7</div></td></tr><tr><td class=\"d57e8cf\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e2fd43\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a465a7\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d791d98\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Marque</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Relations clients</div></td><td class=\"cb49ac\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Acomptes vers\u00e9s</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d29461\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6b9bd7\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0484,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">34,0</div></td><td class=\"d59c7d6\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">352,9</div></td><td class=\"d792f0f\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">429,3</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d44d455\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0302,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201315,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20138,7</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,6</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Regroupement d'entreprises</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Acquisitions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">90,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">93,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0470,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">33,8</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">338,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">508,5</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0352,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s <br/>au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,6</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013182,9</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013160,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013670,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,8</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201395,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,5</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201318,1</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201352,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013168,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises sur cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">14,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013410,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20139,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013191,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013204,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013815,3</div></td></tr><tr><td class=\"d56ee30\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d3085b5\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0059,5</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,8</div></td><td class=\"fa1b9c\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">147,0</div></td><td class=\"d9857f8\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">303,9</div></td><td class=\"d99a874\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d531c79\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0536,7</div></td></tr><tr><td class=\"ed9345\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2586f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2ea1fa\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s et immobilisations en cours</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">708,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">460,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">228,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">597,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0994,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">26,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">263,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">323,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201317,4</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">73,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">52,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013135,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">803,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">547,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">248,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">722,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0321,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013151,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013207,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013109,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013468,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201337,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201324,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013110,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013188,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013258,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013126,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20130,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013572,5</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">615,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">289,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">122,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">722,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0749,4</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Actifs li\u00e9s aux droits d\u2019utilisation au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">125,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">135,8</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des immobilisations corporelles au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">740,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">291,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">130,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">722,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0885,2</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Acomptes vers\u00e9s et immobilisations en cours</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px; margin-right:4px\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">803,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">547,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">248,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">722,6</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0321,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201331,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20135,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201325,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201386,6</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Acquisitions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">47,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">21,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">14,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">227,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">310,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20134,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20135,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201311,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20132,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">208,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">112,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20133,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013328,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20139,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">1\u00a0023,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">653,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">242,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0512,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013188,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013258,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013126,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013572,5</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">6,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">9,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">19,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201345,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201355,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013123,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">4,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">10,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">18,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,5</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Amortissements cumul\u00e9s au <br/>31 d\u00e9c. 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013224,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013299,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013135,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013659,4</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">798,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">353,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">107,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,6</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">1\u00a0853,3</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Actifs li\u00e9s aux droits d\u2019utilisation au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">154,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">8,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">7,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">171,3</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Total des immobilisations corporelles au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">953,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">362,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">114,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,6</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0024,6</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\">Les amortissements sont \u00e9chelonn\u00e9s sur les dur\u00e9es de vie suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>Constructions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">15 \u00e0 50 ans</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">5 \u00e0 15 ans</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier et mat\u00e9riel de bureau</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3 \u00e0 13 ans</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les dotations aux amortissements et la charge de d\u00e9pr\u00e9ciation sont incluses dans le compte de r\u00e9sultat selon l'utilisation des actifs, r\u00e9parties entre les co\u00fbts des ventes, les frais commerciaux et de distribution, les frais de recherche et d\u00e9veloppement, les frais g\u00e9n\u00e9raux et les autres charges op\u00e9rationnelles.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">158,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">5,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">18,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">181,7</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">57,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">63,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201321,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201330,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">197,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">4,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">218,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201360,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201310,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201374,3</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201321,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,2</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201372,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20138,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201382,7</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">125,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">135,8</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">197,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">4,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,3</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">218,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20137,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20137,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">50,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,6</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20139,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201313,1</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">234,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">12,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">17,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">264,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201372,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20138,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201382,7</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201320,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201325,8</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>31 d\u00e9c. 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201380,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20139,4</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201393,1</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">154,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">7,9</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">171,3</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-36": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">R\u00e9conciliation du compte de r\u00e9sultat du segment op\u00e9rationnel</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">EBITDA courant du segment op\u00e9rationnel</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">913,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">779,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations et amortissements</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9l\u00e9ments non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201370,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013106,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat avant imp\u00f4t</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">373,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">219,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les postes \u00ab gains (pertes) de change \u00bb comprennent les gains (pertes) de change li\u00e9s aux d\u00e9p\u00f4ts bancaires et aux pr\u00eats et dettes de financement libell\u00e9s en devises \u00e9trang\u00e8res.</div><div class=\"defaultParagraph_1 Standard\">Les charges d'int\u00e9r\u00eats vers\u00e9es aux entreprises affili\u00e9es sont li\u00e9es aux pr\u00eats accord\u00e9s par la soci\u00e9t\u00e9 m\u00e8re ultime du Groupe, Sartorius\u00a0AG et par Sartorius Finance B.V., entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par Sartorius\u00a0AG (notes 32 et 45).</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9pr\u00e9ciation de la participation dans l\u2019entreprise associ\u00e9e ViroCell Biologics Ltd. (note 7) \u00e9tait incluse dans les autres charges financi\u00e8res en 2025.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe poss\u00e8de une soci\u00e9t\u00e9 de commerciale bas\u00e9e en Turquie. La Turquie \u00e9tait de nouveau consid\u00e9r\u00e9e et pr\u00e9sent\u00e9e comme une \u00e9conomie hyperinflationniste durant l\u2019exercice. Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier. L'indice g\u00e9n\u00e9ral des prix \u00e0 la consommation de l'Institut turc de statistique a \u00e9t\u00e9 retenu (indice appliqu\u00e9 \u00e0 la fin <span class=\"hyperlink-no-style_1\"></span>2025\u00a0: 3\u00a0483,0\u00a0; fin\u00a02024\u00a0: 2\u00a0657,2\u00a0; augmentation de 131<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-37": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>6. </sub></span><div class=\"list-paragraph-container_1\"><sub>Tableau des flux de tr\u00e9sorerie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau des flux de tr\u00e9sorerie pr\u00e9sente l'impact des entr\u00e9es et sorties de tr\u00e9sorerie sur les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie du Groupe. Les flux de tr\u00e9sorerie sont class\u00e9s en trois cat\u00e9gories\u00a0: activit\u00e9s op\u00e9rationnelles, activit\u00e9s d\u2019investissement et activit\u00e9s de financement, conform\u00e9ment \u00e0 la norme IAS 7 (Tableau des flux de tr\u00e9sorerie).</div><div class=\"defaultParagraph_1 Standard\">Dans ce contexte, les \u00e9quivalents de tr\u00e9sorerie sont des actifs qui peuvent \u00eatre convertis en liquidit\u00e9 dans un d\u00e9lai court, g\u00e9n\u00e9ralement inf\u00e9rieur \u00e0 trois mois. Le montant retenu dans le tableau des flux de tr\u00e9sorerie correspond au montant des disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie figurant dans le bilan consolid\u00e9 (note 29). </div><div class=\"defaultParagraph_1 Standard\">Le flux de tr\u00e9sorerie g\u00e9n\u00e9r\u00e9 par l\u2019activit\u00e9 op\u00e9rationnelle est d\u00e9termin\u00e9 selon la m\u00e9thode indirecte. Les postes de variations des provisions, cr\u00e9ances et autres actifs courants, et stocks et dettes fournisseurs (\u00e0 l\u2019exclusion des emprunts et dettes financi\u00e8res) sont corrig\u00e9s pour les changements non mon\u00e9taires, tels que ceux r\u00e9sultant des conversions de devises. Les mouvements des postes correspondants du bilan peuvent donc s\u2019\u00e9carter des montants figurant dans le tableau des flux de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\">Le tableau suivant r\u00e9sume la variation des passifs r\u00e9sultant des activit\u00e9s de financement au cours de la p\u00e9riode\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d74ffbd\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2023</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Effets de change</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres changements non mon\u00e9taires</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2024</div></td></tr><tr><td class=\"cc4aa7\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3\u00a0567,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,3</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013855,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,7</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0724,0</div></td></tr><tr><td class=\"bea1c3\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif de location</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">114,4</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201323,8</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,0</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">52,9</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">145,5</div></td></tr><tr><td class=\"a607e4\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">78,9</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td></tr><tr><td class=\"d74ffbd\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des passifs financiers li\u00e9s aux activit\u00e9s de financement</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">3\u00a0760,7</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">17,3</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013879,2</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,4</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">47,7</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0948,9</div></td></tr><tr><td class=\"d93fede\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d99bf93\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2024</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Effets de change</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres changements non mon\u00e9taires</div></td><td class=\"d9e0703\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2025</div></td></tr><tr><td class=\"b4bb88\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0724,0</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013313,9</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,2</div></td><td class=\"d7fd3ac\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0424,7</div></td></tr><tr><td class=\"d1c2657\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif de location</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">145,5</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201320,9</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">53,9</div></td><td class=\"aad414\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">174,6</div></td></tr><tr><td class=\"d7b926e\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,2</div></td><td class=\"e4fca6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">71,3</div></td></tr><tr><td class=\"d99bf93\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des passifs financiers li\u00e9s aux activit\u00e9s de financement</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0948,9</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">13,3</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013334,8</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u20133,9</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">47,0</div></td><td class=\"d9e0703\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0670,6</div></td></tr><tr><td class=\"d7dddd1\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">Les autres changements non mon\u00e9taires des locations refl\u00e8tent principalement les ajouts d\u00e9coulant de la reconnaissance comptable de nouveaux passifs locatifs (note\u00a018). Pour l\u2019\u00e9volution du passif li\u00e9 \u00e0 l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires, veuillez vous r\u00e9f\u00e9rer \u00e0 la note 36.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-38": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>6. </sub></span><div class=\"list-paragraph-container_1\"><sub>Tableau des flux de tr\u00e9sorerie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau des flux de tr\u00e9sorerie pr\u00e9sente l'impact des entr\u00e9es et sorties de tr\u00e9sorerie sur les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie du Groupe. Les flux de tr\u00e9sorerie sont class\u00e9s en trois cat\u00e9gories\u00a0: activit\u00e9s op\u00e9rationnelles, activit\u00e9s d\u2019investissement et activit\u00e9s de financement, conform\u00e9ment \u00e0 la norme IAS 7 (Tableau des flux de tr\u00e9sorerie).</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-40": {
   "value": "Dans ce contexte, les \u00e9quivalents de tr\u00e9sorerie sont des actifs qui peuvent \u00eatre convertis en liquidit\u00e9 dans un d\u00e9lai court, g\u00e9n\u00e9ralement inf\u00e9rieur \u00e0 trois mois. Le montant retenu dans le tableau des flux de tr\u00e9sorerie correspond au montant des disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie figurant dans le bilan consolid\u00e9 (note 29).",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-39": {
   "value": "Dans ce contexte, les \u00e9quivalents de tr\u00e9sorerie sont des actifs qui peuvent \u00eatre convertis en liquidit\u00e9 dans un d\u00e9lai court, g\u00e9n\u00e9ralement inf\u00e9rieur \u00e0 trois mois. Le montant retenu dans le tableau des flux de tr\u00e9sorerie correspond au montant des disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie figurant dans le bilan consolid\u00e9 (note 29).<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>29. </sub></span><div class=\"list-paragraph-container_1\"><sub>Disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe consid\u00e8re comme \u00e9quivalents de tr\u00e9sorerie tous les placements \u00e0 forte liquidit\u00e9 dont l\u2019\u00e9ch\u00e9ance est inf\u00e9rieure \u00e0 trois mois \u00e0 compter de la date d\u2019acquisition. Cela comprend principalement les d\u00e9p\u00f4ts bancaires et les placements dans des fonds mon\u00e9taires. Les placements dans les fonds mon\u00e9taires pr\u00e9sentent des risques de cr\u00e9dit inf\u00e9rieurs \u00e0 ceux des d\u00e9p\u00f4ts bancaires et sont disponibles quotidiennement. Les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie sont \u00e9valu\u00e9s au co\u00fbt. Aux fins de l\u2019\u00e9tablissement du tableau consolid\u00e9 des flux de tr\u00e9sorerie, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie sont d\u00e9finis conform\u00e9ment \u00e0 ce qui pr\u00e9c\u00e8de. Au 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie s'\u00e9levaient \u00e0 <span class=\"hyperlink-no-style_1\"></span>426,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>678,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros en <span class=\"hyperlink-no-style_1\"></span>2024). Le d\u00e9tail portant sur les actifs liquides soumis \u00e0 des restrictions est consultable dans les notes 41 et 4.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-41": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Le tableau suivant r\u00e9sume la variation des passifs r\u00e9sultant des activit\u00e9s de financement au cours de la p\u00e9riode\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d74ffbd\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2023</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Effets de change</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres changements non mon\u00e9taires</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2024</div></td></tr><tr><td class=\"cc4aa7\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3\u00a0567,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,3</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013855,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,7</div></td><td class=\"d8957a3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0724,0</div></td></tr><tr><td class=\"bea1c3\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif de location</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">114,4</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201323,8</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,0</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">52,9</div></td><td class=\"ae1f47\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">145,5</div></td></tr><tr><td class=\"a607e4\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">78,9</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"ffd72c\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td></tr><tr><td class=\"d74ffbd\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des passifs financiers li\u00e9s aux activit\u00e9s de financement</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">3\u00a0760,7</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">17,3</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013879,2</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,4</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">47,7</div></td><td class=\"d0dcc75\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0948,9</div></td></tr><tr><td class=\"d93fede\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d6fc82d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d99bf93\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2024</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Effets de change</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres changements non mon\u00e9taires</div></td><td class=\"d9e0703\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9cembre 2025</div></td></tr><tr><td class=\"b4bb88\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0724,0</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013313,9</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d7fd3ac\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,2</div></td><td class=\"d7fd3ac\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0424,7</div></td></tr><tr><td class=\"d1c2657\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif de location</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">145,5</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201320,9</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"aad414\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">53,9</div></td><td class=\"aad414\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">174,6</div></td></tr><tr><td class=\"d7b926e\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"e4fca6\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,2</div></td><td class=\"e4fca6\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">71,3</div></td></tr><tr><td class=\"d99bf93\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des passifs financiers li\u00e9s aux activit\u00e9s de financement</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0948,9</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">13,3</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013334,8</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u20133,9</div></td><td class=\"d9e0703\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">47,0</div></td><td class=\"d9e0703\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0670,6</div></td></tr><tr><td class=\"d7dddd1\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">Les autres changements non mon\u00e9taires des locations refl\u00e8tent principalement les ajouts d\u00e9coulant de la reconnaissance comptable de nouveaux passifs locatifs (note\u00a018). Pour l\u2019\u00e9volution du passif li\u00e9 \u00e0 l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires, veuillez vous r\u00e9f\u00e9rer \u00e0 la note 36.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>28. </sub></span><div class=\"list-paragraph-container_1\"><sub>Instruments financiers : principales m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\">Un instrument financier est un contrat qui donne lieu \u00e0 un actif financier pour une entit\u00e9 et \u00e0 un passif financier ou un instrument de capitaux propres pour une autre entit\u00e9. Les notes ci-apr\u00e8s pr\u00e9sentent une vue d\u2019ensemble de l\u2019incidence des instruments financiers sur les \u00e9tats financiers du Groupe Sartorius Stedim Biotech et transmettent des informations compl\u00e9mentaires sur les postes du bilan contenant des instruments financiers.</div><div class=\"defaultParagraph_1 Standard\">Les actifs financiers du Groupe comprennent principalement les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie, les cr\u00e9ances clients et pr\u00eats et les instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive.</div><div class=\"defaultParagraph_1 Standard\">Les passifs financiers du Groupe comprennent principalement des emprunts contract\u00e9s aupr\u00e8s de Sartorius\u00a0AG et Sartorius Finance B.V., des dettes fournisseurs, des dettes de location et des instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur n\u00e9gative. Les passifs financiers autres que les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des instruments financiers respecte la norme IFRS\u00a09 (Instruments financiers). Selon la norme IFRS 9, l\u2019approche de classification et d\u2019\u00e9valuation des actifs financiers repose \u00e0 la fois sur le mod\u00e8le \u00e9conomique de l\u2019entit\u00e9 (d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement, d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement et \u00e0 la vente, ou autres) dans lequel les actifs sont d\u00e9tenus, ainsi que sur les caract\u00e9ristiques contractuelles des flux de tr\u00e9sorerie (crit\u00e8re \u00ab\u00a0SPPI\u00a0\u00bb\u00a0: paiements constitu\u00e9s uniquement du principal et des int\u00e9r\u00eats). Aucune reclassification d\u2019instruments financiers n\u2019a eu lieu au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div><div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>29. </sub></span><div class=\"list-paragraph-container_1\"><sub>Disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe consid\u00e8re comme \u00e9quivalents de tr\u00e9sorerie tous les placements \u00e0 forte liquidit\u00e9 dont l\u2019\u00e9ch\u00e9ance est inf\u00e9rieure \u00e0 trois mois \u00e0 compter de la date d\u2019acquisition. Cela comprend principalement les d\u00e9p\u00f4ts bancaires et les placements dans des fonds mon\u00e9taires. Les placements dans les fonds mon\u00e9taires pr\u00e9sentent des risques de cr\u00e9dit inf\u00e9rieurs \u00e0 ceux des d\u00e9p\u00f4ts bancaires et sont disponibles quotidiennement. Les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie sont \u00e9valu\u00e9s au co\u00fbt. Aux fins de l\u2019\u00e9tablissement du tableau consolid\u00e9 des flux de tr\u00e9sorerie, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie sont d\u00e9finis conform\u00e9ment \u00e0 ce qui pr\u00e9c\u00e8de. Au 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie s'\u00e9levaient \u00e0 <span class=\"hyperlink-no-style_1\"></span>426,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>678,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros en <span class=\"hyperlink-no-style_1\"></span>2024). Le d\u00e9tail portant sur les actifs liquides soumis \u00e0 des restrictions est consultable dans les notes 41 et 4.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>30. </sub></span><div class=\"list-paragraph-container_1\"><sub>Cr\u00e9ances clients courantes</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Autres cr\u00e9ances</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients tiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">156,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">227,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe Sartorius\u00a0AG</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">23,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">192,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des cr\u00e9ances clients et autres cr\u00e9ances sont repr\u00e9sentatives de leur juste valeur compte tenu de la date d'\u00e9ch\u00e9ance et des risques de cr\u00e9dit. Les actifs contractuels sont comptabilis\u00e9s en lien avec des contrats de construction sp\u00e9cifiques aux clients qui remplissent les conditions de comptabilisation du chiffre d\u2019affaires \u00e0 l\u2019avancement, conform\u00e9ment \u00e0 la norme IFRS 15 (note\u00a09).</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les droits relatifs aux cr\u00e9ances clients d\u2019un montant d\u2019environ <span class=\"hyperlink-no-style_1\"></span>307,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>269,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) ont \u00e9t\u00e9 c\u00e9d\u00e9s dans le cadre d\u2019un programme d\u2019affacturage. Les \u00e9ch\u00e9ances des cr\u00e9ances c\u00e9d\u00e9es sont inf\u00e9rieures \u00e0 douze mois. Si les risques de d\u00e9faut ainsi que les risques de change correspondants ont \u00e9t\u00e9 int\u00e9gralement transf\u00e9r\u00e9s \u00e0 l\u2019acqu\u00e9reur des cr\u00e9ances, le Groupe conserve toutefois une partie du risque de retard de paiement. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, le montant maximal de ce risque conserv\u00e9 et figurant dans les cr\u00e9ances clients avoisinait <span class=\"hyperlink-no-style_1\"></span>2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Ce risque maximal est calcul\u00e9 en fonction du volume des cr\u00e9ances c\u00e9d\u00e9es et des co\u00fbts de financement potentiels support\u00e9s par le Groupe entre la date d\u2019\u00e9ch\u00e9ance contractuelle et le paiement tardif. Les passifs associ\u00e9s pr\u00e9sent\u00e9s dans les autres passifs financiers courants s\u2019\u00e9l\u00e8vent \u00e0 <span class=\"hyperlink-no-style_1\"></span>3,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros), dont la juste valeur atteignait <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros). La cession de cr\u00e9ances a entra\u00een\u00e9 une diminution nette des cr\u00e9ances de <span class=\"hyperlink-no-style_1\"></span>304,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>266,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le programme d\u2019affacturage est organis\u00e9 par le d\u00e9partement de tr\u00e9sorerie du Groupe Sartorius\u00a0AG. Dans le cadre de ce programme, toutes les soci\u00e9t\u00e9s participantes du Groupe Sartorius\u00a0AG peuvent c\u00e9der des cr\u00e9ances pour un volume combin\u00e9 de 200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et de 220<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions de dollars am\u00e9ricains.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le poste </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00ab\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0\u00bb</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> concerne naturellement les autres filiales du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">45</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">). Les pertes de valeur sur les cr\u00e9ances clients et autres cr\u00e9ances sont comptabilis\u00e9es au moyen de comptes de provisions distincts. Pour plus de d\u00e9tails sur la d\u00e9termination des provisions pour d\u00e9pr\u00e9ciation</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">,</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> veuillez-vous r\u00e9f\u00e9rer \u00e0 la note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">42</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>31. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres actifs financiers</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres actifs financiers</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Actifs financiers courants</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">23,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">11,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le montant pr\u00e9sent\u00e9 au titre des instruments financiers d\u00e9riv\u00e9s correspond \u00e0 la juste valeur des instruments de couverture du risque de change, principalement des contrats \u00e0 terme (note\u00a039).</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les autres actifs financiers sont \u00e9valu\u00e9s au co\u00fbt amorti selon la m\u00e9thode du taux d'int\u00e9r\u00eat effectif, d\u00e9duction faite des \u00e9ventuelles pertes de valeur. La rubrique \u00ab Autres actifs financiers \u00bb comprend, entre autres, les cr\u00e9ances de pr\u00eats sur d\u2019autres entit\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG pour un montant de </span><span class=\"hyperlink-no-style_1\"></span>3,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros (en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: </span><span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">million d'euros).</span></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>32. </sub></span><div class=\"list-paragraph-container_1\"><sub>Emprunts et dettes financi\u00e8res</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Solde au</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Dont passifs courants</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Dont passifs courants<br/>au 31 d\u00e9c. 2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes aupr\u00e8s des \u00e9tablissements de cr\u00e9dit</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,1</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts aupr\u00e8s de Sartorius\u00a0AG</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts aupr\u00e8s de Sartorius Finance B.V.</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0419,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">552,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0719,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">36,5</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres emprunts aupr\u00e8s des entit\u00e9s du Groupe Sartorius</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des emprunts et dettes financi\u00e8res non courants</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0424,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">557,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0724,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">39,5</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Group a conclu des contrats de pr\u00eat avec sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG ainsi que </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V. (une entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG), pour financer en premier lieu ces acquisitions. En septembre 2023, </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V. a \u00e9mis des obligations non garanties \u00e0 long terme pour un volume total de 3 milliards d'euros, assorties de coupons annuels fixes, destin\u00e9s principalement \u00e0 l'acquisition de Polyplus. Les principales caract\u00e9ristiques de ces \u00e9missions sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d7bb7c0\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d4a0618\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Produit net pour l'\u00e9metteur</div></td><td class=\"d9a314a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Coupon annuel</div></td><td class=\"d68b0d9\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Date d'\u00e9ch\u00e9ance</div></td></tr><tr><td class=\"f75557\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 1 : 3 ans</div></td><td class=\"ab37f5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">646,9</div></td><td class=\"e260f4\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">650,0</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,250%</div></td><td class=\"d8252af\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2026</div></td></tr><tr><td class=\"d791e3c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 2 : 6 ans</div></td><td class=\"d1dac89\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">647,0</div></td><td class=\"d7659b5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">650,0</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,375%</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2029</div></td></tr><tr><td class=\"d791e3c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 3 : 9 ans</div></td><td class=\"d1dac89\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">840,3</div></td><td class=\"d7659b5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">850,0</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,500%</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2032</div></td></tr><tr><td class=\"e4b776\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 4 : 12 ans</div></td><td class=\"d82ab1b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">842,5</div></td><td class=\"d9a43a8\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">850,0</div></td><td class=\"d09cf7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,875%</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2035</div></td></tr><tr><td class=\"d1b0f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d5211b\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d2a9c0b\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les financements obtenus dans le cadre de cette \u00e9mission obligataire ont \u00e9t\u00e9 enti\u00e8rement r\u00e9troc\u00e9d\u00e9s au Groupe Sartorius Stedim Biotech, \u00e0 des conditions identiques, sous forme de pr\u00eats \u00e0 long terme non garantis. Outre le paiement des int\u00e9r\u00eats annuels, une commission de tr\u00e9sorerie est factur\u00e9e, calcul\u00e9e sur la base des co\u00fbts r\u00e9ellement support\u00e9s, augment\u00e9s d\u2019une marge de pleine concurrence. Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, en 2025, le Groupe Sartorius Stedim Biotech a rembours\u00e9 10<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de chacune des quatre tranches de pr\u00eats aux actionnaires, soit un montant nominal de 300<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">L\u2019ensemble des autres emprunts contract\u00e9s aupr\u00e8s des actionnaires de Sartorius\u00a0AG, d\u2019un montant total de 530<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, ont \u00e9t\u00e9 int\u00e9gralement rembours\u00e9s au cours de l\u2019exercice 2024.</div><div class=\"defaultParagraph_1 Standard\">En compl\u00e9ment des emprunts \u00e0 long terme d\u00e9crits ci-dessus, le financement du Groupe Sartorius Stedim Biotech est assur\u00e9 par une ligne de cr\u00e9dit mise \u00e0 disposition par sa soci\u00e9t\u00e9 m\u00e8re Sartorius\u00a0AG ainsi que par des lignes de cr\u00e9dit  bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques et disponibles jusqu\u2019\u00e0 nouvel ordre (note\u00a041). Aucune de ces lignes de cr\u00e9dit ni des dettes financi\u00e8res n\u2019est assortie de covenants.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>33. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres passifs financiers non courants</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 la contrepartie conditionnelle dans le cadre des acquisitions</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">81,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Pour plus de d\u00e9tails sur les contreparties conditionnelles et les passif li\u00e9 \u00e0 l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires, pr\u00e9sent\u00e9s comme des passifs financi\u00e8res non courants lors de l\u2019exercice pr\u00e9c\u00e9dent, se r\u00e9f\u00e9rer \u00e0 la note\u00a036.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>34. </sub></span><div class=\"list-paragraph-container_1\"><sub>Dettes fournisseurs</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs envers des tiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">269,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">274,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs aupr\u00e8s des autres soci\u00e9t\u00e9s du Groupe Sartorius\u00a0AG</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs aupr\u00e8s des participations non consolid\u00e9es</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">277,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">310,0</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>35. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres passifs financiers courants</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">71,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Obligations de remboursement (IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">43,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,3</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">26,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">34,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">141,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">71,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le passif li\u00e9 \u00e0 l\u2019acquisition de participations ne donnant pas le contr\u00f4le concerne notamment Sartorius CellGenix GmbH (note\u00a036). Les instruments financiers d\u00e9riv\u00e9s repr\u00e9sentent la juste valeur des instruments de couverture de change, tels que les contrats \u00e0 terme (principalement li\u00e9es au dollar am\u00e9ricain, note 39). Les obligations de remboursement proviennent majoritairement d\u2019accords de rabais bas\u00e9s sur le volume avec des clients.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"line-height:23px; text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>36. </sub></span><div class=\"list-paragraph-container_1\"><sub>Valeurs comptables et justes valeurs d'instruments financiers par cat\u00e9gorie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau suivant pr\u00e9sente les valeurs comptables et justes valeurs des actifs et passifs financiers ventil\u00e9s par cat\u00e9gorie d'instrument financier selon la norme IFRS 9 au 31 d\u00e9cembre 2025 et au 31 d\u00e9cembre 2024 :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:630px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"e4c45a\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d30621b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Cat\u00e9gorie selon la norme<br/>IFRS 9</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Juste valeur</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Juste valeur<br/>31 d\u00e9c. 2024</div></td></tr><tr><td class=\"db3afa\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Investissements dans des filiales, coentreprises et entreprises associ\u00e9es non consolid\u00e9es</div></td><td class=\"d55976\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de capitaux propres \u00e0 la juste valeur par le bias du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances et autres actifs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0424,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0541,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0724,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0882,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Dettes fournisseurs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers \u00e0 la juste valeur : impact en compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">143,2</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">142,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">137,3</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">134,2</div></td></tr><tr><td class=\"d3e535e\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres passifs financiers</div></td><td class=\"d2aa465\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,9</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,1</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">153,8</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">150,7</div></td></tr><tr><td class=\"d242a59\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d8186b4\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Les montants comprennent la partie non d\u00e9sign\u00e9e des contrats.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les contreparties conditionnelles li\u00e9es aux acquisitions de BIA Separations et de Xell, pr\u00e9c\u00e9demment \u00e9valu\u00e9es \u00e0 la juste valeur, sont arriv\u00e9es \u00e0 \u00e9ch\u00e9ance. Dans les deux cas, aucun paiement suppl\u00e9mentaire du prix d\u2019acquisition bas\u00e9 sur le chiffre d\u2019affaires g\u00e9n\u00e9r\u00e9 ne sera effectu\u00e9. Les passifs li\u00e9s \u00e0 ces contreparties conditionnelles ont donc \u00e9t\u00e9 d\u00e9comptabilis\u00e9s au 31 d\u00e9cembre 2025. La valeur de la contrepartie conditionnelle li\u00e9e \u00e0 l\u2019acquisition de BIA Separations \u00e0 la derni\u00e8re date de cl\u00f4ture, le 31 d\u00e9cembre 2024 (valeur\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros), a \u00e9t\u00e9 comptabilis\u00e9e en compte de r\u00e9sultat en 2025.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles. </div><div class=\"defaultParagraph_1 Standard\">La dette incluse dans les autres passifs financiers au titre de l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires dans la filiale Sartorius CellGenix GmbH est \u00e9valu\u00e9e selon la m\u00e9thode du taux d\u2019int\u00e9r\u00eat effectif. Le Groupe applique l\u2019option consistant \u00e0 comptabiliser directement en capitaux propres toute variation de valeur. Ce passif correspond \u00e0 une option de vente (\u00ab\u00a0put option\u00a0\u00bb) d\u00e9tenue par les actionnaires minoritaires et arrive \u00e0 \u00e9ch\u00e9ance en 2026. Le montant du prix d\u2019achat des actions \u00e0 acqu\u00e9rir d\u00e9pend du chiffre d\u2019affaires des ann\u00e9es 2023 \u00e0 2025. Sur cette base, la dette relative des 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants d\u2019actions en circulation s\u2019\u00e9l\u00e8ve \u00e0 71,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 79,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>37. </sub></span><div class=\"list-paragraph-container_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><sub>Les gains et pertes nets sur instruments financiers</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les gains et pertes nets des diff\u00e9rentes cat\u00e9gories d\u2019instruments financiers sont pr\u00e9sent\u00e9s dans le tableau suivant\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>Cat\u00e9gories selon la norme IFRS 9<br/>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Actifs et passifs financiers \u00e0 la juste valeur : impact en compte de r\u00e9sultat</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20133,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Actifs financiers \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passifs financiers \u00e9valu\u00e9s au co\u00fbt amorti</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le r\u00e9sultat net des actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti ainsi que des actifs financiers \u00e9valu\u00e9s \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global comprend principalement les effets de conversion des devises et les variations de provisions pour pertes de valeur.</div><div class=\"defaultParagraph_1 Standard\">Le r\u00e9sultat net des actifs et passifs financiers \u00e9valu\u00e9s \u00e0 la juste valeur par le biais du compte de r\u00e9sultat comprend essentiellement les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s non d\u00e9sign\u00e9s comme instruments de couverture ainsi que les produits et charges d'int\u00e9r\u00eat relatifs \u00e0 ces instruments financiers, ainsi que les variations des passifs financiers r\u00e9sultant des accords de contrepartie conditionnelle (note 36).</div><div class=\"defaultParagraph_1 Standard\">Le r\u00e9sultat net des actifs financiers \u00e9valu\u00e9s \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global se rapporte aux cr\u00e9ances qui ne sont pas uniquement d\u00e9tenues en vue de l\u2019encaissement des flux de tr\u00e9sorerie contractuels mais qui peuvent \u00eatre c\u00e9d\u00e9es dans le cadre du programme d'affacturage.</div><div class=\"defaultParagraph_1 Standard\">Le r\u00e9sultat net des passifs \u00e9valu\u00e9s au co\u00fbt amorti comprend principalement les effets de la conversion des  devises \u00e9trang\u00e8res.</div><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>39. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux de change et de la comptabilit\u00e9 de </sub><br/><sup>couverture</sup></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 au risque de change car environ 40<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de son chiffre d\u2019affaires est g\u00e9n\u00e9r\u00e9 en dollars am\u00e9ricains et, dans une moindre mesure, dans d\u2019autres devises \u00e9trang\u00e8res. Gr\u00e2ce \u00e0 son r\u00e9seau mondial, le Groupe peut compenser une grande partie des revenus libell\u00e9s en devises \u00e9trang\u00e8res par des co\u00fbts engag\u00e9s dans les m\u00eames devises. La part des revenus g\u00e9n\u00e9r\u00e9e dans les devises \u00e9trang\u00e8res qui d\u00e9passe ces co\u00fbts, appel\u00e9e exposition nette aux devises, est couverte selon un mod\u00e8le de \u00ab\u00a0cash flow at risk\u00a0\u00bb (CfaR) dans les limites d'un budget de risque pr\u00e9d\u00e9termin\u00e9, \u00e0 l\u2019aide des instruments financiers d\u00e9riv\u00e9s. Les ratios de couverture obtenus varient g\u00e9n\u00e9ralement entre 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 80<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les devises concern\u00e9es. Le Groupe applique g\u00e9n\u00e9ralement une strat\u00e9gie de couverture \u00e9chelonn\u00e9e, couvrant une p\u00e9riode allant jusqu'\u00e0 12 mois \u00e0 l'avance. Les mesures prises dans le cadre de la strat\u00e9gie de couverture sont r\u00e9examin\u00e9es \u00e0 intervalles r\u00e9guliers afin de les adapter aux fluctuations des devises.</div><div class=\"defaultParagraph_1 Standard\">Pour la couverture de change, le Groupe utilise des contrats \u00e0 terme. Ces contrats garantissent le droit, tout en cr\u00e9ant l\u2019obligation, de vendre un montant d\u00e9termin\u00e9 de devise \u00e9trang\u00e8re \u00e0 une date d\u2019\u00e9ch\u00e9ance et \u00e0 un taux de change sp\u00e9cifique contre l\u2019euro. Le profit ou la perte r\u00e9sultant de la diff\u00e9rence entre le taux de change actuel et le taux pr\u00e9alablement fix\u00e9 est g\u00e9n\u00e9ralement comptabilis\u00e9 en produit ou en charge dans le r\u00e9sultat net.</div><div class=\"defaultParagraph_1 Standard\">\u00c0 la date de cl\u00f4ture, des contrats \u00e0 terme d\u2019un montant de <span class=\"hyperlink-no-style_1\"></span>297,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>297,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024) ont \u00e9t\u00e9 conclus pour couvrir le risque de fluctuation de la parit\u00e9 du taux de change EUR<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>USD. Ce montant couvre environ 60<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de l'exposition nette attendue au dollar am\u00e9ricain pour une p\u00e9riode de 12 mois. Par ailleurs, d\u2019autres devises \u00e9trang\u00e8res ont fait l\u2019objet de strat\u00e9gie de couvertures mais pour des volumes plus modestes.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les tableaux ci-apr\u00e8s pr\u00e9sentent les contrats de couverture du risque de change en vigueur \u00e0 la date de cl\u00f4ture\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">290,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,10</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">159,55</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,50</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/GBP</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,83</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Montant nominal</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,16</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,48</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CHF</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,92</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,58</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">165,36</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,11</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe mesure le risque de change \u00e0 l'aide d'un mod\u00e8le de cash flow at Risk (CfaR). L'analyse repose sur les flux entrants et sortants attendus en devises \u00e9trang\u00e8res (expositions nettes). Le risque global de change, obtenu en agr\u00e9geant les valeurs absolues de ces expositions nettes, s'\u00e9tablit comme suit \u00e0 la date de cl\u00f4ture, pour les 12 mois \u00e0 venir\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Exposition en devises \u00e9trang\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">966,6 </div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">979,7 </div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">- Dont positions courtes</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100,8 </div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">101,4 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La position de risque du Groupe est refl\u00e9t\u00e9e par le CfaR r\u00e9siduel apr\u00e8s examen de toutes les activit\u00e9s de couverture. L'approche CfaR tient compte de l'impact potentiel des fluctuations de change sur les flux de tr\u00e9sorerie en devises \u00e9trang\u00e8res (par rapport \u00e0 l\u2019euro) en s\u2019appuyant sur une distribution des probabilit\u00e9s. A cet \u00e9gard, les covariances des devises \u00e9trang\u00e8res, pond\u00e9r\u00e9es par les expositions nettes, sont utilis\u00e9es comme facteurs d'entr\u00e9e pour l'estimation de la volatilit\u00e9 du portefeuille, d\u00e9terminante pour le calcul du CfaR. Les corr\u00e9lations entre les devises sont prises en compte ce qui permet de temp\u00e9rer le risque lors de l\u2019agr\u00e9gation.</div><div class=\"defaultParagraph_1 Standard\">L'impact n\u00e9gatif potentiel sur l'EBITDA est d\u00e9termin\u00e9 pour chaque devise sur la base des taux de change r\u00e9els et des expositions nettes, en pr\u00e9sentant un niveau de confiance de 95<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les 12 prochains mois. Le tableau suivant illustre l'impact n\u00e9gatif potentiel pour le Groupe selon l'approche CfaR, sur la m\u00eame p\u00e9riode\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cash flow at risk</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,5 </div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,3 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">Le tableau suivant d\u00e9taille les effets des instruments de couverture li\u00e9s aux risques de change affectant la structure financi\u00e8re et les performances du Groupe\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur positive</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur n\u00e9gative</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Variation de la valeur des <br/>instruments de couverture</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">419,8</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">423,7</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>40. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux d'int\u00e9r\u00eat</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est principalement financ\u00e9 par l'interm\u00e9diaire de sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., une entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Les principaux emprunts sont souscrits \u00e0 taux d\u2019int\u00e9r\u00eat fixes (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">), ce qui limite l\u2019exposition du Groupe aux risques de taux d\u2019int\u00e9r\u00eat. Afin de ma\u00eetriser ce risque, un ratio appropri\u00e9 entre les financements \u00e0 taux fixe et \u00e0 taux variable est g\u00e9n\u00e9ralement maintenu. Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, aucun pr\u00eat \u00e0 taux variables n\u2019est accord\u00e9 par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., au 31 d\u00e9cembre 2025. Par cons\u00e9quent, l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 n\u2019aurait eu aucun d\u2019impact sur les r\u00e9sultats du Groupe. De m\u00eame que l\u2019ann\u00e9e pr\u00e9c\u00e9dente, au 31 d\u00e9cembre 2025, le Groupe ne d\u00e9t</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">e</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">n</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">ai</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">t aucun instrument d\u00e9riv\u00e9 de taux d\u2019int\u00e9r\u00eat en cours destin\u00e9 \u00e0 couvrir le risque de hausse des taux d\u2019int\u00e9r\u00eat.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Outre les emprunts d\u00e9crits ci-dessus, le financement du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est garanti par une ligne de cr\u00e9dit \u00e0 taux d'int\u00e9r\u00eat variable mise \u00e0 disposition par sa soci\u00e9t\u00e9 m\u00e8re, </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Il existe par ailleurs des lignes de cr\u00e9dit bilat\u00e9rales \u00e0 taux d\u2019int\u00e9r\u00eat variables. Compte tenu du faible degr\u00e9 d\u2019utilisation des lignes </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">de cr\u00e9dit au 31 d\u00e9cembre 2025, les risques li\u00e9s \u00e0 l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 ne sont pas significatifs pour le Groupe (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">41</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">).</span></div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>41. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de liquidit\u00e9</sub></div></div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9ch\u00e9ancier des passifs financiers, hors instruments financiers d\u00e9riv\u00e9s, se pr\u00e9sente comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"d46ddd7\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d369ea1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0724,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0570,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">125,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0587,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0857,3</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">145,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">76,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">66,0</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d920f12\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"efe52b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">55,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0316,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">4\u00a0190,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">521,1</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0746,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0923,3</div></td></tr><tr><td class=\"d60d677\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d5e2cba\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0424,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0098,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">633,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">844,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0620,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">174,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">240,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">127,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">141,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0020,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0759,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0082,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">928,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0748,1</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les flux de tr\u00e9sorerie figurant dans les tableaux ci-dessus comprennent les paiements pr\u00e9vus non actualis\u00e9s li\u00e9s aux passifs financiers, y compris les paiements d'int\u00e9r\u00eat calcul\u00e9 \u00e0 partir des taux d\u2019int\u00e9r\u00eat en vigueur \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les emprunts et dettes financi\u00e8res comprennent les emprunts contract\u00e9s aupr\u00e8s de la soci\u00e9t\u00e9 m\u00e8re Sartorius\u00a0AG ainsi que Sartorius Finance B.V. Les autres passifs comprennent notamment la dette li\u00e9e \u00e0 l'acquisition \u00e9ventuelle des int\u00e9r\u00eats minoritaires de Sartorius CellGenix GmbH (note 36).</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les tableaux suivants pr\u00e9sentent l'analyse de liquidit\u00e9 des instruments financiers d\u00e9riv\u00e9s utilis\u00e9s pour couvrir les risques de change (note\u00a039) sur la base de flux de tr\u00e9sorerie non actualis\u00e9s\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&gt; 5 ans</div></td></tr><tr><td class=\"d3f6f88\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">R\u00e9alisation brute</div></td><td class=\"d87df58\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Contrats \u00e0 terme</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">432,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">425,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d228d46\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"b391df\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013415,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013409,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,0</div></td></tr><tr><td class=\"d68c288\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d58fab0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">R\u00e9alisation brute</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats \u00e0 terme</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Sorties de tr\u00e9sorerie</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe ma\u00eetrise le risque de liquidit\u00e9 en maintenant des lignes de cr\u00e9dit et des facilit\u00e9s suppl\u00e9mentaires aupr\u00e8s des banques, en assurant un suivi continu des flux de tr\u00e9sorerie pr\u00e9visionnels et r\u00e9alis\u00e9s, et en g\u00e9rant les profils d\u2019\u00e9ch\u00e9ance des actifs et passifs financiers. Il n\u2019est pas attendu que les sorties de tr\u00e9sorerie surviennent \u00e0 des moments ou pour des montants sensiblement diff\u00e9rents.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La ligne de cr\u00e9dit fournie par le Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, d'un montant total pouvant atteindre 260</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros \u00e0 taux d'int\u00e9r\u00eat variables, a \u00e9t\u00e9 utilis\u00e9e \u00e0 h</span>auteur de 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Par ailleurs, \u00e0 la date de cl\u00f4ture, le Groupe disposait de lignes de cr\u00e9dit bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques, \u00e0 taux d\u2019int\u00e9r\u00eat variable et r\u00e9vocables \u00e0 tout moment, pour un montant avoisinant 129<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: 111</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros). Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, ces lignes n\u2019\u00e9taient pas utilis\u00e9es de mani\u00e8re significative.</span></div><div class=\"defaultParagraph_1 Standard\">Les fonds en liquidit\u00e9s pr\u00e9sents localement dans certains pays (par exemple, la Chine et l\u2019Inde) ne sont disponibles pour le Groupe que pour des transactions transfrontali\u00e8res soumises \u00e0 des contr\u00f4les des changes. Pour les restrictions concernant les fonds d\u00e9tenus par les entit\u00e9s russes du Groupe, veuillez consulter la note\u00a04.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>42. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de cr\u00e9dit</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit correspond au risque de perte financi\u00e8re pour le Groupe si une contrepartie \u00e0 un instrument financier ne respecte pas ses obligations contractuelles. Le risque de cr\u00e9dit d\u00e9coule principalement de la tr\u00e9sorerie et des \u00e9quivalents de tr\u00e9sorerie, ainsi que des cr\u00e9ances clients. En outre, le Groupe est expos\u00e9 au risque de cr\u00e9dit li\u00e9 aux instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive et, dans une faible mesure, aux flux de tr\u00e9sorerie contractuels provenant des titres de cr\u00e9ance.</div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit est g\u00e9r\u00e9 de mani\u00e8re centralis\u00e9e au sein du Groupe par le service de gestion de la tr\u00e9sorerie. Pour les contreparties telles que les banques et les institutions financi\u00e8res, la solvabilit\u00e9 est surveill\u00e9e en continu afin de d\u00e9tecter \u00e0 un stade pr\u00e9coce toute augmentation du risque de cr\u00e9dit. En l\u2019absence de nouvelles informations, le Groupe consid\u00e8re que les actifs financiers concern\u00e9s pr\u00e9sentent toujours un faible risque de cr\u00e9dit.</div><div class=\"defaultParagraph_1 Standard\">Des limites de risque sont attribu\u00e9s aux clients, principalement en fonction du volume d\u2019affaires, de l\u2019exp\u00e9rience pass\u00e9e et de l\u2019\u00e9valuation de la solvabilit\u00e9 du client. Le respect de ces limites est r\u00e9guli\u00e8rement v\u00e9rifi\u00e9 par la direction comp\u00e9tente. Dans certains cas, le Groupe per\u00e7oit des paiements anticip\u00e9s (acomptes) ou exige des lettres de cr\u00e9dit pour \u00e9viter les risques de cr\u00e9dit. Il n\u2019existe pas de concentration significative de risque de cr\u00e9dit par client ou par zone g\u00e9ographique.</div><div class=\"defaultParagraph_1 Standard\">Pour certaines cr\u00e9ances clients, le Groupe peut b\u00e9n\u00e9ficier de contreparties, telles que des garanties pouvant \u00eatre utilis\u00e9es dans le cadre d'accords contractuels au cas o\u00f9 le client ne respecterait pas ses obligations contractuelles de paiement.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels </div><div class=\"defaultParagraph_1 Standard\">Le mod\u00e8le de d\u00e9pr\u00e9ciation de la norme IFRS 9, qui impose la comptabilisation des pertes de cr\u00e9dit attendues, rev\u00eat une importance particuli\u00e8re pour les cr\u00e9ances clients et les actifs contractuels du Groupe conform\u00e9ment \u00e0 la norme IFRS 15. Le Groupe applique l'approche simplifi\u00e9e de la norme IFRS 9 aux cr\u00e9ances clients et aux actifs contractuels. Ainsi, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour ces actifs. Le point de d\u00e9part du nouveau mod\u00e8le de d\u00e9pr\u00e9ciation est une analyse des taux historiques r\u00e9els de pertes de cr\u00e9dit. Ceux-ci sont ajust\u00e9s en tenant compte des informations prospectives et des effets des changements actuels dans l'environnement macro\u00e9conomique, si ceux-ci sont significatifs. En raison du faible niveau des pertes de cr\u00e9dit historiques, le Groupe d\u00e9termine actuellement les pertes de cr\u00e9dit attendues pour l\u2019ensemble du portefeuille de cr\u00e9ances clients. N\u00e9anmoins, les taux de pertes historiques sont analys\u00e9s r\u00e9guli\u00e8rement de mani\u00e8re plus d\u00e9taill\u00e9e afin d\u2019appliquer, le cas \u00e9ch\u00e9ant, des taux de pertes diff\u00e9renci\u00e9s \u00e0 diff\u00e9rents portefeuilles. En <span class=\"hyperlink-no-style_1\"></span>2025, aucun changement significatif concernant le risque de cr\u00e9dit du portefeuille de clients biopharmaceutiques du Groupe n\u2019a \u00e9t\u00e9 observ\u00e9. En raison de la concentration du Groupe sur l'industrie biopharmaceutique, g\u00e9n\u00e9ralement stable et relativement ind\u00e9pendante des \u00e9volutions macro\u00e9conomiques (elle devrait conna\u00eetre une croissance sup\u00e9rieure \u00e0 la moyenne \u00e0 long terme), le Groupe n\u2019enregistre actuellement aucun impact significatif des informations prospectives sur les pertes de cr\u00e9dit attendues.</div><div class=\"defaultParagraph_1 Standard\">Les actifs contractuels sont li\u00e9s \u00e0 des projets pour des clients sp\u00e9cifiques ou particuliers du Groupe. Il est donc consid\u00e9r\u00e9 que les taux de pertes appliqu\u00e9s aux cr\u00e9ances clients constituent une approximation appropri\u00e9e des taux de pertes applicables aux actifs contractuels. En cons\u00e9quence, aucune distinction suppl\u00e9mentaire n\u2019est op\u00e9r\u00e9e entre les cr\u00e9ances clients et les actifs sur contractuels</div><div class=\"defaultParagraph_1 Standard\">Sur cette base, les provisions pour d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels \u00e9taient d\u00e9termin\u00e9es comme suit au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; float:left; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83ac32\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d121d7a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">135,1</div></td><td class=\"d1bd8d0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,9</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">193,9</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,2</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d62c572\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d6bd1b3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:651px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr class=\"eb700c\"><td class=\"cc0b10\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b90507\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d2ba295\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr class=\"d4c9edf\"><td class=\"d1b2dca\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"d2837bf\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">220,2</div></td><td class=\"d904d9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,2</div></td><td class=\"e7f901\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">261,8</div></td></tr><tr class=\"d213883\"><td class=\"d1ff5de\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"c0658e\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"d58c8f1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr class=\"d213883\"><td class=\"f1d1df\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"e7b9e3\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"e698cc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d47d096\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d1c1e71\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,6</div></td><td class=\"d47d096\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td></tr><tr class=\"d279a6a\"><td class=\"d755ebe\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d0623c7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d7dd22\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e4fcf5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les pertes sur cr\u00e9ances attendus sont d\u00e9termin\u00e9es sur la base d'un taux de perte de 0,05<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. En compl\u00e9ment, des d\u00e9pr\u00e9ciations sont \u00e9tablies sur la base d\u2019analyses individuelles. Le nombre de jours de retard constitue un crit\u00e8re essentiel dans ce contexte. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier. Dans un tel cas, les cr\u00e9ances respectives sont d\u00e9comptabilis\u00e9es. </div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les variations des provisions pour d\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 l'ouverture de l'exercice</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Augmentation pendant l\u2019exercice</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises et consommation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Recouvrement des montants pr\u00e9c\u00e9demment d\u00e9pr\u00e9ci\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 la cl\u00f4ture de l'exercice</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\" style=\"clear:none\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>D\u00e9pr\u00e9ciation des autres actifs financiers</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Outre les cr\u00e9ances clients, la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie constituent les actifs financiers les plus significatifs dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025. Les pertes de cr\u00e9dit attendues sont surveill\u00e9es \u00e0 intervalles r\u00e9guliers. En raison de la haute solvabilit\u00e9 des contreparties et des \u00e9ch\u00e9ances courtes, la d\u00e9pr\u00e9ciation qui devrait \u00eatre comptabilis\u00e9e pour ces actifs financiers est non significative. Par cons\u00e9quent, aucune d\u00e9pr\u00e9ciation n\u2019est enregistr\u00e9e pour la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti, aucune d\u00e9pr\u00e9ciation au titre des pertes de cr\u00e9dit attendues pour les douze mois n'est constat\u00e9e au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, eu \u00e9gard au caract\u00e8re non significatif des pertes de cr\u00e9dit historiques. En cas d'augmentation significative du risque de cr\u00e9dit, g\u00e9n\u00e9ralement per\u00e7u lorsqu'un paiement est \u00e9chu depuis plus de 30 jours, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour l'actif financier correspondant. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier, ce qui est en principe le cas lorsque les paiements sont \u00e9chus depuis plus de 90 jours. \u00c0 la date de cl\u00f4ture, aucun indice d\u2019augmentation significative du risque de cr\u00e9dit n\u2019a \u00e9t\u00e9 identifi\u00e9. Les valeurs comptables des actifs financiers repr\u00e9sentent la perte de cr\u00e9dit maximale pour ces actifs \u00e0 la fin de la p\u00e9riode de reporting.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>43. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres risques li\u00e9s aux instruments financiers</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00c0 la date de cl\u00f4ture, le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> n'\u00e9tait pas expos\u00e9 au risque de volatilit\u00e9 du cours des actions. La seule exception concerne la r\u00e9mun\u00e9ration des membres de la haute direction qui per\u00e7oivent une partie de leur r\u00e9mun\u00e9ration (\u00e0 long terme) dont l\u2019un des param\u00e8tres de valorisation est le cours de l'action de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">(</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">44</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">). </span></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-42": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>7. </sub></span><div class=\"list-paragraph-container_1\"><sub>P\u00e9rim\u00e8tre de consolidation</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech incluent les \u00e9tats financiers annuels de toutes les soci\u00e9t\u00e9s qui sont contr\u00f4l\u00e9es directement ou indirectement par Sartorius Stedim Biotech\u00a0S.A. Selon la norme IFRS 10 (\u00c9tats financiers consolid\u00e9s), le Groupe Sartorius Stedim Biotech contr\u00f4le une entit\u00e9 lorsqu'il est expos\u00e9 \u00e0 des rendements variables r\u00e9sultant de son implication dans cette entit\u00e9 et qu'il dispose de la capacit\u00e9 \u00e0 influencer ces rendements par le biais de son pouvoir sur cette entit\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Ces entit\u00e9s sont incluses dans les \u00e9tats financiers consolid\u00e9s d\u00e8s lors que Sartorius Stedim Biotech\u00a0S.A. ou une de ses filiales acquiert ce contr\u00f4le jusqu'\u00e0 la date \u00e0 laquelle le contr\u00f4le cesse. Les filiales sont incluses sur la base de leurs \u00e9tats financiers annuels pour la m\u00eame p\u00e9riode de reporting que la soci\u00e9t\u00e9 m\u00e8re, en utilisant des m\u00e9thodes de reconnaissance et d\u2019\u00e9valuation uniformes au sein du Groupe. Tous les actifs et passifs intragroupes, les capitaux propres, les produits, les charges et les flux de tr\u00e9sorerie li\u00e9s aux transactions entre membres du Groupe sont \u00e9limin\u00e9s lors de la consolidation.</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers <span class=\"hyperlink-no-style_1\"></span>2025 des entit\u00e9s suivantes\u00a0:</div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Biowire Shanghai Ltd., Shanghai, Chine</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Metreon Bioproducts GmbH, Fribourg, Allemagne</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Kobmast Ltd., centre de Hong Kong, Hong Kong</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Polyplus Transfection Pte. Ltd., Singapour, Singapour</div></div><div class=\"defaultParagraph_1 Standard\">ne sont pas int\u00e9gr\u00e9s dans le p\u00e9rim\u00e8tre de consolidation, en raison du caract\u00e8re non significatif de leurs montants. Le chiffre d'affaires et le total des actifs des soci\u00e9t\u00e9s non consolid\u00e9es repr\u00e9sentaient moins de 1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% des chiffres du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Aucune entit\u00e9 n\u2019a \u00e9t\u00e9 incluse pour la premi\u00e8re fois dans le p\u00e9rim\u00e8tre de consolidation au cours de la p\u00e9riode  consid\u00e9r\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">En 2025, Sartorius Stedim Plastics GmbH, Goettingen, Allemagne, a fusionn\u00e9 avec Sartorius Stedim Biotech\u00a0GmbH, Goettingen, Allemagne. En outre, Accessia Pharma SA, Herstal, Belgique a \u00e9t\u00e9 renomm\u00e9e Sartorius Accessia Pharma SA, Herstal, Belgique. Xpress Biologics SA, Herstal, Belgique a \u00e9t\u00e9 renomm\u00e9e Sartorius Xpress Biologics SA, Herstal, Belgique. Bio Elpida SAS, Saint-Priest, France a \u00e9t\u00e9 renomm\u00e9e Sartorius Bio Elpida SAS, Saint-Priest, France. Biological Industries Israel Beit HaEmek Ltd., Kibbutz Beit HaEmek, Isra\u00ebl a \u00e9t\u00e9 renomm\u00e9e Sartorius Biological Industries Ltd., Kibbutz Beit HaEmek, Isra\u00ebl. La forme juridique de Polyplus-Transfection SA, Illkirch-Graffenstaden, France a \u00e9t\u00e9 modifi\u00e9e et la soci\u00e9t\u00e9 a \u00e9t\u00e9 renomm\u00e9e Sartorius Polyplus SAS, Illkirch-Graffenstaden, France. Les entit\u00e9s Biowire Shanghai Ltd., Shanghai, Chine, et Polyplus Transfection Pte. Ltd., Singapour, Singapour, ont \u00e9t\u00e9 dissoutes au cours de la p\u00e9riode consid\u00e9r\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les valeurs comptables des joint-ventures (Distribo GmbH, Goettingen, Allemagne, 26<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et des entreprises associ\u00e9es mises en \u00e9quivalence (ViroCell Biologics Ltd., Brighton, East Sussex, Royaume-Uni, 30<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) s\u2019\u00e9levaient respectivement \u00e0 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Au cours de l\u2019exercice 2025, la quote-part du Groupe dans le r\u00e9sultat de ces joint-ventures et entreprises associ\u00e9es mises en \u00e9quivalence s\u2019\u00e9l\u00e8vait respectivement \u00e0 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros et -2,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et -8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers des soci\u00e9t\u00e9s suivantes sont inclus dans les \u00e9tats financiers du Groupe. Toutes ces entit\u00e9s sont consolid\u00e9es par int\u00e9gration globale. Le pourcentage de d\u00e9tention est \u00e9gal \u00e0 la quote-part en droits de vote :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Quote-part du<br/>capital d\u00e9tenu (en %)</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EMEA</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech\u00a0S.A., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Soci\u00e9t\u00e9 m\u00e8re</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Accessia Pharma S.A., Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">XpressBioX SRL, Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Xpress Biologics S.A., Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Belgium S.A., Woluwe-Saint-Lambert, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Nordic oy, Helsinki, Finlande</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Xell GmbH, Schlo\u00df Holte-Stukenbrock, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius CellGenix GmbH, Freiburg, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">76</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech\u00a0GmbH, Goettingen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim North America Holding GmbH, Goettingen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Systems GmbH, Guxhagen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Cellca GmbH, Ulm, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim UK Ltd., Epsom, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim BioOutsource Ltd., Glasgow, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Albumedix Ltd., Nottingham, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Lab Ltd., Stonehouse, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Chromatography Systems Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">TAP Biosystems Group Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">The Automation Partnership (Cambridge) Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim FMT S.A.S., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim France S.A.S., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Chromatography Resins S.A.S., Cergy, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">PolygenX 2 S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">PolygenX A S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Polyplus S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Aseptics S.A.S., Lourdes, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Chromatography Equipment S.A.S., Pompey, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Bio Elpida S.A.S., Saint-Priest, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Ireland Ltd., Dublin, Irlande</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Biological Industries Ltd., Kibbutz Beit HaEmek, Isra\u00ebl</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Italy S.r.l., Florence, Italie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Netherlands B.V., Amersfoort, Pays-Bas</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Austria GmbH, Vienne, Autriche</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Poland sp. z.o.o., Kostrzyn, Pologne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">LLC Sartorius Stedim RUS, St. Petersburg, Russie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Data Analytics AB, Ume\u00e5, Su\u00e8de</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Switzerland AG, Tagelswangen, Suisse</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius BIA Separations, separacijske tehnologije, d.o.o., Ajdov\u0161\u010dina, Slov\u00e9nie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Spain S.A., Madrid, Espagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Hungaria Kft., Budapest, Hongrie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Biyoteknoloji A.\u015e., Istanbul, Turquie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Bioprocess S.A.R.L., M'Hamdia, Tunisie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\"><br/></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\"><span class=\"hyperlink-no-style_1\"></span>Am\u00e9riques</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Filters Inc., Yauco, Porto Rico</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius DC BPS Americas, Inc., Dover, Delaware, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim North America Inc., Dover, Delaware, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">WaterSep BioSeparations LLC, Boston, Massachusetts, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Asie<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Pacifique</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Australia Pty. Ltd., Dandenong South, Victoria, Australie</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech (Beijing) Co., Ltd., Beijing, Chine</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim (Shanghai) Trading Co., Ltd., Shanghai, Chine</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim India Pvt. Ltd., Bangalore, Inde</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Japan K.K., Tokyo, Japon</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Korea Biotech LLC, S\u00e9oul, Cor\u00e9e du Sud</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Korea Operations LLC, S\u00e9oul, Cor\u00e9e du Sud</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Malaysia Sdn. Bhd., Kuala Lumpur, Malaisie</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Singapore Pte. Ltd., Singapour, Singapour</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Taiwan Inc., New Taipei City, Taiwan</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>23. </sub></span><div class=\"list-paragraph-container_1\"><sub>Int\u00e9r\u00eats minoritaires</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le montant des int\u00e9r\u00eats minoritaires inscrits au bilan consolid\u00e9 s\u2019\u00e9l\u00e8ve \u00e0 hauteur de </span><span class=\"hyperlink-no-style_1\"></span>35,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros (</span><span class=\"hyperlink-no-style_1\"></span>37,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et concerne les filiales </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Korea </span>Biotech (participation du Groupe : 79<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%)<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>et Sartorius CellGenix (participation du Groupe\u00a0: 76<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%). Les 21<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius Korea Biotech sont soumis \u00e0 une option d\u2019achat exer\u00e7able. Le prix d\u2019acquisition de ces int\u00e9r\u00eats minoritaires est variable et d\u00e9pendra des performances commerciales futures de ces entit\u00e9s. Les 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius CellGenix sont soumis \u00e0 des options d\u2019achat et de vente exer\u00e7ables en 2026 (note\u00a036).</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Sartorius Korea Biotech LLC</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">154,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">145,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">9,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">85,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">78,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat attribu\u00e9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Sartorius CellGenix GmbH</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">131,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">149,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat attribu\u00e9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-43": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>7. </sub></span><div class=\"list-paragraph-container_1\"><sub>P\u00e9rim\u00e8tre de consolidation</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech incluent les \u00e9tats financiers annuels de toutes les soci\u00e9t\u00e9s qui sont contr\u00f4l\u00e9es directement ou indirectement par Sartorius Stedim Biotech\u00a0S.A. Selon la norme IFRS 10 (\u00c9tats financiers consolid\u00e9s), le Groupe Sartorius Stedim Biotech contr\u00f4le une entit\u00e9 lorsqu'il est expos\u00e9 \u00e0 des rendements variables r\u00e9sultant de son implication dans cette entit\u00e9 et qu'il dispose de la capacit\u00e9 \u00e0 influencer ces rendements par le biais de son pouvoir sur cette entit\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Ces entit\u00e9s sont incluses dans les \u00e9tats financiers consolid\u00e9s d\u00e8s lors que Sartorius Stedim Biotech\u00a0S.A. ou une de ses filiales acquiert ce contr\u00f4le jusqu'\u00e0 la date \u00e0 laquelle le contr\u00f4le cesse. Les filiales sont incluses sur la base de leurs \u00e9tats financiers annuels pour la m\u00eame p\u00e9riode de reporting que la soci\u00e9t\u00e9 m\u00e8re, en utilisant des m\u00e9thodes de reconnaissance et d\u2019\u00e9valuation uniformes au sein du Groupe. Tous les actifs et passifs intragroupes, les capitaux propres, les produits, les charges et les flux de tr\u00e9sorerie li\u00e9s aux transactions entre membres du Groupe sont \u00e9limin\u00e9s lors de la consolidation.</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers <span class=\"hyperlink-no-style_1\"></span>2025 des entit\u00e9s suivantes\u00a0:</div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Biowire Shanghai Ltd., Shanghai, Chine</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Metreon Bioproducts GmbH, Fribourg, Allemagne</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Kobmast Ltd., centre de Hong Kong, Hong Kong</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Polyplus Transfection Pte. Ltd., Singapour, Singapour</div></div><div class=\"defaultParagraph_1 Standard\">ne sont pas int\u00e9gr\u00e9s dans le p\u00e9rim\u00e8tre de consolidation, en raison du caract\u00e8re non significatif de leurs montants. Le chiffre d'affaires et le total des actifs des soci\u00e9t\u00e9s non consolid\u00e9es repr\u00e9sentaient moins de 1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% des chiffres du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Aucune entit\u00e9 n\u2019a \u00e9t\u00e9 incluse pour la premi\u00e8re fois dans le p\u00e9rim\u00e8tre de consolidation au cours de la p\u00e9riode  consid\u00e9r\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">En 2025, Sartorius Stedim Plastics GmbH, Goettingen, Allemagne, a fusionn\u00e9 avec Sartorius Stedim Biotech\u00a0GmbH, Goettingen, Allemagne. En outre, Accessia Pharma SA, Herstal, Belgique a \u00e9t\u00e9 renomm\u00e9e Sartorius Accessia Pharma SA, Herstal, Belgique. Xpress Biologics SA, Herstal, Belgique a \u00e9t\u00e9 renomm\u00e9e Sartorius Xpress Biologics SA, Herstal, Belgique. Bio Elpida SAS, Saint-Priest, France a \u00e9t\u00e9 renomm\u00e9e Sartorius Bio Elpida SAS, Saint-Priest, France. Biological Industries Israel Beit HaEmek Ltd., Kibbutz Beit HaEmek, Isra\u00ebl a \u00e9t\u00e9 renomm\u00e9e Sartorius Biological Industries Ltd., Kibbutz Beit HaEmek, Isra\u00ebl. La forme juridique de Polyplus-Transfection SA, Illkirch-Graffenstaden, France a \u00e9t\u00e9 modifi\u00e9e et la soci\u00e9t\u00e9 a \u00e9t\u00e9 renomm\u00e9e Sartorius Polyplus SAS, Illkirch-Graffenstaden, France. Les entit\u00e9s Biowire Shanghai Ltd., Shanghai, Chine, et Polyplus Transfection Pte. Ltd., Singapour, Singapour, ont \u00e9t\u00e9 dissoutes au cours de la p\u00e9riode consid\u00e9r\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les valeurs comptables des joint-ventures (Distribo GmbH, Goettingen, Allemagne, 26<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et des entreprises associ\u00e9es mises en \u00e9quivalence (ViroCell Biologics Ltd., Brighton, East Sussex, Royaume-Uni, 30<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) s\u2019\u00e9levaient respectivement \u00e0 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Au cours de l\u2019exercice 2025, la quote-part du Groupe dans le r\u00e9sultat de ces joint-ventures et entreprises associ\u00e9es mises en \u00e9quivalence s\u2019\u00e9l\u00e8vait respectivement \u00e0 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros et -2,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et -8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers des soci\u00e9t\u00e9s suivantes sont inclus dans les \u00e9tats financiers du Groupe. Toutes ces entit\u00e9s sont consolid\u00e9es par int\u00e9gration globale. Le pourcentage de d\u00e9tention est \u00e9gal \u00e0 la quote-part en droits de vote :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Quote-part du<br/>capital d\u00e9tenu (en %)</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EMEA</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech\u00a0S.A., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Soci\u00e9t\u00e9 m\u00e8re</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Accessia Pharma S.A., Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">XpressBioX SRL, Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Xpress Biologics S.A., Herstal, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Belgium S.A., Woluwe-Saint-Lambert, Belgique</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Nordic oy, Helsinki, Finlande</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Xell GmbH, Schlo\u00df Holte-Stukenbrock, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius CellGenix GmbH, Freiburg, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">76</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech\u00a0GmbH, Goettingen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim North America Holding GmbH, Goettingen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Systems GmbH, Guxhagen, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Cellca GmbH, Ulm, Allemagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim UK Ltd., Epsom, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim BioOutsource Ltd., Glasgow, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Albumedix Ltd., Nottingham, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Lab Ltd., Stonehouse, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Chromatography Systems Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">TAP Biosystems Group Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">The Automation Partnership (Cambridge) Ltd., Royston, Royaume-Uni</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim FMT S.A.S., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim France S.A.S., Aubagne, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Chromatography Resins S.A.S., Cergy, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">PolygenX 2 S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">PolygenX A S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Polyplus S.A.S., Illkirch-Graffenstaden, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Aseptics S.A.S., Lourdes, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Chromatography Equipment S.A.S., Pompey, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Bio Elpida S.A.S., Saint-Priest, France</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Ireland Ltd., Dublin, Irlande</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Biological Industries Ltd., Kibbutz Beit HaEmek, Isra\u00ebl</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Italy S.r.l., Florence, Italie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Netherlands B.V., Amersfoort, Pays-Bas</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Austria GmbH, Vienne, Autriche</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Poland sp. z.o.o., Kostrzyn, Pologne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">LLC Sartorius Stedim RUS, St. Petersburg, Russie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Data Analytics AB, Ume\u00e5, Su\u00e8de</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Switzerland AG, Tagelswangen, Suisse</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius BIA Separations, separacijske tehnologije, d.o.o., Ajdov\u0161\u010dina, Slov\u00e9nie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Spain S.A., Madrid, Espagne</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Hungaria Kft., Budapest, Hongrie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Biyoteknoloji A.\u015e., Istanbul, Turquie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Bioprocess S.A.R.L., M'Hamdia, Tunisie</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\"><br/></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\"><span class=\"hyperlink-no-style_1\"></span>Am\u00e9riques</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Filters Inc., Yauco, Porto Rico</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius DC BPS Americas, Inc., Dover, Delaware, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim North America Inc., Dover, Delaware, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">WaterSep BioSeparations LLC, Boston, Massachusetts, \u00c9tats-Unis</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Asie<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Pacifique</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Australia Pty. Ltd., Dandenong South, Victoria, Australie</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Biotech (Beijing) Co., Ltd., Beijing, Chine</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim (Shanghai) Trading Co., Ltd., Shanghai, Chine</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim India Pvt. Ltd., Bangalore, Inde</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Japan K.K., Tokyo, Japon</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Korea Biotech LLC, S\u00e9oul, Cor\u00e9e du Sud</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Korea Operations LLC, S\u00e9oul, Cor\u00e9e du Sud</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Malaysia Sdn. Bhd., Kuala Lumpur, Malaisie</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Singapore Pte. Ltd., Singapour, Singapour</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sartorius Stedim Taiwan Inc., New Taipei City, Taiwan</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>23. </sub></span><div class=\"list-paragraph-container_1\"><sub>Int\u00e9r\u00eats minoritaires</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le montant des int\u00e9r\u00eats minoritaires inscrits au bilan consolid\u00e9 s\u2019\u00e9l\u00e8ve \u00e0 hauteur de </span><span class=\"hyperlink-no-style_1\"></span>35,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros (</span><span class=\"hyperlink-no-style_1\"></span>37,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et concerne les filiales </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Korea </span>Biotech (participation du Groupe : 79<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%)<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>et Sartorius CellGenix (participation du Groupe\u00a0: 76<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%). Les 21<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius Korea Biotech sont soumis \u00e0 une option d\u2019achat exer\u00e7able. Le prix d\u2019acquisition de ces int\u00e9r\u00eats minoritaires est variable et d\u00e9pendra des performances commerciales futures de ces entit\u00e9s. Les 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius CellGenix sont soumis \u00e0 des options d\u2019achat et de vente exer\u00e7ables en 2026 (note\u00a036).</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Sartorius Korea Biotech LLC</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">154,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">145,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">9,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">85,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">78,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat attribu\u00e9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Sartorius CellGenix GmbH</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">131,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">149,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat attribu\u00e9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-44": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>7. </sub></span><div class=\"list-paragraph-container_1\"><sub>P\u00e9rim\u00e8tre de consolidation</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech incluent les \u00e9tats financiers annuels de toutes les soci\u00e9t\u00e9s qui sont contr\u00f4l\u00e9es directement ou indirectement par Sartorius Stedim Biotech\u00a0S.A. Selon la norme IFRS 10 (\u00c9tats financiers consolid\u00e9s), le Groupe Sartorius Stedim Biotech contr\u00f4le une entit\u00e9 lorsqu'il est expos\u00e9 \u00e0 des rendements variables r\u00e9sultant de son implication dans cette entit\u00e9 et qu'il dispose de la capacit\u00e9 \u00e0 influencer ces rendements par le biais de son pouvoir sur cette entit\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Ces entit\u00e9s sont incluses dans les \u00e9tats financiers consolid\u00e9s d\u00e8s lors que Sartorius Stedim Biotech\u00a0S.A. ou une de ses filiales acquiert ce contr\u00f4le jusqu'\u00e0 la date \u00e0 laquelle le contr\u00f4le cesse. Les filiales sont incluses sur la base de leurs \u00e9tats financiers annuels pour la m\u00eame p\u00e9riode de reporting que la soci\u00e9t\u00e9 m\u00e8re, en utilisant des m\u00e9thodes de reconnaissance et d\u2019\u00e9valuation uniformes au sein du Groupe. Tous les actifs et passifs intragroupes, les capitaux propres, les produits, les charges et les flux de tr\u00e9sorerie li\u00e9s aux transactions entre membres du Groupe sont \u00e9limin\u00e9s lors de la consolidation.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-45": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>7. </sub></span><div class=\"list-paragraph-container_1\"><sub>P\u00e9rim\u00e8tre de consolidation</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech incluent les \u00e9tats financiers annuels de toutes les soci\u00e9t\u00e9s qui sont contr\u00f4l\u00e9es directement ou indirectement par Sartorius Stedim Biotech\u00a0S.A. Selon la norme IFRS 10 (\u00c9tats financiers consolid\u00e9s), le Groupe Sartorius Stedim Biotech contr\u00f4le une entit\u00e9 lorsqu'il est expos\u00e9 \u00e0 des rendements variables r\u00e9sultant de son implication dans cette entit\u00e9 et qu'il dispose de la capacit\u00e9 \u00e0 influencer ces rendements par le biais de son pouvoir sur cette entit\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Ces entit\u00e9s sont incluses dans les \u00e9tats financiers consolid\u00e9s d\u00e8s lors que Sartorius Stedim Biotech\u00a0S.A. ou une de ses filiales acquiert ce contr\u00f4le jusqu'\u00e0 la date \u00e0 laquelle le contr\u00f4le cesse. Les filiales sont incluses sur la base de leurs \u00e9tats financiers annuels pour la m\u00eame p\u00e9riode de reporting que la soci\u00e9t\u00e9 m\u00e8re, en utilisant des m\u00e9thodes de reconnaissance et d\u2019\u00e9valuation uniformes au sein du Groupe. Tous les actifs et passifs intragroupes, les capitaux propres, les produits, les charges et les flux de tr\u00e9sorerie li\u00e9s aux transactions entre membres du Groupe sont \u00e9limin\u00e9s lors de la consolidation.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-46": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les valeurs comptables des joint-ventures (Distribo GmbH, Goettingen, Allemagne, 26<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et des entreprises associ\u00e9es mises en \u00e9quivalence (ViroCell Biologics Ltd., Brighton, East Sussex, Royaume-Uni, 30<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) s\u2019\u00e9levaient respectivement \u00e0 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Au cours de l\u2019exercice 2025, la quote-part du Groupe dans le r\u00e9sultat de ces joint-ventures et entreprises associ\u00e9es mises en \u00e9quivalence s\u2019\u00e9l\u00e8vait respectivement \u00e0 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros et -2,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et -8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-47": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les valeurs comptables des joint-ventures (Distribo GmbH, Goettingen, Allemagne, 26<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et des entreprises associ\u00e9es mises en \u00e9quivalence (ViroCell Biologics Ltd., Brighton, East Sussex, Royaume-Uni, 30<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) s\u2019\u00e9levaient respectivement \u00e0 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Au cours de l\u2019exercice 2025, la quote-part du Groupe dans le r\u00e9sultat de ces joint-ventures et entreprises associ\u00e9es mises en \u00e9quivalence s\u2019\u00e9l\u00e8vait respectivement \u00e0 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros et -2,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et -8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfJointVenturesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-48": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les valeurs comptables des joint-ventures (Distribo GmbH, Goettingen, Allemagne, 26<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et des entreprises associ\u00e9es mises en \u00e9quivalence (ViroCell Biologics Ltd., Brighton, East Sussex, Royaume-Uni, 30<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) s\u2019\u00e9levaient respectivement \u00e0 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Au cours de l\u2019exercice 2025, la quote-part du Groupe dans le r\u00e9sultat de ces joint-ventures et entreprises associ\u00e9es mises en \u00e9quivalence s\u2019\u00e9l\u00e8vait respectivement \u00e0 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros et -2,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros et -8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). La valeur comptable r\u00e9siduelle de l\u2019investissement dans ViroCell Biologics Ltd., d\u2019un montant de 6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros, a \u00e9t\u00e9 enti\u00e8rement d\u00e9pr\u00e9ci\u00e9e au cours de la p\u00e9riode consid\u00e9r\u00e9e, de m\u00eame que l\u2019encours du pr\u00eat \u00e0 recevoir de 3,5\u00a0millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-49": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-50": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Le Groupe n'applique pas la m\u00e9thode de la mise en \u00e9quivalence \u00e0 ses participations dans Sartorius Israel Ltd. (int\u00e9r\u00eat de propri\u00e9t\u00e9 du Groupe\u00a0: 51<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) et Nanotein Technologies Inc. (20<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%) pour des raisons de mat\u00e9rialit\u00e9. Sartorius Israel Ltd. est une entreprise associ\u00e9e du Groupe car le Groupe ne contr\u00f4le ni globalement ni conjointement cette entit\u00e9 en raison d'accords contractuels, en conformit\u00e9 avec la norme IAS\u00a028.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-51": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>8. </sub></span><div class=\"list-paragraph-container_1\"><sub>Regroupements d'entreprises</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les regroupements d'entreprises sont comptabilis\u00e9s selon la m\u00e9thode de l'acquisition. La comptabilisation des regroupements d'entreprises exige que la contrepartie transf\u00e9r\u00e9e ainsi que les actifs acquis et les passifs repris soient \u00e9valu\u00e9s \u00e0 leurs justes valeurs respectives \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 Standard\">L'application de la m\u00e9thode de l'acquisition n\u00e9cessite le recours \u00e0 des estimations et des hypoth\u00e8ses, notamment en ce qui concerne les justes valeurs de la contrepartie transf\u00e9r\u00e9e, les immobilisations incorporelles acquises, les immobilisations corporelles, et les passifs repris \u00e0 la date d'acquisition, ainsi que les dur\u00e9es d'utilit\u00e9 des actifs. Ces \u00e9valuations reposent dans une large mesure sur des flux de tr\u00e9sorerie pr\u00e9visionnels. Si les flux de tr\u00e9sorerie r\u00e9els diff\u00e8rent de ceux utilis\u00e9s pour d\u00e9terminer les justes valeurs, cela pourrait affecter de mani\u00e8re significative les r\u00e9sultats futurs du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Pour les acquisitions significatives, l'allocation du prix d'acquisition est r\u00e9alis\u00e9e avec l\u2019assistance de sp\u00e9cialistes en valorisation externes et ind\u00e9pendants. Les valorisations sont bas\u00e9es sur les informations disponibles \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Comme lors de la p\u00e9riode pr\u00e9c\u00e9dente, le Groupe n'a finalis\u00e9 aucune op\u00e9ration de regroupement d'entreprises au cours de l\u2019exercice 2025.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-52": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>8. </sub></span><div class=\"list-paragraph-container_1\"><sub>Regroupements d'entreprises</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les regroupements d'entreprises sont comptabilis\u00e9s selon la m\u00e9thode de l'acquisition. La comptabilisation des regroupements d'entreprises exige que la contrepartie transf\u00e9r\u00e9e ainsi que les actifs acquis et les passifs repris soient \u00e9valu\u00e9s \u00e0 leurs justes valeurs respectives \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 Standard\">L'application de la m\u00e9thode de l'acquisition n\u00e9cessite le recours \u00e0 des estimations et des hypoth\u00e8ses, notamment en ce qui concerne les justes valeurs de la contrepartie transf\u00e9r\u00e9e, les immobilisations incorporelles acquises, les immobilisations corporelles, et les passifs repris \u00e0 la date d'acquisition, ainsi que les dur\u00e9es d'utilit\u00e9 des actifs. Ces \u00e9valuations reposent dans une large mesure sur des flux de tr\u00e9sorerie pr\u00e9visionnels. Si les flux de tr\u00e9sorerie r\u00e9els diff\u00e8rent de ceux utilis\u00e9s pour d\u00e9terminer les justes valeurs, cela pourrait affecter de mani\u00e8re significative les r\u00e9sultats futurs du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Pour les acquisitions significatives, l'allocation du prix d'acquisition est r\u00e9alis\u00e9e avec l\u2019assistance de sp\u00e9cialistes en valorisation externes et ind\u00e9pendants. Les valorisations sont bas\u00e9es sur les informations disponibles \u00e0 la date d'acquisition.</div>Le poste \u00ab\u00a0goodwill\u00a0\u00bb s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>2\u00a0883,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et correspond \u00e0 la diff\u00e9rence entre la contrepartie transf\u00e9r\u00e9e et la juste valeur des actifs nets acquis dans le cadre de regroupements d\u2019entreprises. Conform\u00e9ment \u00e0 la norme IAS 36, le goodwill issu d\u2019un regroupement d\u2019entreprises n\u2019est pas amorti, et doit faire l\u2019objet d\u2019un test de d\u00e9pr\u00e9ciation annuellement ou chaque fois qu\u2019il existe un indice de perte de valeur. L\u2019existence d\u2019indicateurs de d\u00e9pr\u00e9ciation est r\u00e9guli\u00e8rement examin\u00e9e sur la base de plusieurs facteurs, tels que l\u2019\u00e9volution de la planification strat\u00e9gique \u00e0 moyen terme, le rapport entre la capitalisation boursi\u00e8re et les fonds propres du Groupe, ainsi que les performances financi\u00e8res actuelles.<div class=\"defaultParagraph_1 Standard\">Pour les tests de d\u00e9pr\u00e9ciation, le goodwill doit \u00eatre allou\u00e9 \u00e0 chacune des unit\u00e9s g\u00e9n\u00e9ratrices de tr\u00e9sorerie (UGT) de l\u2019acqu\u00e9reur cens\u00e9e b\u00e9n\u00e9ficier des synergies du regroupement. L\u2019UGT repr\u00e9sente le niveau le plus bas auquel l\u2019\u00e9cart d\u2019acquisition est suivi \u00e0 des fins de gestion interne et ne peut pas \u00eatre sup\u00e9rieur \u00e0 un secteur ou segment op\u00e9rationnel. Le Groupe Sartorius Stedim Biotech poursuit une strat\u00e9gie de fournisseur de solutions compl\u00e8tes pour ses clients. En raison des nombreuses interd\u00e9pendances au sein des activit\u00e9s, le niveau le plus bas auquel le goodwill est suivi correspond au segment biopharmaceutique. Par cons\u00e9quent, la totalit\u00e9 du goodwill est allou\u00e9 \u00e0 ce segment.</div><div class=\"defaultParagraph_1 Standard\">Comme en <span class=\"hyperlink-no-style_1\"></span>2024, le test de d\u00e9pr\u00e9ciation r\u00e9alis\u00e9 pour <span class=\"hyperlink-no-style_1\"></span>2025 d\u00e9termine la valeur recouvrable sur la base de la valeur d'utilit\u00e9 du segment Biopharm. Les projections de flux de tr\u00e9sorerie tiennent compte de l\u2019exp\u00e9rience pass\u00e9e et des anticipations futures, notamment en ce qui concerne la croissance attendue du march\u00e9 sur la base d\u2019\u00e9tudes de march\u00e9 externes. Elles s\u2019appuient g\u00e9n\u00e9ralement sur les pr\u00e9visions retenues par la direction du Groupe sur une p\u00e9riode de quatre ans.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-53": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>8. </sub></span><div class=\"list-paragraph-container_1\"><sub>Regroupements d'entreprises</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les regroupements d'entreprises sont comptabilis\u00e9s selon la m\u00e9thode de l'acquisition. La comptabilisation des regroupements d'entreprises exige que la contrepartie transf\u00e9r\u00e9e ainsi que les actifs acquis et les passifs repris soient \u00e9valu\u00e9s \u00e0 leurs justes valeurs respectives \u00e0 la date d'acquisition.</div><div class=\"defaultParagraph_1 Standard\">L'application de la m\u00e9thode de l'acquisition n\u00e9cessite le recours \u00e0 des estimations et des hypoth\u00e8ses, notamment en ce qui concerne les justes valeurs de la contrepartie transf\u00e9r\u00e9e, les immobilisations incorporelles acquises, les immobilisations corporelles, et les passifs repris \u00e0 la date d'acquisition, ainsi que les dur\u00e9es d'utilit\u00e9 des actifs. Ces \u00e9valuations reposent dans une large mesure sur des flux de tr\u00e9sorerie pr\u00e9visionnels. Si les flux de tr\u00e9sorerie r\u00e9els diff\u00e8rent de ceux utilis\u00e9s pour d\u00e9terminer les justes valeurs, cela pourrait affecter de mani\u00e8re significative les r\u00e9sultats futurs du Groupe.</div><div class=\"defaultParagraph_1 Standard\">Pour les acquisitions significatives, l'allocation du prix d'acquisition est r\u00e9alis\u00e9e avec l\u2019assistance de sp\u00e9cialistes en valorisation externes et ind\u00e9pendants. Les valorisations sont bas\u00e9es sur les informations disponibles \u00e0 la date d'acquisition.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-54": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>9. </sub></span><div class=\"list-paragraph-container_1\"><sub>Chiffre d'affaires</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le chiffre d'affaires est comptabilis\u00e9 conform\u00e9ment \u00e0 la norme IFRS 15 (Produits des activit\u00e9s ordinaires tir\u00e9s de contrats conclus avec des clients). Le chiffre d\u2019affaires issu de l\u2019activit\u00e9 commerciale contractuelle avec les clients est ventil\u00e9 par zones g\u00e9ographiques (note 5 \u2013 Information sectorielle) et selon la nature des revenus (r\u00e9currents et non r\u00e9currents). Le Groupe d\u00e9finit les revenus r\u00e9currents comme les revenus provenant des consommables et des services, tandis que les revenus non r\u00e9currents sont principalement d\u00e9finis comme les revenus des instruments.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe fabrique et commercialise des instruments et des consommables destin\u00e9s \u00e0 des clients du secteur biopharmaceutique. Le Groupe satisfait \u00e0 ses obligations de performance en fonction des biens \u00e0 transf\u00e9rer et des services promis. La majorit\u00e9 des revenus provenant de la vente de produits est comptabilis\u00e9e au moment o\u00f9 le client dispose du contr\u00f4le des biens. C'est g\u00e9n\u00e9ralement le cas lorsque les risques et les avantages significatifs li\u00e9s \u00e0 la propri\u00e9t\u00e9 des biens sont transf\u00e9r\u00e9s au client. En cons\u00e9quence, le moment de la comptabilisation peut varier en fonction des accords conclus avec chaque client.</div><div class=\"defaultParagraph_1 Standard\">Lorsque des instruments sont vendus conjointement avec un service initial, tel que la mise en service initiale, et que ces deux \u00e9l\u00e9ments constituent deux obligations de prestation distinctes, le prix de transaction est attribu\u00e9 sur la base des prix de vente s\u00e9par\u00e9s et relatifs. Pour les produits complexes n\u00e9cessitant une installation sur le site du client, le chiffre d\u2019affaires est constat\u00e9 et comptabilis\u00e9 apr\u00e8s l\u2019acceptation formelle du client. Dans une moindre mesure, le chiffre d\u2019affaires est comptabilis\u00e9 au fil du temps dans le cadre d\u2019activit\u00e9s de projet sp\u00e9cifiques au client. Dans ces cas, le chiffre d\u2019affaires est reconnu en fonction de l'avancement du projet, mesur\u00e9 sur la base du pourcentage des co\u00fbts engag\u00e9s \u00e0 ce jour par rapport au total estim\u00e9 des co\u00fbts du contrat (m\u00e9thode des intrants). Le montant des co\u00fbts r\u00e9els engag\u00e9s \u00e0 ce jour refl\u00e8te de mani\u00e8re appropri\u00e9e l'avancement et le transfert du contr\u00f4le au client, dans la mesure o\u00f9 le Groupe dispose d\u2019un droit de remboursement des co\u00fbts engag\u00e9s \u00e0 ce jour, major\u00e9s d'une marge appropri\u00e9e si le projet est annul\u00e9 par le client sans motif valable.</div><div class=\"defaultParagraph_1 Standard\">Les revenus provenant des services sont g\u00e9n\u00e9ralement constat\u00e9s lorsque les services sont ex\u00e9cut\u00e9s ou ont \u00e9t\u00e9 ex\u00e9cut\u00e9s. Lorsque les services sont rendus de mani\u00e8re continue sur une p\u00e9riode donn\u00e9e, le Groupe comptabilise le produit correspondant au fil du temps. Dans ce cas, les revenus sont g\u00e9n\u00e9ralement constat\u00e9s au prorata temporis par rapport \u00e0 la dur\u00e9e totale du contrat. Les ventes de produits sont g\u00e9n\u00e9ralement assorties d\u2019une garantie l\u00e9gale obligatoire, et couverte par des provisions pour garanties (note\u00a025). L\u2019ensemble des garanties \u00e9tendues jug\u00e9es comme significatives est comptabilis\u00e9 comme une obligation de prestation distincte, pour laquelle le chiffre d\u2019affaires est comptabilis\u00e9 sur la dur\u00e9e de la garantie.</div><div class=\"defaultParagraph_1 Standard\">Selon les conditions g\u00e9n\u00e9rales de paiement, les r\u00e8glements des clients sont exigibles \u00e0 court terme, g\u00e9n\u00e9ralement dans un d\u00e9lai de 30 \u00e0 60 jours. Dans une certaine mesure, le Groupe per\u00e7oit des paiements anticip\u00e9s, afin de limiter par exemple les risques de cr\u00e9dit. Par cons\u00e9quent, le Groupe comptabilise r\u00e9guli\u00e8rement des passifs sur contrats de service lorsque les clients paient \u00e0 l'avance.</div><div class=\"defaultParagraph_1 Standard\">Les contrats comportant des composantes de financement significatives n\u2019ont pas d\u2019effet mat\u00e9riel. Le Groupe applique la mesure de simplification pr\u00e9vue par la norme comptable concernant l\u2019existence d\u2019une composante de financement significative. Cela signifie qu\u2019une composante de financement est prise en compte uniquement lorsque la dur\u00e9e entre le transfert des biens ou des services et l\u2019encaissement de la contrepartie est susceptible de d\u00e9passer un an et que l'effet est significatif. </div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-55": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>10. </sub></span><div class=\"list-paragraph-container_1\"><sub>Les co\u00fbts op\u00e9rationnels</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le compte de r\u00e9sultat est pr\u00e9sent\u00e9 selon le format du \u00ab co\u00fbt des ventes \u00bb, c'est-\u00e0-dire que les charges ont \u00e9t\u00e9 directement affect\u00e9es aux diff\u00e9rentes fonctions pertinentes de production, de vente et de marketing, de recherche et d\u00e9veloppement et de frais g\u00e9n\u00e9raux. Les d\u00e9penses relatives \u00e0 des initiatives ou projets transversaux sont imput\u00e9es aux co\u00fbts fonctionnels correspondants selon un principe d\u2019allocation appropri\u00e9.</div><div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab co\u00fbt des ventes \u00bb comprend les co\u00fbts des produits vendus et les co\u00fbts d\u2019acquisition des marchandises vendues. Outre les d\u00e9penses directement imputables, telles que les mati\u00e8res premi\u00e8res et les fournitures, les d\u00e9penses li\u00e9es aux avantages du personnel et les d\u00e9penses d'\u00e9nergie, le co\u00fbt des ventes inclut \u00e9galement les frais g\u00e9n\u00e9raux imputables \u00e0 la zone de production, ainsi que les dotations aux amortissements et d\u00e9pr\u00e9ciations correspondantes.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de vente et de distribution concernent notamment les co\u00fbts des fonctions commerciales et marketing, de la distribution et des \u00e9tudes de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les frais de recherche et d\u00e9veloppement comprennent les co\u00fbts de recherche, ainsi que les frais li\u00e9s au d\u00e9veloppement de produits et de proc\u00e9d\u00e9s, sauf si ces derniers sont comptabilis\u00e9s \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab frais g\u00e9n\u00e9raux \u00bb inclut principalement les charges du personnel et le co\u00fbt des fournitures et du mat\u00e9riel de la fonction administration g\u00e9n\u00e9rale.</div><div class=\"defaultParagraph_1 Standard\">Tous les \u00e9l\u00e9ments du compte de r\u00e9sultat qui ne peuvent pas \u00eatre rattach\u00e9s \u00e0 l\u2019un des domaines fonctionnels susmentionn\u00e9s sont comptabilis\u00e9s en autres produits et charges. Cela comprend essentiellement les effets li\u00e9s \u00e0 la conversion des transactions en devises \u00e9trang\u00e8res, la cession d\u2019immobilisation ainsi que les d\u00e9pr\u00e9ciations des cr\u00e9ances clients.</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9l\u00e9ments non r\u00e9currents, tels que les co\u00fbts de restructuration ou autres produits ou charges non r\u00e9currents, sont g\u00e9n\u00e9ralement pr\u00e9sent\u00e9s dans les charges op\u00e9rationnelles. Si ces derniers ne peuvent \u00eatre imput\u00e9s aux charges op\u00e9rationnelles, les \u00e9l\u00e9ments non r\u00e9currents sont alors comptabilis\u00e9s dans les \u00ab autres produits et charges \u00bb.</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es aux produits sont enregistr\u00e9es en \u00ab autres produits \u00bb lorsqu'il existe une certitude raisonnable que les conditions attach\u00e9es aux subventions soient respect\u00e9es et que les subventions seront per\u00e7ues. Elles sont syst\u00e9matiquement comptabilis\u00e9es en tant que produits sur la p\u00e9riode au cours de laquelle les co\u00fbts correspondants sont enregistr\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les charges op\u00e9rationnelles sont d\u00e9taill\u00e9s dans la ventilation par nature du r\u00e9sultat op\u00e9rationnel (note\u00a014).</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-56": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>10. </sub></span><div class=\"list-paragraph-container_1\"><sub>Les co\u00fbts op\u00e9rationnels</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le compte de r\u00e9sultat est pr\u00e9sent\u00e9 selon le format du \u00ab co\u00fbt des ventes \u00bb, c'est-\u00e0-dire que les charges ont \u00e9t\u00e9 directement affect\u00e9es aux diff\u00e9rentes fonctions pertinentes de production, de vente et de marketing, de recherche et d\u00e9veloppement et de frais g\u00e9n\u00e9raux. Les d\u00e9penses relatives \u00e0 des initiatives ou projets transversaux sont imput\u00e9es aux co\u00fbts fonctionnels correspondants selon un principe d\u2019allocation appropri\u00e9.</div><div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab co\u00fbt des ventes \u00bb comprend les co\u00fbts des produits vendus et les co\u00fbts d\u2019acquisition des marchandises vendues. Outre les d\u00e9penses directement imputables, telles que les mati\u00e8res premi\u00e8res et les fournitures, les d\u00e9penses li\u00e9es aux avantages du personnel et les d\u00e9penses d'\u00e9nergie, le co\u00fbt des ventes inclut \u00e9galement les frais g\u00e9n\u00e9raux imputables \u00e0 la zone de production, ainsi que les dotations aux amortissements et d\u00e9pr\u00e9ciations correspondantes.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de vente et de distribution concernent notamment les co\u00fbts des fonctions commerciales et marketing, de la distribution et des \u00e9tudes de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les frais de recherche et d\u00e9veloppement comprennent les co\u00fbts de recherche, ainsi que les frais li\u00e9s au d\u00e9veloppement de produits et de proc\u00e9d\u00e9s, sauf si ces derniers sont comptabilis\u00e9s \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le poste \u00ab frais g\u00e9n\u00e9raux \u00bb inclut principalement les charges du personnel et le co\u00fbt des fournitures et du mat\u00e9riel de la fonction administration g\u00e9n\u00e9rale.</div><div class=\"defaultParagraph_1 Standard\">Tous les \u00e9l\u00e9ments du compte de r\u00e9sultat qui ne peuvent pas \u00eatre rattach\u00e9s \u00e0 l\u2019un des domaines fonctionnels susmentionn\u00e9s sont comptabilis\u00e9s en autres produits et charges. Cela comprend essentiellement les effets li\u00e9s \u00e0 la conversion des transactions en devises \u00e9trang\u00e8res, la cession d\u2019immobilisation ainsi que les d\u00e9pr\u00e9ciations des cr\u00e9ances clients.</div><div class=\"defaultParagraph_1 Standard\">Les \u00e9l\u00e9ments non r\u00e9currents, tels que les co\u00fbts de restructuration ou autres produits ou charges non r\u00e9currents, sont g\u00e9n\u00e9ralement pr\u00e9sent\u00e9s dans les charges op\u00e9rationnelles. Si ces derniers ne peuvent \u00eatre imput\u00e9s aux charges op\u00e9rationnelles, les \u00e9l\u00e9ments non r\u00e9currents sont alors comptabilis\u00e9s dans les \u00ab autres produits et charges \u00bb.</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es aux produits sont enregistr\u00e9es en \u00ab autres produits \u00bb lorsqu'il existe une certitude raisonnable que les conditions attach\u00e9es aux subventions soient respect\u00e9es et que les subventions seront per\u00e7ues. Elles sont syst\u00e9matiquement comptabilis\u00e9es en tant que produits sur la p\u00e9riode au cours de laquelle les co\u00fbts correspondants sont enregistr\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Les charges op\u00e9rationnelles sont d\u00e9taill\u00e9s dans la ventilation par nature du r\u00e9sultat op\u00e9rationnel (note\u00a014).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfExpensesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-57": {
   "value": "<div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab co\u00fbt des ventes \u00bb comprend les co\u00fbts des produits vendus et les co\u00fbts d\u2019acquisition des marchandises vendues. Outre les d\u00e9penses directement imputables, telles que les mati\u00e8res premi\u00e8res et les fournitures, les d\u00e9penses li\u00e9es aux avantages du personnel et les d\u00e9penses d'\u00e9nergie, le co\u00fbt des ventes inclut \u00e9galement les frais g\u00e9n\u00e9raux imputables \u00e0 la zone de production, ainsi que les dotations aux amortissements et d\u00e9pr\u00e9ciations correspondantes.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de vente et de distribution concernent notamment les co\u00fbts des fonctions commerciales et marketing, de la distribution et des \u00e9tudes de march\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-58": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es aux produits sont enregistr\u00e9es en \u00ab autres produits \u00bb lorsqu'il existe une certitude raisonnable que les conditions attach\u00e9es aux subventions soient respect\u00e9es et que les subventions seront per\u00e7ues. Elles sont syst\u00e9matiquement comptabilis\u00e9es en tant que produits sur la p\u00e9riode au cours de laquelle les co\u00fbts correspondants sont enregistr\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-59": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es aux produits sont enregistr\u00e9es en \u00ab autres produits \u00bb lorsqu'il existe une certitude raisonnable que les conditions attach\u00e9es aux subventions soient respect\u00e9es et que les subventions seront per\u00e7ues. Elles sont syst\u00e9matiquement comptabilis\u00e9es en tant que produits sur la p\u00e9riode au cours de laquelle les co\u00fbts correspondants sont enregistr\u00e9s.</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-60": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>11. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres produits et charges op\u00e9rationnels</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Gains de change</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">31,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">21,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s \u00e0 la diminution des charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits tir\u00e9s de la reprise de provisions et de passifs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s aux subventions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">16,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">37,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201334,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201316,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201311,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201332,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres charges</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201331,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres charges op\u00e9rationnelles</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201381,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201380,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Total autres produits et charges op\u00e9rationnels</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201325,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201343,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le poste \u00ab produits li\u00e9s aux subventions \u00bb comprend notamment des subventions destin\u00e9es \u00e0 couvrir des d\u00e9penses essentiellement li\u00e9es \u00e0 des projets de recherche et de d\u00e9veloppement pour lesquels les crit\u00e8res de la norme IAS 38 (immobilisation incorporelle) ne sont pas remplis. Les gains et pertes de change en <span class=\"hyperlink-no-style_1\"></span>2025 comprenaient un montant de <span class=\"hyperlink-no-style_1\"></span>11,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) au titre du reclassement comptable des autres \u00e9l\u00e9ments du r\u00e9sultat global vers le r\u00e9sultat net (note\u00a039). Les \u00ab\u00a0autres charges\u00a0\u00bb incluent les redevances pour l\u2019utilisation du nom de la marque Sartorius par les entit\u00e9s de Sartorius Stedim Biotech (note\u00a045).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-61": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>11. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres produits et charges op\u00e9rationnels</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Gains de change</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">31,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">21,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s \u00e0 la diminution des charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits tir\u00e9s de la reprise de provisions et de passifs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s aux subventions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">16,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">37,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201334,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201316,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201311,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201332,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres charges</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201331,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres charges op\u00e9rationnelles</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201381,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201380,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Total autres produits et charges op\u00e9rationnels</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201325,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201343,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le poste \u00ab produits li\u00e9s aux subventions \u00bb comprend notamment des subventions destin\u00e9es \u00e0 couvrir des d\u00e9penses essentiellement li\u00e9es \u00e0 des projets de recherche et de d\u00e9veloppement pour lesquels les crit\u00e8res de la norme IAS 38 (immobilisation incorporelle) ne sont pas remplis. Les gains et pertes de change en <span class=\"hyperlink-no-style_1\"></span>2025 comprenaient un montant de <span class=\"hyperlink-no-style_1\"></span>11,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) au titre du reclassement comptable des autres \u00e9l\u00e9ments du r\u00e9sultat global vers le r\u00e9sultat net (note\u00a039). Les \u00ab\u00a0autres charges\u00a0\u00bb incluent les redevances pour l\u2019utilisation du nom de la marque Sartorius par les entit\u00e9s de Sartorius Stedim Biotech (note\u00a045).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-62": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>11. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres produits et charges op\u00e9rationnels</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Gains de change</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">31,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">21,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s \u00e0 la diminution des charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits tir\u00e9s de la reprise de provisions et de passifs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Produits li\u00e9s aux subventions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">16,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres produits</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">37,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201334,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201316,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts non r\u00e9currents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201311,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201332,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Charges li\u00e9es aux dotations pour d\u00e9pr\u00e9ciation clients</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres charges</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201331,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Total des autres charges op\u00e9rationnelles</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201381,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201380,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Total autres produits et charges op\u00e9rationnels</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201325,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201343,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le poste \u00ab produits li\u00e9s aux subventions \u00bb comprend notamment des subventions destin\u00e9es \u00e0 couvrir des d\u00e9penses essentiellement li\u00e9es \u00e0 des projets de recherche et de d\u00e9veloppement pour lesquels les crit\u00e8res de la norme IAS 38 (immobilisation incorporelle) ne sont pas remplis. Les gains et pertes de change en <span class=\"hyperlink-no-style_1\"></span>2025 comprenaient un montant de <span class=\"hyperlink-no-style_1\"></span>11,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) au titre du reclassement comptable des autres \u00e9l\u00e9ments du r\u00e9sultat global vers le r\u00e9sultat net (note\u00a039). Les \u00ab\u00a0autres charges\u00a0\u00bb incluent les redevances pour l\u2019utilisation du nom de la marque Sartorius par les entit\u00e9s de Sartorius Stedim Biotech (note\u00a045).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-63": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les postes \u00ab gains (pertes) de change \u00bb comprennent les gains (pertes) de change li\u00e9s aux d\u00e9p\u00f4ts bancaires et aux pr\u00eats et dettes de financement libell\u00e9s en devises \u00e9trang\u00e8res.</div><div class=\"defaultParagraph_1 Standard\">Les charges d'int\u00e9r\u00eats vers\u00e9es aux entreprises affili\u00e9es sont li\u00e9es aux pr\u00eats accord\u00e9s par la soci\u00e9t\u00e9 m\u00e8re ultime du Groupe, Sartorius\u00a0AG et par Sartorius Finance B.V., entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par Sartorius\u00a0AG (notes 32 et 45).</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9pr\u00e9ciation de la participation dans l\u2019entreprise associ\u00e9e ViroCell Biologics Ltd. (note 7) \u00e9tait incluse dans les autres charges financi\u00e8res en 2025.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe poss\u00e8de une soci\u00e9t\u00e9 de commerciale bas\u00e9e en Turquie. La Turquie \u00e9tait de nouveau consid\u00e9r\u00e9e et pr\u00e9sent\u00e9e comme une \u00e9conomie hyperinflationniste durant l\u2019exercice. Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier. L'indice g\u00e9n\u00e9ral des prix \u00e0 la consommation de l'Institut turc de statistique a \u00e9t\u00e9 retenu (indice appliqu\u00e9 \u00e0 la fin <span class=\"hyperlink-no-style_1\"></span>2025\u00a0: 3\u00a0483,0\u00a0; fin\u00a02024\u00a0: 2\u00a0657,2\u00a0; augmentation de 131<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceCostExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-64": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les postes \u00ab gains (pertes) de change \u00bb comprennent les gains (pertes) de change li\u00e9s aux d\u00e9p\u00f4ts bancaires et aux pr\u00eats et dettes de financement libell\u00e9s en devises \u00e9trang\u00e8res.</div><div class=\"defaultParagraph_1 Standard\">Les charges d'int\u00e9r\u00eats vers\u00e9es aux entreprises affili\u00e9es sont li\u00e9es aux pr\u00eats accord\u00e9s par la soci\u00e9t\u00e9 m\u00e8re ultime du Groupe, Sartorius\u00a0AG et par Sartorius Finance B.V., entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par Sartorius\u00a0AG (notes 32 et 45).</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9pr\u00e9ciation de la participation dans l\u2019entreprise associ\u00e9e ViroCell Biologics Ltd. (note 7) \u00e9tait incluse dans les autres charges financi\u00e8res en 2025.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe poss\u00e8de une soci\u00e9t\u00e9 de commerciale bas\u00e9e en Turquie. La Turquie \u00e9tait de nouveau consid\u00e9r\u00e9e et pr\u00e9sent\u00e9e comme une \u00e9conomie hyperinflationniste durant l\u2019exercice. Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier. L'indice g\u00e9n\u00e9ral des prix \u00e0 la consommation de l'Institut turc de statistique a \u00e9t\u00e9 retenu (indice appliqu\u00e9 \u00e0 la fin <span class=\"hyperlink-no-style_1\"></span>2025\u00a0: 3\u00a0483,0\u00a0; fin\u00a02024\u00a0: 2\u00a0657,2\u00a0; augmentation de 131<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-65": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestIncomeExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-66": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestIncomeExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-67": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>12. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat financier</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Int\u00e9r\u00eats et revenus assimil\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">11,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">18,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants per\u00e7us par des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valorisation du passif de contrepartie conditionnelle</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Gains de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Autres produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Produits financiers</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">40,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">45,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats et assimil\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013138,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013148,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-left:15px\">- dont montants vers\u00e9s \u00e0 des soci\u00e9t\u00e9s affili\u00e9es au Groupe</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013121,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013130,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges sur instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u201310,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charges d'int\u00e9r\u00eats sur engagements de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Quote-part des r\u00e9sultats des entreprises associ\u00e9es</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20138,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l\u2019hyperinflation (IAS 29)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes de change</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201314,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201310,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Charges financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013192,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013196,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013152,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\">Le total des produits et charges d\u2019int\u00e9r\u00eats au titre des actifs et passifs financiers, principalement les pr\u00eats aux actionnaires (note 32), qui ne sont pas \u00e9valu\u00e9s \u00e0 leur juste valeur par le biais du compte de r\u00e9sultat ou des autres \u00e9l\u00e9ments du r\u00e9sultat global, s\u2019\u00e9tablit comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Produits financiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013122,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013132,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-68": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Le Groupe poss\u00e8de une soci\u00e9t\u00e9 de commerciale bas\u00e9e en Turquie. La Turquie \u00e9tait de nouveau consid\u00e9r\u00e9e et pr\u00e9sent\u00e9e comme une \u00e9conomie hyperinflationniste durant l\u2019exercice. Par cons\u00e9quent, la norme IAS 29 (Information financi\u00e8re dans les \u00e9conomies hyperinflationnistes) a \u00e9t\u00e9 naturellement appliqu\u00e9e aux donn\u00e9es locales \u00e9tablies sur la base du co\u00fbt historique. Les gains ou pertes nets r\u00e9sultant de l'inflation des actifs et passifs non mon\u00e9taires significatifs, ainsi que des capitaux propres et de tous les \u00e9l\u00e9ments du compte de r\u00e9sultat, ont \u00e9t\u00e9 comptabilis\u00e9s dans le r\u00e9sultat financier. L'indice g\u00e9n\u00e9ral des prix \u00e0 la consommation de l'Institut turc de statistique a \u00e9t\u00e9 retenu (indice appliqu\u00e9 \u00e0 la fin <span class=\"hyperlink-no-style_1\"></span>2025\u00a0: 3\u00a0483,0\u00a0; fin\u00a02024\u00a0: 2\u00a0657,2\u00a0; augmentation de 131<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-69": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\" style=\"background-color:#FFFFFF\"><sub>13. </sub></span><div class=\"list-paragraph-container_1\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\"><sub>L'imp\u00f4t sur le r\u00e9sultat courant est d\u00e9termin\u00e9</sub></span></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4t sur le r\u00e9sultat courant</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013110,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201372,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4ts diff\u00e9r\u00e9s</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">31,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013107,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts courants sur le r\u00e9sultat sont d\u00e9termin\u00e9s sur la base du r\u00e9sultat fiscal local de la p\u00e9riode et des r\u00e8gles fiscales locales. En outre, les imp\u00f4ts courants incluent des ajustements relatifs aux paiements d\u2019imp\u00f4ts incertains ou aux remboursements d\u2019imp\u00f4ts pour les p\u00e9riodes non \u00e9valu\u00e9es, ainsi que les r\u00e9ajustements pour les ann\u00e9es ant\u00e9rieures. Les variations des actifs et passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont inclus dans la ligne des imp\u00f4ts diff\u00e9r\u00e9s, \u00e0 l'exception des changements comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global ou dans les capitaux propres (note\u00a019).</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le tableau suivant d\u00e9taille l\u2019\u00e9cart entre la charge fiscale th\u00e9orique et la charge d'imp\u00f4t constat\u00e9e pour l'exercice consid\u00e9r\u00e9. La charge fiscale th\u00e9orique est calcul\u00e9e en appliquant le taux d\u2019imposition standard en France au r\u00e9sultat consolid\u00e9 avant imp\u00f4t.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'imposition th\u00e9orique</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,8%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,8%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charge fiscale th\u00e9orique</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201396,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201356,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Diff\u00e9rences permanentes</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201323,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201318,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Diff\u00e9rences de taux d\u2019imposition</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Revenus exon\u00e9r\u00e9s et autres exemptions fiscales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes fiscales non reconnues et diff\u00e9rences temporelles d\u00e9ductibles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4ts relatifs aux exercices pr\u00e9c\u00e9dents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Retenue \u00e0 la source et autres imp\u00f4ts sur le r\u00e9sultat avec une base fiscale diff\u00e9rente</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,1</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013107,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'imposition effectif</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,7%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,6%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">R\u00e9forme fiscale internationale \u2013 Pilier Deux\u00a0:</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">L\u2019objectif de l\u2019imposition minimale (appel\u00e9e \u00ab Pilier Deux \u00bb), adopt\u00e9e par la France en d\u00e9cembre 2023, est de s\u2019assurer que les entreprises concern\u00e9es (grands Groupes) paient un taux effectif d\u2019imp\u00f4t sur les soci\u00e9t\u00e9s d\u2019au moins 15<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Les r\u00e8gles applicables obligent le Groupe \u00e0 payer un imp\u00f4t compl\u00e9mentaire d\u00e8s lors que le taux effectif d\u2019imposition dans le pays concern\u00e9 est inf\u00e9rieur \u00e0 15<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. Compte tenu des dispositions applicables en mati\u00e8re de \u00ab Safe Harbor \u00bb, le Groupe ne s\u2019attend pas \u00e0 ce que la r\u00e9glementation Pilier Deux ait un impact significatif \u00e0 court terme. Comme lors de la p\u00e9riode pr\u00e9c\u00e9dente, la charge fiscale suppl\u00e9mentaire due aux r\u00e8gles de taxation minimale mondiale est demeur\u00e9 n\u00e9gligeable en 2025 (inf\u00e9rieure \u00e0 1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros).</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">Loi en faveur d\u2019un programme d\u2019investissement fiscal imm\u00e9diat en Allemagne\u00a0:</div><div class=\"defaultParagraph_1 Standard\">Le 11 juillet 2025, le Conseil f\u00e9d\u00e9ral a adopt\u00e9 la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer l\u2019Allemagne en tant que site \u00e9conomique \u00bb, pr\u00e9voyant une r\u00e9duction progressive du taux d\u2019imposition des soci\u00e9t\u00e9s \u00e0 partir de l\u2019exercice 2028. Dans ce contexte, les imp\u00f4ts diff\u00e9r\u00e9s des entit\u00e9s allemandes du Groupe ont \u00e9t\u00e9 r\u00e9\u00e9valu\u00e9s au cours de la p\u00e9riode consid\u00e9r\u00e9e. L\u2019all\u00e9gement fiscal exceptionnel qui en a r\u00e9sult\u00e9 s\u00b4\u00e9l\u00e8ve \u00e0 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u00b4euros et se retrouve dans le poste \u00ab\u00a0Autres\u00a0\u00bb, dans le tableau du reconciliation.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>19. </sub></span><div class=\"list-paragraph-container_1\"><sub>Imp\u00f4ts diff\u00e9r\u00e9s</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 THeadfirstText_1\" style=\"line-height:14px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d51564e\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</div></td><td class=\"d51564e\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d92d48a\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\">en millions \u20ac</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">31 d\u00e9c. 2024</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">31 d\u00e9c. 2024</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Reconnu en compte de r\u00e9sultat</span></div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Immobilisations incorporelles</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">7,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">317,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">354,3</div></td><td class=\"e216a9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Immobilisations corporelles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">67,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">44,7</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201324,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Stocks</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">40,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">38,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,9</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cr\u00e9ances clients et autres actifs courants</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20133,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Passif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">40,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">12,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9ficits reportables</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">13,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,3</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201310,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">B\u00e9n\u00e9fices non distribu\u00e9s des filiales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Montant brut</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">108,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">113,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">409,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,1</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,3</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Compensation</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201333,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201349,9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201333,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201349,9</div></td><td class=\"d07aad4\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Montant net</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">75,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">63,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">375,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">358,2</div></td><td class=\"d388e87\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,3</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d5293bc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les actifs ou passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont d\u00e9termin\u00e9s en fonction des diff\u00e9rences temporaires entre les valeurs comptables et la valeur fiscale des actifs et passifs concern\u00e9s, en conformit\u00e9 avec la norme IAS 12, y compris les reports d\u00e9ficitaires et les cr\u00e9dits d\u2019imp\u00f4t, \u00e0 l\u2019exception des cas express\u00e9ment exclus par cette norme. L'\u00e9valuation repose sur les taux d'imposition qui devraient s\u2019appliquer au cours de la p\u00e9riode durant laquelle l\u2019actif sera r\u00e9alis\u00e9 ou le passif r\u00e9gl\u00e9, ou lorsque les pertes fiscales seront utilis\u00e9es. \u00c0 cette fin, le Groupe utilise les taux d\u2019imposition et les r\u00e8gles fiscales adopt\u00e9s ou quasi adopt\u00e9s \u00e0 la date de cl\u00f4ture. L\u2019impact de la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer la place \u00e9conomique de l\u2019Allemagne \u00bb est d\u00e9taill\u00e9 en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d\u00e9coulant de l\u2019imp\u00f4t diff\u00e9r\u00e9 est refl\u00e9t\u00e9e dans l\u2019\u00e9l\u00e9ment \u00ab\u00a0Charge d\u2019imp\u00f4t\u00a0\u00bb dans le compte de r\u00e9sultat, sauf pour ces \u00e9l\u00e9ments qui sont reconnus dans d\u2019autres revenus globaux et pour des effets d\u00e9riv\u00e9s de regroupements d\u2019entreprises.</div><div class=\"defaultParagraph_1 Standard\">Des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont comptabilis\u00e9s pour toutes les diff\u00e9rences temporelles d\u00e9ductibles et les pertes fiscales non utilis\u00e9es dans la mesure o\u00f9 il est probable qu\u2019un b\u00e9n\u00e9fice imposable futur sera disponible pour permettre leur imputation. Les estimations relatives aux b\u00e9n\u00e9fices imposables futurs ainsi qu\u2019\u00e0 la p\u00e9riode de r\u00e9cup\u00e9ration des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s reposent sur des hypoth\u00e8ses, compte tenu de l\u2019incertitude inh\u00e9rente aux \u00e9volutions futures, dont certaines \u00e9chappent au contr\u00f4le de la direction. Ces estimations sont r\u00e9vis\u00e9es lorsque des \u00e9l\u00e9ments probants suffisants sont disponibles. Lorsqu\u2019aucune indication ne permet de conclure \u00e0 la r\u00e9alisation probable de tout ou partie d\u2019une diff\u00e9rence temporelle d\u00e9ductible ou d\u2019une perte fiscale, le montant correspondant n\u2019est pas comptabilis\u00e9 \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe exerce ses activit\u00e9s dans de nombreuses juridictions fiscales. En cons\u00e9quence, les positions fiscales pr\u00e9sent\u00e9es dans les \u00e9tats financiers consolid\u00e9s sont d\u00e9termin\u00e9es en tenant compte des l\u00e9gislations fiscales locales applicables ainsi que des interpr\u00e9tations pertinentes des administrations fiscales concern\u00e9es. En raison de leur complexit\u00e9, ces positions peuvent faire l\u2019objet d\u2019interpr\u00e9tations divergentes entre les contribuables et les autorit\u00e9s fiscales. Le montant des positions fiscales incertaines est d\u00e9termin\u00e9 sur la base de la meilleure estimation du paiement d\u2019imp\u00f4t attendu.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique l\u2019exon\u00e9ration obligatoire concernant la comptabilisation des imp\u00f4ts diff\u00e9r\u00e9s susceptibles de r\u00e9sulter de l\u2019application des r\u00e8gles d\u2019imposition minimale mondiale (Pilier Deux). Les effets de ces r\u00e8gles sur le Groupe sont pr\u00e9sent\u00e9s en note\u00a013.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Imp\u00f4ts diff\u00e9r\u00e9s actifs</div><div class=\"defaultParagraph_1 Standard\">Pour des pertes reportables de <span class=\"hyperlink-no-style_1\"></span>16,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>14,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros), aucun actif d\u2019imp\u00f4t diff\u00e9r\u00e9 n\u2019a \u00e9t\u00e9 constat\u00e9 en raison de l\u2019absence de perspectives fiables de b\u00e9n\u00e9fices imposables futurs. Parmi ces pertes fiscales non utilis\u00e9es, <span class=\"hyperlink-no-style_1\"></span>6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros peuvent encore \u00eatre report\u00e9s pour une dur\u00e9e limit\u00e9e (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>1,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros), dont <span class=\"hyperlink-no-style_1\"></span>0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros expireront au cours des cinq prochaines ann\u00e9es (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">Les actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s d\u2019environ <span class=\"hyperlink-no-style_1\"></span>0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: environ <span class=\"hyperlink-no-style_1\"></span>6,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) concernent des soci\u00e9t\u00e9s ayant enregistr\u00e9 des pertes au cours de l\u2019exercice examin\u00e9 ou de la p\u00e9riode pr\u00e9c\u00e9dente. Ces pertes reportables ont \u00e9t\u00e9 comptabilis\u00e9es comme actifs dans la mesure o\u00f9 l\u2019on suppose que des b\u00e9n\u00e9fices imposables seront disponibles \u00e0 l\u2019avenir pour absorber ces pertes fiscales non utilis\u00e9es et les diff\u00e9rences temporaires d\u00e9ductibles. Cette hypoth\u00e8se est notamment retenue lorsque les pertes r\u00e9sultent d\u2019\u00e9l\u00e9ments exceptionnels ou ponctuels, ou lorsque des diff\u00e9rences temporaires imposables suffisantes existent.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Imp\u00f4ts diff\u00e9r\u00e9s passifs</div><div class=\"defaultParagraph_1 Standard\">Les passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s relatifs aux actifs incorporels concernent essentiellement des actifs acquis dans le cadre de regroupements d\u2019entreprises et sont donc principalement associ\u00e9s aux relations clients et aux technologies.</div><div class=\"defaultParagraph_1 Standard\">Pour les diff\u00e9rences temporaires li\u00e9es aux participations dans des filiales, s\u2019\u00e9levant \u00e0 <span class=\"hyperlink-no-style_1\"></span>50<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>45<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros), aucun passif d\u2019imp\u00f4t diff\u00e9r\u00e9 n\u2019a \u00e9t\u00e9 constat\u00e9, car le Groupe contr\u00f4le l\u2019\u00e9volution de ces diff\u00e9rences temporaires et la r\u00e9alisation de ces passifs n\u2019est pas attendue dans un avenir pr\u00e9visible.</div><div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts sur le r\u00e9sultat comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global se pr\u00e9sentent comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Couvertures des flux de tr\u00e9sorerie</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20139,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9\u00e9valuation des actifs<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>passifs au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u20138,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,8</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d'imp\u00f4ts diff\u00e9r\u00e9s est d\u00e9taill\u00e9 dans le tableau ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">60,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">389,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s dans le r\u00e9sultat net</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201329,5</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">63,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">358,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</span></div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Solde au 1<sup>er </sup>janv. 2025</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">63,2</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">358,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s dans le r\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">75,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">375,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-70": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\" style=\"background-color:#FFFFFF\"><sub>13. </sub></span><div class=\"list-paragraph-container_1\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\"><sub>L'imp\u00f4t sur le r\u00e9sultat courant est d\u00e9termin\u00e9</sub></span></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4t sur le r\u00e9sultat courant</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013110,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201372,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4ts diff\u00e9r\u00e9s</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">31,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013107,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts courants sur le r\u00e9sultat sont d\u00e9termin\u00e9s sur la base du r\u00e9sultat fiscal local de la p\u00e9riode et des r\u00e8gles fiscales locales. En outre, les imp\u00f4ts courants incluent des ajustements relatifs aux paiements d\u2019imp\u00f4ts incertains ou aux remboursements d\u2019imp\u00f4ts pour les p\u00e9riodes non \u00e9valu\u00e9es, ainsi que les r\u00e9ajustements pour les ann\u00e9es ant\u00e9rieures. Les variations des actifs et passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont inclus dans la ligne des imp\u00f4ts diff\u00e9r\u00e9s, \u00e0 l'exception des changements comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global ou dans les capitaux propres (note\u00a019).</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span>Le tableau suivant d\u00e9taille l\u2019\u00e9cart entre la charge fiscale th\u00e9orique et la charge d'imp\u00f4t constat\u00e9e pour l'exercice consid\u00e9r\u00e9. La charge fiscale th\u00e9orique est calcul\u00e9e en appliquant le taux d\u2019imposition standard en France au r\u00e9sultat consolid\u00e9 avant imp\u00f4t.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'imposition th\u00e9orique</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,8%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,8%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charge fiscale th\u00e9orique</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201396,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201356,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Diff\u00e9rences permanentes</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201323,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201318,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Diff\u00e9rences de taux d\u2019imposition</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Revenus exon\u00e9r\u00e9s et autres exemptions fiscales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Pertes fiscales non reconnues et diff\u00e9rences temporelles d\u00e9ductibles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4ts relatifs aux exercices pr\u00e9c\u00e9dents</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Retenue \u00e0 la source et autres imp\u00f4ts sur le r\u00e9sultat avec une base fiscale diff\u00e9rente</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,1</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u2013107,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'imposition effectif</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,7%</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,6%</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>19. </sub></span><div class=\"list-paragraph-container_1\"><sub>Imp\u00f4ts diff\u00e9r\u00e9s</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 THeadfirstText_1\" style=\"line-height:14px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"d51564e\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</div></td><td class=\"d51564e\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 THeadfirstNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d92d48a\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\">en millions \u20ac</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">31 d\u00e9c. 2024</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">31 d\u00e9c. 2024</div></td><td class=\"d3569e5\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Reconnu en compte de r\u00e9sultat</span></div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Immobilisations incorporelles</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">7,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">317,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">354,3</div></td><td class=\"e216a9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Immobilisations corporelles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">67,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">44,7</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201324,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Stocks</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">40,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">38,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,9</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cr\u00e9ances clients et autres actifs courants</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">8,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20133,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Passif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">40,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">12,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,2</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9ficits reportables</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">13,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,3</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201310,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">B\u00e9n\u00e9fices non distribu\u00e9s des filiales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Montant brut</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">108,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">113,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">409,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">408,1</div></td><td class=\"e71754\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,3</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Compensation</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201333,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201349,9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201333,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201349,9</div></td><td class=\"d07aad4\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Montant net</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">75,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">63,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">375,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">358,2</div></td><td class=\"d388e87\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,3</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d5293bc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les actifs ou passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont d\u00e9termin\u00e9s en fonction des diff\u00e9rences temporaires entre les valeurs comptables et la valeur fiscale des actifs et passifs concern\u00e9s, en conformit\u00e9 avec la norme IAS 12, y compris les reports d\u00e9ficitaires et les cr\u00e9dits d\u2019imp\u00f4t, \u00e0 l\u2019exception des cas express\u00e9ment exclus par cette norme. L'\u00e9valuation repose sur les taux d'imposition qui devraient s\u2019appliquer au cours de la p\u00e9riode durant laquelle l\u2019actif sera r\u00e9alis\u00e9 ou le passif r\u00e9gl\u00e9, ou lorsque les pertes fiscales seront utilis\u00e9es. \u00c0 cette fin, le Groupe utilise les taux d\u2019imposition et les r\u00e8gles fiscales adopt\u00e9s ou quasi adopt\u00e9s \u00e0 la date de cl\u00f4ture. L\u2019impact de la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer la place \u00e9conomique de l\u2019Allemagne \u00bb est d\u00e9taill\u00e9 en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d\u00e9coulant de l\u2019imp\u00f4t diff\u00e9r\u00e9 est refl\u00e9t\u00e9e dans l\u2019\u00e9l\u00e9ment \u00ab\u00a0Charge d\u2019imp\u00f4t\u00a0\u00bb dans le compte de r\u00e9sultat, sauf pour ces \u00e9l\u00e9ments qui sont reconnus dans d\u2019autres revenus globaux et pour des effets d\u00e9riv\u00e9s de regroupements d\u2019entreprises.</div><div class=\"defaultParagraph_1 Standard\">Des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont comptabilis\u00e9s pour toutes les diff\u00e9rences temporelles d\u00e9ductibles et les pertes fiscales non utilis\u00e9es dans la mesure o\u00f9 il est probable qu\u2019un b\u00e9n\u00e9fice imposable futur sera disponible pour permettre leur imputation. Les estimations relatives aux b\u00e9n\u00e9fices imposables futurs ainsi qu\u2019\u00e0 la p\u00e9riode de r\u00e9cup\u00e9ration des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s reposent sur des hypoth\u00e8ses, compte tenu de l\u2019incertitude inh\u00e9rente aux \u00e9volutions futures, dont certaines \u00e9chappent au contr\u00f4le de la direction. Ces estimations sont r\u00e9vis\u00e9es lorsque des \u00e9l\u00e9ments probants suffisants sont disponibles. Lorsqu\u2019aucune indication ne permet de conclure \u00e0 la r\u00e9alisation probable de tout ou partie d\u2019une diff\u00e9rence temporelle d\u00e9ductible ou d\u2019une perte fiscale, le montant correspondant n\u2019est pas comptabilis\u00e9 \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe exerce ses activit\u00e9s dans de nombreuses juridictions fiscales. En cons\u00e9quence, les positions fiscales pr\u00e9sent\u00e9es dans les \u00e9tats financiers consolid\u00e9s sont d\u00e9termin\u00e9es en tenant compte des l\u00e9gislations fiscales locales applicables ainsi que des interpr\u00e9tations pertinentes des administrations fiscales concern\u00e9es. En raison de leur complexit\u00e9, ces positions peuvent faire l\u2019objet d\u2019interpr\u00e9tations divergentes entre les contribuables et les autorit\u00e9s fiscales. Le montant des positions fiscales incertaines est d\u00e9termin\u00e9 sur la base de la meilleure estimation du paiement d\u2019imp\u00f4t attendu.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique l\u2019exon\u00e9ration obligatoire concernant la comptabilisation des imp\u00f4ts diff\u00e9r\u00e9s susceptibles de r\u00e9sulter de l\u2019application des r\u00e8gles d\u2019imposition minimale mondiale (Pilier Deux). Les effets de ces r\u00e8gles sur le Groupe sont pr\u00e9sent\u00e9s en note\u00a013.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Imp\u00f4ts diff\u00e9r\u00e9s actifs</div><div class=\"defaultParagraph_1 Standard\">Pour des pertes reportables de <span class=\"hyperlink-no-style_1\"></span>16,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>14,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros), aucun actif d\u2019imp\u00f4t diff\u00e9r\u00e9 n\u2019a \u00e9t\u00e9 constat\u00e9 en raison de l\u2019absence de perspectives fiables de b\u00e9n\u00e9fices imposables futurs. Parmi ces pertes fiscales non utilis\u00e9es, <span class=\"hyperlink-no-style_1\"></span>6,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros peuvent encore \u00eatre report\u00e9s pour une dur\u00e9e limit\u00e9e (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>1,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros), dont <span class=\"hyperlink-no-style_1\"></span>0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros expireront au cours des cinq prochaines ann\u00e9es (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">Les actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s d\u2019environ <span class=\"hyperlink-no-style_1\"></span>0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros (exercice pr\u00e9c\u00e9dent\u00a0: environ <span class=\"hyperlink-no-style_1\"></span>6,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) concernent des soci\u00e9t\u00e9s ayant enregistr\u00e9 des pertes au cours de l\u2019exercice examin\u00e9 ou de la p\u00e9riode pr\u00e9c\u00e9dente. Ces pertes reportables ont \u00e9t\u00e9 comptabilis\u00e9es comme actifs dans la mesure o\u00f9 l\u2019on suppose que des b\u00e9n\u00e9fices imposables seront disponibles \u00e0 l\u2019avenir pour absorber ces pertes fiscales non utilis\u00e9es et les diff\u00e9rences temporaires d\u00e9ductibles. Cette hypoth\u00e8se est notamment retenue lorsque les pertes r\u00e9sultent d\u2019\u00e9l\u00e9ments exceptionnels ou ponctuels, ou lorsque des diff\u00e9rences temporaires imposables suffisantes existent.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Imp\u00f4ts diff\u00e9r\u00e9s passifs</div><div class=\"defaultParagraph_1 Standard\">Les passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s relatifs aux actifs incorporels concernent essentiellement des actifs acquis dans le cadre de regroupements d\u2019entreprises et sont donc principalement associ\u00e9s aux relations clients et aux technologies.</div><div class=\"defaultParagraph_1 Standard\">Pour les diff\u00e9rences temporaires li\u00e9es aux participations dans des filiales, s\u2019\u00e9levant \u00e0 <span class=\"hyperlink-no-style_1\"></span>50<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (exercice pr\u00e9c\u00e9dent\u00a0: <span class=\"hyperlink-no-style_1\"></span>45<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros), aucun passif d\u2019imp\u00f4t diff\u00e9r\u00e9 n\u2019a \u00e9t\u00e9 constat\u00e9, car le Groupe contr\u00f4le l\u2019\u00e9volution de ces diff\u00e9rences temporaires et la r\u00e9alisation de ces passifs n\u2019est pas attendue dans un avenir pr\u00e9visible.</div><div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts sur le r\u00e9sultat comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global se pr\u00e9sentent comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Couvertures des flux de tr\u00e9sorerie</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20139,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">5,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9\u00e9valuation des actifs<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>passifs au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u20138,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,8</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d'imp\u00f4ts diff\u00e9r\u00e9s est d\u00e9taill\u00e9 dans le tableau ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">60,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">389,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s dans le r\u00e9sultat net</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201329,5</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">63,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">358,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Imp\u00f4ts diff\u00e9r\u00e9s actifs</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Imp\u00f4ts diff\u00e9r\u00e9s passifs</span></div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Solde au 1<sup>er </sup>janv. 2025</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">63,2</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">358,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s dans le r\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Comptabilis\u00e9s en autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">75,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">375,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-71": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les imp\u00f4ts courants sur le r\u00e9sultat sont d\u00e9termin\u00e9s sur la base du r\u00e9sultat fiscal local de la p\u00e9riode et des r\u00e8gles fiscales locales. En outre, les imp\u00f4ts courants incluent des ajustements relatifs aux paiements d\u2019imp\u00f4ts incertains ou aux remboursements d\u2019imp\u00f4ts pour les p\u00e9riodes non \u00e9valu\u00e9es, ainsi que les r\u00e9ajustements pour les ann\u00e9es ant\u00e9rieures. Les variations des actifs et passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont inclus dans la ligne des imp\u00f4ts diff\u00e9r\u00e9s, \u00e0 l'exception des changements comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global ou dans les capitaux propres (note\u00a019).</div><div class=\"defaultParagraph_1 Standard\">Les actifs ou passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont d\u00e9termin\u00e9s en fonction des diff\u00e9rences temporaires entre les valeurs comptables et la valeur fiscale des actifs et passifs concern\u00e9s, en conformit\u00e9 avec la norme IAS 12, y compris les reports d\u00e9ficitaires et les cr\u00e9dits d\u2019imp\u00f4t, \u00e0 l\u2019exception des cas express\u00e9ment exclus par cette norme. L'\u00e9valuation repose sur les taux d'imposition qui devraient s\u2019appliquer au cours de la p\u00e9riode durant laquelle l\u2019actif sera r\u00e9alis\u00e9 ou le passif r\u00e9gl\u00e9, ou lorsque les pertes fiscales seront utilis\u00e9es. \u00c0 cette fin, le Groupe utilise les taux d\u2019imposition et les r\u00e8gles fiscales adopt\u00e9s ou quasi adopt\u00e9s \u00e0 la date de cl\u00f4ture. L\u2019impact de la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer la place \u00e9conomique de l\u2019Allemagne \u00bb est d\u00e9taill\u00e9 en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d\u00e9coulant de l\u2019imp\u00f4t diff\u00e9r\u00e9 est refl\u00e9t\u00e9e dans l\u2019\u00e9l\u00e9ment \u00ab\u00a0Charge d\u2019imp\u00f4t\u00a0\u00bb dans le compte de r\u00e9sultat, sauf pour ces \u00e9l\u00e9ments qui sont reconnus dans d\u2019autres revenus globaux et pour des effets d\u00e9riv\u00e9s de regroupements d\u2019entreprises.</div><div class=\"defaultParagraph_1 Standard\">Des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont comptabilis\u00e9s pour toutes les diff\u00e9rences temporelles d\u00e9ductibles et les pertes fiscales non utilis\u00e9es dans la mesure o\u00f9 il est probable qu\u2019un b\u00e9n\u00e9fice imposable futur sera disponible pour permettre leur imputation. Les estimations relatives aux b\u00e9n\u00e9fices imposables futurs ainsi qu\u2019\u00e0 la p\u00e9riode de r\u00e9cup\u00e9ration des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s reposent sur des hypoth\u00e8ses, compte tenu de l\u2019incertitude inh\u00e9rente aux \u00e9volutions futures, dont certaines \u00e9chappent au contr\u00f4le de la direction. Ces estimations sont r\u00e9vis\u00e9es lorsque des \u00e9l\u00e9ments probants suffisants sont disponibles. Lorsqu\u2019aucune indication ne permet de conclure \u00e0 la r\u00e9alisation probable de tout ou partie d\u2019une diff\u00e9rence temporelle d\u00e9ductible ou d\u2019une perte fiscale, le montant correspondant n\u2019est pas comptabilis\u00e9 \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe exerce ses activit\u00e9s dans de nombreuses juridictions fiscales. En cons\u00e9quence, les positions fiscales pr\u00e9sent\u00e9es dans les \u00e9tats financiers consolid\u00e9s sont d\u00e9termin\u00e9es en tenant compte des l\u00e9gislations fiscales locales applicables ainsi que des interpr\u00e9tations pertinentes des administrations fiscales concern\u00e9es. En raison de leur complexit\u00e9, ces positions peuvent faire l\u2019objet d\u2019interpr\u00e9tations divergentes entre les contribuables et les autorit\u00e9s fiscales. Le montant des positions fiscales incertaines est d\u00e9termin\u00e9 sur la base de la meilleure estimation du paiement d\u2019imp\u00f4t attendu.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique l\u2019exon\u00e9ration obligatoire concernant la comptabilisation des imp\u00f4ts diff\u00e9r\u00e9s susceptibles de r\u00e9sulter de l\u2019application des r\u00e8gles d\u2019imposition minimale mondiale (Pilier Deux). Les effets de ces r\u00e8gles sur le Groupe sont pr\u00e9sent\u00e9s en note\u00a013.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-72": {
   "value": "<table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Chiffre d\u2019affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0967,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0780,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Achats consomm\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013563,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013599,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres co\u00fbts et services li\u00e9s aux achats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013162,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013168,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de personnel</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013855,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013852,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements et d\u00e9pr\u00e9ciations</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013318,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013301,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres charges op\u00e9rationnelles</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013541,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013487,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Sous-total</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0441,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132\u00a0409,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">EBIT (R\u00e9sultat op\u00e9rationnel)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">525,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">370,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat financier</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013152,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013151,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Imp\u00f4t sur le r\u00e9sultat</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013107,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201340,7</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Participations ne donnant pas le contr\u00f4le</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">R\u00e9sultat net apr\u00e8s participations ne donnant pas le contr\u00f4le</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">175,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les autres charges op\u00e9rationnelles comprennent notamment des \u00e9l\u00e9ments tels que les gains et pertes de change, les frais de transport, les frais de d\u00e9placement, ainsi que les refacturations pour les services obtenus d'autres entit\u00e9s du Groupe Sartorius\u00a0AG (note\u00a045) et d\u2019autres produits et charges divers de nature op\u00e9rationnelle.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts li\u00e9s aux mati\u00e8res premi\u00e8res sont repartis dans les postes \u00ab Achats consomm\u00e9s \u00bb et \u00ab Autres co\u00fbts et services li\u00e9s aux achats \u00bb dans le tableau pr\u00e9c\u00e9dent. Les frais de personnel se d\u00e9taillent comme suit :</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Frais de personnel </div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Salaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">678,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">680,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges sociales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">161,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">156,3</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges relatives aux retraites et pensions</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,5</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">855,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">852,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-73": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">Frais de personnel </div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Salaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">678,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">680,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges sociales</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">161,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">156,3</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges relatives aux retraites et pensions</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,5</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">855,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">852,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>24. </sub></span><div class=\"list-paragraph-container_1\"><sub>Provisions pour retraites et avantages au personnel</sub></div></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>R\u00e9gimes \u00e0 cotisations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La majorit\u00e9 des entit\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> verse des cotisations dans le cadre des r\u00e9gimes \u00e0 cotisations d\u00e9finies, principalement li\u00e9s \u00e0 des r\u00e9gimes de retraite publics. </span>En <span class=\"hyperlink-no-style_1\"></span>2025, la charge totale comptabilis\u00e9e pour ces r\u00e9gimes s'\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>44,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (en <span class=\"hyperlink-no-style_1\"></span>2024 : <span class=\"hyperlink-no-style_1\"></span>47,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). </div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">R\u00e9gimes \u00e0 prestations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\">Les provisions pour retraites et obligations similaires sont comptabilis\u00e9es dans les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech, conform\u00e9ment aux principes actuariels. La norme IAS\u00a019 (Avantages du personnel) prescrit l\u2019utilisation de la m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es (\u00ab\u00a0projected unit credit method\u00a0\u00bb) comme m\u00e9thode d'\u00e9valuation. Outre les rentes tir\u00e9es des pensions acquises et de l\u2019esp\u00e9rance de vie, cette m\u00e9thode tient compte des augmentations futures de salaires et de pensions.</div><div class=\"defaultParagraph_1 Standard\">Les taux d'actualisation appliqu\u00e9s refl\u00e8tent les taux d'int\u00e9r\u00eat observ\u00e9s \u00e0 la date d'arr\u00eat\u00e9 pour des obligations d\u2019entreprise de premier ordre, libell\u00e9es dans les devises concern\u00e9es (principalement en euro) et pr\u00e9sentant des maturit\u00e9s \u00e9quivalentes. En l\u2019absence d\u2019obligations d\u2019entreprises disponibles avec des \u00e9ch\u00e9ances \u00e0 long terme \u00e9quivalentes, les taux d\u2019int\u00e9r\u00eat sont d\u00e9termin\u00e9s par extrapolation.</div><div class=\"defaultParagraph_1 Standard\">En raison de l'\u00e9volution des conditions du march\u00e9 et de l'\u00e9conomie, les hypoth\u00e8ses cl\u00e9s retenues peuvent diff\u00e9rer des d\u00e9veloppements r\u00e9els et provoquer des variations importantes des obligations de retraite et autres avantages post-emploi. Une analyse de sensibilit\u00e9 est pr\u00e9sent\u00e9e ci-apr\u00e8s.</div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des obligations (et actifs) au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies sont pr\u00e9sent\u00e9es dans les autres \u00e9l\u00e9ments du r\u00e9sultat global, conform\u00e9ment \u00e0 la norme IAS\u00a019.</div><div class=\"defaultParagraph_1 Standard\">Les pertes actuarielles, transf\u00e9r\u00e9es aux r\u00e9serves de retraite, proviennent principalement d\u2019un changement du taux d\u2019actualisation et s\u2019\u00e9l\u00e8vent \u00e0 <span class=\"hyperlink-no-style_1\"></span>1,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>\u20132,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros).</div><div class=\"defaultParagraph_1 Standard\">Un montant de <span class=\"hyperlink-no-style_1\"></span>17,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros concerne en particulier les provisions pour r\u00e9gimes de retraite en Allemagne. Ces provisions totalisaient <span class=\"hyperlink-no-style_1\"></span>19,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros en <span class=\"hyperlink-no-style_1\"></span>2024 et comprenaient essentiellement des engagements directs au titre de r\u00e9gimes \u00e0 prestations d\u00e9finies. Dans le cadre de ces engagements, les salari\u00e9s acqui\u00e8rent des droits pour chaque ann\u00e9e de service rendue \u00e0 l\u2019entreprise. Les prestations d\u00e9pendent du niveau de r\u00e9mun\u00e9ration et de l\u2019\u00e2ge des salari\u00e9s concern\u00e9s. Ces engagements ne sont g\u00e9n\u00e9ralement pas couverts par des actifs. Un montant de <span class=\"hyperlink-no-style_1\"></span>10,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros se rapporte aux prestations de retraite pr\u00e9vues par la l\u00e9gislation fran\u00e7aise, qui consistent en des indemnit\u00e9s vers\u00e9es par le Groupe aux employ\u00e9s lors de leur d\u00e9part \u00e0 la retraite (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>9,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9valuation des obligations concernant les avantages post\u00e9rieurs \u00e0 l\u2019emploi repose sur les principales hypoth\u00e8ses actuarielles suivantes\u00a0:</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Pour l'Allemagne\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en %</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,80</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,17</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des salaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,00</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,00</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des pensions de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,10</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,10</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Pour la France\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en %</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'actualisation</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,80</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3,30</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Taux d'augmentation future des salaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,60</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,25</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les hypoth\u00e8ses de mortalit\u00e9 et d'invalidit\u00e9 s\u2019appuient sur les tables \u00ab\u00a0Richttafeln (RT) 2018 G\u00a0\u00bb de Klaus Heubeck pour l\u2019Allemagne et le tableau \u00ab\u00a0INSEE F 2016-2018\u00a0\u00bb pour la France.</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">Les montants comptabilis\u00e9s dans le compte de r\u00e9sultat et les autres \u00e9l\u00e9ments du r\u00e9sultat global se composent comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbt des services rendus au cours de la p\u00e9riode</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbt des services pass\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">0,8</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Charge nette d'int\u00e9r\u00eats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbt des r\u00e9gimes \u00e0 prestations d\u00e9finies comptabilis\u00e9es en r\u00e9sultat</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Rendement de l'actif du r\u00e9gime (int\u00e9r\u00eats exclus)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9\u00e9valuations du r\u00e9gime</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,8</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden\">Composantes comptabilis\u00e9es en autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20132,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Total</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20131,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u20135,4</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Dans le compte du r\u00e9sultat, le co\u00fbt des services courants au cours de la p\u00e9riode est attribu\u00e9 selon l'affectation des salari\u00e9s aux diff\u00e9rentes fonctions.</div><div class=\"defaultParagraph_1 Standard\">Le montant des obligations li\u00e9es aux r\u00e9gimes \u00e0 prestations d\u00e9finies, pr\u00e9sent\u00e9 dans le bilan consolid\u00e9, est le suivant\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Valeur actuelle des obligations</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Juste valeur des actifs du r\u00e9gime</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201323,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201322,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passif net</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">32,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">33,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9volution de la valeur actualis\u00e9e des obligations est d\u00e9taill\u00e9e ci-apr\u00e8s\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeur actuelle des obligations \u00e0 l'ouverture</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">53,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbt des services rendus au cours de la p\u00e9riode</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbt des services pass\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,8</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Charges d\u2018int\u00e9r\u00eats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">R\u00e9\u00e9valuations du r\u00e9gime</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Indemnit\u00e9s de d\u00e9part \u00e0 la retraite vers\u00e9es au cours de l'exercice</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20133,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cotisations des employ\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres variations</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeur actuelle des obligations \u00e0 la cl\u00f4ture</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,1</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">56,4</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des passifs (ou actifs) des r\u00e9gimes \u00e0 prestations d\u00e9finies se d\u00e9composent comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ajustements li\u00e9s \u00e0 l'exp\u00e9rience</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Modifications li\u00e9es aux hypoth\u00e8ses d\u00e9mographiques</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Modifications li\u00e9es aux hypoth\u00e8ses financi\u00e8res</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u20131,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,6</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Actif du r\u00e9gime</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Actif du r\u00e9gime au 1<sup>er</sup> janv.</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">22,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">23,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Revenus d\u2018int\u00e9r\u00eats</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Rendement de l'actif du r\u00e9gime (int\u00e9r\u00eats exclus)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">R\u00e9\u00e9valuations du r\u00e9gime</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Paiements</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cotisations des employ\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cotisations des employeurs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres variations</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Actif du r\u00e9gime au 31 d\u00e9c.</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">23,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">22,8</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Composition de l'actif du r\u00e9gime</div><div class=\"defaultParagraph_1 Standard\">Les actifs des r\u00e9gimes se composent principalement de contrats d\u2019assurance en Suisse<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>; ils n\u2019incluent pas d\u2019investissements majeurs en actions ou en dette. Sartorius Korea Biotech a d\u00e9pos\u00e9 <span class=\"hyperlink-no-style_1\"></span>6,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>6,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros en <span class=\"hyperlink-no-style_1\"></span>2024) en disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie dans des banques locales.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 berschrift4\">Analyse de sensibilit\u00e9</div><div class=\"defaultParagraph_1 Standard\">Une augmentation ou une diminution des hypoth\u00e8ses actuarielles aurait les impacts suivants sur les obligations au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies (un signe positif [+] indique une augmentation de l\u2019obligation)\u00a0:</div><div class=\"defaultParagraph_1 berschrift5\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>2024\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Hypoth\u00e8ses d\u00e9mographiques</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Esp\u00e9rance de vie</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">+1 an</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131 an</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Impact</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Hypoth\u00e8ses financi\u00e8res</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'actualisation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">+100 bps</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013100 bps</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Impact</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'augmentation future des salaires</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">+50 bps</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201350 bps</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Impact</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Taux d'augmentation future des pensions de retraite</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">+25 bps</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201325 bps</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Impact</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,0</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; min-height:15px; margin-top:1px; margin-bottom:11px\"></div><div class=\"defaultParagraph_1 berschrift5\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>2025\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">\u00a0</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">\u00a0</span></div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Hypoth\u00e8ses d\u00e9mographiques</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Esp\u00e9rance de vie</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">+1 an</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131 an</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Impact</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Hypoth\u00e8ses financi\u00e8res</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Taux d'actualisation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">+100 bps</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013100 bps</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Impact</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Taux d'augmentation future des salaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">+50 bps</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201350 bps</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Impact</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Taux d'augmentation future des pensions de retraite</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">+25 bps</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201325 bps</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Impact</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,1</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,0</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">L'analyse de sensibilit\u00e9 pr\u00e9sent\u00e9e ci-dessus peut ne pas \u00eatre repr\u00e9sentative de la variation r\u00e9elle de l'obligation, car il est peu probable que les changements d\u2019hypoth\u00e8ses se produisent de mani\u00e8re isol\u00e9e. En outre, la valeur actuelle de ces obligations a \u00e9t\u00e9 calcul\u00e9e en utilisant la m\u00eame m\u00e9thode que celle appliqu\u00e9e pour \u00e9valuer les obligations comptabilis\u00e9es dans le bilan consolid\u00e9 (m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es).</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Analyse des \u00e9ch\u00e9ances</div><div class=\"defaultParagraph_1 Standard\">Les flux de tr\u00e9sorerie non actualis\u00e9s des obligations de retraite peuvent \u00eatre r\u00e9partis selon les \u00e9ch\u00e9ances suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">&lt; 1 an</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">24,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">19,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">6 - 10 ans</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">25,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">20,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">&gt; 10 ans</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">109,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">114,1</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">162,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">157,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La dur\u00e9e moyenne pond\u00e9r\u00e9e des obligations au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies est de <span class=\"hyperlink-no-style_1\"></span>13,7\u00a0ann\u00e9es (14,3\u00a0ann\u00e9es en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Autres provisions non courantes</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Total</div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,5</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">13,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,8</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">5,7</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">9,4</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">15,1</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,7</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,4</div></td><td class=\"d0570ab\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">15,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,3</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,7</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d5838c3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,2</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"d8955c9\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,8</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Provisions courantes</div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9volution des provisions courantes au cours des exercices <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 est d\u00e9taill\u00e9e ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,1</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">17,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">17,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les provisions pour garanties incluent notamment les co\u00fbts li\u00e9s aux livraisons de remplacement et aux r\u00e9parations. Des provisions pour risques sp\u00e9cifiques sont comptabilis\u00e9es lorsque leur survenance est jug\u00e9e plus probable qu\u2019improbable. Les risques g\u00e9n\u00e9raux de garantie sont \u00e9valu\u00e9s sur la base de l\u2019exp\u00e9rience pass\u00e9e. Les autres provisions courantes comprennent notamment des contrats on\u00e9reux, des passifs incertains li\u00e9s au personnel, ainsi que des provisions pour int\u00e9r\u00eats en lien avec des risques fiscaux. </div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>26. </sub></span><div class=\"list-paragraph-container_1\"><sub>Avantages sociaux</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; float:left; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Bonus et primes incitatives</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">56,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">40,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cong\u00e9s pay\u00e9s et heures suppl\u00e9mentaires</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Avantages au personnel</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">99,1</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">88,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les dettes au titre des avantages au personnel se d\u00e9composent comme suit\u00a0:</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">R\u00e9mun\u00e9ration des dirigeants</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">En <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025, les membres de la direction ont per\u00e7u les r\u00e9mun\u00e9rations suivantes conform\u00e9ment aux IFRS\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d64cfdb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages \u00e0 court terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages post\u00e9rieurs \u00e0 l'emploi</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres avantages \u00e0 long terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Indemnit\u00e9s de fin de contrat de travail</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Paiements en actions</div></td></tr><tr><td class=\"d010516\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2025<sup>1</sup></div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"fdb5fc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2024<sup>1</sup></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d7dddd1\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1 Pour de plus amples informations, veuillez consulter le chapitre \u00ab Gouvernance d\u2019entreprise \u00bb (pages 215 \u00e0 253).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-74": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>15. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat par action</sub></div></div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS\u00a033 (R\u00e9sultat par action), le b\u00e9n\u00e9fice par action de base (BPA de base) est calcul\u00e9 sur la base du nombre moyen pond\u00e9r\u00e9 d'actions ordinaires pendant la p\u00e9riode.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net apr\u00e8s imp\u00f4ts (en millions \u20ac)</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">266,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">178,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net du Groupe apr\u00e8s imp\u00f4ts (en millions \u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">265,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">175,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat par action (\u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,73</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,81</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat dilu\u00e9 par action (\u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,73</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,81</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Nombre d'actions (statutaire)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Nombre moyen pond\u00e9r\u00e9 d\u2019actions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">96\u00a0808\u00a0325</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actions propres</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201333\u00a0986</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201331\u00a0029</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Nombre moyen pond\u00e9r\u00e9 d'actions utilis\u00e9 pour le calcul du b\u00e9n\u00e9fice par action</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">97\u00a0296\u00a0419</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">96\u00a0777\u00a0296</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Nombre moyen pond\u00e9r\u00e9 d'actions utilis\u00e9 pour le calcul du b\u00e9n\u00e9fice par action dilu\u00e9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">97\u00a0296\u00a0419</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">96\u00a0777\u00a0296</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-75": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>15. </sub></span><div class=\"list-paragraph-container_1\"><sub>R\u00e9sultat par action</sub></div></div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS\u00a033 (R\u00e9sultat par action), le b\u00e9n\u00e9fice par action de base (BPA de base) est calcul\u00e9 sur la base du nombre moyen pond\u00e9r\u00e9 d'actions ordinaires pendant la p\u00e9riode.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net apr\u00e8s imp\u00f4ts (en millions \u20ac)</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">266,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">178,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net du Groupe apr\u00e8s imp\u00f4ts (en millions \u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">265,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">175,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat par action (\u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,73</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,81</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat dilu\u00e9 par action (\u20ac)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,73</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,81</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Nombre d'actions (statutaire)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Nombre moyen pond\u00e9r\u00e9 d\u2019actions</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97\u00a0330\u00a0405</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">96\u00a0808\u00a0325</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actions propres</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201333\u00a0986</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201331\u00a0029</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Nombre moyen pond\u00e9r\u00e9 d'actions utilis\u00e9 pour le calcul du b\u00e9n\u00e9fice par action</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">97\u00a0296\u00a0419</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">96\u00a0777\u00a0296</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Nombre moyen pond\u00e9r\u00e9 d'actions utilis\u00e9 pour le calcul du b\u00e9n\u00e9fice par action dilu\u00e9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">97\u00a0296\u00a0419</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">96\u00a0777\u00a0296</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTreasurySharesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-76": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS\u00a033 (R\u00e9sultat par action), le b\u00e9n\u00e9fice par action de base (BPA de base) est calcul\u00e9 sur la base du nombre moyen pond\u00e9r\u00e9 d'actions ordinaires pendant la p\u00e9riode.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-77": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Immobilisations incorporelles</div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d57eb77\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"d04ce71\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Marque</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Relations clients</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"c27fe3\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"d2b86e4\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0468,9</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">33,7</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,2</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">347,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,8</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0198,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">82,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0484,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">34,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">352,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">429,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0302,3</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s<br/>au 1<sup>er</sup> janv. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013217,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013163,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013119,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013504,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,4</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013100,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,5</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201319,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201342,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013164,6</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,4</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2bf897\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d398f95\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20136,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013182,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013160,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013670,6</div></td></tr><tr><td class=\"fb5602\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"d63f045\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0163,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">27,4</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">170,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">269,1</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1,6</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0631,7</div></td></tr><tr><td class=\"d57e8cf\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e2fd43\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a465a7\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d791d98\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Brevets, licences et droits similaires</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Marque</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Relations clients</div></td><td class=\"cb49ac\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Acomptes vers\u00e9s</div></td><td class=\"e4fe2a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d29461\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6b9bd7\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0484,5</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">34,0</div></td><td class=\"d59c7d6\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">352,9</div></td><td class=\"d792f0f\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">429,3</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"d44d455\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0302,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201315,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20138,7</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,6</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201328,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Regroupement d'entreprises</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Acquisitions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,3</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">90,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">93,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,2</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0470,2</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">33,8</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">338,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">508,5</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0352,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s <br/>au 1<sup>er</sup> janv. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013320,9</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20136,6</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013182,9</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013160,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013670,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,8</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,8</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>amortissements</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201395,6</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,5</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201318,1</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201352,3</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013168,6</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises sur cessions</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,3</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,9</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">14,3</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Transferts de compte \u00e0 compte</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d2241df\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">D\u00e9pr\u00e9ciations<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Amortissements cumul\u00e9s au 31 d\u00e9c. 2025</div></td><td class=\"d6f1406\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013410,7</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20139,0</div></td><td class=\"d9070e5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013191,0</div></td><td class=\"d3ac246\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013204,7</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d5b2382\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013815,3</div></td></tr><tr><td class=\"d56ee30\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"d3085b5\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0059,5</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">24,8</div></td><td class=\"fa1b9c\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">147,0</div></td><td class=\"d9857f8\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">303,9</div></td><td class=\"d99a874\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,5</div></td><td class=\"d531c79\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0536,7</div></td></tr><tr><td class=\"ed9345\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2586f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d2ea1fa\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d95fdc6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">L\u2019amortissement des immobilisations incorporelles se r\u00e9f\u00e8re aux dur\u00e9es de vie utiles suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>Logiciel</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2 \u00e0 10 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Technologies</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3 \u00e0 20 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">4 \u00e0 6 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Relations client</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1 \u00e0 20 ans</div></td></tr><tr><td class=\"daba0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Marque</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">De 2 ans \u00e0 l'infini</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">A compter du 31 d\u00e9cembre 2025, le poste \u00ab Brevets, licences et droits similaires \u00bb inclut les technologies issues de l\u2019acquisition de Polyplus, pour un montant d\u2019environ 659,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 705,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent), avec des dur\u00e9es de vie utiles allant jusqu\u2019\u00e0 16 ans.</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Les amortissements des immobilisations incorporelles sont affect\u00e9s aux fonctions correspondantes dans le compte de r\u00e9sultat. Pour les frais de d\u00e9veloppement capitalis\u00e9s, les amortissements sont comptabilis\u00e9s en \u00ab\u00a0co\u00fbts des ventes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 Standard\">Des d\u00e9pr\u00e9ciations d'un montant de <span class=\"hyperlink-no-style_1\"></span>0,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros ont \u00e9t\u00e9 constat\u00e9es en <span class=\"hyperlink-no-style_1\"></span>2025 sur les frais de d\u00e9veloppement capitalis\u00e9s (7,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Ces pertes de valeur sont renseign\u00e9es dans le compte de r\u00e9sultat au poste de \u00ab\u00a0frais de recherche et d\u00e9veloppement\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-78": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les immobilisations incorporelles sont comptabilis\u00e9es au co\u00fbt diminu\u00e9 du cumul des amortissements calcul\u00e9s selon la m\u00e9thode lin\u00e9aire et d'\u00e9ventuelles pertes de valeur. La dur\u00e9e de vie d\u2019une immobilisation incorporelle correspond \u00e0 la p\u00e9riode durant laquelle le Groupe pr\u00e9voit d\u2019utiliser l'actif. Des tests de d\u00e9pr\u00e9ciation sont r\u00e9alis\u00e9s lorsque sont observ\u00e9es des pertes de valeur et annuellement pour les immobilisations incorporelles qui n\u2019ont pas encore \u00e9t\u00e9 mises en service, telles que celles issues de projets de d\u00e9veloppement en cours, ainsi que pour les immobilisations incorporelles \u00e0 dur\u00e9e de vie ind\u00e9termin\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">L\u2019amortissement des immobilisations incorporelles se r\u00e9f\u00e8re aux dur\u00e9es de vie utiles suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\"><span class=\"hyperlink-no-style_1\"></span>Logiciel</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">2 \u00e0 10 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Technologies</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">3 \u00e0 20 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Co\u00fbts de d\u00e9veloppement capitalis\u00e9s</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">4 \u00e0 6 ans</div></td></tr><tr><td class=\"d8448fe\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Relations client</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1 \u00e0 20 ans</div></td></tr><tr><td class=\"daba0b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Marque</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">De 2 ans \u00e0 l'infini</div></td></tr><tr><td class=\"d6e8c78\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">A compter du 31 d\u00e9cembre 2025, le poste \u00ab Brevets, licences et droits similaires \u00bb inclut les technologies issues de l\u2019acquisition de Polyplus, pour un montant d\u2019environ 659,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 705,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent), avec des dur\u00e9es de vie utiles allant jusqu\u2019\u00e0 16 ans.</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le nom de marque </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, acquis en 2007 (valeur nette comptable : 10,8</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros) et int\u00e9gr\u00e9 au sein de la soci\u00e9t\u00e9 m\u00e8re (</span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.) est consid\u00e9r\u00e9 comme ayant une dur\u00e9e de vie ind\u00e9termin\u00e9e et n\u2019est donc pas amorti. Il n\u2019existe pas de limite pr\u00e9visible \u00e0 la p\u00e9riode durant laquelle ce nom de marque g\u00e9n\u00e9rera des flux de tr\u00e9sorerie nets pour le Groupe. Elle fait l\u2019objet de tests annuels de d\u00e9pr\u00e9ciation au niveau de l\u2019UGT du segment Biopharm</span>.</div><div class=\"defaultParagraph_1 Standard\">Les amortissements des immobilisations incorporelles sont affect\u00e9s aux fonctions correspondantes dans le compte de r\u00e9sultat. Pour les frais de d\u00e9veloppement capitalis\u00e9s, les amortissements sont comptabilis\u00e9s en \u00ab\u00a0co\u00fbts des ventes\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-79": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Des d\u00e9pr\u00e9ciations d'un montant de <span class=\"hyperlink-no-style_1\"></span>0,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros ont \u00e9t\u00e9 constat\u00e9es en <span class=\"hyperlink-no-style_1\"></span>2025 sur les frais de d\u00e9veloppement capitalis\u00e9s (7,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Ces pertes de valeur sont renseign\u00e9es dans le compte de r\u00e9sultat au poste de \u00ab\u00a0frais de recherche et d\u00e9veloppement\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-80": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les co\u00fbts engag\u00e9s dans le cadre du d\u00e9veloppement de nouveaux produits et m\u00e9thodes sont capitalis\u00e9s en tant qu'immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne si les crit\u00e8res de la norme IAS\u00a038.57 sont remplis. Cette capitalisation doit \u00eatre appr\u00e9ci\u00e9e selon son importance, et tenir compte par exemple de l'\u00e9valuation de la faisabilit\u00e9 d'un projet de d\u00e9veloppement, des perspectives de march\u00e9 attendues et de la d\u00e9termination des dur\u00e9es de vie utiles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts de d\u00e9veloppement capitalis\u00e9s couvrent principalement les co\u00fbts du personnel de R&amp;D, les mati\u00e8res premi\u00e8res et fournitures, les services externes et les frais g\u00e9n\u00e9raux directement imputables. Ces immobilisations incorporelles g\u00e9n\u00e9r\u00e9es en interne sont amorties lin\u00e9airement sur leur dur\u00e9e de vie utile, laquelle n\u2019exc\u00e8de g\u00e9n\u00e9ralement pas six ans. En <span class=\"hyperlink-no-style_1\"></span>2025, <span class=\"hyperlink-no-style_1\"></span>90,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros de frais de d\u00e9veloppement ont \u00e9t\u00e9 comptabilis\u00e9s \u00e0 l'actif (<span class=\"hyperlink-no-style_1\"></span>79,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Au 31 d\u00e9cembre 2025, un montant de <span class=\"hyperlink-no-style_1\"></span>139,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros \u00e9tait attribu\u00e9 \u00e0 des projets de d\u00e9veloppement qui ne sont pas encore soumis \u00e0 un amortissement r\u00e9gulier (contre <span class=\"hyperlink-no-style_1\"></span>120,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 Standard\">Toute subvention per\u00e7ue est d\u00e9duite des co\u00fbts de d\u00e9veloppement capitalis\u00e9s si elle est directement attribuable \u00e0 un projet donn\u00e9. Dans le cas contraire, elle est comptabilis\u00e9e en \u00ab autres produits op\u00e9rationnels \u00bb (Note\u00a011) lorsqu\u2019il existe une certitude raisonnable que les conditions associ\u00e9es seront remplies et que les subventions seront effectivement re\u00e7ues.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les crit\u00e8res de reconnaissance ne sont pas remplis, les frais de d\u00e9veloppement sont comptabilis\u00e9s en charges au cours de la p\u00e9riode o\u00f9 ils sont engag\u00e9s. Les co\u00fbts li\u00e9s aux activit\u00e9s de recherche sont \u00e9galement enregistr\u00e9s en charge sur l\u2019exercice concern\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-81": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>17. </sub></span><div class=\"list-paragraph-container_1\"><sub>Immobilisations corporelles</sub></div></div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Acomptes vers\u00e9s et immobilisations en cours</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">708,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">460,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">228,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">597,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">1\u00a0994,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Acquisitions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">26,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">263,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">323,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201317,4</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">73,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">52,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013135,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,1</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">803,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">547,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">248,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">722,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0321,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013151,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013207,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013109,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013468,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20138,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201337,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201349,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201324,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013110,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013188,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013258,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013126,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20130,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u2013572,5</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">615,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">289,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">122,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">722,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0749,4</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Actifs li\u00e9s aux droits d\u2019utilisation au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">125,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">135,8</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des immobilisations corporelles au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">740,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">291,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">130,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">722,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">1\u00a0885,2</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px; margin-bottom:0px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Acomptes vers\u00e9s et immobilisations en cours</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px; margin-right:4px\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">803,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">547,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">248,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">722,6</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0321,8</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201331,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20135,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201325,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201386,6</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Acquisitions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">47,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">21,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">14,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">227,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">310,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20134,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20135,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201311,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20132,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">208,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">112,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20133,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013328,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20139,9</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">1\u00a0023,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">653,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">242,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0512,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013188,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013258,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013126,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013572,5</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">6,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">9,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">19,2</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201345,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201355,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u201323,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013123,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">4,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">10,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">18,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u20130,5</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Amortissements cumul\u00e9s au <br/>31 d\u00e9c. 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013224,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013299,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013135,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u2013659,4</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">798,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">353,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">107,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,6</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">1\u00a0853,3</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Actifs li\u00e9s aux droits d\u2019utilisation au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">154,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">8,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">7,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">0,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">171,3</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Total des immobilisations corporelles au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">953,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">362,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">114,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">593,6</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">2\u00a0024,6</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab\u00a0Immobilisations corporelles\u00a0\u00bb du bilan consolid\u00e9 inclut les actifs li\u00e9s aux droits d'utilisation comptabilis\u00e9s conform\u00e9ment \u00e0 la norme IFRS 16 (note\u00a018). Les immobilisations corporelles sont comptabilis\u00e9es au co\u00fbt d\u2019acquisition, diminu\u00e9 des amortissements cumul\u00e9s et calcul\u00e9s selon la m\u00e9thode lin\u00e9aire sur leur dur\u00e9e de vie utile. Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur. </div><div class=\"defaultParagraph_1 Standard\">Les immobilisations en cours en <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 concernent principalement des projets d\u2019extension des capacit\u00e9s de production en Allemagne, en France, en Cor\u00e9e et \u00e0 Porto Rico. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Les amortissements sont \u00e9chelonn\u00e9s sur les dur\u00e9es de vie suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>Constructions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">15 \u00e0 50 ans</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">5 \u00e0 15 ans</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier et mat\u00e9riel de bureau</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3 \u00e0 13 ans</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les dotations aux amortissements et la charge de d\u00e9pr\u00e9ciation sont incluses dans le compte de r\u00e9sultat selon l'utilisation des actifs, r\u00e9parties entre les co\u00fbts des ventes, les frais commerciaux et de distribution, les frais de recherche et d\u00e9veloppement, les frais g\u00e9n\u00e9raux et les autres charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts d'emprunt sont comptabilis\u00e9s en charges, sauf s\u2019ils sont directement attribuables \u00e0 l'acquisition, \u00e0 la construction ou \u00e0 la production d'un actif qualifi\u00e9, auquel ils sont incorpor\u00e9s au co\u00fbt de cet actif conform\u00e9ment \u00e0 la norme IAS\u00a023. En <span class=\"hyperlink-no-style_1\"></span>2025, des co\u00fbts d\u2019emprunt de 17,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 capitalis\u00e9s, principalement en lien avec de nouveaux sites et d\u2019extensions (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 19,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le taux d\u2019emprunt utilis\u00e9 pour la capitalisation s\u2019\u00e9levait \u00e0 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es \u00e0 des actifs sont d\u00e9duites du co\u00fbt d\u2019acquisition de ces actifs.</div><div class=\"defaultParagraph_1 Standard\">En <span class=\"hyperlink-no-style_1\"></span>2025, comme pour l'exercice <span class=\"hyperlink-no-style_1\"></span>2024, aucune d\u00e9pr\u00e9ciation significative n\u2019a \u00e9t\u00e9 comptabilis\u00e9e sur les immobilisations corporelles.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-82": {
   "value": "<div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab\u00a0Immobilisations corporelles\u00a0\u00bb du bilan consolid\u00e9 inclut les actifs li\u00e9s aux droits d'utilisation comptabilis\u00e9s conform\u00e9ment \u00e0 la norme IFRS 16 (note\u00a018). Les immobilisations corporelles sont comptabilis\u00e9es au co\u00fbt d\u2019acquisition, diminu\u00e9 des amortissements cumul\u00e9s et calcul\u00e9s selon la m\u00e9thode lin\u00e9aire sur leur dur\u00e9e de vie utile. Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur. </div><div class=\"defaultParagraph_1 Standard\">Les immobilisations en cours en <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 concernent principalement des projets d\u2019extension des capacit\u00e9s de production en Allemagne, en France, en Cor\u00e9e et \u00e0 Porto Rico. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Les amortissements sont \u00e9chelonn\u00e9s sur les dur\u00e9es de vie suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>Constructions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">15 \u00e0 50 ans</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">5 \u00e0 15 ans</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier et mat\u00e9riel de bureau</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3 \u00e0 13 ans</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les dotations aux amortissements et la charge de d\u00e9pr\u00e9ciation sont incluses dans le compte de r\u00e9sultat selon l'utilisation des actifs, r\u00e9parties entre les co\u00fbts des ventes, les frais commerciaux et de distribution, les frais de recherche et d\u00e9veloppement, les frais g\u00e9n\u00e9raux et les autres charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les co\u00fbts d'emprunt sont comptabilis\u00e9s en charges, sauf s\u2019ils sont directement attribuables \u00e0 l'acquisition, \u00e0 la construction ou \u00e0 la production d'un actif qualifi\u00e9, auquel ils sont incorpor\u00e9s au co\u00fbt de cet actif conform\u00e9ment \u00e0 la norme IAS\u00a023. En <span class=\"hyperlink-no-style_1\"></span>2025, des co\u00fbts d\u2019emprunt de 17,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 capitalis\u00e9s, principalement en lien avec de nouveaux sites et d\u2019extensions (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 19,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le taux d\u2019emprunt utilis\u00e9 pour la capitalisation s\u2019\u00e9levait \u00e0 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 Standard\">Les subventions li\u00e9es \u00e0 des actifs sont d\u00e9duites du co\u00fbt d\u2019acquisition de ces actifs.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-83": {
   "value": "<div class=\"defaultParagraph_1 Standard\">La rubrique \u00ab\u00a0Immobilisations corporelles\u00a0\u00bb du bilan consolid\u00e9 inclut les actifs li\u00e9s aux droits d'utilisation comptabilis\u00e9s conform\u00e9ment \u00e0 la norme IFRS 16 (note\u00a018). Les immobilisations corporelles sont comptabilis\u00e9es au co\u00fbt d\u2019acquisition, diminu\u00e9 des amortissements cumul\u00e9s et calcul\u00e9s selon la m\u00e9thode lin\u00e9aire sur leur dur\u00e9e de vie utile. Les immobilisations corporelles font l\u2019objet de tests de perte de valeur d\u00e8s l\u2019apparition d\u2019indices de pertes de valeur. </div><div class=\"defaultParagraph_1 Standard\">Les immobilisations en cours en <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 concernent principalement des projets d\u2019extension des capacit\u00e9s de production en Allemagne, en France, en Cor\u00e9e et \u00e0 Porto Rico. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Les amortissements sont \u00e9chelonn\u00e9s sur les dur\u00e9es de vie suivantes\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\"><span class=\"hyperlink-no-style_1\"></span>Constructions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">15 \u00e0 50 ans</div></td></tr><tr><td class=\"d83c3ed\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">5 \u00e0 15 ans</div></td></tr><tr><td class=\"c94e4c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">\u00c9quipement d'atelier et mat\u00e9riel de bureau</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden; margin-bottom:2px\">3 \u00e0 13 ans</div></td></tr><tr><td class=\"d7bf8c5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les dotations aux amortissements et la charge de d\u00e9pr\u00e9ciation sont incluses dans le compte de r\u00e9sultat selon l'utilisation des actifs, r\u00e9parties entre les co\u00fbts des ventes, les frais commerciaux et de distribution, les frais de recherche et d\u00e9veloppement, les frais g\u00e9n\u00e9raux et les autres charges op\u00e9rationnelles.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDepreciationExpenseExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-85": {
   "value": "Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>27. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres obligations financi\u00e8res</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Engagements donn\u00e9s et re\u00e7us</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 \u00e0 des proc\u00e9dures judiciaires, des r\u00e9clamations ainsi qu\u2019\u00e0 des litiges d\u2019ordre fiscal, douanier, social ou autres, qui surviennent dans le cadre normal de ses activit\u00e9s. La direction n\u2019anticipe pas que les co\u00fbts finaux n\u00e9cessaires au r\u00e8glement de ces litiges aient un effet d\u00e9favorable significatif sur la situation financi\u00e8re consolid\u00e9e du Groupe, son compte de r\u00e9sultat ou ses flux de tr\u00e9sorerie. Cela vaut \u00e9galement pour le litige opposant la soci\u00e9t\u00e9 slov\u00e8ne Sartorius BIA Separations d.o.o. Celle-ci est d\u00e9fenderesse dans un litige qui l\u2019oppose \u00e0 son ancienne soci\u00e9t\u00e9 m\u00e8re autrichienne, BIA Separations GmbH, dans le cadre de la proc\u00e9dure d\u2019insolvabilit\u00e9 de cette derni\u00e8re ouverte avant l\u2019acquisition par le Groupe en 2020. En cas de r\u00e9clamation, le Groupe b\u00e9n\u00e9ficie d\u2019une clause de garantie de passif \u00e0 l\u2019encontre des vendeurs de la soci\u00e9t\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCommitmentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-84": {
   "value": "Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les engagements contractuels relatifs \u00e0 l\u2019acquisition d\u2019immobilisations corporelles s\u2019\u00e9levaient \u00e0 environ <span class=\"hyperlink-no-style_1\"></span>200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (110<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024).<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>27. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres obligations financi\u00e8res</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Engagements donn\u00e9s et re\u00e7us</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 \u00e0 des proc\u00e9dures judiciaires, des r\u00e9clamations ainsi qu\u2019\u00e0 des litiges d\u2019ordre fiscal, douanier, social ou autres, qui surviennent dans le cadre normal de ses activit\u00e9s. La direction n\u2019anticipe pas que les co\u00fbts finaux n\u00e9cessaires au r\u00e8glement de ces litiges aient un effet d\u00e9favorable significatif sur la situation financi\u00e8re consolid\u00e9e du Groupe, son compte de r\u00e9sultat ou ses flux de tr\u00e9sorerie. Cela vaut \u00e9galement pour le litige opposant la soci\u00e9t\u00e9 slov\u00e8ne Sartorius BIA Separations d.o.o. Celle-ci est d\u00e9fenderesse dans un litige qui l\u2019oppose \u00e0 son ancienne soci\u00e9t\u00e9 m\u00e8re autrichienne, BIA Separations GmbH, dans le cadre de la proc\u00e9dure d\u2019insolvabilit\u00e9 de cette derni\u00e8re ouverte avant l\u2019acquisition par le Groupe en 2020. En cas de r\u00e9clamation, le Groupe b\u00e9n\u00e9ficie d\u2019une clause de garantie de passif \u00e0 l\u2019encontre des vendeurs de la soci\u00e9t\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-86": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les co\u00fbts d'emprunt sont comptabilis\u00e9s en charges, sauf s\u2019ils sont directement attribuables \u00e0 l'acquisition, \u00e0 la construction ou \u00e0 la production d'un actif qualifi\u00e9, auquel ils sont incorpor\u00e9s au co\u00fbt de cet actif conform\u00e9ment \u00e0 la norme IAS\u00a023. En <span class=\"hyperlink-no-style_1\"></span>2025, des co\u00fbts d\u2019emprunt de 17,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 capitalis\u00e9s, principalement en lien avec de nouveaux sites et d\u2019extensions (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 19,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le taux d\u2019emprunt utilis\u00e9 pour la capitalisation s\u2019\u00e9levait \u00e0 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForBorrowingCostsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-87": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les co\u00fbts d'emprunt sont comptabilis\u00e9s en charges, sauf s\u2019ils sont directement attribuables \u00e0 l'acquisition, \u00e0 la construction ou \u00e0 la production d'un actif qualifi\u00e9, auquel ils sont incorpor\u00e9s au co\u00fbt de cet actif conform\u00e9ment \u00e0 la norme IAS\u00a023. En <span class=\"hyperlink-no-style_1\"></span>2025, des co\u00fbts d\u2019emprunt de 17,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 capitalis\u00e9s, principalement en lien avec de nouveaux sites et d\u2019extensions (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 19,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le taux d\u2019emprunt utilis\u00e9 pour la capitalisation s\u2019\u00e9levait \u00e0 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 4,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBorrowingCostsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-88": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>18. </sub></span><div class=\"list-paragraph-container_1\"><sub>Contrats de location</sub></div></div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des contrats de location est conforme \u00e0 la norme IFRS 16 (Contrats de location). Pour le Groupe, ces contrats de location ne rev\u00eatent pas une importance majeure dans la structure de financement. Les principales consid\u00e9rations concernent des aspects pratiques, tels que la gestion du mat\u00e9riel informatique ou la gestion du parc automobile. Ainsi, les contrats de locations de mat\u00e9riel informatique et de v\u00e9hicules repr\u00e9sentent la majorit\u00e9 des contrats de location du Groupe. La dur\u00e9e des contrats de location est g\u00e9n\u00e9ralement fixe et s'\u00e9tend habituellement sur une p\u00e9riode de trois \u00e0 cinq ans. En revanche, les contrats de location conclus avec des parties li\u00e9es, lorsque le bailleur est une entit\u00e9 contr\u00f4l\u00e9e par la soci\u00e9t\u00e9 m\u00e8re ultime Sartorius\u00a0AG, sont en g\u00e9n\u00e9ral de courte dur\u00e9e, afin d\u2019offrir une flexibilit\u00e9 op\u00e9rationnelle aux deux parties contractantes. Par ailleurs, sur certains sites, le Groupe dispose de contrats de location \u00e0 long terme portant sur des immeubles. Les contrats de location peuvent comporter des options de prolongation incluses dans la dur\u00e9e du contrat de location, conform\u00e9ment \u00e0 la norme IFRS 16, lorsque le Groupe s\u2019est raisonnablement assur\u00e9 de l\u2019exercice de ces options. Le Groupe n'agit pas, de mani\u00e8re significative, en qualit\u00e9 de bailleur.</div><div class=\"defaultParagraph_1 Standard\">Selon la norme IFRS 16, les contrats de location sont comptabilis\u00e9s, en principe, au bilan du preneur. Celui-ci reconna\u00eet un droit d'usage (repr\u00e9sentant son droit d'utiliser le bien lou\u00e9), ainsi qu'une dette de location (r\u00e9sultant de son obligation \u00e0 payer les loyers). Le Groupe applique les exemptions pr\u00e9vues pour les contrats de location de courte dur\u00e9e et les contrats portant sur des actifs de faible valeur, et comptabilise les paiements correspondants en charges, g\u00e9n\u00e9ralement selon la m\u00e9thode lin\u00e9aire sur la dur\u00e9e du contrat concern\u00e9. Par cons\u00e9quent, aucun actif au titre du droit d\u2019utilisation et aucun passif locatif ne sont comptabilis\u00e9s pour ces contrats de location. Par ailleurs, le Groupe n\u2019applique pas la Norme aux contrats de location d\u2019actifs incorporels.</div><div class=\"defaultParagraph_1 Standard\">Dans le bilan consolid\u00e9, le Groupe pr\u00e9sente l'actif du droit d'usage en fonction de la nature de l'actif du contrat de location sous-jacent dans la rubrique \u00ab Immobilisations corporelles \u00bb. Ils sont comptabilis\u00e9s au co\u00fbt, diminu\u00e9s des amortissements cumul\u00e9s et, le cas \u00e9ch\u00e9ant, d\u2019\u00e9ventuelles pertes de valeur. Le co\u00fbt des actifs li\u00e9s au droit d'utilisation comprend la valeur actuelle des paiements des loyers futurs, l\u2019ensemble des paiements vers\u00e9s \u00e0 la date de d\u00e9but du contrat ou avant le commencement du bail, les co\u00fbts directs initiaux ainsi que les co\u00fbts de d\u00e9mant\u00e8lement ou de remise en \u00e9tat de l'actif lou\u00e9. Les actifs li\u00e9s au droit d'utilisation sont g\u00e9n\u00e9ralement amortis sur la dur\u00e9e du contrat de location. Lorsque le transfert de propri\u00e9t\u00e9 l\u00e9gale du bien lou\u00e9 est act\u00e9 \u00e0 la fin de la dur\u00e9e du contrat, l\u2019actif est amorti sur la dur\u00e9e de vie \u00e9conomique de l\u2019actif sous-jacent. Dans le compte de r\u00e9sultat, l\u2019amortissement est comptabilis\u00e9 dans les charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les dettes de location sont pr\u00e9sent\u00e9es s\u00e9par\u00e9ment au bilan. Elles sont initialement comptabilis\u00e9es \u00e0 la valeur actualis\u00e9e des paiements de location futurs. Les paiements de loyers n\u2019incluent g\u00e9n\u00e9ralement pas les paiements relatifs aux composantes non locatives. Le taux d\u2019emprunt marginal du Groupe, sp\u00e9cifique au pays, \u00e0 la devise et \u00e0 la dur\u00e9e du contrat, est g\u00e9n\u00e9ralement utilis\u00e9 pour l\u2019actualisation. Par la suite, la valeur comptable des passifs locatifs est augment\u00e9e des charges d\u2019int\u00e9r\u00eats et diminu\u00e9e des paiements de loyers effectu\u00e9s. Les charges d\u2019int\u00e9r\u00eats sont comptabilis\u00e9es dans le r\u00e9sultat financier et, lorsqu\u2019elles sont pay\u00e9es, dans la section financement du tableau des flux de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les dettes de location s'\u00e9levaient \u00e0 <span class=\"hyperlink-no-style_1\"></span>174,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>145,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Les flux de tr\u00e9sorerie futurs tir\u00e9s des obligations aux contrats de location non encore commenc\u00e9s sur lesquels le Groupe s'est engag\u00e9 s\u2019\u00e9l\u00e8vent \u00e0 <span class=\"hyperlink-no-style_1\"></span>0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d'euros \u00e0 la date de cl\u00f4ture de l\u2019exercice (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Les \u00e9ch\u00e9ances des paiements des loyers futurs sont pr\u00e9sent\u00e9es en note 41. La composition des actifs li\u00e9s aux droits d'utilisation inclus dans les \u00ab Immobilisations corporelles \u00bb ainsi que les principales variations sont pr\u00e9sent\u00e9es dans le tableau ci-dessous :</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">158,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">5,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">18,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">181,7</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">57,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">63,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201321,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201330,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">197,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">4,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">218,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2024</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201360,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201310,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201374,3</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,6</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201321,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201326,2</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au 31 d\u00e9c. 2024</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201372,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20138,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201382,7</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">125,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">135,8</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Terrains, constructions et agencements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Installations techniques, mat\u00e9riels et outillages</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9quipement d'atelier, mat\u00e9riel de bureau et autres \u00e9quipements</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">197,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">4,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,3</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">218,5</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20137,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20137,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Regroupement d'entreprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">50,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,6</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20139,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20132,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201313,1</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Valeurs brutes comptables au 31 d\u00e9c. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">234,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">12,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">17,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">264,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>1<sup>er</sup> janv. 2025</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201372,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20132,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20138,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201382,7</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations aux amortissements</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201320,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20134,2</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201325,8</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises sur cessions</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,4</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Transferts de compte \u00e0 compte</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Amortissements cumul\u00e9s au <br/>31 d\u00e9c. 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201380,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20133,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u20139,4</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u201393,1</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Valeurs nettes comptables au <br/>31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">154,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">8,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">7,9</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">171,3</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le tableau ci-dessous pr\u00e9sente les charges d'int\u00e9r\u00eats comptabilis\u00e9es dans le r\u00e9sultat financier, les flux de tr\u00e9sorerie pour les contrats de location existants, ainsi que les charges relatives aux contrats de location de courte dur\u00e9e et aux contrats portant sur des actifs de faible valeur pour l\u2019exercice clos et l\u2019exercice comparatif. Aucune charge significative n\u2019a \u00e9t\u00e9 comptabilis\u00e9e au titre des paiements de loyers variables au cours de l\u2019exercice.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">12 mois</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024<br/>12 mois</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Charges d'int\u00e9r\u00eats pour les contrats de location</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de location d'actifs de faible valeur</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Co\u00fbts de location \u00e0 court terme</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Remboursement des dettes li\u00e9es au contrat de location</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">23,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des d\u00e9caissements pour les contrats de location</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">30,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">32,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfLeasesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-89": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>18. </sub></span><div class=\"list-paragraph-container_1\"><sub>Contrats de location</sub></div></div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des contrats de location est conforme \u00e0 la norme IFRS 16 (Contrats de location). Pour le Groupe, ces contrats de location ne rev\u00eatent pas une importance majeure dans la structure de financement. Les principales consid\u00e9rations concernent des aspects pratiques, tels que la gestion du mat\u00e9riel informatique ou la gestion du parc automobile. Ainsi, les contrats de locations de mat\u00e9riel informatique et de v\u00e9hicules repr\u00e9sentent la majorit\u00e9 des contrats de location du Groupe. La dur\u00e9e des contrats de location est g\u00e9n\u00e9ralement fixe et s'\u00e9tend habituellement sur une p\u00e9riode de trois \u00e0 cinq ans. En revanche, les contrats de location conclus avec des parties li\u00e9es, lorsque le bailleur est une entit\u00e9 contr\u00f4l\u00e9e par la soci\u00e9t\u00e9 m\u00e8re ultime Sartorius\u00a0AG, sont en g\u00e9n\u00e9ral de courte dur\u00e9e, afin d\u2019offrir une flexibilit\u00e9 op\u00e9rationnelle aux deux parties contractantes. Par ailleurs, sur certains sites, le Groupe dispose de contrats de location \u00e0 long terme portant sur des immeubles. Les contrats de location peuvent comporter des options de prolongation incluses dans la dur\u00e9e du contrat de location, conform\u00e9ment \u00e0 la norme IFRS 16, lorsque le Groupe s\u2019est raisonnablement assur\u00e9 de l\u2019exercice de ces options. Le Groupe n'agit pas, de mani\u00e8re significative, en qualit\u00e9 de bailleur.</div><div class=\"defaultParagraph_1 Standard\">Selon la norme IFRS 16, les contrats de location sont comptabilis\u00e9s, en principe, au bilan du preneur. Celui-ci reconna\u00eet un droit d'usage (repr\u00e9sentant son droit d'utiliser le bien lou\u00e9), ainsi qu'une dette de location (r\u00e9sultant de son obligation \u00e0 payer les loyers). Le Groupe applique les exemptions pr\u00e9vues pour les contrats de location de courte dur\u00e9e et les contrats portant sur des actifs de faible valeur, et comptabilise les paiements correspondants en charges, g\u00e9n\u00e9ralement selon la m\u00e9thode lin\u00e9aire sur la dur\u00e9e du contrat concern\u00e9. Par cons\u00e9quent, aucun actif au titre du droit d\u2019utilisation et aucun passif locatif ne sont comptabilis\u00e9s pour ces contrats de location. Par ailleurs, le Groupe n\u2019applique pas la Norme aux contrats de location d\u2019actifs incorporels.</div><div class=\"defaultParagraph_1 Standard\">Dans le bilan consolid\u00e9, le Groupe pr\u00e9sente l'actif du droit d'usage en fonction de la nature de l'actif du contrat de location sous-jacent dans la rubrique \u00ab Immobilisations corporelles \u00bb. Ils sont comptabilis\u00e9s au co\u00fbt, diminu\u00e9s des amortissements cumul\u00e9s et, le cas \u00e9ch\u00e9ant, d\u2019\u00e9ventuelles pertes de valeur. Le co\u00fbt des actifs li\u00e9s au droit d'utilisation comprend la valeur actuelle des paiements des loyers futurs, l\u2019ensemble des paiements vers\u00e9s \u00e0 la date de d\u00e9but du contrat ou avant le commencement du bail, les co\u00fbts directs initiaux ainsi que les co\u00fbts de d\u00e9mant\u00e8lement ou de remise en \u00e9tat de l'actif lou\u00e9. Les actifs li\u00e9s au droit d'utilisation sont g\u00e9n\u00e9ralement amortis sur la dur\u00e9e du contrat de location. Lorsque le transfert de propri\u00e9t\u00e9 l\u00e9gale du bien lou\u00e9 est act\u00e9 \u00e0 la fin de la dur\u00e9e du contrat, l\u2019actif est amorti sur la dur\u00e9e de vie \u00e9conomique de l\u2019actif sous-jacent. Dans le compte de r\u00e9sultat, l\u2019amortissement est comptabilis\u00e9 dans les charges op\u00e9rationnelles.</div><div class=\"defaultParagraph_1 Standard\">Les dettes de location sont pr\u00e9sent\u00e9es s\u00e9par\u00e9ment au bilan. Elles sont initialement comptabilis\u00e9es \u00e0 la valeur actualis\u00e9e des paiements de location futurs. Les paiements de loyers n\u2019incluent g\u00e9n\u00e9ralement pas les paiements relatifs aux composantes non locatives. Le taux d\u2019emprunt marginal du Groupe, sp\u00e9cifique au pays, \u00e0 la devise et \u00e0 la dur\u00e9e du contrat, est g\u00e9n\u00e9ralement utilis\u00e9 pour l\u2019actualisation. Par la suite, la valeur comptable des passifs locatifs est augment\u00e9e des charges d\u2019int\u00e9r\u00eats et diminu\u00e9e des paiements de loyers effectu\u00e9s. Les charges d\u2019int\u00e9r\u00eats sont comptabilis\u00e9es dans le r\u00e9sultat financier et, lorsqu\u2019elles sont pay\u00e9es, dans la section financement du tableau des flux de tr\u00e9sorerie.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-90": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les actifs ou passifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont d\u00e9termin\u00e9s en fonction des diff\u00e9rences temporaires entre les valeurs comptables et la valeur fiscale des actifs et passifs concern\u00e9s, en conformit\u00e9 avec la norme IAS 12, y compris les reports d\u00e9ficitaires et les cr\u00e9dits d\u2019imp\u00f4t, \u00e0 l\u2019exception des cas express\u00e9ment exclus par cette norme. L'\u00e9valuation repose sur les taux d'imposition qui devraient s\u2019appliquer au cours de la p\u00e9riode durant laquelle l\u2019actif sera r\u00e9alis\u00e9 ou le passif r\u00e9gl\u00e9, ou lorsque les pertes fiscales seront utilis\u00e9es. \u00c0 cette fin, le Groupe utilise les taux d\u2019imposition et les r\u00e8gles fiscales adopt\u00e9s ou quasi adopt\u00e9s \u00e0 la date de cl\u00f4ture. L\u2019impact de la \u00ab Loi pour un programme d\u2019investissement fiscal imm\u00e9diat visant \u00e0 renforcer la place \u00e9conomique de l\u2019Allemagne \u00bb est d\u00e9taill\u00e9 en note\u00a013.</div><div class=\"defaultParagraph_1 Standard\">La variation des actifs et passifs d\u00e9coulant de l\u2019imp\u00f4t diff\u00e9r\u00e9 est refl\u00e9t\u00e9e dans l\u2019\u00e9l\u00e9ment \u00ab\u00a0Charge d\u2019imp\u00f4t\u00a0\u00bb dans le compte de r\u00e9sultat, sauf pour ces \u00e9l\u00e9ments qui sont reconnus dans d\u2019autres revenus globaux et pour des effets d\u00e9riv\u00e9s de regroupements d\u2019entreprises.</div><div class=\"defaultParagraph_1 Standard\">Des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s sont comptabilis\u00e9s pour toutes les diff\u00e9rences temporelles d\u00e9ductibles et les pertes fiscales non utilis\u00e9es dans la mesure o\u00f9 il est probable qu\u2019un b\u00e9n\u00e9fice imposable futur sera disponible pour permettre leur imputation. Les estimations relatives aux b\u00e9n\u00e9fices imposables futurs ainsi qu\u2019\u00e0 la p\u00e9riode de r\u00e9cup\u00e9ration des actifs d\u2019imp\u00f4ts diff\u00e9r\u00e9s reposent sur des hypoth\u00e8ses, compte tenu de l\u2019incertitude inh\u00e9rente aux \u00e9volutions futures, dont certaines \u00e9chappent au contr\u00f4le de la direction. Ces estimations sont r\u00e9vis\u00e9es lorsque des \u00e9l\u00e9ments probants suffisants sont disponibles. Lorsqu\u2019aucune indication ne permet de conclure \u00e0 la r\u00e9alisation probable de tout ou partie d\u2019une diff\u00e9rence temporelle d\u00e9ductible ou d\u2019une perte fiscale, le montant correspondant n\u2019est pas comptabilis\u00e9 \u00e0 l\u2019actif.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe exerce ses activit\u00e9s dans de nombreuses juridictions fiscales. En cons\u00e9quence, les positions fiscales pr\u00e9sent\u00e9es dans les \u00e9tats financiers consolid\u00e9s sont d\u00e9termin\u00e9es en tenant compte des l\u00e9gislations fiscales locales applicables ainsi que des interpr\u00e9tations pertinentes des administrations fiscales concern\u00e9es. En raison de leur complexit\u00e9, ces positions peuvent faire l\u2019objet d\u2019interpr\u00e9tations divergentes entre les contribuables et les autorit\u00e9s fiscales. Le montant des positions fiscales incertaines est d\u00e9termin\u00e9 sur la base de la meilleure estimation du paiement d\u2019imp\u00f4t attendu.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique l\u2019exon\u00e9ration obligatoire concernant la comptabilisation des imp\u00f4ts diff\u00e9r\u00e9s susceptibles de r\u00e9sulter de l\u2019application des r\u00e8gles d\u2019imposition minimale mondiale (Pilier Deux). Les effets de ces r\u00e8gles sur le Groupe sont pr\u00e9sent\u00e9s en note\u00a013.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-91": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>20. </sub></span><div class=\"list-paragraph-container_1\"><sub>Stocks</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Mati\u00e8res premi\u00e8res et approvisionnements</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">208,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">218,8</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">En-cours de production</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">146,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">162,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Produits finis et marchandises</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">329,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">295,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Acomptes vers\u00e9s</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">8,1</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">690,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">684,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Valeur brute des stocks</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">815,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">814,5</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">D\u00e9pr\u00e9ciation des stocks</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013124,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u2013129,7</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Valeur nette des stocks</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">690,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">684,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les mati\u00e8res premi\u00e8res et les fournitures, y compris les marchandises, sont d\u00e9clar\u00e9es sous la rubrique \u00ab\u00a0Stocks\u00a0\u00bb selon la m\u00e9thode du co\u00fbt moyen pond\u00e9r\u00e9. Les produits finis et l\u2019en-cours de production sont \u00e9valu\u00e9s au co\u00fbt de revient. Ce co\u00fbt int\u00e8gre les co\u00fbts directs, pouvant \u00eatre affect\u00e9s \u00e0 ces stocks ainsi qu\u2019une quote-part des frais g\u00e9n\u00e9raux de production et de manutention des mat\u00e9riaux, des frais administratifs g\u00e9n\u00e9raux ainsi que les amortissements et d\u00e9pr\u00e9ciations fond\u00e9s sur la capacit\u00e9 normale de production, sous r\u00e9serve que ces charges soient li\u00e9es \u00e0 la production.</div><div class=\"defaultParagraph_1 Standard\">Les stocks doivent \u00eatre \u00e9valu\u00e9s au plus faible du co\u00fbt et de la valeur nette de r\u00e9alisation. La valeur nette de r\u00e9alisation correspond au prix de vente estim\u00e9 dans le cours normal de l\u2019activit\u00e9, diminu\u00e9 des co\u00fbts estim\u00e9s d\u2019ach\u00e8vement ainsi que des co\u00fbts estim\u00e9s n\u00e9cessaires \u00e0 la commercialisation, \u00e0 la vente et \u00e0 la distribution. Lorsque des risques li\u00e9s aux stocks existent, tels que le risque de r\u00e9duction de la dur\u00e9e de conservation en raison des p\u00e9riodes de stockage ou d\u2019une utilisabilit\u00e9 limit\u00e9e, des d\u00e9pr\u00e9ciations sont comptabilis\u00e9es en cons\u00e9quence.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInventoriesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-92": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les mati\u00e8res premi\u00e8res et les fournitures, y compris les marchandises, sont d\u00e9clar\u00e9es sous la rubrique \u00ab\u00a0Stocks\u00a0\u00bb selon la m\u00e9thode du co\u00fbt moyen pond\u00e9r\u00e9. Les produits finis et l\u2019en-cours de production sont \u00e9valu\u00e9s au co\u00fbt de revient. Ce co\u00fbt int\u00e8gre les co\u00fbts directs, pouvant \u00eatre affect\u00e9s \u00e0 ces stocks ainsi qu\u2019une quote-part des frais g\u00e9n\u00e9raux de production et de manutention des mat\u00e9riaux, des frais administratifs g\u00e9n\u00e9raux ainsi que les amortissements et d\u00e9pr\u00e9ciations fond\u00e9s sur la capacit\u00e9 normale de production, sous r\u00e9serve que ces charges soient li\u00e9es \u00e0 la production.</div><div class=\"defaultParagraph_1 Standard\">Les stocks doivent \u00eatre \u00e9valu\u00e9s au plus faible du co\u00fbt et de la valeur nette de r\u00e9alisation. La valeur nette de r\u00e9alisation correspond au prix de vente estim\u00e9 dans le cours normal de l\u2019activit\u00e9, diminu\u00e9 des co\u00fbts estim\u00e9s d\u2019ach\u00e8vement ainsi que des co\u00fbts estim\u00e9s n\u00e9cessaires \u00e0 la commercialisation, \u00e0 la vente et \u00e0 la distribution. Lorsque des risques li\u00e9s aux stocks existent, tels que le risque de r\u00e9duction de la dur\u00e9e de conservation en raison des p\u00e9riodes de stockage ou d\u2019une utilisabilit\u00e9 limit\u00e9e, des d\u00e9pr\u00e9ciations sont comptabilis\u00e9es en cons\u00e9quence.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-93": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>21. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres actifs</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les autres actifs comprennent principalement les cr\u00e9ances TVA, les charges constat\u00e9es d\u2019avance et les actifs non reclass\u00e9s dans d\u2019autres cat\u00e9gories.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances avec TVA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">51,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9penses constat\u00e9es d\u2019avance</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Autres actifs</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">79,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">69,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-94": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>21. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres actifs</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les autres actifs comprennent principalement les cr\u00e9ances TVA, les charges constat\u00e9es d\u2019avance et les actifs non reclass\u00e9s dans d\u2019autres cat\u00e9gories.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances avec TVA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">51,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9penses constat\u00e9es d\u2019avance</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Autres actifs</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">79,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">69,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-95": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>21. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres actifs</sub></div></div><div class=\"defaultParagraph_1 Standard\">Les autres actifs comprennent principalement les cr\u00e9ances TVA, les charges constat\u00e9es d\u2019avance et les actifs non reclass\u00e9s dans d\u2019autres cat\u00e9gories.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances avec TVA</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">51,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">D\u00e9penses constat\u00e9es d\u2019avance</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,9</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Autres actifs</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">79,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">69,1</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-96": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>22. </sub></span><div class=\"list-paragraph-container_1\"><sub>Capital social</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00c0 l\u2019issue de l\u2019augmentation de capital survenue lors de l\u2019exercice pr\u00e9c\u00e9dent et d\u00e9crite ci-dessous, le capital social de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. est compos\u00e9 de 97\u00a0330\u00a0405 actions d\u2019une valeur nominale de 0,20\u00a0\u20ac chacune.</span></div><div class=\"defaultParagraph_1 Standard\">Au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025, aucun instrument dilutif n\u2019\u00e9tait en circulation. Les actions nominatives inscrites au nom d\u2019un m\u00eame actionnaire depuis au moins quatre ans b\u00e9n\u00e9ficient d\u2019un droit de vote double.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:12px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:12px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:12px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:12px; overflow:hidden\">Nombre d'actions \u00e0 l'ouverture</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">92\u00a0180\u00a0190</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:12px; overflow:hidden\">Nombre d'actions \u00e0 la cl\u00f4ture</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:12px; overflow:hidden\">Valeur nominale de l'action (en \u20ac)</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">0,20</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">0,20</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:12px; overflow:hidden\">Montant du capital social (en millions \u20ac)</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">19,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">19,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">Augmentation de capital en 2024</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">Le 7 f\u00e9vrier 2024, Sartorius Stedim Biotech\u00a0S.A. a proc\u00e9d\u00e9 au placement avec succ\u00e8s de 5\u00a0150\u00a0215 actions aupr\u00e8s d\u2019investisseurs institutionnels dans le cadre d\u2019un placement priv\u00e9 international par voie de constitution acc\u00e9l\u00e9r\u00e9e de livre d\u2019ordres. Les nouvelles actions ont \u00e9t\u00e9 \u00e9mises dans le cadre d\u2019une augmentation de capital avec suppression de droit pr\u00e9f\u00e9rentiel de souscription des actionnaires, au prix de 233,00 euros par action, g\u00e9n\u00e9rant un produit brut de 1,2 milliard d\u2019euros. Les frais de transaction s\u2019\u00e9l\u00e8vent \u00e0 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et \u00e9taient comptabilis\u00e9s en capitaux propres en 2024. Par ailleurs, la charge d\u2019imp\u00f4t sur le r\u00e9sultat li\u00e9e \u00e0 ces frais de transaction a \u00e9t\u00e9 directement comptabilis\u00e9e en capitaux propres (2,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2018euros). Sartorius\u00a0AG, soci\u00e9t\u00e9 m\u00e8re de Sartorius Stedim Biotech\u00a0S.A., a souscrit un montant d\u2019environ 400<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, ce qui repr\u00e9sente environ un tiers de l\u2019augmentation de capital. \u00c0 l\u2019issue de l\u2019augmentation de capital, Sartorius\u00a0AG d\u00e9tient environ 71,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% du capital de la soci\u00e9t\u00e9 (31 d\u00e9cembre 2023\u00a0: 73,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">L\u2019objectif principal de cette augmentation de capital \u00e9tait d\u2019acc\u00e9l\u00e9rer le d\u00e9sendettement du Groupe au-del\u00e0 de la forte g\u00e9n\u00e9ration de tr\u00e9sorerie interne, puis de renforcer sa flexibilit\u00e9 strat\u00e9gique globale. Conform\u00e9ment \u00e0 cet objectif, Sartorius Stedim Biotech a rembours\u00e9, au cours de l\u2018exercice de 2024, des pr\u00eats d\u2019actionnaires obtenus aupr\u00e8s de Sartorius\u00a0AG et de Sartorius Finance B.V. pour un montant nominal total de 830<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (note\u00a032).<br/></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Dividendes</div><div class=\"defaultParagraph_1 Standard\">Le Conseil d'administration soumettra une proposition \u00e0 l'Assembl\u00e9e g\u00e9n\u00e9rale annuelle des actionnaires pour le versement d'un dividende au titre de l'exercice clos le 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, comme suit\u00a0: le paiement d'un dividende net de <span class=\"hyperlink-no-style_1\"></span>0,69\u00a0\u20ac par action (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,69\u00a0\u20ac), soit une distribution totale de <span class=\"hyperlink-no-style_1\"></span>67,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, \u00e0 l\u2019exclusion des titres auto-d\u00e9tenus (en <span class=\"hyperlink-no-style_1\"></span>2024, le montant vers\u00e9 \u00e9tait de <span class=\"hyperlink-no-style_1\"></span>67,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-97": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>22. </sub></span><div class=\"list-paragraph-container_1\"><sub>Capital social</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00c0 l\u2019issue de l\u2019augmentation de capital survenue lors de l\u2019exercice pr\u00e9c\u00e9dent et d\u00e9crite ci-dessous, le capital social de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. est compos\u00e9 de 97\u00a0330\u00a0405 actions d\u2019une valeur nominale de 0,20\u00a0\u20ac chacune.</span></div><div class=\"defaultParagraph_1 Standard\">Au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025, aucun instrument dilutif n\u2019\u00e9tait en circulation. Les actions nominatives inscrites au nom d\u2019un m\u00eame actionnaire depuis au moins quatre ans b\u00e9n\u00e9ficient d\u2019un droit de vote double.</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:12px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:12px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:12px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:12px; overflow:hidden\">Nombre d'actions \u00e0 l'ouverture</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">92\u00a0180\u00a0190</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:12px; overflow:hidden\">Nombre d'actions \u00e0 la cl\u00f4ture</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">97\u00a0330\u00a0405</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:12px; overflow:hidden\">Valeur nominale de l'action (en \u20ac)</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">0,20</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:12px; overflow:hidden\">0,20</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:12px; overflow:hidden\">Montant du capital social (en millions \u20ac)</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">19,5</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:12px; overflow:hidden\">19,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">Augmentation de capital en 2024</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\">Le 7 f\u00e9vrier 2024, Sartorius Stedim Biotech\u00a0S.A. a proc\u00e9d\u00e9 au placement avec succ\u00e8s de 5\u00a0150\u00a0215 actions aupr\u00e8s d\u2019investisseurs institutionnels dans le cadre d\u2019un placement priv\u00e9 international par voie de constitution acc\u00e9l\u00e9r\u00e9e de livre d\u2019ordres. Les nouvelles actions ont \u00e9t\u00e9 \u00e9mises dans le cadre d\u2019une augmentation de capital avec suppression de droit pr\u00e9f\u00e9rentiel de souscription des actionnaires, au prix de 233,00 euros par action, g\u00e9n\u00e9rant un produit brut de 1,2 milliard d\u2019euros. Les frais de transaction s\u2019\u00e9l\u00e8vent \u00e0 8,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et \u00e9taient comptabilis\u00e9s en capitaux propres en 2024. Par ailleurs, la charge d\u2019imp\u00f4t sur le r\u00e9sultat li\u00e9e \u00e0 ces frais de transaction a \u00e9t\u00e9 directement comptabilis\u00e9e en capitaux propres (2,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2018euros). Sartorius\u00a0AG, soci\u00e9t\u00e9 m\u00e8re de Sartorius Stedim Biotech\u00a0S.A., a souscrit un montant d\u2019environ 400<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, ce qui repr\u00e9sente environ un tiers de l\u2019augmentation de capital. \u00c0 l\u2019issue de l\u2019augmentation de capital, Sartorius\u00a0AG d\u00e9tient environ 71,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% du capital de la soci\u00e9t\u00e9 (31 d\u00e9cembre 2023\u00a0: 73,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%).</div><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">L\u2019objectif principal de cette augmentation de capital \u00e9tait d\u2019acc\u00e9l\u00e9rer le d\u00e9sendettement du Groupe au-del\u00e0 de la forte g\u00e9n\u00e9ration de tr\u00e9sorerie interne, puis de renforcer sa flexibilit\u00e9 strat\u00e9gique globale. Conform\u00e9ment \u00e0 cet objectif, Sartorius Stedim Biotech a rembours\u00e9, au cours de l\u2018exercice de 2024, des pr\u00eats d\u2019actionnaires obtenus aupr\u00e8s de Sartorius\u00a0AG et de Sartorius Finance B.V. pour un montant nominal total de 830<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (note\u00a032).<br/></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-98": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Dividendes</div><div class=\"defaultParagraph_1 Standard\">Le Conseil d'administration soumettra une proposition \u00e0 l'Assembl\u00e9e g\u00e9n\u00e9rale annuelle des actionnaires pour le versement d'un dividende au titre de l'exercice clos le 31\u00a0d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, comme suit\u00a0: le paiement d'un dividende net de <span class=\"hyperlink-no-style_1\"></span>0,69\u00a0\u20ac par action (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,69\u00a0\u20ac), soit une distribution totale de <span class=\"hyperlink-no-style_1\"></span>67,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, \u00e0 l\u2019exclusion des titres auto-d\u00e9tenus (en <span class=\"hyperlink-no-style_1\"></span>2024, le montant vers\u00e9 \u00e9tait de <span class=\"hyperlink-no-style_1\"></span>67,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDividendsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-99": {
   "value": "0.69",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-100": {
   "value": "0.69",
   "decimals": 2,
   "dimensions": {
    "concept": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR/xbrli:shares"
   }
  },
  "fact-101": {
   "value": "67100000.0",
   "decimals": -5,
   "dimensions": {
    "concept": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00",
    "unit": "iso4217:EUR"
   }
  },
  "fact-102": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>23. </sub></span><div class=\"list-paragraph-container_1\"><sub>Int\u00e9r\u00eats minoritaires</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le montant des int\u00e9r\u00eats minoritaires inscrits au bilan consolid\u00e9 s\u2019\u00e9l\u00e8ve \u00e0 hauteur de </span><span class=\"hyperlink-no-style_1\"></span>35,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros (</span><span class=\"hyperlink-no-style_1\"></span>37,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et concerne les filiales </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Korea </span>Biotech (participation du Groupe : 79<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%)<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>et Sartorius CellGenix (participation du Groupe\u00a0: 76<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%). Les 21<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius Korea Biotech sont soumis \u00e0 une option d\u2019achat exer\u00e7able. Le prix d\u2019acquisition de ces int\u00e9r\u00eats minoritaires est variable et d\u00e9pendra des performances commerciales futures de ces entit\u00e9s. Les 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants des actions de Sartorius CellGenix sont soumis \u00e0 des options d\u2019achat et de vente exer\u00e7ables en 2026 (note\u00a036).</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:13px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:13px; overflow:hidden\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:13px; overflow:hidden\">Sartorius Korea Biotech LLC</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:13px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">154,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">145,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">7,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">9,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">85,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">78,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:13px; overflow:hidden\">R\u00e9sultat attribu\u00e9</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:13px; overflow:hidden\">1,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Sartorius CellGenix GmbH</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Chiffre d'affaires</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">41,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat net</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Total de l'actif</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">131,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">149,2</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">R\u00e9sultat attribu\u00e9</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-103": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">R\u00e9gimes \u00e0 prestations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\">Les provisions pour retraites et obligations similaires sont comptabilis\u00e9es dans les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech, conform\u00e9ment aux principes actuariels. La norme IAS\u00a019 (Avantages du personnel) prescrit l\u2019utilisation de la m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es (\u00ab\u00a0projected unit credit method\u00a0\u00bb) comme m\u00e9thode d'\u00e9valuation. Outre les rentes tir\u00e9es des pensions acquises et de l\u2019esp\u00e9rance de vie, cette m\u00e9thode tient compte des augmentations futures de salaires et de pensions.</div><div class=\"defaultParagraph_1 Standard\">Les taux d'actualisation appliqu\u00e9s refl\u00e8tent les taux d'int\u00e9r\u00eat observ\u00e9s \u00e0 la date d'arr\u00eat\u00e9 pour des obligations d\u2019entreprise de premier ordre, libell\u00e9es dans les devises concern\u00e9es (principalement en euro) et pr\u00e9sentant des maturit\u00e9s \u00e9quivalentes. En l\u2019absence d\u2019obligations d\u2019entreprises disponibles avec des \u00e9ch\u00e9ances \u00e0 long terme \u00e9quivalentes, les taux d\u2019int\u00e9r\u00eat sont d\u00e9termin\u00e9s par extrapolation.</div><div class=\"defaultParagraph_1 Standard\">En raison de l'\u00e9volution des conditions du march\u00e9 et de l'\u00e9conomie, les hypoth\u00e8ses cl\u00e9s retenues peuvent diff\u00e9rer des d\u00e9veloppements r\u00e9els et provoquer des variations importantes des obligations de retraite et autres avantages post-emploi. Une analyse de sensibilit\u00e9 est pr\u00e9sent\u00e9e ci-apr\u00e8s.</div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des obligations (et actifs) au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies sont pr\u00e9sent\u00e9es dans les autres \u00e9l\u00e9ments du r\u00e9sultat global, conform\u00e9ment \u00e0 la norme IAS\u00a019.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-104": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">R\u00e9gimes \u00e0 prestations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\">Les provisions pour retraites et obligations similaires sont comptabilis\u00e9es dans les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech, conform\u00e9ment aux principes actuariels. La norme IAS\u00a019 (Avantages du personnel) prescrit l\u2019utilisation de la m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es (\u00ab\u00a0projected unit credit method\u00a0\u00bb) comme m\u00e9thode d'\u00e9valuation. Outre les rentes tir\u00e9es des pensions acquises et de l\u2019esp\u00e9rance de vie, cette m\u00e9thode tient compte des augmentations futures de salaires et de pensions.</div><div class=\"defaultParagraph_1 Standard\">Les taux d'actualisation appliqu\u00e9s refl\u00e8tent les taux d'int\u00e9r\u00eat observ\u00e9s \u00e0 la date d'arr\u00eat\u00e9 pour des obligations d\u2019entreprise de premier ordre, libell\u00e9es dans les devises concern\u00e9es (principalement en euro) et pr\u00e9sentant des maturit\u00e9s \u00e9quivalentes. En l\u2019absence d\u2019obligations d\u2019entreprises disponibles avec des \u00e9ch\u00e9ances \u00e0 long terme \u00e9quivalentes, les taux d\u2019int\u00e9r\u00eat sont d\u00e9termin\u00e9s par extrapolation.</div><div class=\"defaultParagraph_1 Standard\">En raison de l'\u00e9volution des conditions du march\u00e9 et de l'\u00e9conomie, les hypoth\u00e8ses cl\u00e9s retenues peuvent diff\u00e9rer des d\u00e9veloppements r\u00e9els et provoquer des variations importantes des obligations de retraite et autres avantages post-emploi. Une analyse de sensibilit\u00e9 est pr\u00e9sent\u00e9e ci-apr\u00e8s.</div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des obligations (et actifs) au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies sont pr\u00e9sent\u00e9es dans les autres \u00e9l\u00e9ments du r\u00e9sultat global, conform\u00e9ment \u00e0 la norme IAS\u00a019.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Autres provisions non courantes</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Total</div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,5</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">13,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,8</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">5,7</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">9,4</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">15,1</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,7</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,4</div></td><td class=\"d0570ab\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">15,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,3</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,7</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d5838c3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,2</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"d8955c9\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,8</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Provisions courantes</div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9volution des provisions courantes au cours des exercices <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 est d\u00e9taill\u00e9e ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,1</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">17,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">17,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les provisions pour garanties incluent notamment les co\u00fbts li\u00e9s aux livraisons de remplacement et aux r\u00e9parations. Des provisions pour risques sp\u00e9cifiques sont comptabilis\u00e9es lorsque leur survenance est jug\u00e9e plus probable qu\u2019improbable. Les risques g\u00e9n\u00e9raux de garantie sont \u00e9valu\u00e9s sur la base de l\u2019exp\u00e9rience pass\u00e9e. Les autres provisions courantes comprennent notamment des contrats on\u00e9reux, des passifs incertains li\u00e9s au personnel, ainsi que des provisions pour int\u00e9r\u00eats en lien avec des risques fiscaux. </div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfProvisionsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-105": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">R\u00e9gimes \u00e0 prestations d\u00e9finies</div><div class=\"defaultParagraph_1 Standard\">Les provisions pour retraites et obligations similaires sont comptabilis\u00e9es dans les \u00e9tats financiers consolid\u00e9s du Groupe Sartorius Stedim Biotech, conform\u00e9ment aux principes actuariels. La norme IAS\u00a019 (Avantages du personnel) prescrit l\u2019utilisation de la m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es (\u00ab\u00a0projected unit credit method\u00a0\u00bb) comme m\u00e9thode d'\u00e9valuation. Outre les rentes tir\u00e9es des pensions acquises et de l\u2019esp\u00e9rance de vie, cette m\u00e9thode tient compte des augmentations futures de salaires et de pensions.</div><div class=\"defaultParagraph_1 Standard\">Les taux d'actualisation appliqu\u00e9s refl\u00e8tent les taux d'int\u00e9r\u00eat observ\u00e9s \u00e0 la date d'arr\u00eat\u00e9 pour des obligations d\u2019entreprise de premier ordre, libell\u00e9es dans les devises concern\u00e9es (principalement en euro) et pr\u00e9sentant des maturit\u00e9s \u00e9quivalentes. En l\u2019absence d\u2019obligations d\u2019entreprises disponibles avec des \u00e9ch\u00e9ances \u00e0 long terme \u00e9quivalentes, les taux d\u2019int\u00e9r\u00eat sont d\u00e9termin\u00e9s par extrapolation.</div><div class=\"defaultParagraph_1 Standard\">En raison de l'\u00e9volution des conditions du march\u00e9 et de l'\u00e9conomie, les hypoth\u00e8ses cl\u00e9s retenues peuvent diff\u00e9rer des d\u00e9veloppements r\u00e9els et provoquer des variations importantes des obligations de retraite et autres avantages post-emploi. Une analyse de sensibilit\u00e9 est pr\u00e9sent\u00e9e ci-apr\u00e8s.</div><div class=\"defaultParagraph_1 Standard\">Les r\u00e9\u00e9valuations des obligations (et actifs) au titre des r\u00e9gimes \u00e0 prestations d\u00e9finies sont pr\u00e9sent\u00e9es dans les autres \u00e9l\u00e9ments du r\u00e9sultat global, conform\u00e9ment \u00e0 la norme IAS\u00a019.</div><div class=\"defaultParagraph_1 Standard\">L'analyse de sensibilit\u00e9 pr\u00e9sent\u00e9e ci-dessus peut ne pas \u00eatre repr\u00e9sentative de la variation r\u00e9elle de l'obligation, car il est peu probable que les changements d\u2019hypoth\u00e8ses se produisent de mani\u00e8re isol\u00e9e. En outre, la valeur actuelle de ces obligations a \u00e9t\u00e9 calcul\u00e9e en utilisant la m\u00eame m\u00e9thode que celle appliqu\u00e9e pour \u00e9valuer les obligations comptabilis\u00e9es dans le bilan consolid\u00e9 (m\u00e9thode des unit\u00e9s de cr\u00e9dit projet\u00e9es).</div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-106": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>25. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres provisions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Une provision est comptabilis\u00e9e lorsqu\u2019il existe, \u00e0 la date de cl\u00f4ture, une obligation actuelle \u2014 juridique ou implicite \u2014 envers des tiers r\u00e9sultant d\u2019\u00e9v\u00e9nements pass\u00e9s, qu\u2019une sortie de ressources est probable et que le montant de l\u2019obligation peut \u00eatre estim\u00e9 de mani\u00e8re fiable. Le montant comptabilis\u00e9 correspond \u00e0 la meilleure estimation de l\u2019obligation \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">La d\u00e9termination du montant des obligations n\u00e9cessite le recours \u00e0 certaines estimations et hypoth\u00e8ses, notamment pour \u00e9valuer la probabilit\u00e9 et le montant des sorties futures de ressources. En r\u00e8gle g\u00e9n\u00e9rale, des estimations significatives interviennent dans la d\u00e9termination des provisions li\u00e9es aux contrats on\u00e9reux, aux co\u00fbts de garantie, aux obligations de pr\u00e9retraite, aux obligations de remise en \u00e9tat et de d\u00e9mant\u00e8lement d\u2019actifs, ainsi qu\u2019aux proc\u00e9dures judiciaires.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Autres provisions non courantes</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Total</div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,5</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">13,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,8</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,8</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,1</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">5,7</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">9,4</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">15,1</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Paiements aux employ\u00e9s au titre de plan de pr\u00e9retraite</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"e274f3\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"d9dede0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,7</div></td><td class=\"c233a1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">9,4</div></td><td class=\"d0570ab\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">15,1</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,2</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20132,3</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fa5c5f\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3eabf9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,7</div></td><td class=\"d2954dc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,6</div></td><td class=\"f8ab99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,3</div></td></tr><tr><td class=\"d2222d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reclassement</div></td><td class=\"d4fc45b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cfad62\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d5838c3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"d8a9e72\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"d38c20b\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,2</div></td><td class=\"d316a96\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"d8955c9\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,8</div></td></tr><tr><td class=\"d57a3f0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d1e6e0d\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d100fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les autres provisions non courantes comprennent principalement des provisions pour plans de pr\u00e9retraite partielle, ainsi que des primes d\u2019anciennet\u00e9 (incluses dans le poste \u00ab\u00a0Autres\u00a0\u00bb). Ces engagements concernent principalement les soci\u00e9t\u00e9s allemandes du Groupe. Les r\u00e9gimes de pr\u00e9retraite partielle permettent aux employ\u00e9s de travailler \u00e0 temps partiel pendant deux \u00e0 cinq ans avant leur retraite officielle.</div><div class=\"defaultParagraph_1 Standard\">Conform\u00e9ment \u00e0 la norme IAS 19, le montant des indemnit\u00e9s de d\u00e9part pour des p\u00e9riodes futures doit \u00eatre comptabilis\u00e9 en r\u00e9sultat net sur la p\u00e9riode de service concern\u00e9e. Les gains et pertes actuariels, ainsi que le co\u00fbt des services pass\u00e9s sont comptabilis\u00e9s en produits ou en charges.</div><div class=\"defaultParagraph_1 Standard\">Les provisions non courantes sont actualis\u00e9es \u00e0 leur valeur actuelle \u00e0 la date de cl\u00f4ture. Pour <span class=\"hyperlink-no-style_1\"></span>2025, le taux d\u2019actualisation pour les salari\u00e9s b\u00e9n\u00e9ficiant du plan de pr\u00e9retraite est de 2,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% (2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% en <span class=\"hyperlink-no-style_1\"></span>2024).</div><div class=\"defaultParagraph_1 Standard\">Depuis 2022, les obligations non courantes li\u00e9es au programme d'int\u00e9ressement \u00e0 long terme (\u00ab\u00a0Long-Term Incentive programme \u2013 LTI\u00a0\u00bb, note\u00a044) sont \u00e9galement pr\u00e9sent\u00e9es dans la rubrique \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb.</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Provisions courantes</div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9volution des provisions courantes au cours des exercices <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025 est d\u00e9taill\u00e9e ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Solde au 1<sup>er</sup> janv. 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,1</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20130,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20133,9</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20131,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20135,8</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">17,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Garanties</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Autres</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d267d1c\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Solde au 1<sup>er</sup> janv. 2025</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">10,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">6,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">17,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,3</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Consommation</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20131,5</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"fe372e\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dotations</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">4,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">5,5</div></td></tr><tr><td class=\"d826a02\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres variations</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,1</div></td></tr><tr><td class=\"cff1fb\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Solde au 31 d\u00e9c. 2025</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">6,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">10,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,3</div></td></tr><tr><td class=\"ab0ed7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les provisions pour garanties incluent notamment les co\u00fbts li\u00e9s aux livraisons de remplacement et aux r\u00e9parations. Des provisions pour risques sp\u00e9cifiques sont comptabilis\u00e9es lorsque leur survenance est jug\u00e9e plus probable qu\u2019improbable. Les risques g\u00e9n\u00e9raux de garantie sont \u00e9valu\u00e9s sur la base de l\u2019exp\u00e9rience pass\u00e9e. Les autres provisions courantes comprennent notamment des contrats on\u00e9reux, des passifs incertains li\u00e9s au personnel, ainsi que des provisions pour int\u00e9r\u00eats en lien avec des risques fiscaux. </div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>27. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres obligations financi\u00e8res</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Engagements donn\u00e9s et re\u00e7us</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 \u00e0 des proc\u00e9dures judiciaires, des r\u00e9clamations ainsi qu\u2019\u00e0 des litiges d\u2019ordre fiscal, douanier, social ou autres, qui surviennent dans le cadre normal de ses activit\u00e9s. La direction n\u2019anticipe pas que les co\u00fbts finaux n\u00e9cessaires au r\u00e8glement de ces litiges aient un effet d\u00e9favorable significatif sur la situation financi\u00e8re consolid\u00e9e du Groupe, son compte de r\u00e9sultat ou ses flux de tr\u00e9sorerie. Cela vaut \u00e9galement pour le litige opposant la soci\u00e9t\u00e9 slov\u00e8ne Sartorius BIA Separations d.o.o. Celle-ci est d\u00e9fenderesse dans un litige qui l\u2019oppose \u00e0 son ancienne soci\u00e9t\u00e9 m\u00e8re autrichienne, BIA Separations GmbH, dans le cadre de la proc\u00e9dure d\u2019insolvabilit\u00e9 de cette derni\u00e8re ouverte avant l\u2019acquisition par le Groupe en 2020. En cas de r\u00e9clamation, le Groupe b\u00e9n\u00e9ficie d\u2019une clause de garantie de passif \u00e0 l\u2019encontre des vendeurs de la soci\u00e9t\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-107": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>27. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres obligations financi\u00e8res</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Engagements donn\u00e9s et re\u00e7us</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 \u00e0 des proc\u00e9dures judiciaires, des r\u00e9clamations ainsi qu\u2019\u00e0 des litiges d\u2019ordre fiscal, douanier, social ou autres, qui surviennent dans le cadre normal de ses activit\u00e9s. La direction n\u2019anticipe pas que les co\u00fbts finaux n\u00e9cessaires au r\u00e8glement de ces litiges aient un effet d\u00e9favorable significatif sur la situation financi\u00e8re consolid\u00e9e du Groupe, son compte de r\u00e9sultat ou ses flux de tr\u00e9sorerie. Cela vaut \u00e9galement pour le litige opposant la soci\u00e9t\u00e9 slov\u00e8ne Sartorius BIA Separations d.o.o. Celle-ci est d\u00e9fenderesse dans un litige qui l\u2019oppose \u00e0 son ancienne soci\u00e9t\u00e9 m\u00e8re autrichienne, BIA Separations GmbH, dans le cadre de la proc\u00e9dure d\u2019insolvabilit\u00e9 de cette derni\u00e8re ouverte avant l\u2019acquisition par le Groupe en 2020. En cas de r\u00e9clamation, le Groupe b\u00e9n\u00e9ficie d\u2019une clause de garantie de passif \u00e0 l\u2019encontre des vendeurs de la soci\u00e9t\u00e9.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-108": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>28. </sub></span><div class=\"list-paragraph-container_1\"><sub>Instruments financiers : principales m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\">Un instrument financier est un contrat qui donne lieu \u00e0 un actif financier pour une entit\u00e9 et \u00e0 un passif financier ou un instrument de capitaux propres pour une autre entit\u00e9. Les notes ci-apr\u00e8s pr\u00e9sentent une vue d\u2019ensemble de l\u2019incidence des instruments financiers sur les \u00e9tats financiers du Groupe Sartorius Stedim Biotech et transmettent des informations compl\u00e9mentaires sur les postes du bilan contenant des instruments financiers.</div><div class=\"defaultParagraph_1 Standard\">Les actifs financiers du Groupe comprennent principalement les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie, les cr\u00e9ances clients et pr\u00eats et les instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive.</div><div class=\"defaultParagraph_1 Standard\">Les passifs financiers du Groupe comprennent principalement des emprunts contract\u00e9s aupr\u00e8s de Sartorius\u00a0AG et Sartorius Finance B.V., des dettes fournisseurs, des dettes de location et des instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur n\u00e9gative. Les passifs financiers autres que les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des instruments financiers respecte la norme IFRS\u00a09 (Instruments financiers). Selon la norme IFRS 9, l\u2019approche de classification et d\u2019\u00e9valuation des actifs financiers repose \u00e0 la fois sur le mod\u00e8le \u00e9conomique de l\u2019entit\u00e9 (d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement, d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement et \u00e0 la vente, ou autres) dans lequel les actifs sont d\u00e9tenus, ainsi que sur les caract\u00e9ristiques contractuelles des flux de tr\u00e9sorerie (crit\u00e8re \u00ab\u00a0SPPI\u00a0\u00bb\u00a0: paiements constitu\u00e9s uniquement du principal et des int\u00e9r\u00eats). Aucune reclassification d\u2019instruments financiers n\u2019a eu lieu au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div><div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div>Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles.La dette incluse dans les autres passifs financiers au titre de l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires dans la filiale Sartorius CellGenix GmbH est \u00e9valu\u00e9e selon la m\u00e9thode du taux d\u2019int\u00e9r\u00eat effectif. Le Groupe applique l\u2019option consistant \u00e0 comptabiliser directement en capitaux propres toute variation de valeur.<div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-109": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>28. </sub></span><div class=\"list-paragraph-container_1\"><sub>Instruments financiers : principales m\u00e9thodes comptables</sub></div></div><div class=\"defaultParagraph_1 Standard\">Un instrument financier est un contrat qui donne lieu \u00e0 un actif financier pour une entit\u00e9 et \u00e0 un passif financier ou un instrument de capitaux propres pour une autre entit\u00e9. Les notes ci-apr\u00e8s pr\u00e9sentent une vue d\u2019ensemble de l\u2019incidence des instruments financiers sur les \u00e9tats financiers du Groupe Sartorius Stedim Biotech et transmettent des informations compl\u00e9mentaires sur les postes du bilan contenant des instruments financiers.</div><div class=\"defaultParagraph_1 Standard\">La comptabilisation des instruments financiers respecte la norme IFRS\u00a09 (Instruments financiers). Selon la norme IFRS 9, l\u2019approche de classification et d\u2019\u00e9valuation des actifs financiers repose \u00e0 la fois sur le mod\u00e8le \u00e9conomique de l\u2019entit\u00e9 (d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement, d\u00e9tention jusqu\u2019\u00e0 l\u2019encaissement et \u00e0 la vente, ou autres) dans lequel les actifs sont d\u00e9tenus, ainsi que sur les caract\u00e9ristiques contractuelles des flux de tr\u00e9sorerie (crit\u00e8re \u00ab\u00a0SPPI\u00a0\u00bb\u00a0: paiements constitu\u00e9s uniquement du principal et des int\u00e9r\u00eats). Aucune reclassification d\u2019instruments financiers n\u2019a eu lieu au cours de l\u2019exercice.</div><div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div>Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-110": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les actifs financiers du Groupe comprennent principalement les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie, les cr\u00e9ances clients et pr\u00eats et les instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive.</div><div class=\"defaultParagraph_1 Standard\">Les passifs financiers du Groupe comprennent principalement des emprunts contract\u00e9s aupr\u00e8s de Sartorius\u00a0AG et Sartorius Finance B.V., des dettes fournisseurs, des dettes de location et des instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur n\u00e9gative. Les passifs financiers autres que les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-111": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les passifs financiers du Groupe comprennent principalement des emprunts contract\u00e9s aupr\u00e8s de Sartorius\u00a0AG et Sartorius Finance B.V., des dettes fournisseurs, des dettes de location et des instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur n\u00e9gative. Les passifs financiers autres que les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s au co\u00fbt amorti.</div>La dette incluse dans les autres passifs financiers au titre de l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires dans la filiale Sartorius CellGenix GmbH est \u00e9valu\u00e9e selon la m\u00e9thode du taux d\u2019int\u00e9r\u00eat effectif. Le Groupe applique l\u2019option consistant \u00e0 comptabiliser directement en capitaux propres toute variation de valeur.",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-112": {
   "value": "<div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-113": {
   "value": "<div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>42. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de cr\u00e9dit</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit correspond au risque de perte financi\u00e8re pour le Groupe si une contrepartie \u00e0 un instrument financier ne respecte pas ses obligations contractuelles. Le risque de cr\u00e9dit d\u00e9coule principalement de la tr\u00e9sorerie et des \u00e9quivalents de tr\u00e9sorerie, ainsi que des cr\u00e9ances clients. En outre, le Groupe est expos\u00e9 au risque de cr\u00e9dit li\u00e9 aux instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive et, dans une faible mesure, aux flux de tr\u00e9sorerie contractuels provenant des titres de cr\u00e9ance.</div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit est g\u00e9r\u00e9 de mani\u00e8re centralis\u00e9e au sein du Groupe par le service de gestion de la tr\u00e9sorerie. Pour les contreparties telles que les banques et les institutions financi\u00e8res, la solvabilit\u00e9 est surveill\u00e9e en continu afin de d\u00e9tecter \u00e0 un stade pr\u00e9coce toute augmentation du risque de cr\u00e9dit. En l\u2019absence de nouvelles informations, le Groupe consid\u00e8re que les actifs financiers concern\u00e9s pr\u00e9sentent toujours un faible risque de cr\u00e9dit.</div><div class=\"defaultParagraph_1 Standard\">Des limites de risque sont attribu\u00e9s aux clients, principalement en fonction du volume d\u2019affaires, de l\u2019exp\u00e9rience pass\u00e9e et de l\u2019\u00e9valuation de la solvabilit\u00e9 du client. Le respect de ces limites est r\u00e9guli\u00e8rement v\u00e9rifi\u00e9 par la direction comp\u00e9tente. Dans certains cas, le Groupe per\u00e7oit des paiements anticip\u00e9s (acomptes) ou exige des lettres de cr\u00e9dit pour \u00e9viter les risques de cr\u00e9dit. Il n\u2019existe pas de concentration significative de risque de cr\u00e9dit par client ou par zone g\u00e9ographique.</div><div class=\"defaultParagraph_1 Standard\">Pour certaines cr\u00e9ances clients, le Groupe peut b\u00e9n\u00e9ficier de contreparties, telles que des garanties pouvant \u00eatre utilis\u00e9es dans le cadre d'accords contractuels au cas o\u00f9 le client ne respecterait pas ses obligations contractuelles de paiement.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels </div><div class=\"defaultParagraph_1 Standard\">Le mod\u00e8le de d\u00e9pr\u00e9ciation de la norme IFRS 9, qui impose la comptabilisation des pertes de cr\u00e9dit attendues, rev\u00eat une importance particuli\u00e8re pour les cr\u00e9ances clients et les actifs contractuels du Groupe conform\u00e9ment \u00e0 la norme IFRS 15. Le Groupe applique l'approche simplifi\u00e9e de la norme IFRS 9 aux cr\u00e9ances clients et aux actifs contractuels. Ainsi, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour ces actifs. Le point de d\u00e9part du nouveau mod\u00e8le de d\u00e9pr\u00e9ciation est une analyse des taux historiques r\u00e9els de pertes de cr\u00e9dit. Ceux-ci sont ajust\u00e9s en tenant compte des informations prospectives et des effets des changements actuels dans l'environnement macro\u00e9conomique, si ceux-ci sont significatifs. En raison du faible niveau des pertes de cr\u00e9dit historiques, le Groupe d\u00e9termine actuellement les pertes de cr\u00e9dit attendues pour l\u2019ensemble du portefeuille de cr\u00e9ances clients. N\u00e9anmoins, les taux de pertes historiques sont analys\u00e9s r\u00e9guli\u00e8rement de mani\u00e8re plus d\u00e9taill\u00e9e afin d\u2019appliquer, le cas \u00e9ch\u00e9ant, des taux de pertes diff\u00e9renci\u00e9s \u00e0 diff\u00e9rents portefeuilles. En <span class=\"hyperlink-no-style_1\"></span>2025, aucun changement significatif concernant le risque de cr\u00e9dit du portefeuille de clients biopharmaceutiques du Groupe n\u2019a \u00e9t\u00e9 observ\u00e9. En raison de la concentration du Groupe sur l'industrie biopharmaceutique, g\u00e9n\u00e9ralement stable et relativement ind\u00e9pendante des \u00e9volutions macro\u00e9conomiques (elle devrait conna\u00eetre une croissance sup\u00e9rieure \u00e0 la moyenne \u00e0 long terme), le Groupe n\u2019enregistre actuellement aucun impact significatif des informations prospectives sur les pertes de cr\u00e9dit attendues.</div><div class=\"defaultParagraph_1 Standard\">Les actifs contractuels sont li\u00e9s \u00e0 des projets pour des clients sp\u00e9cifiques ou particuliers du Groupe. Il est donc consid\u00e9r\u00e9 que les taux de pertes appliqu\u00e9s aux cr\u00e9ances clients constituent une approximation appropri\u00e9e des taux de pertes applicables aux actifs contractuels. En cons\u00e9quence, aucune distinction suppl\u00e9mentaire n\u2019est op\u00e9r\u00e9e entre les cr\u00e9ances clients et les actifs sur contractuels</div><div class=\"defaultParagraph_1 Standard\">Sur cette base, les provisions pour d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels \u00e9taient d\u00e9termin\u00e9es comme suit au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; float:left; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83ac32\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d121d7a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">135,1</div></td><td class=\"d1bd8d0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,9</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">193,9</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,2</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d62c572\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d6bd1b3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:651px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr class=\"eb700c\"><td class=\"cc0b10\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b90507\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d2ba295\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr class=\"d4c9edf\"><td class=\"d1b2dca\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"d2837bf\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">220,2</div></td><td class=\"d904d9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,2</div></td><td class=\"e7f901\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">261,8</div></td></tr><tr class=\"d213883\"><td class=\"d1ff5de\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"c0658e\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"d58c8f1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr class=\"d213883\"><td class=\"f1d1df\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"e7b9e3\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"e698cc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d47d096\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d1c1e71\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,6</div></td><td class=\"d47d096\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td></tr><tr class=\"d279a6a\"><td class=\"d755ebe\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d0623c7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d7dd22\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e4fcf5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les pertes sur cr\u00e9ances attendus sont d\u00e9termin\u00e9es sur la base d'un taux de perte de 0,05<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. En compl\u00e9ment, des d\u00e9pr\u00e9ciations sont \u00e9tablies sur la base d\u2019analyses individuelles. Le nombre de jours de retard constitue un crit\u00e8re essentiel dans ce contexte. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier. Dans un tel cas, les cr\u00e9ances respectives sont d\u00e9comptabilis\u00e9es. </div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les variations des provisions pour d\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 l'ouverture de l'exercice</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Augmentation pendant l\u2019exercice</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises et consommation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Recouvrement des montants pr\u00e9c\u00e9demment d\u00e9pr\u00e9ci\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 la cl\u00f4ture de l'exercice</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\" style=\"clear:none\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>D\u00e9pr\u00e9ciation des autres actifs financiers</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Outre les cr\u00e9ances clients, la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie constituent les actifs financiers les plus significatifs dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025. Les pertes de cr\u00e9dit attendues sont surveill\u00e9es \u00e0 intervalles r\u00e9guliers. En raison de la haute solvabilit\u00e9 des contreparties et des \u00e9ch\u00e9ances courtes, la d\u00e9pr\u00e9ciation qui devrait \u00eatre comptabilis\u00e9e pour ces actifs financiers est non significative. Par cons\u00e9quent, aucune d\u00e9pr\u00e9ciation n\u2019est enregistr\u00e9e pour la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti, aucune d\u00e9pr\u00e9ciation au titre des pertes de cr\u00e9dit attendues pour les douze mois n'est constat\u00e9e au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, eu \u00e9gard au caract\u00e8re non significatif des pertes de cr\u00e9dit historiques. En cas d'augmentation significative du risque de cr\u00e9dit, g\u00e9n\u00e9ralement per\u00e7u lorsqu'un paiement est \u00e9chu depuis plus de 30 jours, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour l'actif financier correspondant. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier, ce qui est en principe le cas lorsque les paiements sont \u00e9chus depuis plus de 90 jours. \u00c0 la date de cl\u00f4ture, aucun indice d\u2019augmentation significative du risque de cr\u00e9dit n\u2019a \u00e9t\u00e9 identifi\u00e9. Les valeurs comptables des actifs financiers repr\u00e9sentent la perte de cr\u00e9dit maximale pour ces actifs \u00e0 la fin de la p\u00e9riode de reporting.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCreditRiskExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-114": {
   "value": "<div class=\"defaultParagraph_1 Standard\">En ce qui concerne la d\u00e9pr\u00e9ciation des actifs financiers, la norme IFRS\u00a09 introduit un mod\u00e8le fond\u00e9 sur les pertes de cr\u00e9dit attendues. Les actifs financiers sont g\u00e9n\u00e9ralement consid\u00e9r\u00e9s comme d\u00e9pr\u00e9ci\u00e9s lorsqu'il existe des indications objectives qui mettent en doute le recouvrement int\u00e9gral des flux de tr\u00e9sorerie associ\u00e9s. Pour les cr\u00e9ances commerciales, le groupe applique une approche simplifi\u00e9e.</div><div class=\"defaultParagraph_1 Standard\">Outre les cr\u00e9ances clients, les disponibilit\u00e9s et \u00e9quivalents de tr\u00e9sorerie constituent l\u2019actif financier le plus essentiel dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025. Aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 comptabilis\u00e9e pour ces actifs financiers en raison de leur caract\u00e8re non significatif en termes de risque.</div><div class=\"defaultParagraph_1 Standard\">Au dernier arr\u00eat\u00e9, aucune d\u00e9pr\u00e9ciation n\u2019a \u00e9t\u00e9 enregistr\u00e9e au 31 d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti au titre des pertes de cr\u00e9dit attendues \u00e0 12 mois, compte tenu de l\u2019historique de pertes non significatif du Groupe. </div><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels </div><div class=\"defaultParagraph_1 Standard\">Le mod\u00e8le de d\u00e9pr\u00e9ciation de la norme IFRS 9, qui impose la comptabilisation des pertes de cr\u00e9dit attendues, rev\u00eat une importance particuli\u00e8re pour les cr\u00e9ances clients et les actifs contractuels du Groupe conform\u00e9ment \u00e0 la norme IFRS 15. Le Groupe applique l'approche simplifi\u00e9e de la norme IFRS 9 aux cr\u00e9ances clients et aux actifs contractuels. Ainsi, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour ces actifs. Le point de d\u00e9part du nouveau mod\u00e8le de d\u00e9pr\u00e9ciation est une analyse des taux historiques r\u00e9els de pertes de cr\u00e9dit. Ceux-ci sont ajust\u00e9s en tenant compte des informations prospectives et des effets des changements actuels dans l'environnement macro\u00e9conomique, si ceux-ci sont significatifs. En raison du faible niveau des pertes de cr\u00e9dit historiques, le Groupe d\u00e9termine actuellement les pertes de cr\u00e9dit attendues pour l\u2019ensemble du portefeuille de cr\u00e9ances clients. N\u00e9anmoins, les taux de pertes historiques sont analys\u00e9s r\u00e9guli\u00e8rement de mani\u00e8re plus d\u00e9taill\u00e9e afin d\u2019appliquer, le cas \u00e9ch\u00e9ant, des taux de pertes diff\u00e9renci\u00e9s \u00e0 diff\u00e9rents portefeuilles. En <span class=\"hyperlink-no-style_1\"></span>2025, aucun changement significatif concernant le risque de cr\u00e9dit du portefeuille de clients biopharmaceutiques du Groupe n\u2019a \u00e9t\u00e9 observ\u00e9. En raison de la concentration du Groupe sur l'industrie biopharmaceutique, g\u00e9n\u00e9ralement stable et relativement ind\u00e9pendante des \u00e9volutions macro\u00e9conomiques (elle devrait conna\u00eetre une croissance sup\u00e9rieure \u00e0 la moyenne \u00e0 long terme), le Groupe n\u2019enregistre actuellement aucun impact significatif des informations prospectives sur les pertes de cr\u00e9dit attendues.</div><div class=\"defaultParagraph_1 Standard\">Les actifs contractuels sont li\u00e9s \u00e0 des projets pour des clients sp\u00e9cifiques ou particuliers du Groupe. Il est donc consid\u00e9r\u00e9 que les taux de pertes appliqu\u00e9s aux cr\u00e9ances clients constituent une approximation appropri\u00e9e des taux de pertes applicables aux actifs contractuels. En cons\u00e9quence, aucune distinction suppl\u00e9mentaire n\u2019est op\u00e9r\u00e9e entre les cr\u00e9ances clients et les actifs sur contractuels</div><div class=\"defaultParagraph_1 Standard\">Sur cette base, les provisions pour d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels \u00e9taient d\u00e9termin\u00e9es comme suit au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; float:left; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83ac32\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d121d7a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">135,1</div></td><td class=\"d1bd8d0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,9</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">193,9</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,2</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d62c572\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d6bd1b3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:651px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr class=\"eb700c\"><td class=\"cc0b10\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b90507\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d2ba295\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr class=\"d4c9edf\"><td class=\"d1b2dca\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"d2837bf\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">220,2</div></td><td class=\"d904d9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,2</div></td><td class=\"e7f901\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">261,8</div></td></tr><tr class=\"d213883\"><td class=\"d1ff5de\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"c0658e\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"d58c8f1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr class=\"d213883\"><td class=\"f1d1df\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"e7b9e3\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"e698cc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d47d096\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d1c1e71\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,6</div></td><td class=\"d47d096\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td></tr><tr class=\"d279a6a\"><td class=\"d755ebe\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d0623c7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d7dd22\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e4fcf5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les pertes sur cr\u00e9ances attendus sont d\u00e9termin\u00e9es sur la base d'un taux de perte de 0,05<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. En compl\u00e9ment, des d\u00e9pr\u00e9ciations sont \u00e9tablies sur la base d\u2019analyses individuelles. Le nombre de jours de retard constitue un crit\u00e8re essentiel dans ce contexte. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier. Dans un tel cas, les cr\u00e9ances respectives sont d\u00e9comptabilis\u00e9es. </div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les variations des provisions pour d\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 l'ouverture de l'exercice</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Augmentation pendant l\u2019exercice</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises et consommation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Recouvrement des montants pr\u00e9c\u00e9demment d\u00e9pr\u00e9ci\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 la cl\u00f4ture de l'exercice</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\" style=\"clear:none\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>D\u00e9pr\u00e9ciation des autres actifs financiers</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Outre les cr\u00e9ances clients, la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie constituent les actifs financiers les plus significatifs dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025. Les pertes de cr\u00e9dit attendues sont surveill\u00e9es \u00e0 intervalles r\u00e9guliers. En raison de la haute solvabilit\u00e9 des contreparties et des \u00e9ch\u00e9ances courtes, la d\u00e9pr\u00e9ciation qui devrait \u00eatre comptabilis\u00e9e pour ces actifs financiers est non significative. Par cons\u00e9quent, aucune d\u00e9pr\u00e9ciation n\u2019est enregistr\u00e9e pour la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti, aucune d\u00e9pr\u00e9ciation au titre des pertes de cr\u00e9dit attendues pour les douze mois n'est constat\u00e9e au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, eu \u00e9gard au caract\u00e8re non significatif des pertes de cr\u00e9dit historiques. En cas d'augmentation significative du risque de cr\u00e9dit, g\u00e9n\u00e9ralement per\u00e7u lorsqu'un paiement est \u00e9chu depuis plus de 30 jours, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour l'actif financier correspondant. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier, ce qui est en principe le cas lorsque les paiements sont \u00e9chus depuis plus de 90 jours. \u00c0 la date de cl\u00f4ture, aucun indice d\u2019augmentation significative du risque de cr\u00e9dit n\u2019a \u00e9t\u00e9 identifi\u00e9. Les valeurs comptables des actifs financiers repr\u00e9sentent la perte de cr\u00e9dit maximale pour ces actifs \u00e0 la fin de la p\u00e9riode de reporting.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-115": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>31. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres actifs financiers</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres actifs financiers</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,8</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Actifs financiers courants</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">23,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">11,7</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le montant pr\u00e9sent\u00e9 au titre des instruments financiers d\u00e9riv\u00e9s correspond \u00e0 la juste valeur des instruments de couverture du risque de change, principalement des contrats \u00e0 terme (note\u00a039).</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les autres actifs financiers sont \u00e9valu\u00e9s au co\u00fbt amorti selon la m\u00e9thode du taux d'int\u00e9r\u00eat effectif, d\u00e9duction faite des \u00e9ventuelles pertes de valeur. La rubrique \u00ab Autres actifs financiers \u00bb comprend, entre autres, les cr\u00e9ances de pr\u00eats sur d\u2019autres entit\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG pour un montant de </span><span class=\"hyperlink-no-style_1\"></span>3,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros (en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: </span><span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">million d'euros).</span></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>35. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres passifs financiers courants</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">71,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Obligations de remboursement (IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">43,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,3</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">26,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">34,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">141,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">71,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le passif li\u00e9 \u00e0 l\u2019acquisition de participations ne donnant pas le contr\u00f4le concerne notamment Sartorius CellGenix GmbH (note\u00a036). Les instruments financiers d\u00e9riv\u00e9s repr\u00e9sentent la juste valeur des instruments de couverture de change, tels que les contrats \u00e0 terme (principalement li\u00e9es au dollar am\u00e9ricain, note 39). Les obligations de remboursement proviennent majoritairement d\u2019accords de rabais bas\u00e9s sur le volume avec des clients.</div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-116": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-117": {
   "value": "<div class=\"defaultParagraph_1 Standard\">Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e. Les instruments qui ne sont pas d\u00e9sign\u00e9s comme instruments de couverture et pour lesquels aucune comptabilit\u00e9 de couverture n'est appliqu\u00e9e sont class\u00e9s comme \u00ab\u00a0d\u00e9tenus \u00e0 des fins de transaction\u00a0\u00bb. Les variations de juste valeur des instruments financiers d\u00e9riv\u00e9s sont comptabilis\u00e9es soit en r\u00e9sultat, soit, dans le cas de relations de couverture, en autres \u00e9l\u00e9ments du r\u00e9sultat global.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe applique les r\u00e8gles de comptabilit\u00e9 de couverture pr\u00e9vues par la norme IFRS\u00a09. Sartorius Stedim Biotech utilise des contrats \u00e0 terme pour couvrir les risques de flux de tr\u00e9sorerie r\u00e9sultant de la variation des taux de change li\u00e9s aux ventes de produits et aux activit\u00e9s de production, et ne d\u00e9signe que l'\u00e9l\u00e9ment au comptant (\u00ab\u00a0spot\u00a0\u00bb) de l'instrument de couverture.</div><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForHedgingExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-118": {
   "value": "Les instruments d\u00e9riv\u00e9s sont \u00e9valu\u00e9s \u00e0 la juste valeur, d\u00e9termin\u00e9e selon la m\u00e9thode de valorisation \u00ab\u00a0mark-to-market\u00a0\u00bb sur la base d\u2019\u00e9valuations reconnues. Les justes valeurs sont bas\u00e9es sur les donn\u00e9es de march\u00e9 disponibles au moment du calcul de la valeur de ces d\u00e9riv\u00e9s et refl\u00e8tent les estimations des conditions de march\u00e9 \u00e0 la fin de l'ann\u00e9e.<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"line-height:23px; text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>36. </sub></span><div class=\"list-paragraph-container_1\"><sub>Valeurs comptables et justes valeurs d'instruments financiers par cat\u00e9gorie</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le tableau suivant pr\u00e9sente les valeurs comptables et justes valeurs des actifs et passifs financiers ventil\u00e9s par cat\u00e9gorie d'instrument financier selon la norme IFRS 9 au 31 d\u00e9cembre 2025 et au 31 d\u00e9cembre 2024 :</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:630px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"e4c45a\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d30621b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Cat\u00e9gorie selon la norme<br/>IFRS 9</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Juste valeur</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"ec75a1\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Juste valeur<br/>31 d\u00e9c. 2024</div></td></tr><tr><td class=\"db3afa\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Investissements dans des filiales, coentreprises et entreprises associ\u00e9es non consolid\u00e9es</div></td><td class=\"d55976\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d9cb020\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,3</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td><td class=\"d91a6a7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de capitaux propres \u00e0 la juste valeur par le bias du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Actifs financiers (non courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">19,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">24,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s \u00e0 la juste valeur par le biais des autres \u00e9l\u00e9ments du r\u00e9sultat global</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">7,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">47,5</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">172,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">201,1</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">192,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">265,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances et autres actifs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">8,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Instruments de dette \u00e0 la juste valeur par le biais du compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres actifs financiers (courant)</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">23,6</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">11,7</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Evalu\u00e9s au co\u00fbt amorti</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">426,1</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">678,9</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0424,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0541,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0724,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">2\u00a0882,6</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Dettes fournisseurs</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">277,8</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">310,0</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s d\u00e9sign\u00e9s comme instruments de couverture <sup>1</sup></div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">s.o.</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,4</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers \u00e0 la juste valeur : impact en compte de r\u00e9sultat</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d411c1d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs financiers</div></td><td class=\"d2edad0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">Passifs financiers</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">143,2</div></td><td class=\"d3aa107\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">142,4</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">137,3</div></td><td class=\"c4ada3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">134,2</div></td></tr><tr><td class=\"d3e535e\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Autres passifs financiers</div></td><td class=\"d2aa465\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,9</div></td><td class=\"d114953\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">143,1</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">153,8</div></td><td class=\"d43a65c\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">150,7</div></td></tr><tr><td class=\"d242a59\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d8186b4\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d4180be\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1<span dir=\"ltr\" style=\"font-size:5px; min-height:5px\">\u00a0</span>Les montants comprennent la partie non d\u00e9sign\u00e9e des contrats.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des instruments financiers ont \u00e9t\u00e9 d\u00e9termin\u00e9es sur la base des informations de march\u00e9 disponibles \u00e0 la date de cl\u00f4ture et les instruments financiers sont class\u00e9s selon la hi\u00e9rarchie \u00e0 trois niveaux d\u00e9finis par la norme IFRS 13.</div><div class=\"defaultParagraph_1 Standard\">Pour le niveau 1, les instruments financiers sont calcul\u00e9s sur la base des prix cot\u00e9s sur des march\u00e9s actifs pour des actifs et des passifs identiques. Pour le niveau 2, les instruments financiers sont calcul\u00e9s sur la base de donn\u00e9es observables de march\u00e9 sur la base des prix du march\u00e9 pour des instruments similaires. Pour le niveau 3, les instruments financiers s\u2019appuient sur les donn\u00e9es non observables de march\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre 2025, les contreparties conditionnelles li\u00e9es aux acquisitions de BIA Separations et de Xell, pr\u00e9c\u00e9demment \u00e9valu\u00e9es \u00e0 la juste valeur, sont arriv\u00e9es \u00e0 \u00e9ch\u00e9ance. Dans les deux cas, aucun paiement suppl\u00e9mentaire du prix d\u2019acquisition bas\u00e9 sur le chiffre d\u2019affaires g\u00e9n\u00e9r\u00e9 ne sera effectu\u00e9. Les passifs li\u00e9s \u00e0 ces contreparties conditionnelles ont donc \u00e9t\u00e9 d\u00e9comptabilis\u00e9s au 31 d\u00e9cembre 2025. La valeur de la contrepartie conditionnelle li\u00e9e \u00e0 l\u2019acquisition de BIA Separations \u00e0 la derni\u00e8re date de cl\u00f4ture, le 31 d\u00e9cembre 2024 (valeur\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros), a \u00e9t\u00e9 comptabilis\u00e9e en compte de r\u00e9sultat en 2025.</div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers comptabilis\u00e9s \u00e0 la juste valeur \u00e0 la date de cl\u00f4ture sont principalement des instruments d\u00e9riv\u00e9s sous forme de contrats de change \u00e0 terme. Ils ont \u00e9t\u00e9 \u00e9valu\u00e9s sur la base des taux de change cot\u00e9s sur les march\u00e9s des devises et des courbes de taux d'int\u00e9r\u00eat disponibles (niveau 2). Par ailleurs, les cr\u00e9ances clients des entit\u00e9s participant au programme d\u2019affacturage, class\u00e9es dans le portefeuille \u00ab d\u00e9tenu pour encaissement et vente \u00bb, sont \u00e9valu\u00e9es \u00e0 la juste valeur. En raison de leurs courtes \u00e9ch\u00e9ances et de leurs faibles risques de cr\u00e9dit (note 42), leur \u00e9valuation suit la m\u00eame approche que celle des cr\u00e9ances clients \u00e9valu\u00e9es au co\u00fbt amorti.</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs pr\u00e9sent\u00e9es pour les passifs financiers comptabilis\u00e9s au co\u00fbt amorti, et notamment les engagements envers Sartorius\u00a0AG, Sartorius Finance B.V. et les banques, ont \u00e9t\u00e9 d\u00e9termin\u00e9s sur la base de la courbe des taux d'int\u00e9r\u00eat du march\u00e9, en tenant compte des \u00e9carts ou \u00ab\u00a0spreads\u00a0\u00bb de cr\u00e9dit indicatifs actuels (niveau 2). Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, les seuls emprunts significatifs pour un montant de 2,4\u00a0milliards d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 2,7\u00a0milliards\u00a0d\u2019euros) proviennent du financement majeur \u00e9tabli en septembre 2023 (voir note 32). Les justes valeurs des ces emprunts reposent sur la valorisation des obligations sous-jacentes de Sartorius Finance B.V. pour lesquelles des valeurs de march\u00e9 sont disponibles (niveau 2). Les taux d\u2019int\u00e9r\u00eat varient entre 2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour ces obligations (2024 : 2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 4,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%), selon les donn\u00e9es de march\u00e9 actuelles. </div><div class=\"defaultParagraph_1 Standard\">La dette incluse dans les autres passifs financiers au titre de l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires dans la filiale Sartorius CellGenix GmbH est \u00e9valu\u00e9e selon la m\u00e9thode du taux d\u2019int\u00e9r\u00eat effectif. Le Groupe applique l\u2019option consistant \u00e0 comptabiliser directement en capitaux propres toute variation de valeur. Ce passif correspond \u00e0 une option de vente (\u00ab\u00a0put option\u00a0\u00bb) d\u00e9tenue par les actionnaires minoritaires et arrive \u00e0 \u00e9ch\u00e9ance en 2026. Le montant du prix d\u2019achat des actions \u00e0 acqu\u00e9rir d\u00e9pend du chiffre d\u2019affaires des ann\u00e9es 2023 \u00e0 2025. Sur cette base, la dette relative des 24<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% restants d\u2019actions en circulation s\u2019\u00e9l\u00e8ve \u00e0 71,3<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (2024\u00a0: 79,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions\u00a0d\u2019euros).</div><div class=\"defaultParagraph_1 Standard\">Les justes valeurs des autres actifs et passifs financiers non mentionn\u00e9s ci-dessus approchent leur valeur comptable en raison de leurs \u00e9ch\u00e9ances principalement \u00e0 court terme. Le risque maximal de perte de cr\u00e9dit est refl\u00e9t\u00e9 par les valeurs comptables des actifs financiers comptabilis\u00e9s dans le bilan consolid\u00e9.</div><div class=\"defaultParagraph_1 Standard\">Le Groupe comptabilise les transferts entre niveaux de la hi\u00e9rarchie de la juste valeur \u00e0 la fin de la p\u00e9riode au cours de laquelle le changement survient. Aucun transfert entre niveaux n\u2019a \u00e9t\u00e9 constat\u00e9 au cours de l\u2019exercice.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-119": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>30. </sub></span><div class=\"list-paragraph-container_1\"><sub>Cr\u00e9ances clients courantes</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>|</sub><span dir=\"ltr\" style=\"font-size:10px; min-height:10px\"><sub>\u00a0</sub></span><sub>Autres cr\u00e9ances</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients tiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">156,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">227,9</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Actifs contractuels (selon IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe Sartorius\u00a0AG</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">23,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Cr\u00e9ances clients</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">192,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">265,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les valeurs comptables des cr\u00e9ances clients et autres cr\u00e9ances sont repr\u00e9sentatives de leur juste valeur compte tenu de la date d'\u00e9ch\u00e9ance et des risques de cr\u00e9dit. Les actifs contractuels sont comptabilis\u00e9s en lien avec des contrats de construction sp\u00e9cifiques aux clients qui remplissent les conditions de comptabilisation du chiffre d\u2019affaires \u00e0 l\u2019avancement, conform\u00e9ment \u00e0 la norme IFRS 15 (note\u00a09).</div><div class=\"defaultParagraph_1 Standard\">Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, les droits relatifs aux cr\u00e9ances clients d\u2019un montant d\u2019environ <span class=\"hyperlink-no-style_1\"></span>307,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>269,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros) ont \u00e9t\u00e9 c\u00e9d\u00e9s dans le cadre d\u2019un programme d\u2019affacturage. Les \u00e9ch\u00e9ances des cr\u00e9ances c\u00e9d\u00e9es sont inf\u00e9rieures \u00e0 douze mois. Si les risques de d\u00e9faut ainsi que les risques de change correspondants ont \u00e9t\u00e9 int\u00e9gralement transf\u00e9r\u00e9s \u00e0 l\u2019acqu\u00e9reur des cr\u00e9ances, le Groupe conserve toutefois une partie du risque de retard de paiement. Au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, le montant maximal de ce risque conserv\u00e9 et figurant dans les cr\u00e9ances clients avoisinait <span class=\"hyperlink-no-style_1\"></span>2,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>2,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Ce risque maximal est calcul\u00e9 en fonction du volume des cr\u00e9ances c\u00e9d\u00e9es et des co\u00fbts de financement potentiels support\u00e9s par le Groupe entre la date d\u2019\u00e9ch\u00e9ance contractuelle et le paiement tardif. Les passifs associ\u00e9s pr\u00e9sent\u00e9s dans les autres passifs financiers courants s\u2019\u00e9l\u00e8vent \u00e0 <span class=\"hyperlink-no-style_1\"></span>3,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>3,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros), dont la juste valeur atteignait <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>0,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros). La cession de cr\u00e9ances a entra\u00een\u00e9 une diminution nette des cr\u00e9ances de <span class=\"hyperlink-no-style_1\"></span>304,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (2024\u00a0: <span class=\"hyperlink-no-style_1\"></span>266,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros). Le programme d\u2019affacturage est organis\u00e9 par le d\u00e9partement de tr\u00e9sorerie du Groupe Sartorius\u00a0AG. Dans le cadre de ce programme, toutes les soci\u00e9t\u00e9s participantes du Groupe Sartorius\u00a0AG peuvent c\u00e9der des cr\u00e9ances pour un volume combin\u00e9 de 200<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros et de 220<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions de dollars am\u00e9ricains.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le poste </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00ab\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Cr\u00e9ances clients sur les autres soci\u00e9t\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0\u00bb</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> concerne naturellement les autres filiales du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">45</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">). Les pertes de valeur sur les cr\u00e9ances clients et autres cr\u00e9ances sont comptabilis\u00e9es au moyen de comptes de provisions distincts. Pour plus de d\u00e9tails sur la d\u00e9termination des provisions pour d\u00e9pr\u00e9ciation</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">,</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> veuillez-vous r\u00e9f\u00e9rer \u00e0 la note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">42</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-120": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>32. </sub></span><div class=\"list-paragraph-container_1\"><sub>Emprunts et dettes financi\u00e8res</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Solde au</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Dont passifs courants</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Solde au<br/>31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Dont passifs courants<br/>au 31 d\u00e9c. 2024</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes aupr\u00e8s des \u00e9tablissements de cr\u00e9dit</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,1</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">4,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,9</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts aupr\u00e8s de Sartorius\u00a0AG</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Emprunts aupr\u00e8s de Sartorius Finance B.V.</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0419,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">552,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0719,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">36,5</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres emprunts aupr\u00e8s des entit\u00e9s du Groupe Sartorius</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total des emprunts et dettes financi\u00e8res non courants</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0424,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">557,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2\u00a0724,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">39,5</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Group a conclu des contrats de pr\u00eat avec sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG ainsi que </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V. (une entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG), pour financer en premier lieu ces acquisitions. En septembre 2023, </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V. a \u00e9mis des obligations non garanties \u00e0 long terme pour un volume total de 3 milliards d'euros, assorties de coupons annuels fixes, destin\u00e9s principalement \u00e0 l'acquisition de Polyplus. Les principales caract\u00e9ristiques de ces \u00e9missions sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d7bb7c0\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d4a0618\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Produit net pour l'\u00e9metteur</div></td><td class=\"d9a314a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Coupon annuel</div></td><td class=\"d68b0d9\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Date d'\u00e9ch\u00e9ance</div></td></tr><tr><td class=\"f75557\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 1 : 3 ans</div></td><td class=\"ab37f5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">646,9</div></td><td class=\"e260f4\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">650,0</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,250%</div></td><td class=\"d8252af\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2026</div></td></tr><tr><td class=\"d791e3c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 2 : 6 ans</div></td><td class=\"d1dac89\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">647,0</div></td><td class=\"d7659b5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">650,0</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,375%</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2029</div></td></tr><tr><td class=\"d791e3c\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 3 : 9 ans</div></td><td class=\"d1dac89\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">840,3</div></td><td class=\"d7659b5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">850,0</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,500%</div></td><td class=\"ab53ce\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2032</div></td></tr><tr><td class=\"e4b776\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Tranche 4 : 12 ans</div></td><td class=\"d82ab1b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">842,5</div></td><td class=\"d9a43a8\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">850,0</div></td><td class=\"d09cf7\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\"><span class=\"hyperlink-no-style_1\"></span>4,875%</div></td><td class=\"d79c76d\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14 septembre 2035</div></td></tr><tr><td class=\"d1b0f6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d5211b\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d2a9c0b\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"d7a5df0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les financements obtenus dans le cadre de cette \u00e9mission obligataire ont \u00e9t\u00e9 enti\u00e8rement r\u00e9troc\u00e9d\u00e9s au Groupe Sartorius Stedim Biotech, \u00e0 des conditions identiques, sous forme de pr\u00eats \u00e0 long terme non garantis. Outre le paiement des int\u00e9r\u00eats annuels, une commission de tr\u00e9sorerie est factur\u00e9e, calcul\u00e9e sur la base des co\u00fbts r\u00e9ellement support\u00e9s, augment\u00e9s d\u2019une marge de pleine concurrence. Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, en 2025, le Groupe Sartorius Stedim Biotech a rembours\u00e9 10<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de chacune des quatre tranches de pr\u00eats aux actionnaires, soit un montant nominal de 300<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros.</div><div class=\"defaultParagraph_1 Standard\">L\u2019ensemble des autres emprunts contract\u00e9s aupr\u00e8s des actionnaires de Sartorius\u00a0AG, d\u2019un montant total de 530<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros, ont \u00e9t\u00e9 int\u00e9gralement rembours\u00e9s au cours de l\u2019exercice 2024.</div><div class=\"defaultParagraph_1 Standard\">En compl\u00e9ment des emprunts \u00e0 long terme d\u00e9crits ci-dessus, le financement du Groupe Sartorius Stedim Biotech est assur\u00e9 par une ligne de cr\u00e9dit mise \u00e0 disposition par sa soci\u00e9t\u00e9 m\u00e8re Sartorius\u00a0AG ainsi que par des lignes de cr\u00e9dit  bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques et disponibles jusqu\u2019\u00e0 nouvel ordre (note\u00a041). Aucune de ces lignes de cr\u00e9dit ni des dettes financi\u00e8res n\u2019est assortie de covenants.</div><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"line-height:23px; text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>38. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du capital et des risques financiers</sub></div></div><div class=\"defaultParagraph_1 berschrift5\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span dir=\"ltr\" style=\"font-weight:bold\">Gestion du capital</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La gestion du capital au sein du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> vise \u00e0 garantir la stabilit\u00e9 financi\u00e8re et la flexibilit\u00e9 n\u00e9cessaires au maintien des activit\u00e9s op\u00e9rationnelles de l\u2019ensemble des soci\u00e9t\u00e9s du Groupe, ainsi qu\u2019\u00e0 la pr\u00e9servation de marges de man\u0153uvre strat\u00e9gique \u00e0 long terme. Les objectifs de la gestion financi\u00e8re sont d\u2019assurer une liquidit\u00e9 permanente, de r\u00e9duire les risques financiers et d\u2019optimiser les co\u00fbts d\u2019investissement en capital. Les principaux indicateurs dans ce contexte englobent l\u2019endettement net, le ratio d\u2019endettement d\u00e9fini comme le rapport entre l\u2019EBITDA </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">courant</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> \u00e0 la dette nette, et le ratio de fonds propres. Dans ce contexte, la dette nette inclut les passifs financiers pr\u00e9sent\u00e9s (note </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">la tr\u00e9sorerie et les</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> \u00e9quivalents de tr\u00e9sorerie (note </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">29</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">).</span></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les indicateurs cl\u00e9s de gestion du capital sont les suivants\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ratio de fonds propres en %</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">51,7%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">48,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Endettement financier net en millions d'euros</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0173,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0190,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ratio de la dette nette sur EBITDA courant</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,38</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,81</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La ligne de cr\u00e9dit fournie par le Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, d'un montant total pouvant atteindre 260</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros \u00e0 taux d'int\u00e9r\u00eat variables, a \u00e9t\u00e9 utilis\u00e9e \u00e0 h</span>auteur de 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Par ailleurs, \u00e0 la date de cl\u00f4ture, le Groupe disposait de lignes de cr\u00e9dit bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques, \u00e0 taux d\u2019int\u00e9r\u00eat variable et r\u00e9vocables \u00e0 tout moment, pour un montant avoisinant 129<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: 111</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros). Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, ces lignes n\u2019\u00e9taient pas utilis\u00e9es de mani\u00e8re significative.</span></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBorrowingsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-121": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>33. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres passifs financiers non courants</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 la contrepartie conditionnelle dans le cadre des acquisitions</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">79,5</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,3</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">2,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">81,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Pour plus de d\u00e9tails sur les contreparties conditionnelles et les passif li\u00e9 \u00e0 l\u2019acquisition d\u2019int\u00e9r\u00eats minoritaires, pr\u00e9sent\u00e9s comme des passifs financi\u00e8res non courants lors de l\u2019exercice pr\u00e9c\u00e9dent, se r\u00e9f\u00e9rer \u00e0 la note\u00a036.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>35. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres passifs financiers courants</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Passif li\u00e9 \u00e0 l'acquisition participations ne donnant pas le contr\u00f4le</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">71,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">16,2</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Obligations de remboursement (IFRS 15)</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">43,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">21,3</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres passifs</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">26,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">34,4</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">141,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">71,9</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le passif li\u00e9 \u00e0 l\u2019acquisition de participations ne donnant pas le contr\u00f4le concerne notamment Sartorius CellGenix GmbH (note\u00a036). Les instruments financiers d\u00e9riv\u00e9s repr\u00e9sentent la juste valeur des instruments de couverture de change, tels que les contrats \u00e0 terme (principalement li\u00e9es au dollar am\u00e9ricain, note 39). Les obligations de remboursement proviennent majoritairement d\u2019accords de rabais bas\u00e9s sur le volume avec des clients.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-122": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>34. </sub></span><div class=\"list-paragraph-container_1\"><sub>Dettes fournisseurs</sub></div></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs envers des tiers</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">269,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">274,6</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs aupr\u00e8s des autres soci\u00e9t\u00e9s du Groupe Sartorius\u00a0AG</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,8</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Dettes fournisseurs aupr\u00e8s des participations non consolid\u00e9es</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,6</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Total</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">277,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">310,0</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-123": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"line-height:23px; text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>38. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du capital et des risques financiers</sub></div></div><div class=\"defaultParagraph_1 berschrift5\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span dir=\"ltr\" style=\"font-weight:bold\">Gestion du capital</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La gestion du capital au sein du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> vise \u00e0 garantir la stabilit\u00e9 financi\u00e8re et la flexibilit\u00e9 n\u00e9cessaires au maintien des activit\u00e9s op\u00e9rationnelles de l\u2019ensemble des soci\u00e9t\u00e9s du Groupe, ainsi qu\u2019\u00e0 la pr\u00e9servation de marges de man\u0153uvre strat\u00e9gique \u00e0 long terme. Les objectifs de la gestion financi\u00e8re sont d\u2019assurer une liquidit\u00e9 permanente, de r\u00e9duire les risques financiers et d\u2019optimiser les co\u00fbts d\u2019investissement en capital. Les principaux indicateurs dans ce contexte englobent l\u2019endettement net, le ratio d\u2019endettement d\u00e9fini comme le rapport entre l\u2019EBITDA </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">courant</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> \u00e0 la dette nette, et le ratio de fonds propres. Dans ce contexte, la dette nette inclut les passifs financiers pr\u00e9sent\u00e9s (note </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">la tr\u00e9sorerie et les</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\"> \u00e9quivalents de tr\u00e9sorerie (note </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">29</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">).</span></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les indicateurs cl\u00e9s de gestion du capital sont les suivants\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>\u00a0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ratio de fonds propres en %</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">51,7%</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">48,7%</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Endettement financier net en millions d'euros</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0173,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0190,6</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Ratio de la dette nette sur EBITDA courant</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,38</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,81</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-124": {
   "value": "<div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Objectifs de la gestion des risques financiers </span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le d\u00e9partement Tr\u00e9sorerie du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est centralis\u00e9 au sein de la soci\u00e9t\u00e9 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Corporate Administration GmbH, une filiale de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Ce d\u00e9partement  centralis\u00e9 fournit des services \u00e0 l\u2019ensemble des soci\u00e9t\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, y compris celles affili\u00e9es au Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, et coordonne l\u2019acc\u00e8s aux march\u00e9s nationaux et internationaux. Par ailleurs, le d\u00e9partement Tr\u00e9sorerie assure le suivi et le contr\u00f4le des risques financiers et cartographie, dans un rapport de synth\u00e8se interne, les risques en fonction de leur gravit\u00e9 et de leur port\u00e9e. Dans cette analyse, se retrouvent principalement les risques de change, les risques de variation des taux d\u2019int\u00e9r\u00eat, les risques de liquidit\u00e9 et les risques de cr\u00e9dit.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> s\u2019efforce de minimiser l\u2019impact du risque des risques de change et de variation des taux d'int\u00e9r\u00eat en ayant recours \u00e0 des instruments financiers primaires ou d\u00e9riv\u00e9s appropri\u00e9s. Les op\u00e9rations de couverture et leur contr\u00f4le sont effectu\u00e9s par des collaborateurs distincts. Les instruments financiers d\u00e9riv\u00e9s sont utilis\u00e9s exclusivement \u00e0 des fins de couverture.</span></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>39. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux de change et de la comptabilit\u00e9 de </sub><br/><sup>couverture</sup></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 au risque de change car environ 40<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de son chiffre d\u2019affaires est g\u00e9n\u00e9r\u00e9 en dollars am\u00e9ricains et, dans une moindre mesure, dans d\u2019autres devises \u00e9trang\u00e8res. Gr\u00e2ce \u00e0 son r\u00e9seau mondial, le Groupe peut compenser une grande partie des revenus libell\u00e9s en devises \u00e9trang\u00e8res par des co\u00fbts engag\u00e9s dans les m\u00eames devises. La part des revenus g\u00e9n\u00e9r\u00e9e dans les devises \u00e9trang\u00e8res qui d\u00e9passe ces co\u00fbts, appel\u00e9e exposition nette aux devises, est couverte selon un mod\u00e8le de \u00ab\u00a0cash flow at risk\u00a0\u00bb (CfaR) dans les limites d'un budget de risque pr\u00e9d\u00e9termin\u00e9, \u00e0 l\u2019aide des instruments financiers d\u00e9riv\u00e9s. Les ratios de couverture obtenus varient g\u00e9n\u00e9ralement entre 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 80<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les devises concern\u00e9es. Le Groupe applique g\u00e9n\u00e9ralement une strat\u00e9gie de couverture \u00e9chelonn\u00e9e, couvrant une p\u00e9riode allant jusqu'\u00e0 12 mois \u00e0 l'avance. Les mesures prises dans le cadre de la strat\u00e9gie de couverture sont r\u00e9examin\u00e9es \u00e0 intervalles r\u00e9guliers afin de les adapter aux fluctuations des devises.</div><div class=\"defaultParagraph_1 Standard\">Pour la couverture de change, le Groupe utilise des contrats \u00e0 terme. Ces contrats garantissent le droit, tout en cr\u00e9ant l\u2019obligation, de vendre un montant d\u00e9termin\u00e9 de devise \u00e9trang\u00e8re \u00e0 une date d\u2019\u00e9ch\u00e9ance et \u00e0 un taux de change sp\u00e9cifique contre l\u2019euro. Le profit ou la perte r\u00e9sultant de la diff\u00e9rence entre le taux de change actuel et le taux pr\u00e9alablement fix\u00e9 est g\u00e9n\u00e9ralement comptabilis\u00e9 en produit ou en charge dans le r\u00e9sultat net.</div><div class=\"defaultParagraph_1 Standard\">\u00c0 la date de cl\u00f4ture, des contrats \u00e0 terme d\u2019un montant de <span class=\"hyperlink-no-style_1\"></span>297,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>297,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024) ont \u00e9t\u00e9 conclus pour couvrir le risque de fluctuation de la parit\u00e9 du taux de change EUR<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>USD. Ce montant couvre environ 60<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de l'exposition nette attendue au dollar am\u00e9ricain pour une p\u00e9riode de 12 mois. Par ailleurs, d\u2019autres devises \u00e9trang\u00e8res ont fait l\u2019objet de strat\u00e9gie de couvertures mais pour des volumes plus modestes.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les tableaux ci-apr\u00e8s pr\u00e9sentent les contrats de couverture du risque de change en vigueur \u00e0 la date de cl\u00f4ture\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">290,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,10</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">159,55</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,50</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/GBP</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,83</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Montant nominal</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,16</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,48</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CHF</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,92</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,58</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">165,36</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,11</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe mesure le risque de change \u00e0 l'aide d'un mod\u00e8le de cash flow at Risk (CfaR). L'analyse repose sur les flux entrants et sortants attendus en devises \u00e9trang\u00e8res (expositions nettes). Le risque global de change, obtenu en agr\u00e9geant les valeurs absolues de ces expositions nettes, s'\u00e9tablit comme suit \u00e0 la date de cl\u00f4ture, pour les 12 mois \u00e0 venir\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Exposition en devises \u00e9trang\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">966,6 </div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">979,7 </div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">- Dont positions courtes</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100,8 </div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">101,4 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La position de risque du Groupe est refl\u00e9t\u00e9e par le CfaR r\u00e9siduel apr\u00e8s examen de toutes les activit\u00e9s de couverture. L'approche CfaR tient compte de l'impact potentiel des fluctuations de change sur les flux de tr\u00e9sorerie en devises \u00e9trang\u00e8res (par rapport \u00e0 l\u2019euro) en s\u2019appuyant sur une distribution des probabilit\u00e9s. A cet \u00e9gard, les covariances des devises \u00e9trang\u00e8res, pond\u00e9r\u00e9es par les expositions nettes, sont utilis\u00e9es comme facteurs d'entr\u00e9e pour l'estimation de la volatilit\u00e9 du portefeuille, d\u00e9terminante pour le calcul du CfaR. Les corr\u00e9lations entre les devises sont prises en compte ce qui permet de temp\u00e9rer le risque lors de l\u2019agr\u00e9gation.</div><div class=\"defaultParagraph_1 Standard\">L'impact n\u00e9gatif potentiel sur l'EBITDA est d\u00e9termin\u00e9 pour chaque devise sur la base des taux de change r\u00e9els et des expositions nettes, en pr\u00e9sentant un niveau de confiance de 95<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les 12 prochains mois. Le tableau suivant illustre l'impact n\u00e9gatif potentiel pour le Groupe selon l'approche CfaR, sur la m\u00eame p\u00e9riode\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cash flow at risk</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,5 </div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,3 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">Le tableau suivant d\u00e9taille les effets des instruments de couverture li\u00e9s aux risques de change affectant la structure financi\u00e8re et les performances du Groupe\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur positive</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur n\u00e9gative</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Variation de la valeur des <br/>instruments de couverture</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">419,8</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">423,7</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>40. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux d'int\u00e9r\u00eat</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est principalement financ\u00e9 par l'interm\u00e9diaire de sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., une entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Les principaux emprunts sont souscrits \u00e0 taux d\u2019int\u00e9r\u00eat fixes (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">), ce qui limite l\u2019exposition du Groupe aux risques de taux d\u2019int\u00e9r\u00eat. Afin de ma\u00eetriser ce risque, un ratio appropri\u00e9 entre les financements \u00e0 taux fixe et \u00e0 taux variable est g\u00e9n\u00e9ralement maintenu. Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, aucun pr\u00eat \u00e0 taux variables n\u2019est accord\u00e9 par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., au 31 d\u00e9cembre 2025. Par cons\u00e9quent, l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 n\u2019aurait eu aucun d\u2019impact sur les r\u00e9sultats du Groupe. De m\u00eame que l\u2019ann\u00e9e pr\u00e9c\u00e9dente, au 31 d\u00e9cembre 2025, le Groupe ne d\u00e9t</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">e</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">n</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">ai</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">t aucun instrument d\u00e9riv\u00e9 de taux d\u2019int\u00e9r\u00eat en cours destin\u00e9 \u00e0 couvrir le risque de hausse des taux d\u2019int\u00e9r\u00eat.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Outre les emprunts d\u00e9crits ci-dessus, le financement du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est garanti par une ligne de cr\u00e9dit \u00e0 taux d'int\u00e9r\u00eat variable mise \u00e0 disposition par sa soci\u00e9t\u00e9 m\u00e8re, </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Il existe par ailleurs des lignes de cr\u00e9dit bilat\u00e9rales \u00e0 taux d\u2019int\u00e9r\u00eat variables. Compte tenu du faible degr\u00e9 d\u2019utilisation des lignes </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">de cr\u00e9dit au 31 d\u00e9cembre 2025, les risques li\u00e9s \u00e0 l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 ne sont pas significatifs pour le Groupe (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">41</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">).</span></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>41. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de liquidit\u00e9</sub></div></div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9ch\u00e9ancier des passifs financiers, hors instruments financiers d\u00e9riv\u00e9s, se pr\u00e9sente comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"d46ddd7\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d369ea1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0724,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0570,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">125,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0587,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0857,3</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">145,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">76,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">66,0</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d920f12\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"efe52b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">55,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0316,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">4\u00a0190,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">521,1</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0746,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0923,3</div></td></tr><tr><td class=\"d60d677\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d5e2cba\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0424,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0098,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">633,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">844,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0620,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">174,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">240,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">127,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">141,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0020,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0759,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0082,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">928,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0748,1</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les flux de tr\u00e9sorerie figurant dans les tableaux ci-dessus comprennent les paiements pr\u00e9vus non actualis\u00e9s li\u00e9s aux passifs financiers, y compris les paiements d'int\u00e9r\u00eat calcul\u00e9 \u00e0 partir des taux d\u2019int\u00e9r\u00eat en vigueur \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les emprunts et dettes financi\u00e8res comprennent les emprunts contract\u00e9s aupr\u00e8s de la soci\u00e9t\u00e9 m\u00e8re Sartorius\u00a0AG ainsi que Sartorius Finance B.V. Les autres passifs comprennent notamment la dette li\u00e9e \u00e0 l'acquisition \u00e9ventuelle des int\u00e9r\u00eats minoritaires de Sartorius CellGenix GmbH (note 36).</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les tableaux suivants pr\u00e9sentent l'analyse de liquidit\u00e9 des instruments financiers d\u00e9riv\u00e9s utilis\u00e9s pour couvrir les risques de change (note\u00a039) sur la base de flux de tr\u00e9sorerie non actualis\u00e9s\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&gt; 5 ans</div></td></tr><tr><td class=\"d3f6f88\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">R\u00e9alisation brute</div></td><td class=\"d87df58\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Contrats \u00e0 terme</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">432,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">425,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d228d46\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"b391df\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013415,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013409,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,0</div></td></tr><tr><td class=\"d68c288\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d58fab0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">R\u00e9alisation brute</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats \u00e0 terme</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Sorties de tr\u00e9sorerie</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe ma\u00eetrise le risque de liquidit\u00e9 en maintenant des lignes de cr\u00e9dit et des facilit\u00e9s suppl\u00e9mentaires aupr\u00e8s des banques, en assurant un suivi continu des flux de tr\u00e9sorerie pr\u00e9visionnels et r\u00e9alis\u00e9s, et en g\u00e9rant les profils d\u2019\u00e9ch\u00e9ance des actifs et passifs financiers. Il n\u2019est pas attendu que les sorties de tr\u00e9sorerie surviennent \u00e0 des moments ou pour des montants sensiblement diff\u00e9rents.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La ligne de cr\u00e9dit fournie par le Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, d'un montant total pouvant atteindre 260</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros \u00e0 taux d'int\u00e9r\u00eat variables, a \u00e9t\u00e9 utilis\u00e9e \u00e0 h</span>auteur de 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Par ailleurs, \u00e0 la date de cl\u00f4ture, le Groupe disposait de lignes de cr\u00e9dit bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques, \u00e0 taux d\u2019int\u00e9r\u00eat variable et r\u00e9vocables \u00e0 tout moment, pour un montant avoisinant 129<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: 111</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros). Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, ces lignes n\u2019\u00e9taient pas utilis\u00e9es de mani\u00e8re significative.</span></div><div class=\"defaultParagraph_1 Standard\">Les fonds en liquidit\u00e9s pr\u00e9sents localement dans certains pays (par exemple, la Chine et l\u2019Inde) ne sont disponibles pour le Groupe que pour des transactions transfrontali\u00e8res soumises \u00e0 des contr\u00f4les des changes. Pour les restrictions concernant les fonds d\u00e9tenus par les entit\u00e9s russes du Groupe, veuillez consulter la note\u00a04.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>42. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de cr\u00e9dit</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit correspond au risque de perte financi\u00e8re pour le Groupe si une contrepartie \u00e0 un instrument financier ne respecte pas ses obligations contractuelles. Le risque de cr\u00e9dit d\u00e9coule principalement de la tr\u00e9sorerie et des \u00e9quivalents de tr\u00e9sorerie, ainsi que des cr\u00e9ances clients. En outre, le Groupe est expos\u00e9 au risque de cr\u00e9dit li\u00e9 aux instruments financiers d\u00e9riv\u00e9s pr\u00e9sentant une juste valeur positive et, dans une faible mesure, aux flux de tr\u00e9sorerie contractuels provenant des titres de cr\u00e9ance.</div><div class=\"defaultParagraph_1 Standard\">Le risque de cr\u00e9dit est g\u00e9r\u00e9 de mani\u00e8re centralis\u00e9e au sein du Groupe par le service de gestion de la tr\u00e9sorerie. Pour les contreparties telles que les banques et les institutions financi\u00e8res, la solvabilit\u00e9 est surveill\u00e9e en continu afin de d\u00e9tecter \u00e0 un stade pr\u00e9coce toute augmentation du risque de cr\u00e9dit. En l\u2019absence de nouvelles informations, le Groupe consid\u00e8re que les actifs financiers concern\u00e9s pr\u00e9sentent toujours un faible risque de cr\u00e9dit.</div><div class=\"defaultParagraph_1 Standard\">Des limites de risque sont attribu\u00e9s aux clients, principalement en fonction du volume d\u2019affaires, de l\u2019exp\u00e9rience pass\u00e9e et de l\u2019\u00e9valuation de la solvabilit\u00e9 du client. Le respect de ces limites est r\u00e9guli\u00e8rement v\u00e9rifi\u00e9 par la direction comp\u00e9tente. Dans certains cas, le Groupe per\u00e7oit des paiements anticip\u00e9s (acomptes) ou exige des lettres de cr\u00e9dit pour \u00e9viter les risques de cr\u00e9dit. Il n\u2019existe pas de concentration significative de risque de cr\u00e9dit par client ou par zone g\u00e9ographique.</div><div class=\"defaultParagraph_1 Standard\">Pour certaines cr\u00e9ances clients, le Groupe peut b\u00e9n\u00e9ficier de contreparties, telles que des garanties pouvant \u00eatre utilis\u00e9es dans le cadre d'accords contractuels au cas o\u00f9 le client ne respecterait pas ses obligations contractuelles de paiement.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">D\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels </div><div class=\"defaultParagraph_1 Standard\">Le mod\u00e8le de d\u00e9pr\u00e9ciation de la norme IFRS 9, qui impose la comptabilisation des pertes de cr\u00e9dit attendues, rev\u00eat une importance particuli\u00e8re pour les cr\u00e9ances clients et les actifs contractuels du Groupe conform\u00e9ment \u00e0 la norme IFRS 15. Le Groupe applique l'approche simplifi\u00e9e de la norme IFRS 9 aux cr\u00e9ances clients et aux actifs contractuels. Ainsi, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour ces actifs. Le point de d\u00e9part du nouveau mod\u00e8le de d\u00e9pr\u00e9ciation est une analyse des taux historiques r\u00e9els de pertes de cr\u00e9dit. Ceux-ci sont ajust\u00e9s en tenant compte des informations prospectives et des effets des changements actuels dans l'environnement macro\u00e9conomique, si ceux-ci sont significatifs. En raison du faible niveau des pertes de cr\u00e9dit historiques, le Groupe d\u00e9termine actuellement les pertes de cr\u00e9dit attendues pour l\u2019ensemble du portefeuille de cr\u00e9ances clients. N\u00e9anmoins, les taux de pertes historiques sont analys\u00e9s r\u00e9guli\u00e8rement de mani\u00e8re plus d\u00e9taill\u00e9e afin d\u2019appliquer, le cas \u00e9ch\u00e9ant, des taux de pertes diff\u00e9renci\u00e9s \u00e0 diff\u00e9rents portefeuilles. En <span class=\"hyperlink-no-style_1\"></span>2025, aucun changement significatif concernant le risque de cr\u00e9dit du portefeuille de clients biopharmaceutiques du Groupe n\u2019a \u00e9t\u00e9 observ\u00e9. En raison de la concentration du Groupe sur l'industrie biopharmaceutique, g\u00e9n\u00e9ralement stable et relativement ind\u00e9pendante des \u00e9volutions macro\u00e9conomiques (elle devrait conna\u00eetre une croissance sup\u00e9rieure \u00e0 la moyenne \u00e0 long terme), le Groupe n\u2019enregistre actuellement aucun impact significatif des informations prospectives sur les pertes de cr\u00e9dit attendues.</div><div class=\"defaultParagraph_1 Standard\">Les actifs contractuels sont li\u00e9s \u00e0 des projets pour des clients sp\u00e9cifiques ou particuliers du Groupe. Il est donc consid\u00e9r\u00e9 que les taux de pertes appliqu\u00e9s aux cr\u00e9ances clients constituent une approximation appropri\u00e9e des taux de pertes applicables aux actifs contractuels. En cons\u00e9quence, aucune distinction suppl\u00e9mentaire n\u2019est op\u00e9r\u00e9e entre les cr\u00e9ances clients et les actifs sur contractuels</div><div class=\"defaultParagraph_1 Standard\">Sur cette base, les provisions pour d\u00e9pr\u00e9ciations des cr\u00e9ances clients et des actifs contractuels \u00e9taient d\u00e9termin\u00e9es comme suit au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2025 et au 31\u00a0d\u00e9cembre\u00a0<span class=\"hyperlink-no-style_1\"></span>2024\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; float:left; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d83ac32\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"ffe2b6\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d121d7a\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d21bb9b\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Total</span></div></td></tr><tr><td class=\"d3e904b\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"cc1cbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">135,1</div></td><td class=\"d1bd8d0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">20,6</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d73127a\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,9</div></td><td class=\"d6fa6a0\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">193,9</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,1</div></td></tr><tr><td class=\"d5d650\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"d1c39cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d97f60b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d3cddbf\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,8</div></td><td class=\"c53d0f\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">14,2</div></td></tr><tr><td class=\"d9a41fc\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"a0fa44\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d62c572\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"c63551\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d6bd1b3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"deb7a6\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:651px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr class=\"eb700c\"><td class=\"cc0b10\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b90507\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">En cours</div></td><td class=\"d2ba295\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u00e0 30 jours</div></td><td class=\"d33f0fc\" colspan=\"2\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 \u00e0 60 jours</div></td><td class=\"d33f0fc\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">61 \u00e0 90 jours</div></td><td class=\"d41f11\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Au-del\u00e0 de 90 jours</div></td><td class=\"d33f0fc\" colspan=\"3\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td></tr><tr class=\"d4c9edf\"><td class=\"d1b2dca\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des cr\u00e9ances clients</div></td><td class=\"d2837bf\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">220,2</div></td><td class=\"d904d9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">5,1</div></td><td class=\"e7f901\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,1</div></td><td class=\"d065825\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,2</div></td><td class=\"e7f901\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">261,8</div></td></tr><tr class=\"d213883\"><td class=\"d1ff5de\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Valeur comptable brute des actifs contractuels</div></td><td class=\"c0658e\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td><td class=\"d58c8f1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d6b8a88\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d65262b\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">17,4</div></td></tr><tr class=\"d213883\"><td class=\"f1d1df\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Provisions pour d\u00e9pr\u00e9ciation</div></td><td class=\"e7b9e3\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"e698cc\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d47d096\" colspan=\"2\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d47d096\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,5</div></td><td class=\"d1c1e71\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,6</div></td><td class=\"d47d096\" colspan=\"3\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,3</div></td></tr><tr class=\"d279a6a\"><td class=\"d755ebe\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d0623c7\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d7dd22\" colspan=\"3\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e4fcf5\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"e6f0fd\" colspan=\"2\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les pertes sur cr\u00e9ances attendus sont d\u00e9termin\u00e9es sur la base d'un taux de perte de 0,05<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%. En compl\u00e9ment, des d\u00e9pr\u00e9ciations sont \u00e9tablies sur la base d\u2019analyses individuelles. Le nombre de jours de retard constitue un crit\u00e8re essentiel dans ce contexte. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier. Dans un tel cas, les cr\u00e9ances respectives sont d\u00e9comptabilis\u00e9es. </div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Les variations des provisions pour d\u00e9pr\u00e9ciation des cr\u00e9ances clients et des actifs contractuels sont pr\u00e9sent\u00e9es ci-dessous\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 l'ouverture de l'exercice</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Augmentation pendant l\u2019exercice</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20135,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20134,4</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Reprises et consommation</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Recouvrement des montants pr\u00e9c\u00e9demment d\u00e9pr\u00e9ci\u00e9s</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,3</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,4</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">\u00c9carts de conversion</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u20130,2</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Provisions pour d\u00e9pr\u00e9ciation \u00e0 la cl\u00f4ture de l'exercice</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201314,2</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u201313,3</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"clear:none; min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\" style=\"clear:none\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>D\u00e9pr\u00e9ciation des autres actifs financiers</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Outre les cr\u00e9ances clients, la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie constituent les actifs financiers les plus significatifs dans le bilan du Groupe \u00e0 la date de cl\u00f4ture du 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025. Les pertes de cr\u00e9dit attendues sont surveill\u00e9es \u00e0 intervalles r\u00e9guliers. En raison de la haute solvabilit\u00e9 des contreparties et des \u00e9ch\u00e9ances courtes, la d\u00e9pr\u00e9ciation qui devrait \u00eatre comptabilis\u00e9e pour ces actifs financiers est non significative. Par cons\u00e9quent, aucune d\u00e9pr\u00e9ciation n\u2019est enregistr\u00e9e pour la tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie.</div><div class=\"defaultParagraph_1 Standard\" style=\"clear:none\">Pour les autres actifs financiers \u00e9valu\u00e9s au co\u00fbt amorti, aucune d\u00e9pr\u00e9ciation au titre des pertes de cr\u00e9dit attendues pour les douze mois n'est constat\u00e9e au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025, eu \u00e9gard au caract\u00e8re non significatif des pertes de cr\u00e9dit historiques. En cas d'augmentation significative du risque de cr\u00e9dit, g\u00e9n\u00e9ralement per\u00e7u lorsqu'un paiement est \u00e9chu depuis plus de 30 jours, les pertes de cr\u00e9dit attendues sur la dur\u00e9e de vie sont comptabilis\u00e9es pour l'actif financier correspondant. Un d\u00e9faut est g\u00e9n\u00e9ralement per\u00e7u lorsqu'il n'existe plus d\u2019espoir raisonnable de recouvrer un actif financier, ce qui est en principe le cas lorsque les paiements sont \u00e9chus depuis plus de 90 jours. \u00c0 la date de cl\u00f4ture, aucun indice d\u2019augmentation significative du risque de cr\u00e9dit n\u2019a \u00e9t\u00e9 identifi\u00e9. Les valeurs comptables des actifs financiers repr\u00e9sentent la perte de cr\u00e9dit maximale pour ces actifs \u00e0 la fin de la p\u00e9riode de reporting.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-125": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>39. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux de change et de la comptabilit\u00e9 de </sub><br/><sup>couverture</sup></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe est expos\u00e9 au risque de change car environ 40<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de son chiffre d\u2019affaires est g\u00e9n\u00e9r\u00e9 en dollars am\u00e9ricains et, dans une moindre mesure, dans d\u2019autres devises \u00e9trang\u00e8res. Gr\u00e2ce \u00e0 son r\u00e9seau mondial, le Groupe peut compenser une grande partie des revenus libell\u00e9s en devises \u00e9trang\u00e8res par des co\u00fbts engag\u00e9s dans les m\u00eames devises. La part des revenus g\u00e9n\u00e9r\u00e9e dans les devises \u00e9trang\u00e8res qui d\u00e9passe ces co\u00fbts, appel\u00e9e exposition nette aux devises, est couverte selon un mod\u00e8le de \u00ab\u00a0cash flow at risk\u00a0\u00bb (CfaR) dans les limites d'un budget de risque pr\u00e9d\u00e9termin\u00e9, \u00e0 l\u2019aide des instruments financiers d\u00e9riv\u00e9s. Les ratios de couverture obtenus varient g\u00e9n\u00e9ralement entre 0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% et 80<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les devises concern\u00e9es. Le Groupe applique g\u00e9n\u00e9ralement une strat\u00e9gie de couverture \u00e9chelonn\u00e9e, couvrant une p\u00e9riode allant jusqu'\u00e0 12 mois \u00e0 l'avance. Les mesures prises dans le cadre de la strat\u00e9gie de couverture sont r\u00e9examin\u00e9es \u00e0 intervalles r\u00e9guliers afin de les adapter aux fluctuations des devises.</div><div class=\"defaultParagraph_1 Standard\">Pour la couverture de change, le Groupe utilise des contrats \u00e0 terme. Ces contrats garantissent le droit, tout en cr\u00e9ant l\u2019obligation, de vendre un montant d\u00e9termin\u00e9 de devise \u00e9trang\u00e8re \u00e0 une date d\u2019\u00e9ch\u00e9ance et \u00e0 un taux de change sp\u00e9cifique contre l\u2019euro. Le profit ou la perte r\u00e9sultant de la diff\u00e9rence entre le taux de change actuel et le taux pr\u00e9alablement fix\u00e9 est g\u00e9n\u00e9ralement comptabilis\u00e9 en produit ou en charge dans le r\u00e9sultat net.</div><div class=\"defaultParagraph_1 Standard\">\u00c0 la date de cl\u00f4ture, des contrats \u00e0 terme d\u2019un montant de <span class=\"hyperlink-no-style_1\"></span>297,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>297,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024) ont \u00e9t\u00e9 conclus pour couvrir le risque de fluctuation de la parit\u00e9 du taux de change EUR<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>|<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>USD. Ce montant couvre environ 60<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% de l'exposition nette attendue au dollar am\u00e9ricain pour une p\u00e9riode de 12 mois. Par ailleurs, d\u2019autres devises \u00e9trang\u00e8res ont fait l\u2019objet de strat\u00e9gie de couvertures mais pour des volumes plus modestes.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\">Les tableaux ci-apr\u00e8s pr\u00e9sentent les contrats de couverture du risque de change en vigueur \u00e0 la date de cl\u00f4ture\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2024<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">290,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,6</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,10</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">55,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">37,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">159,55</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">13,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,50</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,45</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/GBP</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,83</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>31 d\u00e9c. 2025<br/>en millions d'euros</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance : <br/>1 - 12 mois</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">\u00c9ch\u00e9ance au bout d\u2019un an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Montant nominal</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Prix d'exercice moyen</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/USD</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">297,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,16</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SGD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">54,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,48</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CHF</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">18,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,92</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/CAD</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">10,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,58</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/JPY</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">33,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">165,36</div></td></tr><tr><td class=\"d426afc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrat \u00e0 terme EUR/SEK</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">9,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">11,11</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe mesure le risque de change \u00e0 l'aide d'un mod\u00e8le de cash flow at Risk (CfaR). L'analyse repose sur les flux entrants et sortants attendus en devises \u00e9trang\u00e8res (expositions nettes). Le risque global de change, obtenu en agr\u00e9geant les valeurs absolues de ces expositions nettes, s'\u00e9tablit comme suit \u00e0 la date de cl\u00f4ture, pour les 12 mois \u00e0 venir\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Exposition en devises \u00e9trang\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">966,6 </div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">979,7 </div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">- Dont positions courtes</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100,8 </div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">101,4 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">La position de risque du Groupe est refl\u00e9t\u00e9e par le CfaR r\u00e9siduel apr\u00e8s examen de toutes les activit\u00e9s de couverture. L'approche CfaR tient compte de l'impact potentiel des fluctuations de change sur les flux de tr\u00e9sorerie en devises \u00e9trang\u00e8res (par rapport \u00e0 l\u2019euro) en s\u2019appuyant sur une distribution des probabilit\u00e9s. A cet \u00e9gard, les covariances des devises \u00e9trang\u00e8res, pond\u00e9r\u00e9es par les expositions nettes, sont utilis\u00e9es comme facteurs d'entr\u00e9e pour l'estimation de la volatilit\u00e9 du portefeuille, d\u00e9terminante pour le calcul du CfaR. Les corr\u00e9lations entre les devises sont prises en compte ce qui permet de temp\u00e9rer le risque lors de l\u2019agr\u00e9gation.</div><div class=\"defaultParagraph_1 Standard\">L'impact n\u00e9gatif potentiel sur l'EBITDA est d\u00e9termin\u00e9 pour chaque devise sur la base des taux de change r\u00e9els et des expositions nettes, en pr\u00e9sentant un niveau de confiance de 95<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>% pour les 12 prochains mois. Le tableau suivant illustre l'impact n\u00e9gatif potentiel pour le Groupe selon l'approche CfaR, sur la m\u00eame p\u00e9riode\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">31 d\u00e9c. 2024</div></td></tr><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Cash flow at risk</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">28,5 </div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">22,3 </div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift5\"><span dir=\"ltr\" style=\"font-weight:bold\">Comptabilit\u00e9 de couverture</span></div><div class=\"defaultParagraph_1 Standard\">Les instruments financiers d\u00e9riv\u00e9s sont \u00e9valu\u00e9s lors de leur acquisition au co\u00fbt, puis \u00e0 leur juste valeur aux dates ult\u00e9rieures de cl\u00f4ture. Les variations de valeur des instruments financiers d\u00e9riv\u00e9s sont g\u00e9n\u00e9ralement comptabilis\u00e9es dans le compte de r\u00e9sultat \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\">Lorsque les instruments financiers d\u00e9riv\u00e9s servent \u00e0 couvrir le risque de flux de tr\u00e9sorerie li\u00e9s aux risques de change et qu\u2019ils r\u00e9pondent aux conditions d\u2019une couverture comptable pr\u00e9vue par la norme IFRS 9, les ajustements de valeur de la partie efficace de l'instrument sont comptabilis\u00e9s dans les autres \u00e9l\u00e9ments du r\u00e9sultat global. En <span class=\"hyperlink-no-style_1\"></span>2025, ces ajustements cumul\u00e9s atteignaient de <span class=\"hyperlink-no-style_1\"></span>4,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre un montant de <span class=\"hyperlink-no-style_1\"></span>\u201328,1<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros en <span class=\"hyperlink-no-style_1\"></span>2024). Seul l'\u00e9l\u00e9ment comptant ou \u00ab\u00a0spot\u00a0\u00bb des contrats \u00e0 terme utilis\u00e9s pour couvrir les risques de flux de tr\u00e9sorerie est d\u00e9sign\u00e9 comme instrument de couverture. Les montants comptabilis\u00e9s initialement en capitaux propres sont retrait\u00e9s en r\u00e9sultat net au cours de la p\u00e9riode lorsque les transactions couvertes affectent le r\u00e9sultat net. Les variations des r\u00e9serves de couverture figurent au tableau des variations des capitaux propres. La partie non d\u00e9sign\u00e9e ou inefficace des instruments de couverture est quant \u00e0 elle comptabilis\u00e9e dans le r\u00e9sultat financier du compte de r\u00e9sultat.</div><div class=\"defaultParagraph_1 Standard\">Le rapport \u00e9conomique entre l\u2019instrument de couverture et l\u2019\u00e9l\u00e9ment sous-jacent, ainsi que l\u2019efficacit\u00e9 de l\u2019op\u00e9ration de couverture sont d\u00e9termin\u00e9s sur la base de la coh\u00e9rence des caract\u00e9ristiques contractuelles significatives des transactions (\u00ab\u00a0critical term match\u00a0\u00bb). \u00c0 ce titre, le Groupe proc\u00e8de \u00e0 une analyse qualitative de ces crit\u00e8res. L\u2019inefficacit\u00e9 de la couverture peut \u00eatre identifi\u00e9e lorsque la mise en place et les valeurs des transactions futures s'\u00e9carte des hypoth\u00e8ses initiales ou lorsque le Groupe observe une variation significative du risque de cr\u00e9dit de ses contreparties. Pour les \u00e9l\u00e9ments couverts d\u00e9sign\u00e9s, le ratio de couverture est de 100<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>%.</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">Le tableau suivant d\u00e9taille les effets des instruments de couverture li\u00e9s aux risques de change affectant la structure financi\u00e8re et les performances du Groupe\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"a9fdd9\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur positive</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Instruments de couverture \u00e0 la juste valeur n\u00e9gative</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Variation de la valeur des <br/>instruments de couverture</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Montant nominal</div></td></tr><tr><td class=\"a5000a\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2024</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,9</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u201311,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">419,8</div></td></tr><tr><td class=\"abe3b5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Contrats \u00e0 terme de gr\u00e9 \u00e0 gr\u00e9 au 31 d\u00e9cembre 2025</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,1</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">15,5</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">423,7</div></td></tr><tr><td class=\"b55555\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les variations de valeur des \u00e9l\u00e9ments couverts correspondent aux variations de valeur des instruments de couverture, mais de signe oppos\u00e9. Les instruments de couverture dont la juste valeur est positive sont class\u00e9s dans le bilan au poste \u00ab\u00a0Actifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres actifs financiers (courants)\u00a0\u00bb. Les instruments de couverture dont la juste valeur est n\u00e9gative sont retrait\u00e9s dans le bilan au poste \u00ab\u00a0Autres passifs financiers (non courants)\u00a0\u00bb ou \u00ab\u00a0Autres passifs financiers (courants)\u00a0\u00bb.</div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>40. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion des risques de taux d'int\u00e9r\u00eat</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est principalement financ\u00e9 par l'interm\u00e9diaire de sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., une entit\u00e9 enti\u00e8rement d\u00e9tenue et contr\u00f4l\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Les principaux emprunts sont souscrits \u00e0 taux d\u2019int\u00e9r\u00eat fixes (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">), ce qui limite l\u2019exposition du Groupe aux risques de taux d\u2019int\u00e9r\u00eat. Afin de ma\u00eetriser ce risque, un ratio appropri\u00e9 entre les financements \u00e0 taux fixe et \u00e0 taux variable est g\u00e9n\u00e9ralement maintenu. Comme lors de l\u2019exercice pr\u00e9c\u00e9dent, aucun pr\u00eat \u00e0 taux variables n\u2019est accord\u00e9 par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V., au 31 d\u00e9cembre 2025. Par cons\u00e9quent, l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 n\u2019aurait eu aucun d\u2019impact sur les r\u00e9sultats du Groupe. De m\u00eame que l\u2019ann\u00e9e pr\u00e9c\u00e9dente, au 31 d\u00e9cembre 2025, le Groupe ne d\u00e9t</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">e</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">n</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">ai</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">t aucun instrument d\u00e9riv\u00e9 de taux d\u2019int\u00e9r\u00eat en cours destin\u00e9 \u00e0 couvrir le risque de hausse des taux d\u2019int\u00e9r\u00eat.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Outre les emprunts d\u00e9crits ci-dessus, le financement du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est garanti par une ligne de cr\u00e9dit \u00e0 taux d'int\u00e9r\u00eat variable mise \u00e0 disposition par sa soci\u00e9t\u00e9 m\u00e8re, </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Il existe par ailleurs des lignes de cr\u00e9dit bilat\u00e9rales \u00e0 taux d\u2019int\u00e9r\u00eat variables. Compte tenu du faible degr\u00e9 d\u2019utilisation des lignes </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">de cr\u00e9dit au 31 d\u00e9cembre 2025, les risques li\u00e9s \u00e0 l\u2019\u00e9volution des taux d\u2019int\u00e9r\u00eat du march\u00e9 ne sont pas significatifs pour le Groupe (note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">41</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">).</span></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>43. </sub></span><div class=\"list-paragraph-container_1\"><sub>Autres risques li\u00e9s aux instruments financiers</sub></div></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00c0 la date de cl\u00f4ture, le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> n'\u00e9tait pas expos\u00e9 au risque de volatilit\u00e9 du cours des actions. La seule exception concerne la r\u00e9mun\u00e9ration des membres de la haute direction qui per\u00e7oivent une partie de leur r\u00e9mun\u00e9ration (\u00e0 long terme) dont l\u2019un des param\u00e8tres de valorisation est le cours de l'action de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">(</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">44</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">). </span></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfMarketRiskExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-126": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>41. </sub></span><div class=\"list-paragraph-container_1\"><sub>Gestion du risque de liquidit\u00e9</sub></div></div><div class=\"defaultParagraph_1 Standard\">L\u2019\u00e9ch\u00e9ancier des passifs financiers, hors instruments financiers d\u00e9riv\u00e9s, se pr\u00e9sente comme suit\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"d46ddd7\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"d369ea1\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0724,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0570,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">125,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0587,4</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0857,3</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">145,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">172,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">76,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">66,0</div></td></tr><tr><td class=\"d6fb100\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"d657e24\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">310,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d920f12\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"efe52b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">137,9</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">55,7</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,3</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"fdfde6\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"a7b920\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0316,9</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">4\u00a0190,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">521,1</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0746,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0923,3</div></td></tr><tr><td class=\"d60d677\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d5e2cba\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Emprunts et dettes financi\u00e8res</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2\u00a0424,7</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0098,1</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">633,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">844,2</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0620,3</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats de location-financement</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">174,6</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">240,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">30,5</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">82,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">127,7</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Dettes fournisseurs</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">277,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Autres passifs (instruments d\u00e9riv\u00e9s exclus)</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">143,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">141,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">2,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Passifs financiers</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0020,2</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">3\u00a0759,3</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0082,8</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">928,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">1\u00a0748,1</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Les flux de tr\u00e9sorerie figurant dans les tableaux ci-dessus comprennent les paiements pr\u00e9vus non actualis\u00e9s li\u00e9s aux passifs financiers, y compris les paiements d'int\u00e9r\u00eat calcul\u00e9 \u00e0 partir des taux d\u2019int\u00e9r\u00eat en vigueur \u00e0 la date de cl\u00f4ture.</div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les emprunts et dettes financi\u00e8res comprennent les emprunts contract\u00e9s aupr\u00e8s de la soci\u00e9t\u00e9 m\u00e8re Sartorius\u00a0AG ainsi que Sartorius Finance B.V. Les autres passifs comprennent notamment la dette li\u00e9e \u00e0 l'acquisition \u00e9ventuelle des int\u00e9r\u00eats minoritaires de Sartorius CellGenix GmbH (note 36).</div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\"><br/></div><div class=\"defaultParagraph_1 Standard\" style=\"line-height:1.1; text-align:left; margin-top:1px; margin-bottom:11px\">Les tableaux suivants pr\u00e9sentent l'analyse de liquidit\u00e9 des instruments financiers d\u00e9riv\u00e9s utilis\u00e9s pour couvrir les risques de change (note\u00a039) sur la base de flux de tr\u00e9sorerie non actualis\u00e9s\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Valeur comptable<br/>au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2024</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">&gt; 5 ans</div></td></tr><tr><td class=\"d3f6f88\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">R\u00e9alisation brute</div></td><td class=\"d87df58\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">\u00a0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\">Contrats \u00e0 terme</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">16,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\">0,0</div></td></tr><tr><td class=\"d64c9d5\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Sorties de tr\u00e9sorerie</div></td><td class=\"d88a2bb\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">432,2</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">425,4</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">6,8</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d228d46\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"b391df\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013415,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u2013409,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">\u20136,6</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d2a304e\"><div class=\"defaultParagraph_1 TBodytotalText_1\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d3395bb\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,6</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">16,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,4</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\">0,0</div></td></tr><tr><td class=\"d68c288\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"d58fab0\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"line-height:14px; overflow:hidden; text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Valeur comptable</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Flux de tr\u00e9sorerie au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&lt; 1 an</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">1 \u2013 5 ans</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\" style=\"line-height:14px; overflow:hidden\">&gt; 5 ans</div></td></tr><tr><td class=\"a50a87\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">R\u00e9alisation brute</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodysubtotalText_1\" style=\"line-height:14px; overflow:hidden\">Contrats \u00e0 terme</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodysubtotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6ffd4a\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Sorties de tr\u00e9sorerie</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">124,1</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"d5586f0\"><div class=\"defaultParagraph_1 TBodynormalText_1\" style=\"line-height:14px; overflow:hidden\">Entr\u00e9es de tr\u00e9sorerie</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u2013123,4</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\" style=\"line-height:14px; overflow:hidden\">\u00a0</div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodytotalText_1\" style=\"line-height:14px; overflow:hidden\">Instruments financiers d\u00e9riv\u00e9s</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,7</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 TBodytotalNumber_1\" style=\"line-height:14px; overflow:hidden\">0,0</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 StandardohneAbstand_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 Standard\">Le Groupe ma\u00eetrise le risque de liquidit\u00e9 en maintenant des lignes de cr\u00e9dit et des facilit\u00e9s suppl\u00e9mentaires aupr\u00e8s des banques, en assurant un suivi continu des flux de tr\u00e9sorerie pr\u00e9visionnels et r\u00e9alis\u00e9s, et en g\u00e9rant les profils d\u2019\u00e9ch\u00e9ance des actifs et passifs financiers. Il n\u2019est pas attendu que les sorties de tr\u00e9sorerie surviennent \u00e0 des moments ou pour des montants sensiblement diff\u00e9rents.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">La ligne de cr\u00e9dit fournie par le Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, d'un montant total pouvant atteindre 260</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros \u00e0 taux d'int\u00e9r\u00eat variables, a \u00e9t\u00e9 utilis\u00e9e \u00e0 h</span>auteur de 0,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros au 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d'euros). Par ailleurs, \u00e0 la date de cl\u00f4ture, le Groupe disposait de lignes de cr\u00e9dit bilat\u00e9rales \u00e0 court terme suppl\u00e9mentaires accord\u00e9es par des banques, \u00e0 taux d\u2019int\u00e9r\u00eat variable et r\u00e9vocables \u00e0 tout moment, pour un montant avoisinant 129<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (<span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0: 111</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros). Comme l\u2019ann\u00e9e pr\u00e9c\u00e9dente, ces lignes n\u2019\u00e9taient pas utilis\u00e9es de mani\u00e8re significative.</span></div><div class=\"defaultParagraph_1 Standard\">Les fonds en liquidit\u00e9s pr\u00e9sents localement dans certains pays (par exemple, la Chine et l\u2019Inde) ne sont disponibles pour le Groupe que pour des transactions transfrontali\u00e8res soumises \u00e0 des contr\u00f4les des changes. Pour les restrictions concernant les fonds d\u00e9tenus par les entit\u00e9s russes du Groupe, veuillez consulter la note\u00a04.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfLiquidityRiskExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-127": {
   "value": "<span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>44. </sub></span><div class=\"list-paragraph-container_1\"><sub>Paiements fond\u00e9s sur des actions</sub></div></div><div class=\"defaultParagraph_1 Standard\">Le Groupe Sartorius Stedim Biotech participe \u00e0 un programme d'int\u00e9ressement \u00e0 long terme (\u00ab Long-Term Incentive programme \u2013 LTI \u00bb) introduit au cours de l'exercice 2022 par le Groupe Sartorius\u00a0AG. Le programme LTI constitue une composante de r\u00e9mun\u00e9ration \u00e0 long terme destin\u00e9e \u00e0 certains salari\u00e9s occupant des postes de direction au sein du Groupe. Au d\u00e9but de chaque ann\u00e9e civile, chaque participant se voit attribuer des actions pr\u00e9f\u00e9rentielles virtuelles de Sartorius\u00a0AG, lesquelles donnent lieu \u00e0 un paiement en num\u00e9raire apr\u00e8s une p\u00e9riode de quatre ans. En cons\u00e9quence, les paiements relatifs aux tranches d\u2019actions virtuelles attribu\u00e9es en 2022, 2023, 2024 et 2025 sont pr\u00e9vus respectivement au cours des premiers trimestres de 2026, 2027, 2028 et 2029. Le nombre d'actions virtuelles varie en fonction des performances r\u00e9alis\u00e9es sur les quatre ann\u00e9es pr\u00e9c\u00e9dant la p\u00e9riode de versement. Des objectifs sont d\u00e9finis selon trois axes pond\u00e9r\u00e9s de mani\u00e8re \u00e9gale\u00a0: la croissance organique du chiffre d\u2019affaires, la marge EBITDA courant et la ma\u00eetrise des \u00e9missions de CO<sub>2</sub>. L'\u00e9valuation des obligations de paiement fond\u00e9 sur des actions repose sur la performance r\u00e9alis\u00e9e \u00e0 ce jour, sur les hypoth\u00e8ses de performance future au cours des ann\u00e9es restantes et ce jusqu\u2019\u00e0 la date du paiement, ainsi que sur le cours actuel de l'action de Sartorius\u00a0AG. En <span class=\"hyperlink-no-style_1\"></span>2025, les charges du personnel li\u00e9 au programme LTI, y compris les effets de l'\u00e9valuation \u00e0 la juste valeur s'\u00e9levaient \u00e0 0,5<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d'euros (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,0<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d\u2019euros). La juste valeur de l'obligation s\u2019\u00e9levant \u00e0 0,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million\u00a0d'euros \u00e0 la date de cl\u00f4ture du 31 d\u00e9cembre <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>2024\u00a0: 0,2<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d'euros), est renseign\u00e9e au poste de \u00ab\u00a0Autres provisions non courantes\u00a0\u00bb (note\u00a025).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-128": {
   "value": "<div class=\"defaultParagraph_1 berschrift1\"><sup>4.8 Autres informations</sup></div><div class=\"defaultParagraph_1 Standard\" style=\"margin-bottom:13px\">Les \u00e9tats financiers consolid\u00e9s ont \u00e9t\u00e9 arr\u00eat\u00e9s selon le principe de la continuit\u00e9 d\u2019exploitation.</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGoingConcernExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-129": {
   "value": "<div class=\"defaultParagraph_1 berschrift2\"><sub>Faits marquants apr\u00e8s la date de cl\u00f4ture</sub></div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Aucun \u00e9v\u00e9nement significatif n\u2019est survenu apr\u00e8s la date de cl\u00f4ture.</span></div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-130": {
   "value": "<div class=\"defaultParagraph_1 berschrift2\"><sub>Effectifs</sub></div><div class=\"defaultParagraph_1 Standard\" style=\"margin-bottom:13px\">L\u2019effectif moyen employ\u00e9 durant l\u2019exercice s\u2019\u00e9l\u00e8ve \u00e0 <span class=\"hyperlink-no-style_1\"></span>10\u00a0098 personnes en <span class=\"hyperlink-no-style_1\"></span>2025 (<span class=\"hyperlink-no-style_1\"></span>10\u00a0215 personnes en <span class=\"hyperlink-no-style_1\"></span>2024).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-131": {
   "value": "<div class=\"defaultParagraph_1 berschrift3-Nummeriert\" style=\"text-indent:0; display:flex; margin-left:0px\"><span class=\"numbering-7-level-0-customTab-19\" dir=\"ltr\"><sub>45. </sub></span><div class=\"list-paragraph-container_1\"><sub>Parties li\u00e9es</sub></div></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>Descriptif g\u00e9n\u00e9ral</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'actionnaire majoritaire de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. est </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, qui d\u00e9tient une participation majoritaire dans la soci\u00e9t\u00e9 \u00e0 hauteur de 71,5</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">% du capital et \u00e0 environ 83</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">% des droits de vote. Le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> est organis\u00e9 en deux divisions\u00a0: la division \u00ab\u00a0Bioprocess Solutions\u00a0\u00bb (principalement g\u00e9r\u00e9e par le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) et la division \u00ab\u00a0Laboratoires, Produits et Services\u00a0\u00bb (principalement g\u00e9r\u00e9e par les autres soci\u00e9t\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\">). Du fait de cette structure, il d\u00e9tient deux filiales dans la plupart des pays o\u00f9 le Groupe est pr\u00e9sent et que ces derni\u00e8res partagent les locaux, le personnel et d'autres ressources. Par ailleurs, les soci\u00e9t\u00e9s du Groupe allemand assurent diverses fonctions centrales et fournissent, en cons\u00e9quence, des services aux entit\u00e9s \u00e0 travers le monde. La soci\u00e9t\u00e9 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Corporate Administration GmbH, filiale \u00e0 100</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">% de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG, regroupe diverses fonctions exclusivement d\u00e9di\u00e9es aux enjeux du Groupe, telles que des services financiers, de ressources humaines, de technologie de l\u2019information, de relations investisseurs, de marketing et juridique. Ces prestations sont factur\u00e9es au sein du Groupe et aussi, dans une large mesure, \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">. Les m\u00e9thodes et principes de d\u00e9termination des refacturations entre les entit\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> et les autres entit\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG sont demeur\u00e9s inchang\u00e9s depuis le 31 d\u00e9cembre 2024.</span></div><div class=\"defaultParagraph_1 Standard\">Les structures d\u00e9crites conduisent \u00e0 diverses relations et transactions avec les parties li\u00e9es. Les transactions entre Sartorius Stedim Biotech\u00a0S.A. et ses filiales (note\u00a07) ont \u00e9t\u00e9 \u00e9limin\u00e9es lors de la consolidation et ne sont pas mentionn\u00e9es dans la pr\u00e9sente note. Des d\u00e9tails sur les transactions entre le Groupe Sartorius Stedim Biotech et les autres parties li\u00e9es, appartenant au Groupe Sartorius, sont mentionn\u00e9s ci-apr\u00e8s<span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div><div class=\"defaultParagraph_1 Standard\">Un contrat de service \u00e0 long terme existe avec une coentreprise (\u00ab joint venture \u00bb) pour lequel des d\u00e9penses de 11,8<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros ont \u00e9t\u00e9 engag\u00e9es dans les \u00e9tats financiers consolid\u00e9s au cours de l\u2019exercice (contre 10,9<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent). Les dettes commerciales associ\u00e9es s\u2019\u00e9levaient \u00e0 2,6<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros au 31 d\u00e9cembre 2025 (contre 1,4<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>million d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent). Sur la base des d\u00e9penses de l\u2019exercice, les engagements estim\u00e9s sur la dur\u00e9e du contrat, jusqu\u2019\u00e0 fin 2033, s\u2019\u00e9l\u00e8vent \u00e0 environ 94<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros (contre 98<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span>millions d\u2019euros l\u2019exercice pr\u00e9c\u00e9dent).</div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Ventes, achats et commissions</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Dans certains domaines d\u2019activit\u00e9, des soci\u00e9t\u00e9s du Groupe </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">agissent en tant que sous-traitants pour le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> et vice versa. Les transactions correspondantes sont d\u00e9taill\u00e9es dans le tableau ci-dessous comme \u00ab\u00a0chiffre d\u2019affaires\u00a0\u00bb et \u00ab\u00a0achats\u00a0\u00bb. Par ailleurs, certains groupes de produits du portefeuille </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> sont commercialis\u00e9s par d\u2019autres entit\u00e9s </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\">. En contrepartie de l\u2019organisation de ces ventes, le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> verse des commissions, g\u00e9n\u00e9ralement calcul\u00e9es en pourcentage du chiffre d\u2019affaires g\u00e9n\u00e9r\u00e9.</span></div><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Chiffre d'affaires</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Achats</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Commissions</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Cr\u00e9ances clients</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Dettes fournisseurs</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2025</span></div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Parties li\u00e9es du Groupe Sartorius</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">100,6  </div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,3  </div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,4  </div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">30,1  </div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0426,3  </div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 THeadsingleText_1\">en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Chiffre d'affaires</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2024</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Achats</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2024</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Commissions</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2024</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Cr\u00e9ances clients</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2024</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">Dettes fournisseurs</span><br/><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">au 31 d\u00e9c. 2024</span></div></td></tr><tr><td class=\"f39b54\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Parties li\u00e9es du Groupe Sartorius</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">97,0</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">23,7</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,1</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">25,8</div></td><td class=\"d5a0e85\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2\u00a0753,3</div></td></tr><tr><td class=\"d6a504\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 berschrift4\" style=\"font-size:16px; font-weight:normal; color:#000000; min-height:16px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">Frais de gestion et autres frais li\u00e9s aux actionnaires</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le conseil d\u2019administration de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG (soci\u00e9t\u00e9 m\u00e8re allemande de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) assure \u00e9galement dans une large mesure la direction du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">. Des \u00ab\u00a0frais de gestion\u00a0\u00bb sont factur\u00e9s \u00e0 ce titre \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">GmbH. En outre, deux des membres du conseil d'administration de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. sont \u00e9galement membres du conseil d'administration de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Conform\u00e9ment \u00e0 la politique de r\u00e9mun\u00e9ration introduite en 2022 (voir le rapport de gouvernance sur les r\u00e9mun\u00e9rations pour plus de d\u00e9tails), les membres du conseil d'administration concern\u00e9s re\u00e7oivent d\u00e9sormais une r\u00e9mun\u00e9ration distincte de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. Celle-ci est initialement vers\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG puis rembours\u00e9e par </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'utilisation du nom de marque </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> par les entit\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> donne lieu \u00e0 une redevance de marque. Les autres fonctions relatives aux actionnaires telles que la consolidation comptable, la mise en conformit\u00e9 (compliance) et la relation investisseur du Groupe sont assur\u00e9es par la soci\u00e9t\u00e9 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Corporate Administration GmbH, en Allemagne. Ces services sont factur\u00e9s \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le tableau ci-dessous r\u00e9capitule les frais d\u00e9crits\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de gestion factur\u00e9s \u00e0 Sartorius Stedim Biotech\u00a0GmbH</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Remboursement de la r\u00e9mun\u00e9ration des membres du conseil d'administration</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Redevances et frais de licence de marque</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres fonctions li\u00e9es aux actionnaires</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 berschrift4\">Emprunts</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Les emprunts contract\u00e9s par le Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> aupr\u00e8s de sa soci\u00e9t\u00e9 m\u00e8re </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG et de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Finance B.V. sont d\u00e9taill\u00e9s \u00e0 la note </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">32</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">. Les conditions associ\u00e9es, telles que les taux d'int\u00e9r\u00eat et les frais de tr\u00e9sorerie, y sont \u00e9galement pr\u00e9cis\u00e9es. Les charges d\u2019int\u00e9r\u00eats aff\u00e9rentes sont pr\u00e9sent\u00e9es \u00e0 la note</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">12</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">.</span></div><div class=\"defaultParagraph_1 berschrift4\"><span class=\"hyperlink-no-style_1\"></span>Frais administratifs et co\u00fbts partag\u00e9s</div><div class=\"defaultParagraph_1 Standard\">Comme d\u00e9crit ci-dessus, les soci\u00e9t\u00e9s du groupe partagent, dans la plupart des pays, certaines fonctions et certains co\u00fbts. Les contrats sous-jacents comprennent principalement des accords de partage de locaux et de fonctions administratives centrales, tels que la comptabilit\u00e9 et le contr\u00f4le de gestion, la gestion des ressources humaines et les services informatiques. \u00c0 ce titre, les soci\u00e9t\u00e9s concern\u00e9es facturent les loyers, salaires, charges sociales et autres d\u00e9penses de fonctionnement, ainsi qu'une marge b\u00e9n\u00e9ficiaire au prorata des services qu'elles fournissent.</div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le contrat le plus important dans ce contexte est celui conclu entre </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">GmbH (Allemagne) et </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Corporate Administration GmbH. Cette derni\u00e8re fournit toutes les fonctions administratives et de service centrales \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">GmbH et \u00e0 d\u2019autres soci\u00e9t\u00e9s du Groupe. Le calcul des frais de service inclut g\u00e9n\u00e9ralement une majoration bas\u00e9e sur les principes de pleine concurrence pour les t\u00e2ches routini\u00e8res, conform\u00e9ment aux directives de l\u2019OCDE et de l\u2019UE (par exemple, co\u00fbt major\u00e9 de 3</span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\">\u00a0</span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">%). </span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">En </span><span class=\"hyperlink-no-style_1\"></span>2025<span dir=\"ltr\" style=\"background-color:#FFFFFF\">, des services d\u2019un montant d\u2019environ </span><span class=\"hyperlink-no-style_1\"></span>103,7<span dir=\"ltr\" style=\"font-size:7px; min-height:7px\"> </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d\u2019euros ont \u00e9t\u00e9 fournis \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">GmbH (100,4 </span><span dir=\"ltr\" style=\"font-size:7px; min-height:7px\"> </span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">millions d'euros en </span><span class=\"hyperlink-no-style_1\"></span>2024<span dir=\"ltr\" style=\"background-color:#FFFFFF\">). </span>Ce montant couvre les fonctions suivantes\u00a0:</div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Technologies de l\u2019information, strat\u00e9gie et gestion des donn\u00e9es\u00a0;</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Ressources humaines, finances, communication d\u2019entreprise\u00a0;</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Environnement, sant\u00e9 et s\u00e9curit\u00e9 (EHS), entretien des b\u00e2timents\u00a0; et</div></div><div class=\"defaultParagraph_1 Aufzhlung_1\" style=\"text-indent:0; display:flex; margin-left:0px; margin-right:57px\"><span class=\"numbering-5-level-0-customTab-2\" dir=\"ltr\" style=\"font-family:'Wingdings'; min-height:0\">\u25fe  </span><div class=\"list-paragraph-container_1\">Services centraux (par exemple, gestion de la flotte et des assurances) et organisation g\u00e9n\u00e9rale.</div></div><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">R\u00e9mun\u00e9ration des dirigeants</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">En <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025, les membres de la direction ont per\u00e7u les r\u00e9mun\u00e9rations suivantes conform\u00e9ment aux IFRS\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d64cfdb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages \u00e0 court terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages post\u00e9rieurs \u00e0 l'emploi</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres avantages \u00e0 long terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Indemnit\u00e9s de fin de contrat de travail</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Paiements en actions</div></td></tr><tr><td class=\"d010516\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2025<sup>1</sup></div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"fdb5fc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2024<sup>1</sup></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d7dddd1\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1 Pour de plus amples informations, veuillez consulter le chapitre \u00ab Gouvernance d\u2019entreprise \u00bb (pages 215 \u00e0 253).</div><div class=\"defaultParagraph_1 TNote_NoBottomMargin_1\" style=\"min-height:15px\"></div><div class=\"defaultParagraph_1 TNote_1\" style=\"min-height:15px\"></div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  },
  "fact-132": {
   "value": "<div class=\"defaultParagraph_1 berschrift4\">Frais de gestion et autres frais li\u00e9s aux actionnaires</div><div class=\"defaultParagraph_1 Standard\"><span class=\"hyperlink-no-style_1\"></span><span class=\"hyperlink-no-style_1\"></span><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le conseil d\u2019administration de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG (soci\u00e9t\u00e9 m\u00e8re allemande de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">) assure \u00e9galement dans une large mesure la direction du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\">. Des \u00ab\u00a0frais de gestion\u00a0\u00bb sont factur\u00e9s \u00e0 ce titre \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">GmbH. En outre, deux des membres du conseil d'administration de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. sont \u00e9galement membres du conseil d'administration de </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG. Conform\u00e9ment \u00e0 la politique de r\u00e9mun\u00e9ration introduite en 2022 (voir le rapport de gouvernance sur les r\u00e9mun\u00e9rations pour plus de d\u00e9tails), les membres du conseil d'administration concern\u00e9s re\u00e7oivent d\u00e9sormais une r\u00e9mun\u00e9ration distincte de </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A. Celle-ci est initialement vers\u00e9e par </span>Sartorius\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">AG puis rembours\u00e9e par </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">L'utilisation du nom de marque </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> par les entit\u00e9s du Groupe </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> donne lieu \u00e0 une redevance de marque. Les autres fonctions relatives aux actionnaires telles que la consolidation comptable, la mise en conformit\u00e9 (compliance) et la relation investisseur du Groupe sont assur\u00e9es par la soci\u00e9t\u00e9 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> Corporate Administration GmbH, en Allemagne. Ces services sont factur\u00e9s \u00e0 </span>Sartorius<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Stedim<span dir=\"ltr\" style=\"background-color:#FFFFFF\"> </span>Biotech\u00a0<span dir=\"ltr\" style=\"background-color:#FFFFFF\">S.A.</span></div><div class=\"defaultParagraph_1 Standard\"><span dir=\"ltr\" style=\"background-color:#FFFFFF\">Le tableau ci-dessous r\u00e9capitule les frais d\u00e9crits\u00a0:</span></div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d4876a5\"><div class=\"defaultParagraph_1 THeadsingleText_1\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\"><span dir=\"ltr\" style=\"font-weight:bold; font-family:'TT Norms Pro Light'\">2025</span></div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">2024</div></td></tr><tr><td class=\"dde3ba\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Frais de gestion factur\u00e9s \u00e0 Sartorius Stedim Biotech\u00a0GmbH</div></td><td class=\"acbaf5\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">3,8</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,5</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Remboursement de la r\u00e9mun\u00e9ration des membres du conseil d'administration</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,7</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,3</div></td></tr><tr><td class=\"d4d563d\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Redevances et frais de licence de marque</div></td><td class=\"c25c5b\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">19,6</div></td><td class=\"d3cd6cd\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">12,0</div></td></tr><tr><td class=\"d636739\"><div class=\"defaultParagraph_1 TBodynormalText_1\">Autres fonctions li\u00e9es aux actionnaires</div></td><td class=\"e68d99\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,8</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">2,2</div></td></tr><tr><td class=\"d262685\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 Standard\" style=\"min-height:15px\"></div><span class=\"hyperlink-no-style_1\"></span><div class=\"defaultParagraph_1 berschrift4\">R\u00e9mun\u00e9ration des dirigeants</div><div class=\"defaultParagraph_1 Standard\" style=\"page-break-after:avoid\">En <span class=\"hyperlink-no-style_1\"></span>2024 et <span class=\"hyperlink-no-style_1\"></span>2025, les membres de la direction ont per\u00e7u les r\u00e9mun\u00e9rations suivantes conform\u00e9ment aux IFRS\u00a0:</div><table class=\"NormaleTabelle\" dir=\"ltr\" style=\"width:631px; border-collapse:collapse; margin:0px auto 0px 0px; border-style:none\"><tr><td class=\"d64cfdb\"><div class=\"defaultParagraph_1 THeadsingleText_1\" style=\"text-align:left\"><span class=\"hyperlink-no-style_1\"></span>en millions \u20ac</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Total</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages \u00e0 court terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Avantages post\u00e9rieurs \u00e0 l'emploi</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Autres avantages \u00e0 long terme</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Indemnit\u00e9s de fin de contrat de travail</div></td><td class=\"b16e1e\"><div class=\"defaultParagraph_1 THeadsingleNumber_1\">Paiements en actions</div></td></tr><tr><td class=\"d010516\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2025<sup>1</sup></div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,7</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,5</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,3</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"cdd134\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"fdb5fc\"><div class=\"defaultParagraph_1 TBodynormalText_1\">2024<sup>1</sup></div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">1,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,2</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td><td class=\"d386fe9\"><div class=\"defaultParagraph_1 TBodynormalNumber_1\">0,0</div></td></tr><tr><td class=\"d7dddd1\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td><td class=\"b83891\"><div class=\"defaultParagraph_1 TDummyRow_1\" style=\"text-align:left; margin:0px\"></div></td></tr></table><div class=\"defaultParagraph_1 TNote_1\">1 Pour de plus amples informations, veuillez consulter le chapitre \u00ab Gouvernance d\u2019entreprise \u00bb (pages 215 \u00e0 253).</div>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
    "language": "fr",
    "entity": "scheme:52990006IVXY7GCSSR39",
    "period": "2025-01-01T00:00:00/2026-01-01T00:00:00"
   }
  }
 }
}